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Abstract
The pituitary glycoproteins LH and FSH are secreted from gonadotrophs
via regulated and constitutive pathways under control of GnRH. Several
distinct types of secretory vesicles (granules) have been previously
reported to contain gonadotrophins colocalised with Ca+ + -binding
aggregative granin proteins. The putative role of granins in
gonadotrophin granulogenesis was investigated in this thesis using
recombinant DNA technology. Mammalian expression constructs were
transfected into cell lines permitting comparative expression levels for
each of the proteins under investigation.
Expression of LH and FSH in transiently transfected JEG3 (human
choriocarcinoma) and CHO cells was demonstrated by RT-PCR and confocal
microscopy. Although granin expression did not affect the degree of hCG
storage in JEG3 cells, chromogranin A (CgA) and secretogranin II (Sgll)
did exert an enhancement of hCG expression. oLH expression in CHO cells
also appeared to be enhanced by CgA. In addition Sgll appeared to reduce
storage of oLH in cotransfected CHO cells. Like hCG, LH and FSH exhibited
dispersed distribution within the cytosol suggesting constitutive secretion.
CgA and chromogranin B (CgB) displayed punctate expression within
transfected CHO cells. Coexpression of CgB and oLH in CHO cells
demonstrated their colocalisation in the ER and TGN but not within CgB-
only secretory vesicles. In contrast CgA expression appeared to induce
formation of CgA and LH-containing secretory vesicles (310-640nm
diameter). Their apparent divergence into oLH- and CgA-only vesicles
towards the periphery of the cell suggests that this granin does not have a
role in LH exocytosis correlating with in vivo data. The suggested role of
CgA in pre-exocytotic sorting and retention of LH is strengthened by the
observation of reduced LH storage in high passage LPT2 cells (mouse
gonadotrophs with regulated LH secretion) with undetectable levels of
intracellular CgA.
Fusions of oLH and oFSH P-subunits with enhanced green fluorescent
protein (EGFP) exhibited granin-independent aggregation in CHO and LPT2
cells cotransfected with the gonadotrophin a-subunit. Observation of live
CHO cells expressing the a-subunit and an EGFPC-oFSHp fusion protein
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revealed that these aggregates exhibited vesicle-like movement within the
cytoplasm and subplasmalemmal areas culminating in exocytosis.
Analysis of whole mouse pituitaries using confocal microscopy
demonstrated the prevalence of bihormonal gonadotrophs and their close
relationship with capillaries. Gonadotrophs exhibited differential
localisation of LH and FSH. Colocalised LH and CgA occurred towards the
periphery of the cell whereas FSH remained in more central areas of the
cytosol. CgA was absent from areas juxtaposed to capillaries whereas LH
immunoreactivity remained. This is in accordance with previously
reported data and in vitro observations. Pituitaries from transgenic mice
expressing stabilised oFSH(3 mRNA under control of the LH promoter
exhibited an approximate 4-fold increase in FSH expression. Comparison
with non-transgenics by confocal microscopy suggests that
overexpression of FSH leads to increased colocalisation with LH in the
regulated secretory pathway. Unexpectedly a 2-fold increase in Sgll
expression was also observed in this transgenic model and may represent
adaptation of the gonadotroph to increased regulated secretion.




AcCoA acetyl coenzyme A
ACTH adrenocorticotrophin
aGSU alpha gonadotrophin subunit
AMV avian myeloblastosis virus
ANOVA analysis of variance
AP-1 activator protein 1 (c-fos & c-jun)
AP-2 activator protein 2
AS antisense




[Ca++]j intracellular calcium concentration
[Ca++]ex extracellular calcium concentration
cAMP cyclic 3',5' adenosine monophosphate
CAT chloramphenicol acetyl transferase





CHO Chinese hamster ovary
Ci Curie
ACm change in membrane capacitance
CMV cytomegalovirus
CPE carboxypeptidase E
c p m counts per minute
CRE cAMP-response element
CREB CRE binding protein
CREM CRE modulating protein
CSP cysteine string protein
CTP carboxy-terminal peptide
DAG di acylglycerol
DARS donkey anti-rabbit serum
DFX dexamethasone
DOPE L-dioleoyl phosphatidylethanolamine
DOTAP N-[ 1 -(2,3-Dioleoyloxy)propyl]-N,N,N-trimethyl-
ammonium salts
DMEM Dulbecco's modification of Eagle's medium
DNA deoxyribonucleic acid
DPBS Dulbecco's phosphate buffered saline
e2 oestradiol
EDTA ethylene diaminetetra-acetic acid
efDMEM oestrogen-free cDMEM
EGFP enhanced green fluorescent protein





FACS fluorescence-activated cell sorting
FCS fetal calf serum




GAPDH glyceraldehyde 3-phosphate dehydrogenase
GH growth hormone





HEPES A-[2-hydroxyethyl] piperazine-A'-[2-ethane sulfonic acid]
HPD hypothalamically disconnected
HSV-IE Herpes simplex virus immediate early region











oLH(3/oFSH(3 stabilised oFSH(3 gene under control of the oLHp promoter
mA milli-amperes
MAPK mitogen-activated protein kinase
MAPKK MAPK kinase
mRNA messenger ribonucleic acid
neoR neomycin resistance
NRS normal rabbit serum
NSF /V-ethylmaleimide-sensitive factor
CD optical density
ORF open reading frame
OVX ovariectomized
PAGE polyacrylamide gel electrophoresis
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PCR polymerase chain reaction
PIP2 phosphatidylinositol 4,5-bisphosphate
PKA cAMP-dependent protein kinase







RPA RNase protection assay
r p m revolutions per minute
RT-PCR reverse transcriptase polymerase chain reaction
SDS sodium dodecyl sulphate
SEM standard error of the mean
SgH secretogranin II
SNAP-25 synaptosome-associated protein of 25 kDa
aSNAP soluble NSF attachment protein a
SNARE SNAP receptor




TEC thin layer chromatography
TPA 1 2-0 -tetradecanoylphorbol -13-acetate





VAMP vesicle-associated membrane protein
X-gal 5-bromo-4-chloro-3-indolyl-(I-D-galactopy ranosii
All DNA sequences are shown in the 5'->3' orientation unless stated.
All protein sequences are shown in the amino-terminal -> carboxy-
terminal orientation unless stated.
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The studies described in this thesis relate to investigations aimed at
improving the understanding of posttranslational processes during the
differential secretion of the pituitary gonadotrophins luteinising
hormone (LH) and follicle-stimulating hormone (FSH). Although this
research represents basic science, it will be made clear during the
following literature review that LH and FSH are crucial to normal
reproductive physiology. Furthermore in vivo studies carried out during
the past 30 years have revealed significant detail regarding the
physiological functions of LH and FSH and their interactions with target
organs. More recently the advent of recombinant DNA technology has led
to detailed knowledge regarding genetic regulation of the gonadotrophin
genes. Although considerable work has been undertaken regarding these
areas, a relatively small proportion has focused on the intracellular
aspects relating to the most fundamental question of LH and FSH secretion;
how are they differentially secreted? The main aim of this thesis is to
answer this question.
The remainder of this chapter will review the findings of several key
papers related to gonadotrophin secretion, the factors controlling it and
the molecular mechanisms by which it occurs. A brief overview of the
reproductive physiology of the oestrous cycle in the mouse and the ewe
will be followed by more detailed discussion of the molecules involved and
their interaction. The cellular organisation of the anterior pituitary and
detailed discussion of the genetic organisation and protein structure of
key molecules will be covered. A summary of the evidence derived from
analyses of secretion in neuroendocrine tissues in vivo will be given.
Granins, implicated in this section will then be discussed in detail with
regard to regulation of expression, protein structure and possible
intracellular roles. Evidence gained from patch-clamp and other in vitro
studies of neuroendocrine secretion will be discussed with regard to
protein sorting, granulogenesis and exocytosis. Particular attention will
be given to the specific molecules implicated in these processes.
1
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1.2.1 The Oestrous Cycle
The oestrous cycle describes the rhythmic appearance of sexual
receptivity known as oestrous. The biological significance of this cycle is
that it allows control over the time at which parturition will occur. This is
important as it may increase the chance of offspring survival if timed to
coincide with favourable environmental conditions. Much of the
understanding of the oestrus cycle has been obtained from work carried
out on the ewe. Data from ovine models will be related to the more limited
findings obtained from work with rodents as the final experimental
chapter within this thesis regards studies on murine gonadotrophs.
The oestrous cycle of the ewe lasts for 17 days throughout the breeding
season of October to March (Goodman & Karsch, 1980). In the ewe this
cycle can be divided into two parts, the luteal phase (day 2 to day 13) and
the periovulatory phase (day 14 to day 1) where day 0 of the cycle is the
time of ovulation (oestrus) (Baird & McNeilly, 1981). Rodent oestrus cycles
are shorter than those of sheep lasting approximately 4 to 5 days
(Greenwald & Roy, 1994). A brief description of the main differences
between ovine and rodent oestrus cycles will be given after more detailed
coverage of the abundant data regarding the ovine oestrus cycle.
1.2.2 The Luteal Phase
Luteolysis, occurring around day 14 in the ewe, is triggered by the
luteolysin prostaglandin F2a (PGF2a) which is secreted by the
endometrium (Baird & McNeilly, 1981). Positive control of PGF2a has been
shown by oestradiol administration which triggers release of PGF2a .
Conversely, a prolonged luteal phase occurs after irradiation-induced
ablation of oestrogenic follicles (Hixon et al., 1983; Karsch et al., 1970).
The functional corpus luteum which is formed in the ovary produces
serum concentrations of progesterone up to 4ng/ml; these characterise
the ovine luteal phase. Specifically secretion of progesterone occurs from
the luteinized granulosa and theca cells of the recently ruptured follicle
(Hauger et al., 1977). Throughout the luteal phase this progesterone,
together with oestradiol from the developing waves of follicles, prevents
the occurrence of the LH surge. Immunisation against progesterone leads
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to ovulation approximately 96 hours later in the ewe (Thomas et al., 1987).
Exogenous progesterone given during the follicular phase also prevents
the high levels of oestradiol present at the end of the luteal phase from
triggering the LH surge and arrests follicle maturation (Baird & McNeilly,
1981).
1.2.3 The Follicular Phase
Following luteolysis, progesterone serum levels fall rapidly resulting in a
wave of follicle growth (Smeaton & Robertson, 1971). The growing follicles
produce increased serum concentrations of oestradiol which in turn affect
pituitary gonadotrophin secretion. LH responds to oestradiol positively
(Webb & England, 1982; Karsch et al., 1983) whereas FSH synthesis is
negatively regulated (Baird & McNeilly, 1981; Campbell et al., 1990).
Inhibin secretion from developing follicles also regulates follicle-
stimulating hormone (FSH) expression negatively (Baird et al., 1991). This
is particularly important in human reproduction where FSH levels are
more tightly controlled. Declining FSH concentrations lead to selection of a
dominant follicle which is able to proceed to ovulation (Scaramuzzi et al.,
1993). In rodents a secondary rise in FSH serum levels may recruit greater
numbers of larger follicles for subsequent ovulation
Mutual positive feedback between LH and oestradiol leads to ever rising
serum levels of LH (Currie & McNeilly, 1995). LH released in a pulsatile
fashion culminates in the LH surge near the end of the follicular phase
(Hauger et al., 1977; Pant et al., 1977) with ovulation occurring
approximately 24 hours later (Cumming et al., 1971).
1.2.4 The Periovulatory Period
Behavioural oestrus coincides with a surge-type release of LH and FSH
(Baird & McNeilly, 1981). The preovulatory LH surge is mediated by high
concentrations of oestradiol which promote increased GnRH pulse
frequency (Clarke et al., 1987; Moenter et al, 1991) sensitising the
gonadotrophs to GnRH (Clarke et al., 1984) and leading in turn to a
synchronistic release of massive amounts of LH; a surge.
Serum concentrations of LH greater than 5ng/ml which occur during the
surge inhibit follicular aromatase (Moore, 1974; Baird & McNeilly, 1981)
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resulting in reduced oestradiol production. The destructive effect of high
LH concentrations leads to cessation of the mutual positive feedback loop
and a concomitant decrease in LH secretion.
A second period of elevated serum concentrations of FSH occurs 20-30
hours after the LH surge; this is known as the FSH rebound (Baird &
McNeilly, 1981; Salmonsen et al, 1985). The function of this secondary
surge may be to recruit primordial follicles into the next developing wave
(Smeaton & Robertson, 1971; Pant et al., 1977; McNatty et al., 1981; Lahlou-
Kassi et al., 1984).
1.2.5 The Rodent Oestrus Cycle
Terminology regarding the temporal assembly of the rodent oestrus cycle
differs from that of the ovine oestrus cycle and is broken up into oestrus,
metestrus, diestrus and proestrus. Essentially the oestrus cycle of rodents is
similar to that of sheep except that the luteal phase (diestrus) is much
shorter. The relatively large size of follicles in rodents is caused by higher
levels of FSH due to reduced circulating inhibin. These larger follicles do
not require a prolonged period of growth therefore the luteal phase is
much shorter at only 1-2 days (Greenwald & Roy, 1994). The biological
significance of this difference is that rodents are capable of producing
multiple ova (approximately 10 per rat) in a relatively short time. This
strategy of reproduction is in contrast to that of sheep which produce 1-2
offspring per year and reflects the 'boom or bust' approach to colonisation
favoured by rodents (Short, 1985).
1.3.1 The Hypothalamo-Pituitary-Gonadal Axis
Development and maintenance of mammalian reproductive function is
regulated by the hypothalamus, the pituitary gland and the gonads. Co¬
ordinated positive and negative feedback between these glands is crucial
for reproductive fitness and is carried out by systemic transmission of
glycoproteins, peptides and steroids. A simplified schematic representation
of the hypothalamo-pituitary-gonadal axis is contained in figure 1.3.1a.
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Figure 1.3.1a: Schematic representation of the hypothalamo-
pituitary-gonadal axis in the non-primate female.
Hypothalamic stimulation of the pituitary gonadotrophs by GnRH is
modulated by the positive oestrogen feedback from the developing
wave of follicles. Recently oestradiol has been demonstrated to act
on the GnRH neurons via noradrenergic neurons in the caudate
region of the brain. Oestradiol also acts directly on the gonadotroph
during positive and negative feedback. Progesterone from the
corpus luteum negatively regulates GnRH release via stimulation of
P-endorphin secretion. Gonadotrophs secrete FSH and LH
differentially acting positively on gonadal development and
function respectively. Inhibin secreted by the follicles negatively
regulates FSH|3 expression. Activin is secreted by the pituitary gland
increasing FSHfi expression. Follistatin binds and inhibits the
positive regulation of FSH expression by activin.
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1.3.2 Secretion of Gonadotrophin-Releasing Hormone
Gonadotrophin-releasing hormone (GnRH) is a decapeptide derived from
the 56 amino acid (aa) precursor gonadotrophin-releasing hormone-
associated peptide (GAP) (Seeburg & Adelman, 1984). Mammalian species
exhibit complete conservation of the GnRH sequence whereas the amino
acid sequence of GAP is approximately 85% conserved between mouse, rat
and human. GAP stimulates prolactin (PRL) secretion at low
concentrations but inhibits it at higher concentrations (Seeburg et al.,
1987), GAP also stimulates LH secretion although with much lower efficacy
than GnRH (Nickolics et al., 1985).
GnRH is released from a population of neurons whose origins are found in
several areas of the fore brain (Lehman et al, 1986; Sherwood et al, 1976;
Silverman et al, 1987; Witkin et al, 1982). In the ovine there are
approximately 2500 GnRH neurons (Caldani et al, 1988). Anterograde
axonal transport of GnRH terminates at the median eminence where the
decapeptide is stored until required for release. Transport via the
hypophyseal portal blood vessel brings GnRH in contact with the anterior
pituitary gland where it stimulates expression of LHp, FSHp and the a
gonadotropin subunit (aGSU) genes as well as secretion of the mature
hormones (Dierschkle et al., 1970; Schally et al., 1971; Aiyer et al., 1974b;
Lincoln & Fraser, 1979; Fraser & McNeilly, 1982). Immunoneutralisation of
GnRH abolishes LH secretion in the ewe (Clarke et al., 1978; McNeilly,
1984)^ ram (Lincoln & Fraser, 1979), ovariectomized rats (Snabels & Kelch,
1979), castrated male rats (Ellis et al., 1983) and stump-tailed macaques
(Fraser & McNeilly, 1982). Naturally occurring or steroid-induced LH
surges are also inhibited by immunoneutralisation of GnRH in female rats
and sheep and gilts (Fraser & McNeilly, 1982; Fraser & McNeilly, 1983; Koch
et al, 1973; Blake & Kelch, 1981; Esbenshade & Britt, 1985). Pulsatile
administration of GnRH to ovariectomized (OVX) and hypothalamically
disconnected (HPD) rhesus monkeys restored normal gonadotrophin
secretory profiles and menstrual cycles (Knobil et al., 1980).
The 'GnRH pulse generator' located in a region of the arcuate nucleus of
the mediobasal hypothalamus controls release of GnRH from the median
eminence (Goodman & Karsch, 1981; Knobil, 1981). Secretion by the GnRH-
containing GT1 cell line is inhibited by exposure to PRL (Milenkovic et al.,
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1994) and GnRH release in women can be inhibited by administering an
analogue of met-enkephalin (del-Pozo & Martin-Perez, 1985).
Hypothalamic stimulation of GnRH release can be increased by opioid
antagonist administration which results in greater LH pulse frequency
during the luteal phase and greater amplitude during the follicular phase
in the ewe (Brooks et al., 1986). Pulsatility of GnRH release is important for
maintenance of gonadotrophin serum levels as administration of
continuous GnRH to OVX and HPD rhesus monkeys leads to a decline in LH
and FSH serum levels. However, this effect is reversible upon provision of
a pulsatile GnRH regime (Belchetz et al, 1978). Similar studies in ewes
(Clarke et al., 1984) and clinical investigations of GnRH deficiency in
humans have also shown the need for GnRH pulsatility (Santoro et al, 1986;
Leyendecker et al, 1980; Crowley, 1980; Shoemaker et al, 1981),
Continuous sampling to measure the GnRH pulse profiles of a conscious
female sheep using the method of Moenter et al (1991), revealed profile
details while incurring limited tissue damage. During the luteal phase
GnRH pulse frequencies of 0.25±0.05 pulses/hr with a mean amplitude of
3.2+1.0 pg/min were reported, the frequency of these pulses rose to over 1
pulse/hr at early follicular phase (Moenter et al, 1991). During two periods
prior to the GnRH surge (-24 to -28hrs and -8 to -2hrs) pulse amplitude
decreased whereas the frequency continued to rise (Evans et al., 1997).
This GnRH surge, which triggers the LH surge and continues after it,
reaches plasma concentrations of approximately 20pg/ml (Moenter et al,
1991). Although studies have reported a direct correlation between GnRH
and LH pulses (Clarke & Cummins, 1982; Levine et al, 1982; Vugt et al, 1983)
some GnRH pulses during the onset of the GnRH surge did not result in a
release of LH (Moenter et al, 1991). The presence of GnRH in cerebrospinal
fluid has been postulated to be part of an alternative feedback loop.
However, administration of radioactively-labelled GnRH to the third
ventricle of cannulated ewes did not result in elevated radioactivity in
hypophyseal blood samples. A role for GnRH in the CSF has yet to be
determined (Skinner et al., 1998).
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1.3.3 The Anterior Pituitary
The anterior pituitary is derived from Kathke's pouch which is identified
during foetal development as a slight thickening and invagination of the
oral ectoderm. There are five cell types within the anterior pituitary
defined by the types of hormone they produce. Differentiation of anterior
pituitary cell types occurs during foetal development. Corticotrophs
secrete adrenocorticotrophin (ACTH) and are the first cell type to be
established within the anterior pituitary. Thyrotrophs secrete thyroid-
stimulating hormone (TSH), gonadotrophs secrete follicle-stimulating
hormone (FSH) and luteinising hormone (LH) and somatotrophs secrete
growth hormone (GH). Lactotrophs, secreting prolactin (PRL) are the last
anterior pituitary cell type to differentiate (Simmons et al., 1990).
Crucially gonadotrophs express the GnRH receptor (GnRH-R), a G-protein
coupled receptor (GPCR) which when activated stimulates gonadotrophin
secretion (discussed later) (Conn et al., 1987).
1.3.4 The Gonads
The gonads are the target organs for LH and FSH and each exerts a specific
effect. The biological effect of gonadotrophins is mediated through
receptor binding on the target cell therefore subtle changes in the
structure of the hormone may exert different levels of activation. Indeed
this has been shown to be true as deglycosylated (more acidic) forms of the
gonadotrophins which are produced as a result of increasing age or
removal of testosterone are less effective than more basic forms secreted
in response to GnRH stimulation (Reader et al., 1983; Wide & Hobson, 1983).
FSH stimulates follicular growth in female mammals (Clark et al., 1979) and
promotes spermatogenesis in the Sertoli cells of males (Dorrington et al.,
1975). LH acts synergistically with FSH in females (McNeilly et al., 1991a)
and later enables selection of dominant follicles during declining FSH
concentrations and high frequency, low amplitude LH pulses (Campbell et
al., 1995). Ovulation is normally triggered by LH (Cumming et al., 1971)
although it can be triggered artificially using CG which has a longer
serum half life (Picton et al., 1990). In the male LH binds to and activates
LH receptors on Leydig cells promoting androgen secretion which in turn
promotes development of secondary sexual characteristics (Sharpe, 1994).
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Positive and negative feedback occurs from the gonads in the form of
steroids such as oestradiol, progesterone and testosterone and effects the
hypothalamus as well as the pituitary gland (Keri et al., 1991; Couzinet &
Schaison, 1993). Positive regulation of LH secretion by oestradiol occurs in
the absence of progesterone leading to the LH surge. The mechanisms
whereby oestradiol exerts its effect are both direct and indirect. Oestradiol
may affect LH(3 expression by increasing transcription directly via an
oestrogen response element (ERE) in the promoter (Shupnik &
Rosenzweig, 1991) and indirectly by increasing the expression and
number of GnRH-receptors (GnRH-R) present on the gonadotroph (Clarke
et al., 1988; Turgeon et al., 1996). The relatively low numbers of oestrogen
receptors in GnRH neurons suggests that an alternative mechanism of
positive regulation of GnRH secretion by oestrogen may exist (Jennes et
al., 1997). Recently a mechanism has been proposed whereby the positive
regulation of GnRH secretion by oestrogen occurs via noradrenergic
neurons in the caudate region of the brain. This model may also account
for the observed 16 hour time-delay between oestrogen administration and
the onset of the LH surge (Clarke 1998 - personal communication).
Progesterone acts via stimulation of (3-endorphin release to reduce GnRH
release from the hypothalamus (Horton et al., 1989; Couzinet & Schaisson,
1993). Although testosterone positively regulates FSHp expression by
increasing its mRNA half-life (Paul et al., 1990; Perheentupa et al., 1993), it
may also act indirectly via alterations in GnRH release from the
hypothalamus resulting in negative feedback (Shupnik, 1996a).
The gonadal peptides activin and inhibin are secreted from gonadotrophs
as well as the gonads and are related to the transforming growth factor-P
family (de Krester & Robertson, 1989). These gonadal peptides regulate FSH
expression with no effect on that of LH (Shupnik, 1996b). Activin acts both
transcriptionally and at the level of mRNA stability to increase FSHp
expression (Attardi & Winters, 1993; Weiss et al., 1995) with inhibin acting
antagonistically (Attardi & Winters, 1993; Weiss et al., 1993). Follistatin is a
structurally unrelated peptide which is also secreted from extragonadal
tissues including folliculo-stellate cells and gonadotrophs in the anterior
pituitary. Follistatin acts indirectly to stimulate FSHp expression by
binding inhibin (Carroll et al., 1989). Recently it has been suggested that
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the role of gonadal activin and follistatin in FSHp expression is limited by
the low proportion which remains unbound (and therefore active) within
the blood (de Krester 1998 - personal communication).
Further detail relating to regulation of specific gonadotrophin subunit
genes by steroids and gonadal peptides is discussed in sections 1.4.3-5.
1.4.1 Gonadotrophs
The majority of gonadotrophs are immunopositive for both LH and FSH and
comprise approximately 10-15% of the anterior pituitary.
Gonadotrophs often exist as single cells or small clusters and are
surrounded by lactotrophs (Allaerts et al., 1991). A paracrine relationship
between these closely associated cells has been suggested (Sato, 1980).
Intriguingly, gonadotrophs secrete these two structurally similar
glycoproteins differentially through constitutive and regulated secretory
pathways demonstrated in vitro (Muyan et al., 1994). FSH which is
expressed at low levels is secreted through the constitutive pathway in
small secretory vesicles ubiquitous among mammalian cells. Basal LH
secretion is also secreted via the constitutive pathway (McNeilly et al.,
1991b). LH, which for normal reproductive health in females requires
large amounts in order to produce an LH surge, is stored in large electron-
dense vesicles or granules prior to ligand-stimulated release (Misro &
Conn, 1988). The molecular mechanisms which underlie the differential
secretion of LH and FSH may involve granins as these molecules colocalise
within secretory vesicles (Hillarp, 1958; Fischer-Colbrie et al., 1987;
Watanabe et al., 1998b).
Neuroendocrine cells secrete proteins such as hormones and
neurotransmitters via a specialised regulated pathway (Orci et al., 1987).
This exclusivity of this regulated pathway to cells of neuroendocrine
origin has recently been disputed. The Chinese hamster ovary (CHO) cell
line has recently been shown to secrete glycosylated proteins via a cryptic
regulated pathway (Chavez et al., 1996). Although this has yet to be
demonstrated in vivo, these findings suggest that the regulated secretion
of proteins may occur in a wide variety of cell types. The presence of a
regulated pathway in gonadotrophs is visually apparent by the presence
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of electron-dense secretory vesicles within the cytoplasm. The 40-fold
difference between LH and FSH content within the pituitary gland reflects
differential expression and predominate secretion via the regulated and
constitutive pathways respectively (McNeilly et al., 1991b).
Granule morphology is complex with many different sizes and densities
reported. Large vesicles 500nm in diameter which contain an electron-
dense core immunoreactive for LH and a periphery immunoreactive for
FSH are present within the cytoplasm. Colocalisation of the granins
chromogranin A (CgA) and secretogranin II (Sgll) occurs with the LH and
FSH in these larger vesicles. Proximal to the plasma membrane (PM),
smaller electron-dense vesicles (also referred to as granules) 200nm in
diameter exist which are immunoreactive for LH and Sgll but not FSH
(Watanabe et al., 1991; Watanabe et al., 1998b). Sex-related differences in
granule morphology have been reported for vesicles containing CgA but
not for those containing SgIL In female rats CgA-containing granules are
generally much smaller than their male counterparts and vary
throughout the oestrus cycle (Watanabe et al., 1998a).
1.4.2 Gonadotrophins
Gonadotrophins are heterodimeric glycoproteins (Li & Starman, 1964;
Ward et al, 1966) which comprise a common alpha subunit (aGSU) and a
specific beta subunit (Liao & Pierce, 1970; Morgan & Canfield, 1971). They
belong to a superfamily of cysteine-knot growth factors which activate
GPCRs (Lapthorn et al., 1994). LH, FSH, thyroid-stimulating hormone (TSH)
and chorionic gonadotrophin (CG) all share the aGSU in their
heterodimeric structure. LH and FSH are secreted from gonadotrophs
whereas thyrotrophs secrete TSH which maintains thyroid function by
activating the TSH receptor (TSH-R) (Nagayama et al., 1990). CG which is
found exclusively in primates and equids is secreted from chorionic
trophoblasts. CG binding and activation of the LH receptor maintains
pregnancy (Stewart & Allen, 1981).
Molecular detail regarding the genetic organisation of the aGSU and p
subunits of FSH and LH will now be discussed. A schematic representation
of the genetic organisation for the three gonadotrophin subunits is shown
in figure 1.4.2a for reference during the following discussion.
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Figure 1.4.2a: The organisation of the aGSU, LH(3 and FSH(3 genes.
The aGSU gene is by far the largest of the three gonadotrophin
genes depicted here. The greater length of this gene is
conferred by the large first intron which ranges from 6.5 to
14.7Kb between species. The aGSU promoter details are specific
to the human gene as this contains elements necessary for
placental expression. The FSH(3 gene contains a relatively large
3' untranslated region which is responsible for the short half-
life of the mRNA.
JRE (junctional regulatory element), CRE (cAMP-response element), TSE
(trophoblast-specific element), ERE (oestrogen- response element), AP-1
(activator protein 1 binding site), SF-1 (steroidogenic factor 1 binding
site), GSE (gonadotroph-specific element). The representations are not
drawn to scale (modified from Bousfield et al 1994).
1.4.3 The Glycoprotein Alpha Subunit
A common alpha subunit in the structure of gonadotrophins may
represent an evolutionary economy in biochemical expenditure;
functional motifs inherent in receptor activation and binding would not
require additional expression for each bioactive heterodimer.
Furthermore, an evolutionary advantage may be obtained by the absence
of selection pressures for large single chain molecules.
Control of aGSU expression during primate and equid development is
limited to the gonadotrophs and thyrotrophs of the pituitary and
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trophoblasts in the placenta. In other species no aGSU expression is
observed in the placenta. Investigation of the controlling factors may now
be aided by the development of the aGSU expressing pituitary-derived cell
lines, aT3-l (Windle et al., 1990) and LpT2 (Thomas et al., 1996), which
complement studies using the JEG3 choriocarcinoma cell line (Kohler &
Bridson, 1971).
The aGSU gene occurs as a single copy in the human genome and is located
on chromosome 6 (Fiddes & Talmadge, 1984). The gene contains four exons;
exon 1 contains untranslated sequences and is separated from exon 2,
which encodes the signal peptide and the first nine amino acids of the
mature molecule, by a large intron which varies in size from 6.5 to 14.7 Kb
depending on the species. Exons 3 and 4 encode the remaining amino acids
of the mature polypeptide, 10 to 71 and 72 to 96 respectively. Exon 4 also
contains sequence information for the 3' untranslated region. The coding
sequences for the aGSU of several species including murine, ovine and
human are highly homologous and range from 730 to 800 nucleotides in
length (Bousfield et al, 1994). For example, the ovine molecule comprises
72 nucleotides encoding a 24 amino acid signal sequence and 288
nucleotides coding for the mature protein of 96 amino acids, the 5' 70
nucleotides and 3' 287 nucleotides contain untranslated sequences (Bello et
al., 1989).
In the rat, mRNA transcripts for the aGSU gene are detected at embryonic
day 11.5 which precedes the respective P subunits. In species other than
human and equid, expression is confined to a placode of somatic ectoderm
which subsequently develops into Rathke's pouch, precursor of the
anterior pituitary (Simmons et al., 1990).
aGSU gene expression is regulated by several frans-activating proteins
acting upstream of the aGSU gene. The human aGSU gene enhancer
comprises four distinct types of enhancer elements which include a
trophoblast-specific element (TSE) between -159bp and -182bp which
binds the placental protein TSEB (Delegeane et al., 1987), a GATA element (-
141 to -161 bp) which binds a-ACT and two cAMP-responsive elements
(CRE). The aGSU CREs are palindromic sequences of tgacgtca between -146
and -111 which bind the ubiquitous CRE-binding protein (CREB) (Jameson
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et al., 1988b; Horn et al., 1992). Placental expression is also enhanced by a
unique ccaat-binding protein located at -93bp (Kennedy et al, 1990) and
binding to the junctional regulatory element (JRE) immediately
downstream of the CREs (Anderson et al., 1990). Species other than human
and equine lack the necessary TSE, gata and CREs to allow placental
expression of aGSU gene (Bokar et al., 1989). Gonadotroph-specific
expression of the aGSU gene is regulated by the 54kDa transcription factor
SF-1 which binds to the gonadotroph-specific element (GSE) located
between -219bp and -211bp. The exact sequence to which the 54kDa
protein binds is tgaccttgt with this sequence showing strong
conservation in many mammalian species (Horn et al., 1992; Brown et al.,
1993; Keri & Nilson, 1996; Halvorson et al., 1996). The first five bases of the
GSE shows homology with the nuclear steroid hormone receptor
superfamily (Naar et al., 1991).
Regulation of mRNA stability, like that of transcriptional activity, is a key
mechanism for control of gene expression. Measurement of mRNA from
cultured cells at time-points after administration of a transcriptional
inhibitor such as actinomycin D allows evaluation of mRNA stability. The
half-life of the aGSU mRNA is 6.5+0.25 hours and by 9 hours of
actinomycin D exposure the poly-A tail of remaining aGSU mRNA is
reduced by 80-90% (Bouamoud et al., 1992).
Secondary structure of the aGSU is conferred by the formation of 5
disulphide bridges between cysteine residues (Lapthorn et al., 1994),
conservation of the nucleotide sequences encoding these key amino acid
residues is apparent even between mammals and teleosts (Bousfield et al,
1994). Disulphide bond formation within the aGSU structure is undertaken
in the rough endoplasmic reticulum (RER) and occurs cotranslationally
(Mise & Bahl, 1980). Disulphide bridges form between the cysteine residues
at positions 7 and 31, 10 and 60, 28 and 82, 32 and 84 and 59 and 87 in the
aGSU (Lapthorn et al., 1994). Mutation of nucleotide sequences responsible
for encoding the cysteine residues at either 7, 31, 32, 59 or 87 to alanine did
not affect the aGSU conformation and produced bioactive hCG from
cotransfected Chinese Hamster ovary (CHO) cells. Similar mutations
affecting cysteines at 10, 28, 60, 82 or 84 caused conformational changes
which resulted in reduced dimer formation and an increased rate of aGSU
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degradation (Furuhashi et al., 1994). Expression of a(3 fusions in vitro has
demonstrated that disruption of the disulphide bridge between residues 10
and 60 reduces heterodimer formation to 5% of wild-type levels but still
produces a bioactive single-chain hCGa(3 molecule (Sato et al., 1997).
Certain sequence deletions between the cysteine residues have been
implicated in species specificity of heterodimer formation (Burzawa-
Gerard & Fontaine, 1976). Deletion of the P-T-P motif at residues 38-40 in
the aGSU abolished hCG dimerisation in transfected CHO cells. Similarly
any substitutions of Tyr37 or Thr39 also prevented hCG dimerisation (Sato et
al., 1997). Clearly dimer formation is, at least in part, controlled by
structural features of the aGSU. The role played by the respective p-
subunits is discussed in the following sections.
Expression of mutated aGSU in CHO cells stably cotransfected with either
the human FSH(3 or human CGp allowed evaluation of respective receptor
activation on 293 cells stably transfected with the FSH-receptor (FSH-R) or
LH-receptor (LH-R) DNA. For FSH activity residues His90 and Lys91 within
the aGSU are crucial. FSH-R binding was improved by the substitution of
aGSU valine for Lys91 but reduced subsequent cAMP production to
undetectable levels. Similar results were obtained when LH-R activation
was measured after the same residues were mutated in the hCG aGSU.
Mutation of aGSU His90 to either arginine or proline reduced FSH binding
to the FSH-R but did not alter hCG binding to the LH-R (Zeng et al., 1995).
A-glycosylation occurs at asparagine residues 56 and 82 in the aGSU (52
and 78 in human) with the former being essential for biological activity of
hCG (Matzuk et al., 1989). Interactions between the aGSU and either FSH or
LH P-subunit have been shown to determine the differential glycosylation
of the aGSU within each functionally specific dimer. The asparagine-
linked oligosaccharides of the aGSU in bovine LH terminate with a S04-
4GalNAcP(l->4)GlcNAcP(l->2)Mana . However aGSU on FSH terminates with
sialic acida-Galp( 1->4)GlcNAcp( 1->2)Mana . Apparently association of the
aGSU with the FSHp prevents recognition of the dimer by a specific N-
acetylgalactosamine transferase which is responsible for the differential
glycosylation of the aGSU in LH. These observations suggest a possible
mechanism whereby differential sorting of LH and FSH may occur as well
as allowing functional specificity (Smith & Baenziger, 1988). A recognition
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sequence of P-X-R/K has been reported for this enzyme (Smith &
Baenziger, 1992).
The aGSU clearly fulfils roles within each glycoprotein dimer and it is not
a static structure to which the (3 subunits adapt. Although the role of
bioactivity is clearly suggested and undoubtedly important, the
significance of differential glycosylation with regard to intracellular
trafficking is of particular relevance to the studies described in this
thesis.
Free aGSU displays O -glycosylation at Thr43 which prevents LH
dimerisation in vitro (Parsons et al., 1983). Placental free aGSU does not
exhibit such O-glycosylation and appears to prevent CG dimerisation via N-
glycosylations (Thotakura & Blithe, 1995). The higher rate of synthesis and
resistance to degradation of the aGSU in comparison to the glycoprotein (3
subunits leads to an excess of free aGSU which is successfully secreted
(Kourides et al., 1980). An intracellular role of the excess of degradation-
resistant aGSU produced in gonadotrophs has not been determined.
However, it seems likely that the abundance of intracellular aGSU may
prevent the tightly controlled coexpression of (3 subunits becoming
subjected to less precise control by lysosomal degradation in the absence
of sufficient aGSU (Bassetti et al., 1995).
The exact role of free extracellular aGSU is unclear although some studies
suggest a role in lactotroph differentiation (Begeot et al., 1984), prolactin
secretion from cultured human decidua (Blithe et al., 1991) and perhaps in
stimulation of neoplastic growth (Bidart et al., 1997). Transgenic knockouts
are not appropriate for determining the role of free aGSU as absence of
this subunit prevents formation of the heterodimeric gonadotrophins thus
abolishing normal thyroid and gonadal development (Kendall et al., 1995)
1.4.4 Follicle-stimulating Hormone
The human, bovine, pig and rat follicle-stimulating hormone (FSH) |3
subunits are encoded by a single gene (Jameson et al., 1988a; Kim et al.,
1988; Gharib et al., 1989). The human gene is located on chromosome 11
(Naylor et al., 1983). The presence of a putative ovine FSH|3 (oFSH(3)
pseudogene showing 87% homology to oFSH(3 distinguishes it from the
other species (Guzman et al., 1991). Further investigation into the
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expression characteristics of this putative pseudogene has yet to be
reported.
The FSHP gene spans over 5000bp, the ovine sequence is 5191 bp in length,
containing three exons and two introns. The long 3' untranslated sequence
contributes greatly to the mRNA which is over twice the length of the
aGSU and LHp mRNAs at approximately 1700 bp in length. The mRNA half-
life of FSHp has been reported as 1.0 ±0.13 hours in primary cultured rat
pituitary cells (Bouamoud et al., 1992) and removal of the 3' untranslated
sequence results in significantly increased mRNA expression in transient
transfections (Mountford et al., 1992).
Recently, information regarding the presence of two functional activator
protein-1 (AP-1) binding sites within the oFSH(3 promoter has been
reported. These elements present at -120 and -83 are flanked by two non¬
functional AP-l-like sites at -155 and -10. The functionality of the
elements was confirmed by site-directed mutagenesis and activation by 12-
O-tetradecanoylphorbol-13-acetate (TPA) in vitro. In vivo evidence that
these AP-1 sites are functional is demonstrated by the presence of c-fos
and c-jun within the nucleus of over 75% of FSHp-containing
gonadotrophs (Strahl et al., 1997). The presence of these sites suggests that
an FSH(3 transcriptional response to GnRH-R activation via the mitogen-
activated protein kinase (MAPK) signalling pathway may occur (Naor et
al., 1998).
The human FSHp gene expresses four mRNA species which is in contrast
with other species which produce only one (Jameson et al., 1988a). An
alternate splicing donor site located in the first exon results in 35% of
transcripts with a 33 base 5' untranslated region as opposed to the normal
63 bases. Polyadenylation variants account for the other two mRNA species
and 20% of FSHp mRNA lack the long 3' untranslated sequence due to
incorporation of a stop codon at the consensus AATAAA sequence. The
conventional FSHp mRNA molecule of 1700 bases in length arises from
polyadenylation at a site homologous to that found in non-human species
(Gharib et al., 1990). Regulation of FSHp expression in vivo has been
shown to occur both transcriptionally and posttranslationally. Gonadal
peptides inhibin and activin appear to act at different stages of FSHp
synthesis with opposing effects and without affecting expression of the
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aGSU or LHP genes. Inhibin has been demonstrated as reducing oFSHp
transcription by 50% (Clarke et al., 1993) whereas activin promotes rFSHp
mRNA abundance by stabilising the mRNA molecule (Carroll et al., 1991)
and by increasing transcription (Weiss et al., 1995).
The ovine FSHp mRNA translates into a polypeptide of lllaa with two sites
of A-glycosylation at the asparagine residues at positions 6 and 23 (Sairam
et al., 1981). Conservation of 12 cysteine residues within all gonadotrophin
p-subunits imparts their related structures. In comparison to disulphide
bond formation within the aGSU, disulphide bonds within the P-subunits
occur between amino- and carboxy-terminal regions and may result in a
more rigid structure (Tsunasawa et al., 1977). Due to the relative scarcity of
FSH in comparison to CG and LH, the majority of structural studies have not
been carried out using FSH. Some detail has been extrapolated from
structural comparisons with other gonadotrophin p-subunits and is
discussed in the following section. Interestingly, over 50% of the residues
in this sequence are required for bioactivity which is nearly twice that of
LHP aa sequences (Bousfield et al, 1994). oFSH serum concentrations range
between 0.5-6ng/ml and the serum half-life is approximately 160 minutes
(Roche, 1996). The presence of sulphated oligosaccharides for which a
receptor is expressed in the liver ensures that target organ exposure to
FSH is limited (Fiete et al., 1991). The biological significance of this may be
that serum concentrations of FSH do not accumulate and that efficient
clearance allows the pulsatile secretion profile of FSH in peripheral blood
to be maintained.
Transgenic knockouts of the FSHp gene demonstrate the physiological
requirement for the FSH heterodimer in normal reproductive function as
males were found to be subfertile and females infertile. Female infertility
arose due to the lack of antral follicle formation. Males demonstrated
reduced seminiferous tubule volume whereas Leydig cells appeared
similar to controls. These data are in accordance with the known roles of
FSH in vivo (Kumar et al., 1997).
1.4.5 Luteinising Hormone
Luteinising hormone (LH) is the heterodimeric glycoprotein comprised of
the aGSU and the specific LHp subunit. The human LHP subunit is encoded
Chapter One Literature Review
by a single gene located on chromosome 19 (Naylor et al., 1983). Activation
of the LHp gene is restricted to cells of the gonadotroph lineage occurring
at embryonic day 16.5 (el6.5) in rat development (Simmons et al., 1990).
The related P subunit of chorionic gonadotrophin (CGp) is encoded by a
total of 7 genes or pseudogenes which are transcribed at various levels of
efficiency due to altered 5' sequences. All of these genes are expressed
within placental trophoblasts (Bo & Boime, 1992). Genetic duplication of an
ancestral LHp gene and subsequent rearrangement may have led to the
evolution of this CGP gene cluster (Talmadge et al., 1984). Homology of the
LHp and CGP genes is high within the coding regions but 5' untranslated
sequences and promoters appear to have a divergent relationship. Using
the human choriocarcinoma cell line JEG3 which expresses hCG, it has
been demonstrated that the CGp promoter contains a cAMP-responsive
element (CRE) and is functionally distinct from that of the aGSU promoter.
Unlike transcription of the aGSU gene, CGp transcription is inhibited by
cycloheximide administration and thus is dependent on de novo protein
synthesis. Furthermore the CGp CRE does not bind CREB but does contain
binding sites for multiple placentally-expressed transcription factors
(Talmadge et al., 1984; Milsted et al., 1987; Jameson & Lindell, 1988) .
Far less has been revealed about the regulation of the LHP gene than the
aGSU due to the protracted development of a cell line expressing the LHP
gene. The LPT2 ceH line expresses both the LH a and P subunits which are
stored in dense-core vesicles and are secreted under control of the GnRH-R
(Thomas et al., 1996). Currently no data from LPT2 cells regarding LHp
promoter structure have been reported. Previous studies using rat LHp
promoter resections to assay reporter gene transcription in transfected
primary rat pituitary cultures has revealed that only a relatively small
region of the upstream untranslated sequence is necessary for efficient
transcription. Sequences contained between -1700bp and -75bp were not
required for reporter gene expression in this system (Kim et al., 1990) and
transgenic studies in mice have shown that sequences within -1900bp are
sufficient for expression of a reporter gene specifically within the
gonadotroph cell lineage (Brown et al., 1993). The primary cell culture of a
tissue such as the pituitary gland, which contains a heterogeneous
population of cells, may present misleading results due to possible
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transfection of multiple cell types and subsequent reporter activity from
lineages not normally involved in LH expression in vivo. Oestradiol
exposure increases LH secretion from gonadotrophs in vitro (Turgeon et
al., 1996) and in vivo (Jackson et al., 1975). Using the GH3
somatomammotroph cell line an oestrogen response element (ERE)
containing the palindromic sequence GGACACCATCTGTCC has been located at
-1 173bp. Promoter resections containing this sequences exhibited
enhanced reporter expression by 1.7 to 3-fold. Furthermore constructs
containing two copies of the ERE showed an increase of 2.5 to 4-fold
(Shupnik & Rosenzweig, 1991). The presence of an activator protein-1 (AP-
1) binding site within the rLHp promoter (Shupnik, 1996b) may allow a
transcriptional response to GnRH-R activation via protein kinase-C (PKC)-
dependent stimulation of the MAPK pathway (Naor et al., 1998).
Using the mouse gonadotroph-derived aGSU-expressing ocT3-l cell line, a
gonadotroph-specific element (GSE) in the rat LHP was characterised and
found to specifically bind the orphan nuclear receptor steroidogenic
factor-1 (SF-1) (Halvorson et al., 1996). LHp sequences show high
homology (>75%) between bovine, human and rat genes. The presence of a
SF-1 motif (tgaccttg) at -124bp is likely to contribute to the tissue
specificity of oLHp transcription. The LHp gene also contains a TATAA box at
-31bp, a short (7bp) 5' untranslated sequence within exon 1 and a
polyadenylation site 21bp from the end of the transcriptional unit (Brown
et al., 1993).
Disruption of the rat LHp promoter SF-1 binding site in transgenic mice
resulted in almost complete inhibition of expression of the CAT reporter in
males and females. Interestingly this reduction could not be compensated
for using induction with GnRH after gonadoectomy (Keri & Nilson, 1996).
Although SF-1 binding sites are present within the aGSU and LHP
promoters no such binding sites have been located in the corresponding
regions of the FSHp gene. It has been postulated that SF-1 may control
tissue-specific expression of the FSHp gene indirectly (Brown & McNeilly,
1997). Disruption of the gene encoding another transcription factor, NGFI-
A, produces infertile female transgenic mice as a consequence of a
deficiency in LH. Reduced transcription of other key hormones such as
prolactin and FSHp as well as the GnRH-R appeared unaffected. Although
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LH was undetectable (by immunoblotting) in female NGFI-A knockouts,
levels were only decreased in males suggesting differences in
transcriptional regulation. Parallel cotransfection experiments
undertaken in vitro using the aT3-l and CV-1 cell lines determined a
synergistic relationship between SF-1 and NGFI-A binding. This effect was
inhibited by mutation of the guanosine residues in the canonical NGFI-A
binding site located at -50bp (Lee et ai, 1996). Similar experiments using
the LPT2 ceH line (male murine gonadotroph) (Thomas et al., 1996) may
reveal mechanisms exclusive to the regulation of LHP transcription in the
male.
The oLHp gene, when transcribed, produces a 1069bp heterologous nuclear
RNA (hnRNA) molecule which contains three exons of 22bp, 168bp and
335bp. The mRNA half life for oLHp is 44 +0.5 hours (Bouamoud et al.,
1992).
The oLHp gene encodes a protein 141aa in length which includes a 20aa
signal peptide (Brown et al., 1993). The closely related hCGp gene produces
a polypeptide with a high degree of homology to LHp but differs at the
carboxy terminus due to the presence of an additional 31aa sequence. The
carboxy-terminal peptide (CTP) is hydrophilic in nature displaying O-
glycosylation at four serine residues. The CTP is believed to have arisen as
a consequence of a frameshift mutation which resulted in a readthrough
at nucleotides encoding amino acid 114 (Talmadge et al., 1984).
The conservation among all gonadotrophin P subunits of 12 cysteine
residues reveals the location of 6 disulphide bonds (Tsunasawa et al., 1977).
These disulphide bonds are largely responsible for the rigid structure of
gonadotrophin p subunits. Circular dichrographic spectral analyses of
gonadotrophin subunits before and after dimerisation have revealed that
whereas the P subunits remain similar the a subunit structure is dynamic
(Jirgensons & Ward, 1970). More recent work by Lapthorn et al (1994)
examined the crystal structure of hCG and although it revealed detailed
information regarding the molecular interactions of the aGSU and hCGp
subunit it failed to relate these to free aGSU. The sequence similarity
between the CGP and LHP genes suggests that the structure of their
respective dimer may also be similar. Notably, the interaction of the aGSU
and the hCGp subunits occurs via the C-A-G-Y sequence (hCGp 34-36) and is
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stabilised by a disulphide bridge. The C-A-G-Y sequence appears conserved
in mammalian species with some species variation occurring at the
alanine residue. Notably oLH(3 contains a glycine residue in place of the
alanine but maintains the consensus in the corresponding FSH sequence
(Bousfield et al, 1994). This disulphide bridge formed between cysteine
residues at hCGp 26 and 110 forms a loop which wraps around the aGSU.
This unusual motif is also essential for binding to the LH receptor
(Lapthorn et al., 1994). The structural dominance of the (3 subunit
presumably reflects the functional specificity that gonadotrophin (3
subunits impart on the dimeric hormone.
Formation of the hLH dimer has been investigated using CHO cells
transfected with aGSU and mutant LH(3 or CG(3 expression constructs.
Comparison of the rate of hLH assembly to that of CG revealed that the
former occurs with less efficiency. The main structural differences
between the (3-subunits are the carboxy-termini and the A-linked
glycosylations. The LH(3 subunit possesses a hydrophobic carboxy-
terminus whereas the serine-rich CTP of hCGp is hydrophilic. Furthermore
hLHp unlike other LHP subunits is not A-glycosylated at residue 13 due to
disruption of the recognition sequence. Considerable mutational analysis
and expression of chimeric P-subunits has revealed that the interaction of
the amino- and carboxy-termini of the hLHp subunit is responsible for its
relative inefficiency of dimer formation. LHP appears to be unique among
the gonadotrophin P-subunits as FSHp and TSHp combine with the aGSU at
rates comparable to that of hCGp (Matzuk & Boime, 1989).
LH serum concentrations range from 0.5 to lOOng/ml and the half-life of
the 32kDa protein is approximately 20 minutes which reflects rapid
clearance by the kidneys (Roche, 1996). Like FSH, LH contains sulphated
oligosaccharides whereas hCG does not. The pituitary gonadotrophins
including TSH are rapidly cleared by the liver while hCG remains in the
serum (Fiete et al., 1991).
Although a direct transgenic knockout of the LHp gene has yet to be
reported, the NGFI-A transcription factor knockout abolished expression
of the LHp gene causing subfertility in males and infertility in females
(Lee et al., 1996).
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1.4.6 The GnRH Receptor and Intracellular Signalling
Gonadotroph cells express the GnRH-R on the PM and specific high
affinity binding of GnRH activates multiple second messenger systems
(Conn et al., 1987; Huckle & Conn, 1987; Wooge & Conn, 1987). The GnRH-R
is a member of the GPCR family and contains seven transmembrane
regions with a truncated intracellular carboxy-terminus. Ligand-receptor
binding induces dimerisation and micro-aggregation of GnRH-R molecules
(Conn, 1984). A recent review by Naor et al describes functional mutations
of the GnRH-R structure in great detail (Naor et al., 1998).
The single copy of the human GnRH-R gene located on chromosome 4
contains three exons and spans over 18.9kb. The gene encodes a 327 amino
acid protein which is highly homologous to sequences in the sheep, rat,
mouse and cow (Kakar et al., 1992; Reinhart et al, 1992; Tsutsumi et al., 1992;
Eidne et al., 1992; Brooks et al., 1993; Chi et al., 1993; Illing et al., 1993).
Control of GnRH-R expression in gonadotrophs is a crucial part of the
hypothalamo-pituitary gonadal axis as it provides a means for regulating
the amount of signal received by the gonadotroph.
The inhibitory effect of progesterone on GnRH-R mRNA has been
demonstrated in vitro using ovine pituitary cultures (Sealfon et al., 1990).
In vivo studies of GnRH-R mRNA regulation throughout the oestrus cycle
of sheep investigated the role of GnRH, E2 and inhibin. In normal ewes
GnRH-R mRNA levels appear to coincide with serum E2 (Brooks et al., 1993),
although either GnRH-R antagonists or inhibin decrease mRNA levels in
the absence of E2 (Brooks & McNeilly, 1994). Further regulation of the
GnRH signal detected by gonadotrophs occurs via internalisation of the
GnRH-R after chronic agonist treatment (Schvartz & Hazum, 1987) and
may be mediated by the asparagine-arginine-serine (D-R-S) motif present
on the second intracellular domain of the receptor (Arora et al., 1995).
Desensitisation of the GnRH-R also occurs which dampens the
gonadotrophs response to hypothalamic stimulation (Gorospe & Conn,
1987).
The effects of GnRH-R activation within gonadotrophs include stimulation
of gonadotrophin gene transcription and modulation of gonadotrophin
exocytosis (McNeilly et al., 1991b) (figure 1.4.6a). The myriad of second
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messenger systems allows precise control of the intracellular response to
receptor activation. Furthermore, as a result of the amplification inherent
in the cascade of protein interactions, a reduced quantity of agonist may
be required thus reducing the likelihood of nonspecific interactions.
Although the exact signalling pathway involved in GnRH-R stimulation of
gonadotrophin subunit transcription has yet to be revealed, GnRH-R
activation leads to formation of the transcription factors c-jun and c-fos
via MAPK cascade. AP-1 formation by c-jun and c-fos could lead to
transcription of gonadotrophin subunit genes although this has yet to be
demonstrated. As has already been discussed the rLHp (Shupnik, 1996b)
and oFSHp (Strahl et al., 1997) promoters contain AP-1 binding sites which
may facilitate a positive transcriptional response to GnRH-R activation.
The rat secretogranin II promoter (see section 1.6.3) also contains multiple
AP-1 sequences although with single base deviations from the consensus
(Jones et al., 1996). However as yet no clear relationship between SgH
transcription and GnRH-R activation has been demonstrated.
GnRH-R activation also controls the release of gonadotrophins via
intracellular signalling. Phospholipid metabolism is increased by GnRH-R
activation as a result of guanosine triphosphate protein (G protein)
activity (Hawes et al., 1992b). G proteins catalyse breakdown of membrane-
bound phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG) by phospholipase C (PLCp)
(Huckle & Conn, 1988; Keisel, 1993). DAG is also produced as a result of
phospholipase D (PLD) activity. Activation of phospholipase A2 (PLA2)
leads to production of leukotrienes which also stimulate LH release
(Anderson, 1996).
IP3 production initiates a Ca++ spike by activating its Ca++ channel receptor
located on the endoplasmic reticulum (ER) (Shangold et al, 1988) and
perhaps other intracellular Ca++ ([Ca++]j) stores. The exact role of elevated
intracellular IP3 concentrations is unclear as GnRH and sodium-fluoride
mediated LH release can both be uncoupled from IP3 turnover (Hawes e t
al., 1992b), furthermore GnRH-R desensitisation can also be uncoupled
(Hawes et al., 1992a).





















Figure 1.4.6a: Schematic representation of intracellular signalling
by the G11RH-R (adapted from Anderson 1996 and Naor el al 1998).
This simplified diagram indicates the multiple effects of activation of
the GnRH receptor (GnRH-R) within a gonadotroph. Activation of
this G protein coupled receptor releases the a subunit of the G
protein which activates PLCp in turn catalysing cleavage of PIP2. The
products of this cleavage DAG and IP3 are responsible for the
subsequent intracellular cascades. The assignment of myosin 11B to
movement of gonadotrophin vesicles is putative.
Gonadotrophin releasing hormone (GnRH), GnRH receptor (GnRH-R),
phopholipase C (PLC), phosphoinositide 4,5-bisphosphate (PIP2), inositol
1,4,5-trisphosphate (IP3), diacylglycerol (DAG), Ca++-dependent protein kinase
(PKC), voltage-operated calcium channel (VOCC), IP3 receptor (IP3-R), mitogen-
activated protein kinase kinase (MAPKK), mitogen-activated protein kinase
(MAPK), activator protein 1 (AP-1, contains c-jun and c-fos), endoplasmic
reticulum (ER), rough ER (RER)
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DAG activates PKC which mobilises extracellular Ca++ ([Ca++]ex) (Andrews
et al, 1990; Izumi et at, 1990) Using the reverse haemolytic plaque assay LH
exocytosis was measured in response to GnRH treatment in the presence of
PKC inhibitors such as retinal and isoquinolone sulphonamide (also
known as H7). This demonstrated the role of PKC in mediating LH release
after repeated exposure to GnRH lasting in excess of 90 minutes (Lewis et
at., 1989) and correlates with the model of GnRH-induced LH(3 transcription
via PKC stimulation of the MAPK pathway (Naor et at., 1998). PKC isoforms
exist within the anterior pituitary (Johnson et al., 1993) and it has been
demonstrated using permeabilised cells that although PKCe is not required,
PKC a and PKCp are crucial for ligand-stimulated exocytosis. PKC mediates
Ca++ influx by activation of L-type voltage-gated Ca++ channels (Anderson,
1996). PKC sensitisation to Ca++ is increased by DAG (Kishimoto et al, 1980)
and this process has been implicated in LH release by the application of
phorbol esters (Smith et al., 1984). The many isoforms of PKC may be
responsible for the wide-ranging effects of GnRH-R activation through
specific interaction with a variety of key transcription factors (Cesnjaj e t
al., 1994).
Using patch-clamped cells with monophasic Ca++ fluxes in Ca++-free media
it has been demonstrated that LH exocytosis can occur independently of
[Ca++]ex (Tse et al., 1993). However, more recent experiments suggest that
activation of the GnRH-R results in a biphasic Ca++ flux, where an initial
peak is followed by a plateau. The biphasic nature of this response has
been shown to derive from mobilisation of both [Ca+ + ]j and [Ca+ + ]ex
(McArdle et al., 1996). Modulation of these specific fluxes by the ovarian
steroids E2 and progesterone demonstrated that pretreatment of rat
gonadotrophs with InM E2 for 48 hours enhanced the oscillatory response
when challenged with GnRH. The effect of progesterone in conjunction
with E2 had different effects depending on the length of exposure prior to
GnRH treatment. Short-term (3hrs) exposure to progesterone caused a
biphasic Ca++ flux in 30% of GnRH-treated cells whereas no control cells
exhibited this response. Long-term (48hrs) progesterone exposure reduced
the majority of Ca++ fluxes to subthreshold levels (Ortmann et al., 1992).
Other agents which result in Ca++ oscillations such as ionomycin, Ca+ +
channel activators, Ca++ ionophores and Ca++-loaded liposomes stimulate LH
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exocytosis with similar efficacy to GnRH (Conn et al, 1979; Conn & Rodgers,
1980c; Conner al, 1980b; Conn et al, 1980a; Conn et al, 1983). Activin has
been shown to inhibit the activity of GnRH-R-associated Ca++ channels.
However, the molecular interactions by which this mechanism may
positively regulate FSH exocytosis remains unclear (Katayama & Conn,
1994).
1.5.1 In vivo Studies of Neuroendocrine Secretion
Application of GnRH to gonadotrophs can cause different intracellular
responses. Priming, in which an enhanced rate of GnRH-stimulated LH
release is observed after prior exposure to GnRH was reported as early as
1974 (Aiyer et al., 1974a). Although observations of priming of
gonadotrophs in cultured rat and mouse pituitaries were reported soon
after (discussed in section 1.7.3) in vivo studies relating to intracellular
observations were not reported until 20 years later. Transmission electron
microscopy (EM) analyses of sheep pituitaries throughout the oestrus
cycle demonstrated a priming of gonadotrophs in response to GnRH. The
frequency of gonadotrophs exhibiting polarisation of granules towards a
local blood vessel increased from 20% in the mid-luteal phase to 90%
during the LH surge. Granules participating in the mass-exocytotic episode
appeared to be 130-150nm in diameter as after the LH surge only granules
of 300nm remained. At 24 hours post-surge gonadotrophs appeared devoid
of all granule classes. Although priming appeared restricted to the smaller
class of granules, larger granules were obviously released subsequent to
the surge. Results from this study did not allow elucidation of the
mechanism by which these larger granules were exocytosed. Whether
these larger granules condense to form releasable granules or factors
governing size exclusion become amenable to release of previously
retained LH is not yet clear. Interestingly, replenishment of the
degranulated cytoplasm was apparent in the post-surge gonadotrophs by
LH-immunoreactivity in rough endoplasmic reticulum (RER) (Currie &
McNeilly, 1995). A key point of this paper is the observation that granule
polarisation occurs towards local blood vessels which is in contrast to the
following in vivo study.
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Although confocal microscopy of dual-labelled gonadotrophs does not
possess the resolution of EM it does allow accurate assessment of
colocalisation events. OVX ewes administered 50mg oestradiol benzoate
showed a specific mobilisation of LH-only granules to an area adjacent to
the PM. Although 17% of control ewes contained mobilised LH granules,
83% of gonadotrophs in oestradiol benzoate-treated ewes exhibited LH
granule mobilisation. Thomas (Thomas & Clarke, 1997) suggests that
polarisation is not directed in the gonadotrophs of animals around the time
of the LH surge. Exact monitoring of the serum levels for the individual
animals was not reported thus preventing determination of the individuals
proximity to the surge. This may be significant in that post-surge
polarised granules may be absent from membrane areas juxtaposed to the
blood vessel. Closer examination of images presented in this study clearly
shows areas of PM devoid of LH immunoreactivity. It is possible that these
areas represent sites of release post-surge. Using this method of
microscopy did not permit the localisation of adjacent blood vessels.
Interestingly, FSH-containing granules remained dispersed within the
cytosol in all gonadotrophs observed (Thomas & Clarke, 1997).
Although FSH is primarily released via the constitutive pathway resulting
in tonic secretion profiles as observed in GnRH-antagonist treated animals
some episodic secretion has been reported. Continuous sampling of the
hypophyseal portal blood vessel which is in close proximity to
gonadotrophs and for which peripheral vessels are not a source of blood
has allowed accurate measurements of FSH profiles to be made
(Padmanabhan et al., 1997). Peripheral blood samples may not reflect the
true nature of pulsatile FSH release due to the reduced half-life of isoforms
released episodically; 25 minutes versus 3 to 6 hours (Akbar et al., 1974).
Close correlation of GnRH profiles and FSH release was reported in
conjunction with GnRH-independent pulses and tonic secretion
(Padmanabhan et al., 1997). These characteristics contrast with previous
measurements of peripheral blood which suggest only tonic secretion
(Wallace & McNeilly, 1986). While this study may implicate as yet
undetermined FSH-specific secretagogues as well as other possible
mechanisms it should be noted that a paper by the same laboratory
reported similar episodic, GnRH-independent and basal secretion events
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for LH (Midgley et al., 1997). Perhaps the most relevant finding of these
papers is the observation that the time-lag between GnRH pulses and FSH
pulses is almost indiscernible in comparison to the 1.26 minutes between
GnRH and LH (Midgley et al., 1997; Padmanabhan et al., 1997). These results
suggest that GnRH-dependent release of a labile FSH isoform is more rapid
than that of LH. The rapid exocytosis of FSH may represent a difference
between the dynamics of constitutive vesicles in comparison to the much
larger LH-containing regulated granules. GnRH-stimulated
rearrangement of actin bundles (Anderson, 1996) in non-primed cells may
allow more mobile constitutive vesicles to move towards the PM en masse
thus mimicking an episodic release comparable to that of LH which ensues
after slow transit of granules to the PM.
Granins, which will be discussed in the following section, have been
implicated in regulated secretion of gonadotrophins (Huttner & Natori,
1995). A recent study demonstrated the correlation between granin
regulation and granule morphology in gonadotrophs. The frequency of
granules immunoreactive for chromogranin A (CgA) or secretogranin II
(Sgll) was reported in castrated rats treated with either testosterone or
oestradiol. Larger granules (>300nm diameter) present in the cytoplasm of
gonadotrophs are immunoreactive for LH, FSH, Sgll and CgA whereas
smaller granules (<200nm diameter) show immunoreactivity for LH and
Sgll (Watanabe et al., 1991). A recent study of gonadotrophs in the ewe has
demonstrated that LH granules, polarised during oestradiol treatment, also
contain Sgll and cysteine-string protein (CSP) (Thomas et al., 1998). This
data substantiates evidence for a role of Sgll during release of small
granules in the LH surge (Watanabe et al., 1991; Currie & McNeilly, 1995).
Castrated rats exhibit reduced CgA expression in comparison to controls
which is restored by administration of testosterone. The frequency of
large granules was markedly reduced in castrated rats but again returned
to control levels after treatment with testosterone. Changes in Sgll
expression and frequency of granule immunoreactivity was not as
striking as that of CgA in castrated males (Watanabe et al., 1998b). Studies
on female rats also show an absence of large CgA-immunoreactive
granules in accordance with the findings in castrated rats (Watanabe e t
al., 1998a). CgA-dependent aggregation of LH has been reported and is
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discussed in section 1.7.2 (Colomer et al., 1995). The effect of reduced LH
aggregation was not reported by Watanabe. However, down regulation of
GnRH by administration of testosterone causing reduced LH expression did
not prevent the appearance of large CgA-immunoreactive granules
(Watanabe et al., 1998b). Non-functioning (endocrinological^ silent)
pituitary adenomas have been demonstrated to contain chromogranin B
(CgB) and Sgll in electron-dense granules devoid of hormone. CgA
expression appeared less robust as 20% (1/5) of the neoplasms did not
contain any CgA-immunoreactivity. These data suggest that hormones are
not required for granin-containing granule formation (Rosa et al, 1992).
CgB has been shown to colocalise with other granins and LH in the bovine
anterior pituitary suggesting a co-operative role during regulatory
secretion (Bassetti et al., 1990). CgB overexpression under control of the
cytomegalovirus (CMV) promoter in transgenic mice led to sorting of the
granin to exocrine zymogen granules in pancreatic acinar cells. This
suggests that due to the conservation of cellular mechanisms integral to
secretion the correct sorting of this granin and presumably others is not
restricted to cells of neuroendocrine origin (Natori et al., 1998).
In castrated rats LH(3 subunit expression exceeds that of the aGSU which
leads to degradation of the excess (3-subunits. Degradation of the (3-subunits
occurs in lysosomal compartments but does not colocalise with
immunoreactivity for aGSU, FSH(3 or Sgll (Bassetti et al., 1995).
Other membrane-associated proteins have been reported as key
components to vesicle fusion during exocytosis. Although details
regarding the interactions of these proteins have been almost entirely
derived from studies using in vitro technologies, a recent study by
Jacobsson & Meister (1996) at the Karolinska Institute has provided
excellent detail regarding protein expression within the pituitary gland of
male rats. Interpretation of in situ hybridisation analyses has determined
an abundance of specific mRNA for synaptotagmin-I, CSP, cellubrevin,
vesicle-associated membrane protein (VAMP)-2, munc-18, synaptosome-
associated protein of 25kDa (SNAP-25)-a, soluble NSF attachment protein a
(aSNAP) and syntaxins 1A, 4, and 5 in the anterior and intermediate lobes.
These areas also contained less abundant message for synaptotagmin III,
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SNAP-25b and syntaxin 2. mRNA was absent for species of synaptotagmin
II, VAMP-1 and syntaxins IB and 3.
Confocal observations revealed the colocalisation of synaptotagmin I-III
immunoreactivities with those of all major pituitary hormones except LH
and FSH. However, all hormone-expressing cells within the anterior lobe
showed immunoreactivities for VAMP, CSP, V-ethylmaleimide soluble
factor (NSF), aSNAP, SNAP-25 and syntaxin (Jacobsson & Meister, 1996). In
contrast to these results a more recent study of the pituitary in the ewe
during oestradiol benzoate treatment revealed that syntaxin was not
present in any pituitary cells and synaptotagmin was only detected in
gonadotrophs and lactotrophs. The expression of these proteins within the
pituitary did not change in response to oestradiol benzoate (Thomas et al.,
1998). Surprisingly this study did not investigate changes in either mRNA
or protein levels during oestradiol benzoate treatment.
The proposed interaction of these molecules is discussed within section
1.7.3 and represented schematically in figure 1.7.3a. Taken in the context
of findings in other systems (see section 1.7.3), these data give compelling
evidence that the molecular mechanisms involved in regulated exocytosis
are highly conserved throughout neuroendocrine cell lineages.
The following section will centre on the role of granins. Two main reasons
have led to their investigation as potential sorting proteins within
gonadotrophs. Firstly they are abundantly expressed in a variety of
neuroendocrine tissues (O'Connor, 1983; Fischer-Colbrie et al 1987) and
secondly, they are present within the secretory granules of gonadotrophs
(Watanabe et al., 1991).
1.6.1 The Granin Family
Co-storage of acidic water-soluble proteins with catecholamines in bovine
adrenal chromaffin cells was first reported as early as 1958 (Hillarp, 1958).
Almost ten years later Schneider et al named the protein Chromogranin A
(Schneider et al., 1967). Granin molecules are acidic (anionic) secretory
glycoproteins expressed in all neuronal and endocrine cell lineages
(O'Connor, 1983). Members of the family are defined by the presence of a
decapeptide motif E-S/N-L-X-A/D-X-D/E-X-E-L and multiple dibasic
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cleavage sites from which peptide products are derived (Gerdes et al.,
1989).
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Several granin-type molecules have been putatively identified and some
such as Sgll reassigned falsely as a novel protein Slip (Conn et al., 1992). It
is interesting to note from table 1.6.1 that the range of molecular weights
for granins is considerable. It may also be noted that exact roles have not
been assigned for any granins although some bioactivity has been
associated with the many granin-derived peptides (see section 1.6.6). Only
the three granin molecules chromogranin A (CgA), chromogranin B (CgB
- also known as secretogranin I) and secretogranin II (Sgll - also known
as chromogranin C) have been studied in detail (Eiden et al., 1987). The
following discussion will focus on these three prominent granins.
During the past 15 years the investigation of the role of granins has
centred on three main areas; bioactive peptides, disease markers and
regulated secretion.
Peptides, formed as a result of proteolytic processing within the secretory
granule, exhibit a wide range of roles including secretagogues,
antibacterial agents and cell adhesion molecules (Zhang et al., 1994; Drees
& Hamilton, 1994; Muller & Tougard, 1995; Strub et al., 1996; Jin et al., 1996;
Muller et al., 1997).
Detection of abnormally high serum CgA levels has clinical relevance as a
marker for neoplasia in neuroendocrine tissue (Deftos et al., 1987; Secco et
al., 1996; Hsiao et al., 1990), the prostate (Deftos & Abrahamsson, 1998) and
in cases of hypertension (O'Connor, 1985; Takiyyuddin et al., 1995).
Detection of CgA-like immunoreactivity in the cerebrospinal fluid of
schizophrenic patients has been used as an indicator of tonic arousal
(Vankammen et al., 1991). Radioimmunoassays (RIAs) (O'Connor, 1984;
Syversen et al., 1994) and immunohistochemical analyses (Schmid et al.,
1991; Schmid et al., 1994) have been used effectively in diagnosis of these
conditions.
Colocalisation of granins with other secretory proteins has led to
speculation that one of their roles may be in sorting specific types of
proteins during regulated secretion in a variety of different tissues
(Huttner & Natori, 1995; Watanabe et al., 1998a). The putative role of
granins in regulated secretion will be the main focus of this section after
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discussion of granin gene structure and regulation. A brief summary of
granin-derived peptides will conclude discussion of granins.
1.6.2 Organisation of Granin Genes
CgA, CgB and Sgll are each encoded by single copy genes in mammalian
genomes. The human CgA gene is located on chromosome 14q32 (Murray et
al., 1987) whereas the rat and mouse genes are located on chromosomes 6
and 12 respectively (Simon-Chazottes et al., 1993). The human CgB and Sgll
gene loci are 20pter-pl2 and 2q35-q36 respectively (Mahata et al., 1996).
Murine CgB is located on chromosome 2 (Jenkins et al., 1991) whereas Sgll
is found on mouse chromosome 1 and rat chromosome 9 (Mahata et al.,
1996). An evolutionary relationship, perhaps that of gene duplication,
between CgA and CgB is suggested by homology at the amino- and carboxy-
terminal encoding regions (Pohl et al., 1990).
The CgA gene contains 8 exons in human (Mouland et al, 1994), mouse (Wu
et al, 1991) and bovine genomes (Iacangelo et al., 1991). The bovine and
mouse CgA genes span 13.6kb and llkb respectively (Iacangelo et al., 1991;
Wu et al., 1991). Although the organisation of the CgB gene appears similar
to that of CgA, it has only five exons of which the third is the largest (Pohl
et al., 1990). The structure of the mouse Sgll gene is unlike those of CgA
and CgB as it consists of only two exons. The second exon encodes the
entire protein as the first contains only 5' untranslated (UT) sequences
(Schimmel et al., 1992) (figure 1.6.2a).
Exon assignment within the CgA gene corresponds to the function of the
transcribed protein and subsequently cleaved peptides which are
described in detail below. The signal peptide is encoded by exon 1 with
exons 2-5 encoding the amino-terminal domain. Exons 6 and 7 contain
sequence information for variable domains and exon 8 encodes the second
conserved domain, at the carboxy-terminal region (Hendy et al., 1995). CgB
exons are similarly organised with regard to assignment for exons 1, 2 and
3. Notably, exon 3 in each gene contains conserved sequences for cysteine
residues important for formation of a disulphide loop. Exon 5 in CgB
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corresponds to the carboxy-terminal encoding sequences equivalent to
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Figure 1.6.2a: Schematic representation of granin gene organisation.
Of the three granins depicted here CgA has the most complex genetic
organisation with 8 exons. CgB shows similarity to CgA in the first
three exons and last exon. The Sgll gene is the simplest in structure
with only two exons, the second of which contains the entire coding
region. Promoter details are limited as indicated by the putative
assignment of the DRE (distal regulatory element) to that of CgA and
near consensus (nc) binding sites for AP-1 (activator protein 1) and
CRE (cAMP-response element). The introns and promoters are not
drawn to scale.
1.6.3 Regulation of Granin Expression
Chromogranin A
Expression of the CgA gene in non-neuroendocrine cells such as
enterochromaffin-like cells, which influence gastric acid secretion by
parietal cells, has been shown to be affected by nicotine and famotidine
(an H2-receptor antagonist). CgA mRNA and protein levels were both
increased in rats fed famotidine and/or nicotine. Administration of both
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factors resulted in a rise of the CgA mRNA to 18S rRNA ratio from 0.61 ±0.04
to 0.96±0.04, CgA protein levels increased from 7.4±1.2 to 14.7±2.0 1
pmol/gram of tissue (Gomez et al., 1997).
Secretion of CgA from the parathyroid gland has been shown to be
positively regulated by 1,25-dihydroxyvitamin D. mRNA levels increased
by 1.6, 3.2 and 5.6-fold upon administration of 10, 50 and 250 pmol/100
grams body weight, respectively (Soliman et al., 1997). Primary cultures of
porcine parathyroid cells treated with pancreastatin, a CgA-derived
peptide (see below), exhibited negative regulation of CgA expression
through several mechanisms. Using nuclear run-on assays it has been
demonstrated that pancreastatin at 10"7M reduced CgA transcription by
52% after 12 hours. Pancreastatin also affected CgA mRNA stability and
reduced the half-life from 33 to 18 hours. The presence of pancreastatin
reduced secretion of CgA, as measured by RIA, by 40% after only 4 hours
(first time point) and by 80% after 24hrs. The effect on CgA secretion may
actually occur far quicker as pancreastatin affects parathyroid secretion
within an hour of administration (Zhang et al., 1994).
Glucocorticoid treatment has been shown to positively regulate CgA
expression in the rat pituitary (Fischer-Colbrie et al., 1989). In the mouse
adrenocorticotroph AtT-20 cell line 48 hour exposure to dexamethasone
(DEX) increased CgA mRNA levels by 2.5-fold and CgA secretion by five¬
fold (Wand et al., 1991).
E2-treatment of rat pituitary cell aggregates demonstrated a 50% reduction
in mRNA levels using 10~8M E2 with 34% reduction in CgA protein
expression. Interestingly, this treatment did not reduce the expression of
gonadotrophin subunits emphasising the importance of co-ordinate
regulation by pulsatile GnRH regimes (Anouar & Duval, 1992).
Recently the promoter structure for the human CgA (hCgA) gene has been
studied with particular regard to regulation of expression in
neuroendocrine cells. The location of three upstream domains; a distal
positive domain (-4.8 to -2.2kb), a proximal negative domain (-258 to
-181 bp) and the proximal positive domain (-147 to -61bp) was determined
(Canaff et al., 1998).
The proximal positive domain contains the most highly conserved
sequences and those which are necessary for basal transcription in
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neuroendocrine cells. In rodent, bovine and human CgA proximal domains
there are four conserved sequences; a gaga sequence, a cAMP response
element (CRE) (Mouland et al., 1994), a tg box and a tata box. Deletion of
the CRE resulted in background reporter expression levels in all cell lines
tested except TT cells (human thyroid) where deletion of the tg box was
also required. Furthermore, the relative input of upstream sequences was
assessed in promoter constructs containing up to 2300bp of 5' sequence.
Reporter expression from these constructs fell by 50-75% (Canaff et al.,
1998). This construct however, excludes the majority of the distal positive
domain while including the proximal negative domain. The role of the CRE
in cAMP-stimulated hCgA expression was demonstrated to be cAMP-
dependent protein kinase (PKA)-dependent as administration of a PKA
inhibitor, H89, prevented stimulation while also reducing basal
transcription by 85% (Canaff et al., 1998). In this system cAMP binds to
PKA allowing its dissociation from the holoenzyme which permits entry of
PKA subunits into the nucleus to activate CREB by phosphorylation
(Spaulding, 1993).
Other studies have suggested that a distal regulatory element (DRE)
between-570 and -555 may increase reporter expression in BEN cells by
five-fold (Nolan et al., 1994). Further investigation suggested that DRE
activity is dependent on a unique DRE-binding factor (DBF), expressed
specifically in neuroendocrine cells, which mediates assembly of a
functional transcription complex (Nolan et al., 1996). However, the more
recent study by Canaff et al where several cell lines of neuroendocrine
and non-neuroendocrine origin were used, suggests that BEN cells may be
exceptional with regard to enhancement of reporter expression by this
sequence (Canaff et al., 1998). Screening of DBF expression in a range of
cell lines and in vivo may demonstrate its role more clearly.
The significance of an ERE and a glucocorticoid-response element (GRE)-
like sequence (Iacangelo et al., 1991) were not investigated in any of the
three studies discussed in the previous paragraph. However, the presence
of these elements within the bovine CgA promoter suggests that the
observations of positive and negative regulation by DEX and E2
respectively, may also occur through similar sequences in conserved
rodent CgA promoters (Fischer-Colbrie et al., 1989; Wand et al., 1991;
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Anouar & Duval, 1992). Recent observations of changes in CgA-
immunoreactive granule sizes throughout the rat oestrus cycle and the
prevalence of larger CgA-immunoreactive granules in males provides
clear in vivo evidence for the regulatory role of E2 presumably through
the ERE (Watanabe et al., 1998b; Watanabe et al., 1998a). However the
mechanism by which testosterone has been demonstrated to exert a
positive effect on CgA expression in rats has yet to be reported (Watanabe
et al., 1998b)
The exact mechanisms whereby CgA expression is controlled in widespread
tissues remain unclear. The presence of a CRE within the proximal positive
domain does however substantiate evidence of positive regulation by
factors increasing intracellular cAMP levels. Ligand binding to the G
protein coupled GnRH-R leads to an intracellular cascade which via
diacylglycerol (DAG) activation of PKC generates cAMP (Anderson, 1996).
Although yet to be demonstrated in vivo it is likely that GnRH would have
a stimulatory role on CgA transcription.
Chromogranin B
The promoter structure for CgB has not been studied in as much detail as
that of CgA. However certain motifs and characteristics have been
characterised. The murine CgB promoter is very GC-rich with the 5'
proximal 215bp exhibiting 75% GC. The TATA box is present at -31bp and a
CRE further upstream at position -102. An Spl binding site, also present in
the parathyroid hormone promoter, is located at -134bp. The CRE may allow
response to external factors such as GnRH whereas the high GC content of
the promoter may restrict expression of the gene to specific tissues (Pohl
et al., 1990).
In PC-12 cells treated with the adenylate cyclase activator forskolin (FSK)
the rise in intracellular cAMP concentrations led to increased
accumulation of CgB mRNA. This required PKA activation but occurred
independently of de novo protein synthesis. Furthermore the positive
regulatory effect of FSK on CgB transcription reached 601±87% of control 2
hours post-treatment with accumulated mRNA rising 2.5-fold and protein
concentrations increasing by more than 3-fold (Thompson et al., 1994).
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Accumulation of CgB mRNA is stimulated in GH3B6 cells by InM E2
treatment and occurs maximally after 48-72 hours exposure (Laverriere et
al., 1991). If this effect is a result of transcriptional induction it contrasts
with effects observed for CgA and Sgll (Anouar & Duval, 1992).
A 3-fold reduction of CgB expression by DEX administration in studies using
a transgenic murine somatomammotroph-derived cell line has been
reported (Thiny et al., 1994). This observation correlates with previous in
vitro evidence using the rat somatomammotroph GH3B6 cell line where
DEX was shown to reduce CgB mRNA accumulation to 23% of control levels
(Laverriere et al., 1991). In the PC-12 cell line treatment with either FSK or
cycloheximide did not reduce the CgB half-life of 19+6 hours (Thompson et
al., 1994).
Secretogranin II
The regulation of Sgll expression by administration of secretagogues or
the PKC activator 12-(9-tetradecanoylphorbol-13-acetate (TPA) has been
investigated by two laboratories using primary cultures of bovine
chromaffin cells. Fischer-Colbrie et al (1990) reported no change in Sgll
mRNA levels after treatment with nicotine, however Soszynski et al (1993)
observed a considerable (150+27%) increase in Sgll protein levels. Both
groups reported that administration of TPA led to mRNA abundance
increasing 3.2-fold and protein by 97+7%. Combination of forskolin and
TPA treatment produced a rise in Sgll levels comparable with those
observed by Soszynski et al (1993) after nicotinergic stimulation (Fischer-
Colbrie et al., 1990; Soszynski et al., 1993). The findings from these groups
suggest that, in chromaffin cells, Sgll expression is positively regulated
by the action of PKC and cAMP-dependent mechanisms. The disparity
between Sgll mRNA and protein abundance after nicotinic stimulation
may arise through a reduction in the level of RNA degradation induced by
undetermined effectors of nicotinergic receptors. Further research is
required to clarify this point as is equivalent secretagogue-based work
using pituitary-derived cells.
A study using rat pituitary cultures demonstrated a 30% decrease in Sgll
mRNA levels after a 72 hour exposure to 10 8 M oestradiol (E2) (Anouar &
Duval, 1992). The negative regulation of Sgll by E2 contrasts with findings
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in a transgenic mouse somatomammotroph-derived cell line (Thiny et al.,
1994) and in vivo observations of both male and female rat gonadotrophs
where no change in response to E2 was reported (Fischer-Colbrie et al.,
1989; Watanabe et al., 1998a). The effect of E2 during a controlled pulsatile
GnRH regime has yet to be reported but may reflect the effects of co¬
ordinate regulation of gene expression not exerted during in vitro studies.
This may be particularly relevant in light of the putative role of AP-1
production by activated GnRH-R and the presence of near-consensus AP-1
sequences within the rat Sgll promoter discussed below (Jones et al., 1996).
DEX treatment of a cell line derived from transgenic murine
somatomammotrophs demonstrated a 1.5-fold increase in Sgll mRNA levels
(Thiny et al., 1994). Despite this more recent analysis of the rat Sgll
promoter failed to find a glucocorticoid response element (see below)
(Jones et al., 1996).
Studies on Sgll promoter regulation in PC-12 cells demonstrated a down-
regulation of mRNA levels in response to FSK treatment. FSK
administration required at least 48 hours to exert its negative effect upon
mRNA levels eventually reducing them to 22% of control levels. The
opposite effect of FSK on the rate of Sgll transcription was observed when
the protein synthesis inhibitor cycloheximide was administered in
conjunction leading to a rise of 1290+96% of control levels. The relatively
low endogenous rate of transcription appeared unaffected by FSK
treatment which suggests that cAMP production (induced by FSK) may
affect Sgll mRNA stability. Alternatively, due to the marked rise in Sgll
mRNA accumulation during combined administration of FSK and
cycloheximide it has been postulated that expression of labile regulatory
proteins is halted leading to unrestricted stimulation of Sgll transcription
by cAMP (Thompson et al., 1994). Specific labile regulatory proteins which
interact with the Sgll promoter have yet to be characterised.
Promoter detail relating to the rat Sgll gene has recently been revealed
using resections of a 2.6Kb 5' untranslated region upstream of a luciferase
reporter gene. The location of proximal elements and distal enhancer
sequences were determined by reporter assays after transfection of
neuroendocrine or non-neuroendocrine cell lines. Sequence analysis
revealed the presence of a consensus TATA box at -27 to -31 bp, a CRE at -65
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to -72 and a caat box sequence at -158bp. Furthermore the proximal 450bp
5' regions of mouse and rat Sgll genes exhibit over 90% homology. Distal
elements for binding of known transcription factors were also revealed by
sequence analysis. Two Pit-1 sites are located at -2537 to -2529bp and -1254
to 1246bp as well as 15 E boxes (bind helix-loop-helix transcription factors)
which span the region between -2531 and -173bp. Binding elements
differing by only one base from the consensus were found for activator
protein-1 (AP-1) 9 times within the -2639 to -304bp region. Four activator
protein-2 (AP-2; binding induced by cAMP) sites were also found between
-2602 and -69bp and a one base consensus deviation was found for CRE at
-1786 to 1779bp. Notably, sequences permitting oestrogen receptor or
glucocorticoid receptor binding are absent from the sequences of rat Sgll
promoter investigated in this study (Jones et al., 1996). More recently a
19bp element (at -80 to -62) responsible for the transcriptional effects of
cycloheximide treatment has been demonstrated to bind a complex
containing CREB and CRE-modulator (CREM) or activating transcription
factor-1 (ATF-1). Although FSK increases the response to cycloheximide
from 3.8- to between 8- and 12-fold, no change in formation of this protein
complex was observed. The authors suggest that FSK may enhance the
transcriptional response to cycloheximide by aiding interaction with
general transcription machinery (Jones & Scammel, 1998).
The absence of an ERE within the Sgll promoter correlates well with the
lack of Sgll modulation during the oestrus cycle of rats (Watanabe et al.,
1998a) and in males (Fischer-Colbrie et al., 1989). The reduction in Sgll
mRNA levels in vitro during E2 treatment (Anouar & Duval, 1992) and the
presence of near-consensus AP-1 binding sites (Jones et al., 1996) may
suggest a positive regulatory role for GnRH which counteracts that of E2 in
vivo maintaining levels of Sgll expression (see section 1.4.6).
Pit-1 binding sites within the Sgll promoter may allow specific expression
within lactotrophs and thyrotrophs. However as yet Sgll appears limited to
relatively low expression in somatomammotroph cells (Hashimoto et al.,
1987).
The presence of a consensus CRE and a distal one-base deviation CRE
within the rat Sgll promoter correlate well with these findings from
studies using PC-12 cells (Jones et al., 1996).
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It is possible that elements responsible for negative regulation by E2, such
as the ERE observed in bovine CgA promoter sequences, are located distal to
the -2612bp analysed by Jones et al. Positively regulating sequences such
as GRE which may explain induction of Sgll expression in murine
somatomammotrophs may also be located upstream of the -2612bp used in
reporter constructs (Jones et al., 1996; Thiny et al., 1994).
Overall it is apparent from these studies that a number of molecular
signalling pathways are used to regulate granin gene expression. This is
consistent with their diverse tissue expression. However it is not clear
whether granin genes are regulated by similar means in a variety of
tissues or whether their regulation is specifically controlled to meet the
secretory requirements of the cell type in question. It is likely that these
three prominent granins CgA, CgB and Sgll are regulated within the
gonadotroph in line with the large fluctuations reported for the
gonadotrophins LH and FSH. As yet no studies have been carried out to
determine the regulation of granin genes across the oestrus cycle.
1.6.4 Protein Structure of Granins
Prior to discussing putative roles for members of the granin family some
detailed structural characteristics and interactions will be described.
The anionic nature of these glycoproteins derives from the high content
of glutamic acid and proline residues, typically 25% and 10% respectively,
pi values range between 4.5 and 5.5 (Fischer-Colbrie & Schober, 1987). The
murine CgA gene contains a unique poly-glutamine insertion in exon 5
(Iacangelo & Eiden, 1995) the significance of which remains to be
determined. The high degree of posttranslational modification within
granins includes N- and O - glycosylation, phosphorylation, sulphation,
pyroglutamylation, carboxymethylation, a-amylation and disulphide bond
formation. Although posttranslational modifications may determine rates
and specificities of proteolytic processing, the significance of these
modifications in terms of intracellular interactions has not been reported.
However a brief summary of posttranslational modifications found on
granins will now be given. Glycosylation of CgA and CgB is similar as both
contain approximately 5% sugar residues. CgA and CgB may differ as CgB
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contains more fucose and mannose. CgB contains /V-glycosylation sites
whereas O-glycosylation may be predominant in bovine CgA. Chromaffin
granule CgA and CgB are both phosphorylated at serine and threonine
residues with a maximum of five phosphoserine residues per molecule. CgB
shows sulphated tyrosine residues and sulphation of carbohydrate side
chains whereas CgA shows only the latter. However, CgA labelled in PC-12
cells exhibits a proteoglycan form but the amount in vivo may be limited
and no proteoglycan forms of CgB exist in bovine tissue.
Pyroglutamylation in which glutamic acid residues are converted to
pyroglutamyl residues by glutamic cyclase occurs for CgB-derived peptides
in the adrenal medulla. Carboxymethylation of CgA may occur
cotranslationally as carboxymethylase is a cytosolic enzyme. a-Amidation
of the carboxy-terminal glycine residue of the CgA-derived peptide
pancreastatin has been reported although the significance of this
modification has not been determined. For more detailed discussion of
posttranslational modifications in granins refer to Winkler & Fischer-
Colbrie 1992 (Winkler & Fischer-Colbrie, 1992). Single disulphide bonds are
present within the amino-terminal regions of both CgA and CgB but are
absent from the structure of Sgll and it has been suggested that these
represent a type of conformational sorting signal (Gerdes et al., 1989). A
putative receptor for this conformational signal had been suggested as
carboxypeptidase E (CPE) after initial studies demonstrated an interaction
(Cool et al., 1997). However cells expressing antisense (AS)-CPE do not
exhibit misrouting of CgA suggesting redundancy in this mechanism
(Normant & Loh, 1998).
Human and bovine CgA contain 439 and 431aa respectively with an 18aa
signal peptide located at the amino-terminus. The predicted molecular
mass of CgA is 48kDa whereas analysis by SDS-PAGE determines a mass of
70kDa (Iacangelo et al., 1986).
The CgB polypeptide is longer than either CgA or Sgll, the human form is
657aa and the bovine 626aa, both of which have a 20aa signal sequence
(Bauer & Fischer-Colbrie, 1991). The predicted molecular mass of bovine
CgB is 71.5kDa (Bauer & Fischer-Colbrie, 1991) although its migration by
SDS-PAGE corresponds to a protein of lOOkDa (Gill et al., 1991). The bovine
Sgll polypeptide is 586aa long, with a predicted molecular mass is 67.5kDa
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but with migration by SDS-PAGE corresponding to a mass of 86kDa
(Fischer-Colbrie et al., 1990).
Predicted and apparent molecular weights for granins are often dissimilar
due to the high level of posttranslational modification and the abundance
of acidic residues which retard the protein in the presence of SDS.
Granins are low affinity, high capacity Ca+ + -binding molecules. For
example each molecule of CgA binds 32 and 55 Ca++ molecules at pH 7.5 and
5.5 respectively with a Kp of 2-4mM (Yoo & Albanesi, 1991). Clearly pH has
a striking effect on granin structure.
Effects of changes in intracellular calcium concentrations ([Ca++]j) and pH
on the structure and functional behaviour of granins will now be covered.
pH values decrease with passage through the regulated secretory pathway
from pH 7.5 within the ER decreasing to about pH 6.3 in the trans-Golgi
network (TGN) with a further decrease to between pH5.0 and 5.5 in mature
secretory granules. Changes in [Ca+ + ]j inversely correlate with the
decrease in pH with basal levels in the ER rising to 40nM within mature
granules. It may be possible that microdomains of even higher [Ca+ + ]i
within discrete areas of the cell (Thorn, 1996) may facilitate extreme
conformational interactions between granins and components of the
secretory pathway.
The oligomerisation of CgA at pH5.5 and 35mM Ca++ is entropic which
results in nearly all secretory vesicle CgA being tetrameric. 96% of CgA is
dimeric at pH 7.5 with no Ca++ which corresponds to conditions within the
ER and c/s-Golgi (Yoo & Lewis, 1992). A specific region including residues
407 to 431aa has been demonstrated as a crucial for entropic dimerisation
and tetramerisation of CgA independently of [Ca++]j (Yoo & Lewis, 1993).
Although CgA clearly forms oligomeric structures Sgll and CgB may
remain monomeric throughout the regulated secretory pathway (Yoo &
Albanesi, 1991; Yoo, 1995).
Changes in pH and [Ca++]j also play a role in determining the aggregation
of CgA and CgB in vitro. Furthermore, increases in [Ca++]j also determine,
through conformational changes, the hydrophobicity of CgA and CgB thus
influencing their affinity for membrane interactions. Using the
fluorescent hydrophobic region-specific probe 4,4'-bis(l-
anilinonapthalene 8-sulphonate) (Rosen & Weber, 1969), increases in
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fluorescence were observed in samples containing CgA after addition of
Ca + + . The high sensitivity of CgB to [Ca+ + ]j (discussed below) caused
aggregation and prevented observation of increases in hydrophobicity
(Yoo, 1995).
pH and Ca++ induced conformational changes in CgA and CgB have also
been studied using CD spectroscopy (Yoo & Albanesi, 1991; Yoo, 1995).
Shifts from pH 7.5 to 5.5 caused CgB a-helicity to rise from 15 to 20%,
addition of 0.2mM Ca++ increased a-helicity further to 25% and reduced
random coil from 70 to 65%. For comparable conformational change in CgA
Ca + + concentrations in excess of lOmM were required (Yoo & Albanesi,
1990a). Ca++ concentrations greater than 2mM induced aggregation of CgB
as determined by turbidity assays. Aggregation characteristics of CgA and
CgB in the presence of different [Ca+ + ]i at pH 5.5 and 7.5 have been
compared using turbidity assays which measure absorbance at 320nm. The
comparison shows that maximal CgA aggregation requires 40mM Ca+ +
whereas maximal CgB aggregation, which is six-fold higher than that of
CgA, occurs at only 4mM Ca++. In order to obtain a level of aggregation
giving an A3 20nm of 0.2, CgB requires 0.2mM Ca++ whereas for CgA a
concentration of 33mM is needed (Yoo, 1995). These analyses indicate a
165-fold greater sensitivity of CgB than CgA to Ca+ + . Possible reasons for
the difference in aggregation dynamics for CgA and CgB proposed by Yoo
et al (1995) include the greater propensity for CgB to reveal hydrophobic
domains and maintained monomeric status which may allow greater
mobility for molecular interactions (Yoo, 1995).
Co-aggregation of CgA and CgB using mixtures of the two granins showed
aggregation at Ca++ concentrations intermediate to the maximal values
normally required. Co-aggregation at 13mM Ca++ was obtained most
effectively with a CgA:CgB ratio of nearly 3:1 (0.4mg/ml:0.15mg/ml). In
chromaffin granules CgB concentrations are approximately 10-fold less
than CgA. At this ratio co-aggregation occurred with 30mM Ca++ which is
2.5 fold higher than that required for similar concentrations of CgB alone
but 30% lower than needed for CgA (Yoo, 1995).
Aggregation of Sgll in PC-12 cells has been demonstrated at pH5.2 in the
presence of lOmM Ca++. Absence of Ca++ or an increase in pH to 7.4 reduced
the aggregative behaviour of Sgll. Secretion of Sgll was limited to
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approximately 3.5% of total Sgll expression in normal PC-12 cells.
However, cells treated with ammonium chloride which prevents formation
of low pH environments intracellularly exhibited an increase in Sgll
release to 45% of total Sgll expressed. This suggests that disruption of Sgll
aggregation prevents retention of Sgll within the cell. Most importantly,
Sgll aggregates formed under permissive conditions excluded IgG
suggesting a sorting mechanism specific for proteins secreted by the
regulated pathway (Gerdes et al., 1989). Treatment of gonadotrophin-
secreting cultures with ammonium chloride or similar agents has not been
reported but this may elucidate an aggregative role of Sgll in retention of
LH.
CgA and CgB have also been shown to interact with secretory membranes
(Kang & Yoo, 1997; Yoo & Kang, 1997) and CgA more specifically with the
membrane-bound 1,4,5-trisphosphate receptor (IP3-R) (Yoo & Lewis, 1994)
and CPE (Cool et al., 1997). Truncated forms of CgA and CgB as well as
specific peptides were used to determine key regions in the granin
structure involved in membrane interactions. Truncated CgA proteins
lacking the N-terminal region l-39aa which contains the conserved
sequence IVEVI SDTL SKP S PMPVSKE (18-37aa) failed to bind membrane-
containing columns at pH5.5 (Kang & Yoo, 1997). Membrane-binding by
CgB was stronger than that of CgA as increasing the pH from 5.5 to 7.5 in
conjunction with 1M KC1 was required for elution. Although truncated
proteins lacking the conserved l-48aa failed to bind the membrane-coated
column, proteins lacking the C-terminal residues at 450-626aa exhibited
only 50% of the binding shown by the intact molecule. It was suggested
that the carboxy-terminal region of CgB may be involved in
intramolecular interactions determining amino-terminal conformations
integral in membrane binding (Yoo & Kang, 1997)
The intramolecular disulphide bond of CgB between residues 16 and 37,
which although critical for sorting to the regulated pathway (see below),
is not crucial for aggregation under in vitro conditions equivalent to those
found in the TGN (Chanat et al., 1994). The lack of sorting to a regulated
pathway in PC-12 cells suggests that conformational integrity imparted by
the disulphide bond facilitates binding to an as yet uncharacterised
receptor involved in protein sorting (Chanat et al., 1994). These results are
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not to be confused with those published in the paper by Yoo and Kang
which demonstrate that the N-terminal peptide corresponding to residues
16 to 37 bind the vesicle membrane at pH5.5 (Yoo & Kang, 1997). This pH is
equivalent to values within the secretory vesicle, as opposed to pH6.4 and
lOmM [Ca++]i which is equivalent to the TGN.
The IP3-R is a 260kDa eight transmembrane region receptor/Ca++ channel
located on secretory granules (Furuichi et al., 1989). CgA binding is
specific to four residues on the second intraluminal loop of the IP3-R and
may bind via an amino-terminal motif leaving more dynamic regions free
to interact with other granins, secretory proteins and Ca++ (Yoo & Lewis,
1994).
A conserved region at 40-55aa within CgA corresponds to a calmodulin-
binding region and shows complete conservation between all CgA
molecules. The binding to calmodulin is Ca++ dependent with a dissociation
constant of 17nM which is comparable with other calmodulin-binding
proteins (Yoo, 1992).
The functional implications of these structural characteristics and
interactions within the regulated secretory pathway will be discussed in
the following section.
1.6.5 Intracellular Roles
The two main putative intracellular roles for granins are protein sorting
and granulogenesis (Iacangelo & Eiden, 1995). A third role relating to
granule structure is that of [Ca++]j mobilisation during exocytosis (Yoo &
Lewis, 1994). This final role may be particularly significant in light of in
vivo evidence for the absence of conventional calcium sensors such as
synaptotagmin in rat gonadotrophs (Jacobsson & Meister, 1996).
Functional studies of CgA and CgB using in vitro aggregation and
conformational analyses by Yoo et al (1995) have led to the suggestion that
the two granins work in concert during granulogenesis. The high Ca+ +
sensitivity of CgB may predispose it to form aggregates before CgA prior to
entering the TGN. Furthermore the greater affinity of CgB, in comparison
with CgA, for membranes suggests that it may bind the lipid envelope
before CgA. Membrane interactions have not been reported for Sgll
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although, like CgA and CgB, it does exhibit pH- and Ca+ + -dependent
aggregation (Cierdes et al., 1989).
Co-aggregation of CgA and CgB when mixed in permissive conditions may
not be surprising. Co-aggregation of otherwise non-aggregative proteins
of physiological relevance such as LH suggests a clear role for granins.
Adrenal extracts containing CgA induced aggregation of pituitary samples
containing LH in the presence of 25mM Ca++ at pH5.8. PRL aggregation
appears to occur spontaneously in the same conditions whereas
aggregation of processing enzymes such as dopamine (3-hydroxylase and
peptidyl glycine a-amidating monooxygenase is CgA-dependent (Colomer
et al., 1995). The specific nature of the coaggregative qualities of granins
is illustrated by the observation that neither CgA or Sgll induce
aggregation of proteins such as IgG which are normally secreted via the
constitutive pathway (Colomer et al., 1995; Gerdes et al., 1989).
A sequential and co-operative aggregation of secretory proteins may
occur, CgB the first to undergo conformational change in response to
increased pH and Ca++ binds the c/s-Golgi membrane and aggregates with
itself and subsequently CgA. CgA aggregation and tetramerisation may
allow interaction with a large number of secretory proteins within the
TGN lumen. Binding of Ca++ by CgA exposes hydrophobic regions
increasing the likelihood of membrane interactions. 40mM [Ca++]i within
the secretory vesicle causes CgA binding to the second intraluminal loop
of the second messenger receptor IP3-R. Conformational changes induced
by IP3 binding to the IP3-R may be transmitted to CgA. IP3-R and CgA
interactions may facilitate mobilisation of Ca++ from the vesicle lumen in
turn causing conformational changes in CgB which may aid vesicle
collapse during the exocytotic event (Yoo & Albanesi, 1990b). Although the
putative role of CPE as a sorting receptor for CgA has recently been
disproven (Normant & Loh, 1998) it is possible that a similar granin-
specific mechanism may exist. This is suggested by the misrouting of CgB
in which the putative conformational sorting signal had been disrupted
(Kromer et al., 1998). Interestingly this study also demonstrated correct
sorting of CgB when the intact molecule was coexpressed suggesting co¬
operative sorting presumably mediated by aggregation. The colocalisation
of Sgll in the smallest category of gonadotrophin granules (Watanabe et
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al., 1991) which appear to be preferentially released during the LH surge
(Currie & McNeilly, 1995; Thomas et al., 1998) may indicate a role during
the final stages of membrane fusion.
How this proposed scenario fits into the popular model of exocytotic
tethering, docking and fusion (Burgoyne & Morgan, 1993) (see figure
1.7.4a) is unclear but may be addressed during the course of this thesis.
1.6.6 Granin-derived Peptides
Although a considerable number of studies have been undertaken
elucidating the numerous cleavage products of granins and their various
wide-ranging roles (for a recent review see Fischer-Colbrie, 1996), only a
brief summary of the current understanding will be given in the
following section. Figure 1.6.1a summarises the diversity of peptides
produced from CgA, CgB and Sgll.
CgA has the greatest number of derived peptides within the granin family.
In the adrenal medulla 50% of CgA molecules undergo proteolysis whereas
in the anterior pituitary a lower percentage is processed. The reasons for
this difference remain unclear (Barbosa et al., 1991), but may relate to
post-translational processing. Pancreastatin corresponds to residues 240-
288 in the carboxy-terminal region of porcine CgA (Tatemoto et al., 1986;
Iacangelo et al., 1988). Pancreastatin was initially demonstrated as
inhibiting glucose-stimulated insulin release (Tatemoto et al., 1986), and
subsequently for amylase release from the exocrine pancreas (Funakoshi
et al., 1988) and gastric acid from parietal cells (Lewis et al., 1988).
Stimulatory effects of pancreastatin have been reported for glucagon and
L-arginine-stimulated insulin release (Ishizuka et al., 1991). Further detail
concerning inhibition of parathyroid hormone (PTH) and CgA secretion
from the parathyroid gland (Fasciotto et al., 1989) has been elucidated with
regard to transcriptional inactivation and decrease of mRNA stability.
Pancreastatin at concentrations of 10"9 to 10"7M decreased CgA and PTH
secretion by 75% and 93% after only four hours and mRNA abundance
decreased after 12 hours by 87% and 80%. Half-lives of CgA and PTH mRNAs
were reduced from 33hrs to 18hrs and from 38hrs to 20hrs, respectively
(Zhang et al., 1994). Other peptides with similar roles include parastatin
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(347-419aa) and p-granin (l-113aa with phosphorylated Ser81) (Strub et al.,
1997).
Chromogranin A (431 aa)
1-113 124-143 347-419
mm mm


















Figure 1.6.6a: Naturally occurring granin-derived peptides.
Although CgA is the shortest of the granins shown here, it has
the greatest number of derived peptides. The vasostatins (I &
II) have been shown to inhibit endothelin-1. Chromostatin
inhibits catecholamine release whereas pancreastatin,
parastatin and P-granin reduce parathyroid and CgA secretion.
P -granin is similar to vasostatin except that it is
phosphorylated at Ser8 b GAWK is the only peptide derived from
CgB and has yet to be assigned a role. Secretogranin LT and
secretoneurin are both secretagogues for dopamine,
dynorphin B and gamma-aminobutyric acid. The lengths of the
undigested granins shown refer to bovine forms (aa=amino
acids). The peptide sequences are shown amino-terminus to
carboxy-terminus with the filled (black) area corresponding to
the signal peptide.
Chapter One Literature Review 5 1
Other naturally occurring CgA-derived peptides include chromostatin
(124-143aa) which may inhibit the secretion of catecholamines from
chromaffin cells (Galindo et al., 1991) and vasostatins I (l-76aa) and II (1-
113aa) which inhibits the action of endothelin-1 preventing vascular
tension (Aardal & Helle, 1992). Other CgA fragments have been
investigated for roles which range from pro-adhesion (Gasparri et al.,
1997) to antibacterial activity (Strub et al., 1996).
An intracellular role of CgA proteolysis as a competitive inhibitor of the
prohormone convertase PC2 has been suggested (Seidah et al., 1987), and it
is conceivable that a similar role exists for other granins. Indeed SgV
(7B2) has been shown to specifically interact with PC2 in a regulatory
manner (Braks & Martens, 1994).
The main peptide derived from CgB is GAWK (420-493aa) and although its
role has yet to be determined it is used as a marker for pancreatic islet
tumours and pheochromocytoma (Sekiya et al., 1989). Similarly use of the
monoclonal antisera HISL-19 which detects SglV has been used in
diagnosis of medullary thyroid carcinoma (Neuhold & Ullrich, 1993).
Secretoneurin is a 33aa peptide derived from Sgll (154-186aa) which has
been show to stimulate dopamine release from rat striatal slices (Saria e t
al., 1993). Effects of secretoneurin and secretogranin LT (133-151 aa) on
secretion of dynorphin B, dopamine, gamma-aminobutyric acid, glutamate
and aspartate from the rat substantia nigra and neostriatum has revealed
specificities and dose-dependent relationships of these peptides (You et al.,
1996). Other Sgll-derived peptides have yet to be assigned biological
functions although their presence within secretory granules provides a
useful marker for enzymatic activity within the dynamic granule lumen
(Muller & Tougard, 1995; Urbe et al., 1997).
Granin processing within the distinct secretory pathways of gonadotrophs
has yet to be investigated in detail. The interaction of granin-derived
peptides with other granule contents may have distinct regulatory
consequences taken in light of the compelling evidence for inhibition of
secretion in a variety of cell lines.
c
A
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1.7.1 In vitro Studies of Neuroendocrine Secretion
Studies using the recently isolated LPT2 ceU line have focused on exocytosis
(see later) and hormonal priming. This second area of gonadotrophin
research has not been possible until development of this novel cell line
and thus stands alone within this section of the literature review. LPT2
cells treated with four lOnM GnRH pulses per day over four days secreted
progressively more LH each day. The greatest rise in LH release was
apparent after the first GnRH pulse each day with the subsequent pulses
eliciting a much smaller response. This observation suggests that LH
abundance intracellularly is depleted after the first pulse each day and
requires an extended period of non-stimulation to replenish stores. GnRH-
R and LHP gene expression were also altered by GnRH treatment. GnRH-R
mRNA abundance was significantly raised after 3 days of treatment with
0.2nM E2 and 20nM DEX in the absence of GnRH pulses and further
increased by a daily GnRH regime. LHP mRNA was unchanged by steroids
alone but rose significantly in response to GnRH treatment. aGSU mRNA
exhibited no significant change after 3 days of treatment with either
steroids alone or in conjunction with GnRH (Turgeon et al., 1996).
The remainder of this section will be divided into three stages; sorting,
granulogenesis and exocytosis.
1.7.2 Protein Sorting
Sorting is believed to occur within the ER and Golgi apparatus prior to
transport towards the cell surface although definitive proof for pituitary
gonadotrophins has yet to be reported. Using CHO and HepG2 cells Weiland
et al demonstrated that the constitutive pathway is the default route for
protein traffic and requires no specialised signal (Weiland et al., 1987).
Expression of both LH subunits in transfected CHO cells similarly did not
lead to storage via a regulated pathway expressing only unglycosylated
hormone (Bielinska et al., 1994). This is despite recent evidence which
suggests that CHO cells are capable of regulated secretion (Chavez et al.,
1996). Expression of the same constructs in the rat somatomammotroph-
derived GH3 cell line led to storage of LH in an intracellular pool which
was releasable by stimulation with FSK or KC1. Similar expression of hCG
led to storage within the same pool although with less efficiency. The aGSU
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expressed alone was released via the constitutive pathway (Bielinska et al.,
1994). Comparison of LH and FSH secretion from transfected GH3 cells
revealed differential sorting of the two hormones in vitro. Basal secretion
of LH was undetectable by SDS-PAGE whereas FSH was readily observed.
Stimulation of the transfected cells with either KC1 or FSK caused release of
both hormones. However the magnitude of secretagogue-stimulated
release of FSH was far smaller than that of LH indicating more efficient
storage of LH than FSH (Muyan et al., 1994). It may be noted that GH3 cells
express Sgll (Janovick et al., 1995) although the expression of other
proteins involved in the regulated pathway is assumed by the appearance
of storage granules. Nevertheless the presence of at least Sgll further
implicates the granin in storage and release of LH.
The aggregative properties of granins and their colocalisation with
regulated secretory proteins has led to speculation that they are sorting
factors. However, differential sorting of PRL and GH in bovine
somatomammotrophs may occur by preferential self-aggregation
(Hashimoto et al., 1987) whereas LH only aggregates in the presence of
granins in vitro (Colomer et al., 1995). The aggregative characteristics of
LH in the presence of granins and its storage in granin-expressing GH3
cells is compelling evidence for a role of granins in sorting of
gonadotrophins to a regulated pathway.
1.7.3 Granulogenesis
Movement of vesicles by tubulin after release from the TGN was initially
suggested by their interaction in a cell-free system (Sherline et al., 1977)
More recently use of nocodazole which inhibits tubulin polymerisation
has demonstrated the relationship during granule maturation in PC-12
cells (Tooze et al., 1991). Secretion of CgB expressed as a fusion protein with
the green fluorescent protein (GFP) has been shown to occur via a
constitutive pathway in stably transfected Vero cells. Inhibition of
microtubule polymerisation using nocodazole reduced the rate of secretion
for the fusion protein by approximately 50%. Furthermore real-time
visualisation of nocodazole-treated cells showed a significantly reduced
motility of secretory vesicles in comparison to untreated cells (Wacker et
al., 1997).
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The proteolytic processing of Sgll in PC-12 cells transfected with PC2
expressing plasmids, has been used as an indicator for intragranular pH.
The acidity of granules was shown to increase from pH6.3 in immature
secretory granules (ISGs) which is equivalent to that of the TGN, to pH5.0-
5.5 in mature granules (Urbe et al., 1997). In bovine primary cultures of
chromaffin cells, granules have been observed to swell when stimulated
by nicotine or extracellular K+. Granule diameters of 234nm prior to
stimulation increase to approximately 275nm and this increase occurs
prior to fusion with the plasma membrane. Ammonium chloride, which
raises intragranular pH, inhibits 50% of catecholamine secretion by
preventing granule swelling. Ammonium chloride treated chromaffin
cells contain large granules which juxtapose to the PM but do not fuse
efficiently (Ornberg et al., 1995). The observation of granule swelling
prior to exocytosis from gonadotrophs has not been reported, indeed a
trend appears of smaller granules being proximal to the PM (Watanabe et
al., 1991; Currie & McNeilly, 1995). However granule swelling during
regulated secretion of gonadotrophins may now be investigated by similar
ammonium chloride treatment of the LPT2 cell line.
Total granules in a single chromaffin cell number approximately 20000
and out of this population only about 1000 are within lOnm of the PM
(Steyer et al., 1997). The role of actin as a barrier between the stored
granules and the PM has been investigated in cultured lactotrophs from
normal female rats. F-actin which is localised at the periphery of the
lactotroph becomes disassembled at foci after treatment with
secretagogues such as forskolin (FSK) or TRH. Inhibition of this
disassembly by exposure to as little as 50nM dopamine reduces PRL
secretion (Carbajal & Vitale, 1997). The myosin motor and Rho GTPase
activating protein Myr5 has been shown to interact directly with actin
filaments (Mooseker & Cheney, 1995). Scinderin contains two actin- and
two PIP2-binding sites and causes rearrangement of peripheral actin
filaments in chromaffin cells. Peptides designed to bind these sites blocked
Ca + + -induced noradrenaline exocytosis in a dose-dependent manner
(Zhang et al., 1996). Myr5 and scinderin may represent an excellent
candidates for co-ordination of different second messenger signalling
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pathways with actin rearrangements. Following disassembly of a region of
the cortical actin network, the recruited granules move towards the PM.
F-actin barriers and disassembly may play important roles in control of
regulated gonadotrophin release. Evidence for the role of myosin motors
in the movement of granules towards the PM has recently been reported
by the inhibition of LH release in wortmannin-treated rat gonadotrophs.
Both cultured rat pituitary gonadotrophs and aT3-l cells were found to
contain the 20kDa phosphorylation-dependent protein non-muscle myosin
IIB light chain. These results strongly suggest that this myosin motor
plays a role in granule movement during the stages immediately prior to
exocytosis (Rao et al., 1997).
1.7.4 Exocytosis
Much of the work on neuroendocrine exocytosis has involved the use of
primary cultures of bovine chromaffin cells and the adrenal medulla-
derived PC-12 cell line. Three types of experimental approach have been
used to study proteins involved in exocytosis. Microinjection of proteins
into cells during patch-clamp analyses where membrane capacitance
readings may be made which relate to individual fusion events (Burgoyne
& Handel, 1994). Selectively porated cells may be studied by addition of
neurotoxins and implicated proteins prior to stimulation of exocytosis with
Ca++ (Baker & Knight, 1978). Transfection of a marker either transiently or
stably allows the effects of treatments with specific neurotoxins such as
tetanus toxin or secretion of co-transfected gene products to be quantified
(Chung et al., 1995).
Detailed knowledge concerning the temporal assembly of a fusion complex
has been gained using selectively porated chromaffin cells (Baker &
Knight, 1978). Leakage of factors involved in Ca+ + -triggered exocytosis
prevents repeated assays but allows reconstitution of the necessary factors
individually and dissection of exocytotic processes (Sarafian et al., 1987).
In chromaffin cells several key molecules have been identified which
have a role in intracellular membrane interactions. Soluble proteins
include A-ethylmaleimide sensitive fusion protein (NSF) (Block et al.,
1988) and the soluble NSF attachment proteins (SNAPs), a-SNAP and (3-
SNAP (Clary et al., 1990). SNAP receptors (SNAREs) are normally
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membrane-bound and include vesicle-associated membrane protein
(VAMP), synaptosome-associated protein of 25kDa (SNAP-25) and syntaxin
1 (Sollner et al., 1993). Burgoyne and Morgan (1998) have proposed a model
for exocytosis based on use of porated chromaffin cells (figure 1.7.4a). The
key element in this model is that it allows for the separation of proximal
granules into primed and ATP-dependent pools. Primed granules are not
only in close proximity with the PM but are also docked requiring only a
Ca++ flux to trigger ATP-independent fusion (Holz et al., 1989).
Future studies, particularly using mammalian and yeast two-hybrid
systems, may reveal key motifs involved in fusion complex formation.
More traditional biophysical studies measure changes in membrane
capacitance (ACm). Increases in ACm reflect an increase in cell surface
area as a consequence of lipid incorporation into the PM during vesicle
fusion. Reductions in ACm indicate endocytotic episodes reducing the cell
surface area to its pre-exocytotic value. Applying this patch-clamp
methodology Tse et al (1993) have investigated exocytosis from cultured
gonadotrophs. The male rat gonadotroph contains approximately 10 000
granules with a 200nm diameter of which 600 to 1000 are located within
200nm of the PM. Each granule contributes 1.3 femtoFerands (fF) to the PM
capacitance, a 10 second exposure of GnRH caused a ACm of approximately
700fF which relates to an increase in cell surface area of 10% and the
release of 540 granules. The involvement of [Ca++]j during exocytosis was
demonstrated by the absence of ACm in the presence of the calcium
chelator EGTA. The source of calcium involved in triggering exocytotic
fusion was demonstrated as being intracellular by the observation of
increased [Ca+ + ]j after GnRH stimulation in calcium-free media and
secondly the lack of a comparable increase in cumulative ACm in the
presence of extracellular calcium (Tse et al., 1993). Recent studies using
aT3-l cells and video imaging of [Ca++]j using calcium fluorophores has
demonstrated the importance of the biphasic [Ca+ + ]j flux. In accordance
with previous findings by Tse et al (1993) the first spike of [Ca++]j from
intracellular stores was shown to cause exocytosis. Replenishment of these
stores was shown to require the action of voltage-gated channels and
extracellular calcium (McArdle et al., 1996). Voltage-gated release of
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Figure 1.7.4a: A model for neuroendocrine exocytosis (adapted
from Burgoyne & Morgan 1998 and Robinson & Martin 1998).
Initial segregation of the vesicles from the plasma membrane is
achieved by the actin barrier which may be dissolved in a calcium
and ATP-dependcnt manner by as yet undetermined proteins. This
stage may be referred to as a recruitment of secretory vesicles. N-
ethylmaleimide-sensitive factor (NSF) complexed with soluble NSF
attachment protein a (aSNAP) may facilitate changes in SNAP
receptor (SNARE eg. syntaxin) structure in an ATP-dependent
process which permits subsequent membrane interactions. The
first stage of the exocytotic event in this model is tethering which
may be mediated by as yet undetermined cytoskeletal elements.
Docking of vesicles involves interaction of SNAREs on each
membrane and may induce conformational change. In this fully
docked state fusion of the primed vesicles is independent of ATP
requiring only a calcium flux. A further role of NSF and aSNAP
may also exist alter exocytosis in the recycling of vesicle
membrane proteins to the ER and TGN.
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calcium failed to trigger exocytosis despite a rise in [Ca+ + ]j equivalent to
that which causes exocytosis in chromaffin cells (Augustine & Neher,
1992). Speculation that calcium released from voltage-gated stores may not
be in close proximity or is segregated from the area at which vesicle
fusion occurs in gonadotrophs explaining the lack of response exhibited
by the pituitary cell (Tse et al., 1993). Another possibility may be that
chromaffin granules have voltage-gated channels whereas gonadotroph
granules do not.
Certainly chromaffin granules have been demonstrated to contain the IP3-
R/Ca++ channel which interacts with CgA (Yoo & Lewis, 1994) but as yet
the same has not been demonstrated in gonadotrophs.
GnRH-stimulated exocytosis has been demonstrated to be dependent on the
GTP-binding Rab3B protein in cultured rat gonadotrophs. Antisense
oligonucleotides (AS) directed against Rab3B reduced the percentage of
cells expressing the protein from 94.6±1.7 to 70.8±2.8%. In Rab3B-negative
cells exocytosis (measured using the fluorophore TMA-DPH) was reduced to
less than 20% of control cells without adversely affecting LH expression or
[Ca + + ]j . RIA of secreted LH and FSH from AS-treated populations
demonstrated an approximate 20% decrease in basal and GnRH-stimulated
release of both gonadotrophins (Tasaka et al., 1998). Although the exact
mechanism by which Rab3B mediates GnRH-induced and basal exocytotic
events has yet to be determined, these data clearly shows that Rab3B is
crucial for secretion of each pituitary gonadotrophin via constitutive and
regulated pathways.
Exocytosis in the LPT2 ceH line has been limited so far to a single report. In
this study the exocytotic response of single cells was measured using ACm .
The effect of E2 and DEX on LH release was found to be critical. Although
cells treated with GnRH in the absence of 0.2nM E2 and 20nM DEX did elicit
a rise in [Ca++]j , a significantly smaller ACm was observed than in E2/DEX-
treated cells. The authors suggest that this data represents mediation of the
exocytotic response by E2 through sensitisation of the fusion machinery
(Thomas et al., 1996). Future studies using this cell line may elucidate the
role of actin, exocytotic machinery and granins within this model.
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1.8 Summary
This chapter has described the oestrus cycle of the ewe and described the
major differences to those of rodents illustrating the physiological
importance of gonadotrophins in reproduction. Clearly LH and FSH fulfil
specific but related roles which is reflected in their relative abundancies.
Control of their expression in gonadotrophs is complex and represents co¬
ordinate regulation by the hypothalamic decapeptide GnRH, steroids and
gonadal peptides within the hypothalamo-pituitary-gonadal axis.
Posttranslational control of LH and FSH expression also influences
bioactivity and release. Intracellularly this is manifest by the appearance
of small (<200nm) electron-dense secretory vesicles containing LH and
SgIL These represent the regulated secretory pathway in which LH is
stored until release in massive quantities during the LH surge through
which its biological role of inducing ovulation may be achieved. The
growth and selection of follicles does not require large releases of FSH
from the pituitary therefore secretion occurs predominantly via the
constitutive pathway. Posttranslational sorting of gonadotrophins to the
different secretory pathways may be mediated by Ca+ + -binding
aggregative proteins known as granins. Colocalisation of specific granins
during distinct stages of gonadotrophin granulogenesis as well as
induction of LH aggregation in vitro implicates them in this process. CgA
and CgB appear to be involved in the aggregation and sorting of
gonadotrophins with Sgll perhaps fulfilling a role during the latter stages
of secretion. A specific role for the abundant granin-derived peptides has
yet to be assigned within the gonadotroph. Regulation of granin
expression may involve several intracellular signalling pathways as
suggested by the multiple transcription factor binding elements within
their promoters. CgA in particular appears to be upregulated in response
to testosterone. Other biologically relevant responses of granin expression
have yet to be determined in vivo. Exocytosis from gonadotrophs is
triggered by [Ca+ + ]j fluxes and appears to involve conserved molecular
machinery expressed in other neuroendocrine tissues. SNAREs have been
implicated by their presence in gonadotrophs in vivo yet unlike Rab3B,
their functionality remains to be demonstrated.
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Clearly studies of gonadotropin secretion have, and continue to be
undertaken, using widely different approaches both in vivo and in vitro.
It is also apparent that through these diverse studies physiologically
relevant molecular data regarding the enigma of differential
gonadotrophin secretion is being obtained.
1.9 Scope of this Thesis
These studies aim to investigate the mechanisms involved in the
intracellular processing of pituitary gonadotrophins with particular focus
on the putative roles of CgA, CgB and Sgll in gonadotrophin sorting and
aggregation. In order to carry out these investigations a predominantly in
vitro approach will be complemented by in vivo studies using normal and
transgenic mice.
Gonadotrophin-secreting cell lines are limited with only the placentally-
derived JEG3 and recently characterised pituitary-derived LPT2 cell line
currently available. The human JEG3 cell line secretes CG presumably via a
constitutive pathway (Kohler & Bridson, 1971) whereas murine LPT2 cells
store and secrete LH under control of GnRH (Thomas et al., 1996). Use of
these relatively complex cell lines will be balanced by studies using the
CHO cell line (Puck et al., 1958) which is of non-neuroendocrine origin. An
immediate aim of this thesis is to develop an in vitro expression system
that will permit the study of gonadotrophins and granins within these
three cell lines. Assessment of the effects of granins on gonadotrophin
overexpression in each of these cell lines will be carried out using
conventional biochemical techniques in conjunction with indirect
immunofluorescence and fluorophore-fusion protein expression.
1.10 Layout of this Thesis
The following chapter will detail materials used and general methodology
employed throughout this thesis. Appendices I and II contain details
regarding buffers and suppliers respectively.
The five main experimental chapters follow chapter two. The first of these
details design and isolation of specific mammalian expression constructs
used in the subsequent three chapters. Chapters four, five and six contain
studies carried out using the JEG3, CHO and LPT2 ce'l lines respectively. The
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final experimental chapter focuses on investigations carried out on
normal and transgenic murine gonadotrophs in vivo. After the
experimental chapters a general discussion will follow in which the main
findings of this thesis will be developed into a model of gonadotrophin
secretion. Questions raised by this model will be used to propose possible
approaches for future studies of gonadotrophin secretion.
Chapter Two
General Materials and Methods
2.1 Introduction
This chapter details routine methods used to manipulate DNA, culture
various mammalian cell lines as well as more general laboratory
procedures. The composition of routinely used buffers can be found in
Appendix I and a complete list of suppliers is contained in Appendix II.
Control of substances hazardous to health (COSHH) safety guidelines for the
handling of hazardous chemicals and biohazardous materials were
followed. Where indicated this required the use of fume hoods, sharps bins,
special areas for use of radioisotopes and a Level II biocontainment
cabinet. Operator protection often required the use of one or more of the
following; laboratory coats, latex gloves, protective eyewear and a lead
apron.
2.2 General Materials
General chemicals were purchased from Merck-BDH (UK) and were
AnalaR grade for use in molecular biology techniques. Water was double
distilled and deionised prior to autoclaving for use in molecular biology
techniques. Autoclaving of solutions was not carried out for less stringent
methods such as immunocytochemistry.
The tables below contain details of specialised materials used and are
grouped into general areas of methodology.
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Table 2.2b: Sources of Clones and Vectors.




pcDNA3.1/His/1 acZ 8.6kb Invitrogen[NLl
pBluescript KS+ 2.96kb Stratagene [USA]
pcDNA3 5.45kb Clontech [UK]
pEGFP-C 1 & pEGFP-C3
carboxy-terminal fusion vectors
4.7kb Clontech [UK]
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full-length oFSHp cDNA in pSP72 4.05kb
(1.59kb)
T.E.Adams [Aus]
oFSH|3 genomic clone with HSV-IE




pHCGA-4 (pGEM3 with full length




pbChrB73 (pcDV-1 with full length




pbSgII61 (pcDV-1 with full length




Table 2.2c: Molecular Biology Kits
Kits Supplier
Hybaid Recovery (DNA purification
kit II)
Hybaid [UK]
MoBio UltraCleanTM MiniPrep Kit CamBio rUKl
Qiagen Endofree™ Plasmid Kit Oiagen TUK1
Qiagen Gel Purification Kit Oiagen rUK]
Titan™ RT-PCR kit Boehringer Mannheim [UK1
Wizard Plus™ MiniPrep Kit Promega [UK]
Ready-to-Go™ ligase tubes Pharmacia [UK1




ECL/ECF Western blotting kits Amersham [UK1
r<?4:PRIME™ DNA labelling system Amersham Life Sciences fUK]
Table 2.2d: Mammalian Cell lines and Materials.
Mammalian Cell Culture Source
Chinese Hamster Ovary (CHO) cell
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JEG3 human choriocarcinoma cell
line (ECACC number 92120308)
ECACC [UK]




Dulbecco's Modification of Eagle's
Medium (DMEM)
Sigma-Aldrich [UK]
Pipette pump Jencons [UK]
Inverted Light Microscope Olympus [UK]
Soldering Iron Merck (BDH) TUK1




G418 solution Sigma-Aldrich [UK]








DOTAP Boehringer Mannheim [UK]
Clonfectin7 M Clontech [USA]
PerFect™ lipid system Invitrogen [NL]
TfxlO Promega TUK]
Multiwell tissue culture plates (48,
24, 12 & 6 well varieties)
CoStar [UK]
NUNC 1.8ml Cryotubes Gibco BRL TUK]
Tissue Culture Flasks
(1 62cm2,75cm2 & 25cm2 sizes)
CoStar [UK]




ocGSU (R20) rabbit A.S. McNeilly [MRC, CRB]








bovine Chromogranin A rabbit R. Fischer-Colbrie [Austria]
bovine Chromogranin B rabbit R. Fischer-Colbrie [Austria]
human FSH (M91) rabbit A.S. McNeilly [MRC, CRB]
bovine LH
(clone 518B7)
mouse J. Roser [USA]
human Secretogranin II
(clone C-19)






Bodipy 630/650 Molecular Probes [NL1
Citifluor UKC ruKi
Goat anti-rabbit FITC conjugate Sigma-Aldrich [UK]
Goat anti-rabbit TRITC conjugate Sigma-Aldrich [UK]
Goat anti-mouse FITC conjugate Sigma-Aldrich [UK1
Goat anti-mouse TRITC conjugate Sigma-Aldrich [UK]
Propidium Iodide Sigma-Aldrich [UK1
Normal Rabbit Serum SAPU rUKl
Donkey anti-Rabbit Serum SAPU [UK]
Table 2,2g: Specialised Computer Software.
Specialised Computer Software Source
AssayZap P.Taylor [MRC, CRB1
Adobe Photoshop 5 MacWarehouse [UK]
LSM 510 Zeiss [UK]
Chapter Two General Materials and Methods
GGG MRC Human Genome Mapping
Project (HGMP) Internet Resource
GeneJockey II P.Taylor [MRC, UK1
ImageQuant Molecular Dynamics [UK1
Microsoft Excel version 4.0 MacWarehouse TUK1
GB-Stat version 6.5 Dynamic Microsystems [USA1
StatView version 4.02 MacWarehouse fUKl
2.3 Molecular Biology
2.3.1 Restriction Endonuclease Digestion
Restriction enzymes and buffers were obtained from Boehringer
Mannheim (UK), MBI Fermentas (UK) or Promega (UK) and were used in
accordance with the manufacturers guidelines. Enzyme reactions
contained 2-3 units of enzyme per pg of DNA, the volume of enzyme added
did not exceed 10% of the total reaction volume and the reaction was mixed
by gentle flicking before incubation.
2.3.2 Agarose Gel Electrophoresis
Separation of DNA molecules on agarose (Agarose MP; Boehringer
Mannheim, UK) gels allowed visual confirmation of DNA size and
concentration. Gel concentrations varied from 0.8% to 2% depending on
the size of the molecules to be separated. Low concentration gels, used for
separating plasmid DNA, were buffered in TAE (40mM Tris acetate, ImM
EDTA pE18) whereas TBE buffer (45mM Tris borate, ImM EDTA pH8) was used
for high resolution of DNA fragments typically less than 500bp in length.
Ethidium bromide (Sigma-Aldrich, UK) was added to both the gel and the
running buffer at a final concentration of 0.5pg/ml. When using TAE
buffeied gels, samples were loaded with lOx Blue loading butter (see
Appendix I). 6x OJ loading buffer (see Appendix I) was used for higher
concentration TBE buffered gels. Hin dill or H i n dill/E c oRl restricted
Lambda bacteriophage genome was used as molecular size markers for
comparison with restriction digests. Estimation of DNA concentration was
also carried out by comparison with these markers. Products from reverse
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transcriptase polymerase chain reactions (RT-PCRs) were compared with
lOObp molecular size markers (Promega, UK). Voltage applied to the gel
varied from 1.5-2.0mV/cm for overnight applications to 8-10mV/cm for
30-90 minutes dependent on the size of fragments to be resolved.
Visualisation of DNA in the presence of the fluorescent intercalating
agent ethidium bromide was undertaken using an ultraviolet
transilluminator (302nm wavelength). Photographs were taken using a
Polaroid 667 camera.
2.3.3 Extraction of DNA from Agarose Gel
Removal of contaminating polysaccharides and ethidium bromide from
DNA separated in agarose gels was necessary because these components
inhibit the activity of enzymes used in downstream applications. Three
methods were used to extract DNA fragments separated by agarose gel
electrophoresis; Spin-X tubes (CoStar, UK) Hybaid Recovery II (Hybaid, UK)
and Qiagen Gel Purification kit (Qiagen, UK). All kits were used in
accordance with the manufacturers guidelines.
2.3.4 Phenol Chloroform Extraction
Phenol chloroform extraction separates nucleic acids from proteins and
was used for purification of DNA after enzymatic treatment. Low volume
samples were increased to 500pl with TE buffer (lOmM TrisHCl ImM EDTA,
pH8) to minimise sample loss in subsequent manipulations. During all
transfers of the aqueous phase careful attention was made to avoid contact
with the interphase to prevent protein contamination. It should also be
noted that handling of phenol, like all hazardous chemicals, was in
accordance with COSHH guidelines.
An equal volume of TE-saturated phenol was added, then the sample was
vigorously vortexed followed by centrifugation at 13000 rpm for 5 minutes
in an Heraeus Sepatech Biofuge 13. The upper aqueous phase was then
transferred to a separate microcentrifuge tube. Subsequently a half
volume of phenol was applied to the transferred aqueous phase and again
vortexed. A half volume of chloroform was then added to the mixture and
vortexed to remove phenol from the nucleic acid fraction. Centrifugation
was repeated and the aqueous phase transferred. To completely remove
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phenol from the nucleic acid fraction chloroform was added in an equal
volume. After a 2 minute centrifugation and transfer of the supernatant
the purified DNA-containing solution was returned to ice where
precipitation and concentration followed as detailed below.
2.3.5 Precipitation of Nucleic Acids
Precipitation of nucleic acids followed the method of Shapiro (Shapiro,
1981). For this application 2 volumes of absolute ethanol and 0.3M sodium
acetate pH 5.2 were used. The precipitating sample was incubated at -20°C
for at least 30 minutes before it was centrifuged for 15 minutes at
13000rpm and 4°C in an Heraeus Sepatech Biofuge 22R with HFA 22.2 rotor.
The pellet was then washed to remove any residual salts. This was achieved
by vortexing in 70% ethanol followed by centrifugation for 5 minutes.
This step was repeated before the pellet was air-dried and resuspended in
an appropriate volume of TE buffer. Preparations were stored at -20°C.
2.3.6 Dephosphorylation of Linear DNA
In order to form a phosphodiester bond between two bases of the same DNA
strand DNA ligase requires adenosine triphosphate (ATP) and a 5'-P04~ and
a 3'-OH group on each DNA strand (Legerski & Robberson, 1985). Removal
of the 5'-P04" groups from linearised plasmids prevents religation and
formation of a circular DNA structure. Linear DNA strands are poorly
transformed into competent bacteria in comparison to covalently-closed
circular DNA structures. These factors are exploited in ligation of DNA
sequences with compatible 5' and 3' ends.
Removal of 5'-P04" groups was initially undertaken using calf intestinal
phosphatase (CIP; Boehringer Mannheim, UK) however the recently
available shrimp alkaline phosphatase (SAP; Boehringer Mannheim, UK)
was subsequently used. Both enzymes are efficient dephosphorylation
enzymes but SAP has the advantage of being more easily heat inactivated.
Residual CIP activity is often present after incubation at 65°C thus
preventing insert ligation due to continued dephosphorylation.
Use of CIP and SAP was in accordance with manufacturers guidelines
except ten times more enzyme was used per reaction to ensure complete
removal of 5'-P04_ groups.
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Inactivation of CIP was achieved by incubation at 56°C for 30 minutes in
the presence of 0.5% SDS, lOOmg/ml Proteinase K (Sigma-Aldrich, UK) and
5mM EDTA.
2.3.7 DNA Ligation
Ligation of DNA fragments with cohesive or 'sticky' ends is more efficient
than blunt-ended ligations of DNA. Sticky-ended fragments are
characterised by overhanging 5' or 3' single-stranded DNA (ssDNA). T4
DNA ligase catalyses ligation of both types of DNA fragments. For all
ligations Ready-to-Go™ ligase tubes (Pharmacia, UK) containing 6 Weiss
units of lyophilised T4 DNA ligase were used in accordance with the
manufacturers guidelines unless stated. These tubes also contain
polyethylene glycol so as to promote interactions of DNA termini by
macromolecular crowding.
Calculation of the amount of vector and insert DNA to be included in the
reaction was determined by a ratio of 3:1 for the insert to vector termini.
The amount of insert DNA to be added to the 50ng (lOOng for blunt-ended
ligations) of vector was estimated as a function of their relative lengths.
For example, ligation of an 600bp insert into a 5400bp vector would require
nine times more vector than insert (i.e. 50ng:5.6ng) in order to give a ratio
of 1:1 DNA termini as the vector is nine times the length of the insert.
Flowever, for a 3:1 ratio of insert to vector required to give optimal
recombinant formation 16.7ng of the insert is required. These
approximations were based on studies by Legerski & Robberson (Legerski
& Robberson, 1985).
Either two or three control reactions were performed during ligations
dependent on the ligation being attempted. Linearised vector in the
absence of the insert fragment and without T4 DNA ligase was incubated
under normal ligation conditions. Linearised DNA is poorly transformed
into competent bacteria so any colonies formed indicate the presence of
undigested vector within the ligation. During ligation of phosphatase-
treated linearised DNA a similar reaction was performed under the same
conditions in the presence of T4 DNA ligase. This second control was
essential for determining the efficiency of 5' dephosphorylation which
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when low leads to a high background of self-ligated vectors. The final
control reaction contains linearised plasmid with compatible ends which
is incubated in the presence of T4 DNA ligase. This reaction demonstrates
the efficiency of the ligase reaction.
2.3.8 Bacterial Transformation
Bacterial transformation requires that the cells be competent. Competency
relates to the propensity of the bacteria for DNA uptake and may be
induced by chemical means.
An overnight culture of an appropriate E.coli strain in LB broth was
grown at 37°C with vigorous incubation. 200pl of this culture was then
used to inoculate 50mls of fresh LB broth. This culture was incubated until
the optical density (OD) at a wavelength of 600nm reached 0.3-0.5. Cells at
this OD were in the logarithmic stage of growth critical for the
preparation of competent cells. The cultures were centrifuged in an
Heraeus Sepatech Megafuge 1.0 with swing-out rotor at 3000rpm for 10
minutes at 4°C. The bacterial pellet was resuspended in 5ml of solution CM1
(lOmM NaAc pH5.6 , 5mM NaCl & 50mM MnCL) and incubated on ice for 20
minutes. Centrifugation was repeated and the bacterial pellet resuspended
in solution CM2 (lOmM NaAc pH5.6, 5% glycerol, 70mM CaCL & 5mM MnCl2)
before incubation on ice.
Transformation of these cells was undertaken immediately using l-3pl of a
ligation reaction. The DNA and bacteria mixture was incubated on ice for
30 minutes prior to heat shock at 42°C for 90 seconds which promotes DNA
uptake. The cells were then returned to ice for 2 minutes, 1ml of room
temperature LB broth was added and the cells were then incubated for 1
hour. 50-200pl of this culture was spread on LB agar plates containing the
appropriate antibiotic, left to dry for 10 minutes at room temperature
before overnight incubation at 37°C.
Competent cells of various Escherichia coli K12 strains including JM109
(GibcoBRL, UK) (Yanisch-Perron et al., 1985), DH5a (GibcoBRL, UK)
(Hanahan, 1983) and Epicurian Coli SURE2 (Stratagene, USA) were used in
accordance with manufacturers guidelines. Transformation of these
strains was undertaken by essentially similar means involving incubation
on ice and heat-shock.
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All competent cells used were deficient in the recA recombination enzyme.
In addition to this, SURE2 competent cells were also deficient in an enzyme
pathway involved in recombination of DNA cruciform structures (formed
by inverted repeats) and Z-DNA sequences (formed by alternating
sequences of purines and pyrimidines) (Gough & Murray, 1983). If no
transformants were obtained with JM109 or DH5a competent cells, possibly
due to formation of DNA cruciforms and Z-DNA, then SURE2 cells were
used.
A control transformation was always undertaken to assess the competency
of prepared or supplied cells, lng of pGEM3 plasmid was added to the
transformation mixture as described above. For certain high competency
cells such as the SURE2 strain only lOpg of pUC18 was added in accordance
with manufacturers guidelines.
2.3.9 Preparation of Bacterial Glycerol stocks
Long-term storage of bacterial stocks was undertaken at -70°C by addition
of a solution containing 40% glycerol, lOmM MgS04 and 0.5% NaCl to an
equal volume of a fresh overnight stationary phase bacterial culture.
2.3.10 Isolation of Plasmid DNA
Plasmid DNA was isolated from bacterial cultures of 3-5 ml (minipreps) and
500ml (megapreps) volumes. All cultures contained the appropriate
antibiotic for the plasmid used and were incubated at 37°C for
approximately 16 hours with vigorous agitation. Either ampicillin (Sigma-
Aldrich, UK) at 100pg/ml or kanamycin (Sigma-Aldrich, UK) at 30pg/ml
were used depending on the selection marker present within the vector,
a) Minipreps
For isolation of limited quantities of plasmid DNA (<50pg), small 3-5 ml
cultures were harvested using the MoBio UltraClean™ (CamBio, UK)
miniprep kit. The following modifications were made to the manufacturers
guidelines. All centrifugation steps were performed for a minimum of 2
minutes. Furthermore, despite using only 1.5ml of culture, centrifugation
after addition of the binding buffer (solution 3) required extension to 10
minutes to prevent the appearance of a flocculant solution.
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b) Megapreps
Two methods were used when large-scale isolation of plasmid DNA was
required for application in transfection procedures (see section 2.4.8). The
Qiagen Endofree Megaprep kit was used in accordance with the
manufacturers guidelines.
The use of caesium chloride-ethidium bromide density gradient
centrifugation was also carried out for preparation of high purity DNA
(Sambrook et al., 1989).
500ml of LB broth was inoculated with 1ml of a preculture inoculated
approximately 24 hours earlier. Cultures were transferred to 250ml
Nalgene centrifuge tubes and centrifuged at 6 000 rpm for 10 min at 4°C
using a JA-14 fixed angle rotor in a J2-21 Beckman centrifuge. The
bacterial pellets were gently resuspended in a total of 36ml of buffer PI
(lOOpg/ml RNase A, 50mM TrisHCl pH8, lOmM Na2EDTA pH 8) to prevent
complete rupturing of the cell membrane which may allow release of
genomic material. 36ml of buffer P2 (0.2N NaOH, 1% SDS) was then added to
the suspension and incubated for exactly 5 minutes at room temperature.
This alkali buffer partially lyses the cell membrane allowing release of
the relatively small plasmid DNA while retaining the larger unwanted
genomic material. Addition of 36ml of chilled buffer P3 (3M KAc pH5.5)
and incubation for 15 minutes on ice neutralises the alkali lysis reaction
and reduces the viscosity of the lysate. Centrifugation for 20 minutes at
7000 rpm and 4°C followed. The supernatant was carefully filtered through
Miracloth (20-25pm pore size; CamBio, UK) to produce a transparent
solution containing the plasmid DNA. This DNA was transferred to 14ml
Falcon centrifuge tubes and precipitated by addition of 0.6 volumes of
isopropanol. After gentle mixing the samples were centrifuged using a JA-
20.1 aluminium fixed angle rotor in the same centrifuge for 20 minutes at
10 000 rpm. The pellet was then resuspended in TE buffer and phenol
extracted. Plasmid DNA was precipitated at -20°C for at least 15 minutes in
the presence of 10% volume of 3M NaAc pH5 and 2 volumes of 100%
ethanol. At this stage samples were accumulated and processed when
sufficient numbers existed to fill the ultracentrifuge rotor (see later). The
precipitated sample was then centrifuged for 5 minutes at 10 000 rpm and
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4°C before repeated washing with 70% ethanol. The translucent pellet was
resuspended in 2ml of TE buffer and stored on ice during the following
preparatory stages.
Preparation of the caesium chloride (Boehringer Mannheim, UK) gradient
was carried out as follows. Exactly 11.2ml of sterile water was added to a
14ml screw-cap centrifuge tube and the meniscus carefully marked on the
side of the tube then the water was discarded. CsCl (9.46g) was weighed into
the tube then the DNA sample, 500pl ethidium bromide (lOmg/ml; Sigma-
Aldrich, UK) and TE buffer were added until the solution reached the
11.2ml mark made previously. The plasmid solution was then added to
duplicate 6ml ultracentrifuge tubes (model 03945-7K04; Sorvall, UK) so that
the volume reached the neck of the tube. Crimped tubes were then
weighed and balanced against each other with each having a weight of
approximately 10.8g. The balanced ultracentrifuge tubes were loaded into a
TV-1665 titanium rotor which was then sealed with 2001bs per square inch
of torque. The samples were then centrifuged in a Sorvall UltraPro 80
ultracentrifuge at 225000 g for 16 hours at 20°C. The ultracentrifuge was
programmed in accordance with the manufacturers guidelines so that the
rotor decelerated slowly allowing gradual reorientation of the DNA band.
This step ensured that a distinct band was formed which allowed easy
visualisation and removal under ultraviolet light.
Using a low wavelength ultraviolet light source (254nm) to minimise DNA
crosslinking the plasmid DNA band was located and removed using an 18-
gauge needle attached to a 5ml syringe. The plasmid DNA band was always
below any contaminating genomic material. RNA molecules and proteins
which had formed a pellet on the side of the tube were avoided during the
removal process. Isolated plasmid DNA was transferred to a 14ml screw-cap
centrifuge tube to which an equal volume of CsCl-saturated isopropanol
was added. Vigorous shaking and removal of the upper phase was repeated
until the red coloration of ethidium bromide was no longer visible. The
lower phase was transferred to a 14ml screw-cap centrifuge tube which
was subsequently filled with 70% ethanol, mixed and precipitated at -70°C
for 20 minutes. Prior to centrifugation for 10 minutes at 7000rpm and 4°C,
the sample was warmed by hand for 2-3 minutes to resolubilise any
coprecipitated salts. The pellets were then transferred to microcentrifuge
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tubes and washed twice in 70% ethanol before air drying of the DNA pellet
and resuspension in 1ml of TE buffer. After a final phenol extraction the
DNA was again precipitated in 300mM NaAc pH5 and 100% ethanol before
two washes in 70% ethanol and resuspension in 1ml of TE buffer, lpl of the
purified plasmid was analysed after electrophoresis on a 0.8% agarose gel
and by spectrophotometrical analysis at 260 and 280nm.
2.3.11 Spectrophotometrical Analysis of Nucleic Acids
The amount and quality of purified nucleic acids was assessed by analysis
of optical density (OD) at two ultraviolet wavelengths, 260 and 280nm. At
260 nm nucleic acids are detected where an OD equal to 1 is equivalent to
50pg/ml of double-stranded DNA or 40pg/ml of ssDNA or RNA. OD readings
at 280nm indicate the presence of other high molecular weight molecules
including proteins and carbohydrates. High quality preparations should
possess a 260:280 ratio of approximately 1.8 for DNA and 2 for RNA. For
transfection procedures only purified DNA with a 260:280 ratio between 1.7
and 1.8 was used.
2.3.12 Guidelines for use of RNA
RNA molecules are subject to nuclease digestion by RNases. A variety of
RNases are present on skin therefore vigilant use of gloves during RNA
application was carried out at all times. RNases are particularly resistant to
heat inactivation thus autoclaving alone is not sufficient to ensure their
destruction. RNase-free pipette tips containing filters (Promega, UK) were
used for all transfers of liquids. Solutions for use in RNA applications were
treated with 0.1% of the RNase inhibitor diethyl pyrocarbonate (DEPC)
(Fedorcsak & Ehrenberg, 1966) and left to evaporate overnight in a fume
hood prior to autoclaving. RNA preparations were kept on ice while in use
and were stored at -70°C.
2.3.13 Extraction of RNA
RNA is comprised of three subtypes; messenger RNA (mRNA), transfer
RNA (tRNA) and ribosomal RNA (rRNA). RNA was extracted from cell lines
using Tri-reagent (Sigma-Aldrich, UK) in accordance with the
manufacturers guidelines.
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Media was removed from the cultures followed by washing with Dulbecco's
phosphate buffered saline (DPBS). 1ml of Tri-reagent was added per cm2 of
culture surface immediately lysing the cells. The lysate was then
transferred into microcentrifuge tubes and incubated at room temperature
for 5 minutes. 200pl of chloroform was added per ml of lysate and the tubes
were then vigorously shaken for 15 seconds. After incubation at room
temperature for a further 10 minutes, the tubes were centrifuged for 15
minutes at 4°C and 13000rpm in an Heraeus Sepatech Biofuge 22R with HFA
22.2 rotor. The aqueous phase was then transferred and an equal volume of
isopropanol added before mixing and incubation at room temperature for
10 minutes. Following further centrifugation the pellets' were washed
twice in 75% ethanol, air-dried and resuspended in DEPC-treated sterile
water. The purity of the RNA preparation was assessed by
spectrophotometrical analysis as described in section 2.3.11.
2.3.14 Reverse Transcriptase Polymerase Chain Reaction
This modification (Mocharla et al., 1990) of the polymerase chain reaction
(PCR) (Mullis et al., 1986) utilises the viral enzyme reverse transcriptase
(RT) to produce template DNA for amplification by PCR. During these
studies the Titan™ kit (Boehringer Mannheim, UK) was used in
accordance with the manufacturers guidelines with the following
modifications. Elongation steps were performed at 72°C which is /I°C
higher than the recommended temperature. This modification aimed to
reduce amplification of non-specific fragments. The Titan™ kit contains a
mix of three enzymes; the avian myeloblastosis virus (AMV) RT, Taq DNA
polymerase and the high fidelity DNA polymerase Pwo. Pwo DNA
polymerase has a proof-reading capability which compensates for the
relatively high error rate of Taq polymerase which is one base
approximately every 1000 bases.
2.3.15 Oligonucleotide Primer Design
Oligonucleotides were designed specifically for use in RT-PCR using a
combination of the GCG (MRC HGMP resource) and GeneJockeyll computer
software programs (P.Taylor, MRC CRB). When designing the requisite pair
of specific oligonucleotides several guidelines were observed.
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Firstly the length of the molecules was constrained to between 18 and 22
bases. The melting temperature (Tm) of the oligonucleotide dimer was
designed to be between 55 and 65°C where possible and was estimated using
the calculation below.
Tm = (G+C x 4°C) + (A+T x 2°C)
The Tm for each primer in a pair was manipulated by changes in
oligonucleotide length so that the difference in Tm did not exceed 3°C.
A site for hybridisation on the target molecule was chosen where the
presence of two guanosine monophosphate or cytidine monophosphate
bases at the 3' end of the oligonucleotide would allow secure attachment of
the oligonucleotide. This was particularly important for the 3' end as it was
from this terminus that polymerisation occurred.
Using the GCG software, intramolecular annealing was assessed for each
primer. The formation of hairpin loops as depicted in figure 2.3.15a below,
provided a 3' end from which primer extension could be initiated. Primers








C II I I II I I I
tctgggacct
Figure 2.3.15a: Hairpin formation by oligonucleotide primers.
Primers with internal sequence homology may 'self-anneal'
allowing polymerisation without binding to the target sequence.
These hairpin structures were unable to bind the target sequence
and were therefore effectively 'removed' from subsequent rounds of
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Annealing between pairs of primers was also minimised to avoid formation
of primer-dimers (figure 2.3.15b). Reactions in which this occurred were
characterised by the presence of very short DNA sequences and reduced
amplification of the target.
5' 3'
PO4--G CAATCCCGGATGGATCC-OH





3. I I I I I I I II I I II I I II I II I I I 5'
HO-C GTTAGGGCCTACCTAGGTTTG C-PO4-
Figure 2.3.15b: Mmer-dimer formation by oligonucleotide primers.
Pairs of primers with sequence homology may preferentially anneal
to each other allowing polymerisation without binding to the target
sequence. Formation of these short DNA structures prevented primer
binding to the target sequence effectively 'removing' the primers
from subsequent rounds of polymerisation and reducing the
efficiency of the reaction.
By designing primers to target sequences which did not contain more than
three base stretches of the same nucleotide both hairpin-loops and
primer-dimers were reduced.
Although these guidelines were always used, for some target sequences the
high GC content prevented complete compliance.
All oligonucleotides were supplied by Genosys (UK).
2.3.16 Agarose Gel Electrophoresis
under Denaturing Conditions
RNA molecules were separated by denaturing agarose gel electrophoresis.
A 1% agarose gel containing 3-(/V-morpholino)propanesulfonic acid
(MOPS; Sigma-Aldrich, UK) buffer (see Appendix I) and 2.2M formaldehyde
were prepared in a fume hood.
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RNA in final volume of 12pl was mixed with 25pl deionised formamide, 5pl
lOx MOPS buffer (see Appendix I) and 8pl 40% formaldehyde. This mixture
was then heated at 65°C for 5 minutes and cooled on ice before addition of
5pl blue loading dye (Appendix I). Denatured RNA samples were loaded
onto the gel and electrophoresed for approximately 16 hours.
2.3.17 Transfer Of Nucleic Acids to Nylon Membranes
Transfer of DNA to nylon membranes followed the method described by
Southern (Southern, 1975) and was as follows.
As high molecular weight DNA transfers inefficiently from agarose gels,
the genomic DNA was hydrolysed to fragments of approximately lkb in
length. This was achieved by incubation of the gel at room temperature
for 15 minutes in weak HC1 (22ml/litre) which depurinated residues within
the DNA structure. Two 15 minute exposures to 0.5N NaOH denatured the
DNA after which the gel was neutralised in 3M NaCl 500mM TrisHCl pH7.4
for 1 hour.
RNA gels required no pretreatment before transfer and both RNA and DNA
from agarose gels were transferred to membranes in similar ways.
Transfer of DNA or RNA molecules separated by agarose gel
electrophoresis as previously described was mediated by construction of
the apparatus shown in figure 2.3.17d.
A concentration gradient was established using SSC buffer (see Appendix
I). Both RNA and DNA transfer methods used a reservoir of 20x SSC. 3MM
paper directly above the nylon membrane was soaked in either 2x SSC for
DNA transfer or 3x SSC for RNA transfer. Paper towels were changed
frequently and the presence of cling-film ensured that the buffer did not
circumvent the agarose gel during the transfer process. The weight on top
of the paper towels ensured that the apparatus was compact facilitating
efficient buffer migration. The transfer process was carried out for
approximately 16 hours at room temperature. Crosslinking of the
transferred nucleic acid to the nylon membrane was achieved by exposure
to ultraviolet light in a Spectrolinker XL-1000 (Stratagene, USA) set to
'optimal crosslinking'.
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Figure 2.3.17a: Apparatus used for transfer of nucleic acids to
nylon membranes.
After agarose gel electrophoresis the separated nucleic acids in the
gel were transferred to the nylon membrane using a diffusion
gradient. The lower reservoir contained 20xSSC whereas the 3MM
paper was soaked in either 2xSSC or 3xSSC. Cling-film surrounding
the gel prevented the 20xSSC bypassing it. Paper towels were
changed regularly during the transfer process so as to prevent
premature equilibration. An appropriate weight was placed on top of
the apparatus to ensure efficient liquid transfer.
2.3.18 Radioactive Labelling of DNA probes
Specific cDNA molecules were used as probes to detect RNA or DNA
fragments transferred to nylon membranes. The rerU'PRIME™ kit
(Amersham, UK) was used in accordance with manufacturers guidelines to
incorporate [a32P]-deoxycytidine triphosphate (dCTP; DuPont NEN, UK) with
a specific activity of 3000Ci/mmol. This system is based in the method
devised by Feinberg & Vogelstein (Feinberg & Vogelstein, 1983) except that
random nonomeric primers were used in place of the original hexamers.
Verification of the labelling procedure was undertaken by addition of lpl
of the reaction to glass filter paper which was left to dry before removal of
unincorporated nucleotides by washing in 5% trichloroacetic acid (TCA)
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20mM sodium pyrophosphate solution. The sample was then washed in 70%
ethanol and dried before detection of incorporated [33P] -deox ycy ti di ne
monophosphate residues by Cerenkov counting. It should be noted that
detection of disintegrations per minute (dpm) in dry filters containing 32P
is only 25% efficient using the [3H] channel of the scintillation counter.
Hence dpm/pg DNA were calculated by multiplying the total counts per
minute (cpm) by four. All probes were radiolabeled in excess of lxl 09
dpm/pg DNA.
2.3.19 Hybridisation of DNA probes
Nylon membranes were washed in 3X SSC to remove residual agarose prior
to a prehybridisation in Church & Gilbert hybridisation buffer (see
Appendix I) (Church & Gilbert, 1984) at 65°C for 2 hours using a Hybaid
Midi dual 14 oven (Hybaid, UK). The specific DNA probes labelled with [32P]-
dCTP were denatured in 0.2M NaOH at 4°C for 5-10 minutes before addition
to the hybridisation mix. Hybridisation of the probes was carried out in
Church & Gilbert hybridisation buffer at 65°C for approximately 16 hours.
To remove excess unhybridised probe, the membranes were given a
preliminary vigorous 30 second wash in 2X SSC and 0.1% SDS at 65°C
followed by three 20 minute washes. The membranes were air-dried at
room temperature before exposure in a Phosphorlmager cassette for 24-72
hours followed by scanning on a Molecular Dynamics STORM1 M
Phosphorlmager and quantitation using Molecular Dynamics
ImageQuant™ software (Molecular Dynamics, UK).
2.4 Mammalian Cell Culture
2.4.1 Established Cell lines
Culture of various established cell lines was undertaken. These included
the human choriocarcinoma JEG3 cell line (Kohler & Bridson, 1971), the
mouse adrenocorticotroph AtT-20 cell line (Gumbiner & Kelly, 1982), the
mouse gonadotroph aT3-l cell line (Windle et al., 1990), the Chinese
hamster ovary (CHO) cell line and the CHO-derived CHO-K1 cell line (Puck
et al., 1958) the rat somatomammotroph GH3 cell line (Tashjian et al., 1968)
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and the recently described mouse gonadotroph L|3T2 cell line (Thomas et
al„ 1996).
2.4.2 Cell Culture Suite Design
A small self-contained cell culture suite was designed for exclusive use of
established cell lines. Class 2 microbiological air flow cabinets, C02
incubators, a bench-top swing-out rotor centrifuge, a -20°C freezer and a
refrigerator were to be contained in this suite. Control of air-flow was the
major consideration in the layout of the suite. Previous experience from
culture work undertaken elsewhere had shown that air currents were
often the cause of serious contamination of incubators and an example
scenario is depicted in figure 2.4.2ai. For this reason incubators were
situated facing away from the suite door. Furthermore the door to the suite
was constructed in a sliding format so as to minimise generation of air
currents during entry and exit of the suite. The layout of the cell culture
facility used during these studies is depicted in figure 2.4.2aii.
2.
Figure 2.4.2a: Floorplans of two cell culture facilities demonstrating
the significance of airflow from exterior sources.
i) Airflow (arrow) within the cell culture suite is generated by the
external door which directs potentially contaminating air towards the
incubator (I), ii) The cell culture suite used during these studies has a
sliding door which generates less airflow into the facility. In addition
the incubator is positioned facing away from the external door to
minimise airborne contamination. Airflow cabinet (C), CO2 incubator (I).
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2.4.3 General Aseptic Technique
Specific laboratory coats were used for cell culture and were changed
weekly. Long latex gloves were used to fully cover wrists when arms were
extended. Isopropanol diluted to 70% in double-distilled water was used to
sterilise all surfaces, bottles and instruments during use. A Class II
Microbiological Safety cabinet was used for all manipulations of living
mammalian cell cultures. The safety cabinet was cleaned with the
antiseptic solution Tisept and sprayed with 70% isopropanol prior to and
after use. Routine cleaning of the safety cabinet was undertaken using
bleach solution which was rinsed off all surfaces using 70% isopropanol.
The HEPA-filtered air-flow within the cabinet prevents airborne
transmission of particles between the cabinet and the external
environment in both directions (see figure 2.4.3a). This characteristic
protects the operator from harmful airborne effects of biohazardous
materials while also preventing airborne contamination of cultures.
The Sanyo C02 incubator used to culture cells was humidified using a pan
containing double-distilled and autoclaved water saturated with copper
sulphate. The incubator door was never left open for more time than
necessary so as to prevent non-sterile air-flow contaminating the water
pan or surfaces.
i A Figure 2.4.3a: Schematic representation
of a Class II Microbiological Airflow Saftey
cabinet.
Airflow (dashed arrows) is HEPA-filtcred
prior to entering the sterile cabinet.
Airborne contamination (red dashed
arrow) via the operator access hatch is
prevented by a 'curtain' of air which
directs the external airflow away from the
working area. This airflow is then directed
out of the cabinet via another HEPA filter.
E3= HEPA fillei
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2.4.4 Resuscitation of Cell lines
Frozen ampoules were removed from dry ice and left at room temperature
for 1 minute followed by thawing at 37°C for 2-3 minutes. Thawed
suspensions were washed in Dulbecco's Modification of Eagle's Medium
with 10% fetal calf serum (FCS) and 100 units/ml penicillin and 0.1 mg/ml
streptomycin (this mix will be referred to as cDMEM) and then centrifuged
for 5 minutes at 1000 rpm in a Sorvall Econospin centrifuge with swing-
out rotor (DuPont, UK). Removal of supernatant was followed by
resuspension in 5ml cDMEM and culture in the following conditions.
2.4.5 Routine Passaging of Cell lines
All cell lines were maintained in tissue culture flasks with 25cm2 culture
area. The flasks containing 5ml cDMEM were incubated at 37°C with 5% CO2
in a humidified incubator. Occasionally, for cell lines in which growth
rate appeared adversely affected HyClone fetal calf serum was used in
place of that supplied by Sigma-Aldrich. This had the effect of recovering
individual cell line proliferation to acceptable levels and proved especially
effective for culture of LPT2 cells. All FCS was batch-tested for optimum
growth of cell lines used in these studies.
Culture medium was removed from confluent cultures by aspiration with a
sterile Pasteur pipette attached to a vacuum pump. After each use of the
aspiration apparatus bleach solution was used to rinse the tubing for
future applications in order to prevent possible cross-contamination.
cDMEM was replaced with Dulbecco's phosphate buffered saline (DPBS) in
order to dilute inhibitory serum concentrations for subsequent
application of trypsin. DPBS was removed by aspiration prior to addition of
500pl lx trypsin-EDTA solution (0.05% trypsin, 0.02% EDTA) per 25cm2
culture surface. The degree of trypsinisation was controlled by
concentration of the trypsin-EDTA solution, duration of application and
incubation temperature. These parameters varied for each cell line used
and is summarised in table 2.4.5a below.
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Table 2.4.5a: Trypsinisation of Cell lines.
Cell Line Trypsin EDTA Incubation Duration of
Solution Temperature Incubation
(sees)
CFD lx 37°C 30
CHO-K1 lx 37°C 45
JEG3 lx 37°C 120
LPT2 0.1 x room temp. 10
Trypsin is inhibited by FCS therefore addition of cDMEM was undertaken
when cells were observed to detach from the culture surface. The cells
were resuspended using a sterile plastic Pasteur pipette with an aperture
of approximately 1mm. This suspension was then diluted in cDMEM and
applied to sterile culture vessels. The dilution used depended on the rate of
proliferation of the cell line and the time at which achievement of
confluency was desired. Cell suspensions were not over-diluted as this
often reduced the viability of the culture.
2.4.6 Estimation of Cell Number
lOOpl of a cell suspension was mixed with 900pl DPBS prior to addition to a
haemocytometer with coverslip attached. The loaded haemocytometer was
viewed using an inverted microscope. Cells were counted within the four
corner squares of the counting chamber. Each square corresponds to a
volume of 0.1mm3 or 10~4 cm3. In order to calculate the number of cells per
ml of the original suspension the mean figure from four squares was
multiplied by 105.
2.4.7 Long-term Storage of Cell lines
Stocks of cell lines were maintained in the liquid phase of a nitrogen
storage vessel (Merck BDH, UK). Cultures maintained as previously
described were used when confluency was estimated as between 60-80%.
Cells were trypsinised as previously described and resuspended in 5ml
cDMEM prior to centrifugation for 5 minutes at 1000 rpm in a Sorvall
Econospin centrifuge with swing-out rotor (DuPont, UK). Removal of the
supernatant by aspiration and resuspension of the pellet in 500pl FCS
chilled to 4°C followed. This suspension was transferred to 1.8ml NUNC
cryotubes. Addition of 500pl 20% dimethyl sulphoxide (DMSO) in FCS chilled
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to 4°C was followed by overnight (approximately 16 hours) incubation at
-70°C in a Nalgene container which contained a 250ml reservoir of
isopropanol. Use of this specialised apparatus controlled the temperature
descent of the cell suspension to approximately 1°C per minute and
improved cell viability. Following overnight incubation at -70°C frozen
ampoules were transferred to liquid nitrogen for long-term storage.
2.4.8 Transient Transfections
Cell lines were transiently transfected with DNA constructs so as to assess
the characteristics of their expression. Various methods exist for
introduction of exogenous nucleic acids into mammalian cells including
microinjection, electroporation, viral transfection, calcium chloride-based
and lipid-based methods. During these studies calcium chloride- and lipid-
based methods were used. For all transfections cells were plated in the
appropriate vessels (flasks, dishes or chamber slides) at a density which
produced 50-80% confluency 16-24 hours later. Assessment of the
transient gene expression was undertaken by various means 24-72 hours
later. All constructs used in transfections were purified by CsCl density
gradient centrifugation or the Endofree Megaprep kit (Qiagen, UK) so as to
reduce toxicity caused by contaminating bacterial endotoxins.
2.4.9 P-Galactosidase Staining
Transfection of the pcDNA3.1/Flis/lacZ plasmid (Invitrogen, NL) which
contains the P-galactosidase gene allowed relatively simple assessment of
transfection efficiency through colorimetric staining and counting of
positive (blue) cells.
Cells were fixed for 5 minutes at room temperature in DPBS containing 2%
formaldehyde and 0.2% gluteraldehyde. After washing with DPBS the cells
were incubated overnight at 37°C in DPBS containing 5mM K3Fe(CN)6, 5mM
K4Fe(CN)g, 2mM MgCl2 with lmg/ml 5-bromo-4-chloro-3-indolyl-P-D -
galactopyranoside (X-gal). Cells were washed with DPBS and the number of
blue-stained cells established. Cells were viewed at lOOx magnification
using an inverted microscope and representative photomicrographs were
taken using a Labovert inverted microscope with a Ricoh KR-10M camera
and Leitz Periplan LT 160mm lens. For high transfection efficiencies 4
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counts of 250 cells per field of view were undertaken using a multichannel
counter and the positive proportion represented as a percentage.
2.5 Protein Analysis
2.5.1 Protein Extraction
Proteins were extracted from cell lines in lOOmM sodium carbonate as this
has been previously determined to be the optimal buffer for isolation of
gonadotrophins [ A.S .McNeilly - personal communication]. After
resuspension in the buffer the cells were incubated at room temperature
for an hour. To ensure complete release of proteins from intracellular
compartments the samples were exposed to three alternating cycles of 5
minutes incubation in a dry ice ethanol bath and 5 minutes at 37°C
followed by vigorous vortexing. Lysates were then centrifuged at
13000rpm for 5 minutes in an Heraeus Sepatech Biofuge 13 at room
temperature to remove cell debris and the supernatant transferred and
stored at -20°C.
2.5.2 Total Protein Quantification
Following the method of Bradford (Bradford, 1976) total protein
concentrations in cell lysates were determined. 200-fold dilution of the
lysate in a total of 1ml sterile water was followed by brief vortexing. 200pl
of protein dye (Bio-Rad, UK) was subsequently added to the diluted sample
and mixed by inverting 6 times. Protein standards containing 25, 12.5, 6.25,
3.125, 1.56 and 0.78pg/ml bovine serum albumin (BSA; Sigma-Aldrich, UK)
were similarly treated. Mixing of the samples and standards was
undertaken without formation of excessive bubbles as these cause
aberrant OD readings. OD at 595nm was measured after incubation of the
samples at room temperature for 5 minutes.
2.5.3 Assessment of Chloramphenicol
acetyltransferase Activity
Chloramphenicol acetyltransferase (CAT) is a tetrameric cytosolic
molecule comprised of 23kDa subunits. CAT activity in the presence of
acetyl coenzyme A (AcCoA) inhibits binding of the antibiotic
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chloramphenicol to the 50S subunit of ribosomes. Chloramphenicol is
converted to hydroxy acetoxy derivatives by CAT which are unable to bind
the ribosomal component and therefore unable to inhibit protein
synthesis at the translation stage. It is the production of these derivatives
which is detected in the CAT assay using radioactively-labelled
chloramphenicol separated by thin layer chromatography (TLC).
CAT activity was assessed using the method of Gorman et al (Gorman et ai,
1 982) as follows. A volume of cell lysate containing 2pg of protein as
determined by Bradford assay was added to 0.25M TrisHCl pH7.8 giving a
final volume of 193pi 1. Inactivation of CAT inhibitors was achieved by
incubation at 65°C for 10 minutes. 2pl 14C-chloramphenicol (50 Ci/mmol)
and 5pl 50mM acetyl coenzyme A (Boehringer Mannheim, UK) were
subsequently added to the reaction and mixed before incubation at 37°C for
5-30 minutes. Extraction of the 14C-chloramphenicol was achieved by
addition of 600pl ethyl acetate and vortexing for 10 seconds 3 times. The
sample was then centrifuged at room temperature for 30 seconds at
13000rpm in an Heraeus Sepatech Biofuge 13 before careful transfer of the
organic phase to a new microcentrifuge tube. The transferred sample was
then vacuum-dried before resuspension in 20p 1 ethyl acetate and
separation by TLC in a solvent containing a 95:5 ratio of chloroform to
methanol. The dry TLC plate was exposed for at least 48 hours in a
Phosphorlmager cassette before scanning on a STORM™ Phosphorlmager
and quantification using ImageQuant™ software (Molecular Dynamics,
UK],
The increased mobility of the mono- and diacetate forms of 14C -
chloramphenicol allowed their separation from unconverted 14C -
chloramphenicol. The amount of CAT activity was determined as the
percentage of acetylated 14C-chloramphenicol per sample (Gorman et al.,
1982).
2.5.4 Iodination of Antigens
Antigens were iodinated using the chloramine-T method. 500pCi 125I was
added to lOpl chloramine-T (2mg/ml in 0.25M PBS) and 5gg of antigen and
vortexed for 15 seconds. lOpl sodium metabisulphate (2mg/ml in 0.25M
PBS) was then added prior to vortexing for a further 20 seconds. 1ml 1%
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BSA in 0.05M PBS was added to the reaction and vortexed for 30 seconds
halting the iodination reaction. Total counts were established prior to
application of the sample to a 30cm Sephadex G100 column (1cm diameter)
coated with 1% BSA in 0.05M PBS. After adding the sample to the column,
residual 125I in the reaction tube was counted. This allowed calculation of
the total radioactivity applied to the column. Forty 30-drop fractions were
collected using a Gilson model 201 fraction collector and radioactivity
plotted to assess labelling of the antigen. Peak fractions were pooled and
stored in a lead-lined container at -20°C.
2.5.5 Radioimmunoassays
Various radioimmunoassays (RIAs) were performed during these studies
however the general methodology employed for all RIAs will be described
here.
Unless otherwise stated lOOpl of appropriately diluted sample was added to
10x75mm plastic test tubes containing 200pl 0.1% bovine serum albumin
(BSA; Sigma-Aldrich, UK) in 0.075M PBS using a Microlab automatic
pipettor. lOOpl of primary antisera was subsequently added to each tube,
mixed and incubated for at least 16 hours at 4°C. The appropriate tracer was
diluted to approximately 15000 cpm per lOOpl in 0.1% BSA 0.075M PBS.
Following addition of lOOpl of the diluted tracer to each tube and mixing,
they were incubated at 4°C for at least 16 hours. lOOpl each of secondary
antisera and normal antisera were added to the tubes, mixed and incubated
for a further 16 hours at 4°C. All assays used normal rabbit serum (NRS;
SAPU, UK) and donkey anti-rabbit serum (DARS; SAPU, UK). Following this
final incubation the immunocomplexes were separated by addition of 1ml
0.9% saline, 4% PEG 6000 and 0.2% Triton X-100 and centrifugation at
3000rpm in a Sorvall Omnispin R centrifuge (DuPont, UK) for 25 minutes at
4°C. Supernatants were removed and tubes were left to dry at room
temperature. Radioactivity was measured using a 1261 Multigamma
counter (Wallac, UK) and data analysed using AssayZap (P.Taylor, MRC
CRB).
The sensitivity of the LH RIAs was 0.2ng/ml and 0.08ng/ml for the FSH
RIA. The intra- and inter-assay coefficients of variation were <7% and
<10% respectively over the concentration range of the samples in all RIAs.
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2.5.6 Gel Electrophoresis of Proteins
under Denaturing Conditions
Separation of denatured protein subunits was undertaken by
polyacrylamide gel electrophoresis (PAGE) in the presence of the anionic
detergent sodium dodecyl sulphate (SDS; Boehringer Mannheim, UK)
(Laemmli, 1970). Polyacrylamide crosslinked by N,N'-
methylenebisacrylamide in the presence of ammonium persulfate and
N, N, N', A'-tetramethylethylenediamine (TEMED; Sigma-Aldrich, UK)
provided the matrix in which the proteins were separated. High resolution
of the protein bands was achieved by using a discontinuous gel containing
stacking and resolving components. The stacking gel at 5% acrylamide was
less dense than the resolving gel which varied between 6% and 15%
depending on the range of protein sizes at which resolution required. The
pH of the stacking gel was 6.8 whereas the resolving gel and running
buffer were at pH8.8. These two differences caused migrating proteins to
be concentrated at the interface between the two gel types prior to
separation within the resolving gel producing distinct bands.
Protean II xi vertical gel apparatus (Bio-Rad, UK) were used to pour and
run all SDS-PAGE gels. Acrylamide solutions (10% acrylamide in 375mM
TrisHCl pH8.8 and 1% SDS) were degassed before 1mm thick resolving gels
were poured and covered with a 1:1 mixture of butanol and water ensuring
that a level upper margin was produced. The gel was left to polymerise at
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room temperature for 30-60 minutes then the butanoTwater mixture was
removed and replaced with 250mM TrisHCl pH8.8 and stored at 4°C
overnight. The 5% stacking gel containing 125mM TrisHCl pH6.8 and 1%
SDS was similarly degassed prior to pouring and addition of an appropriate
comb. Polymerisation was left to occur at room temperature while samples
were prepared for loading. Denaturation of a known amount of protein
between 20 and 50pg was subjected to denaturation by boiling for 5
minutes in the SDS-PAGE loading buffer (see Appendix I). Both reducing
and non-reducing loading buffers were used. The reducing buffer
contained 0.2% (3-mercaptoethanol (Sigma-Aldrich, UK) to prevent
oxidation of the protein. The samples were left to cool at room temperature
before addition to the gel. A constant current of 20mA was applied through
the stacking gel and 30mA through the resolving gel in SDS-PAGE
running buffer (see Appendix I) for 3-4 hours. The gel apparatus was
assembled following the manufacturers guidelines.
2.5.7 Gel Electrophoresis of Proteins
under Non-denaturing Conditions
Assessment of multimeric protein abundance was undertaken by PAGE
under non-denaturing conditions as follows.
Gels and buffers were identical to those used during SDS-PAGE except that
no SDS was added (see Appendix I). The Bio-Rad Protean II xi vertical gel
tank (Bio-Rad, UK) was used in accordance with manufacturers guidelines.
Samples were loaded using buffer which contained no SDS or (3-
mercaptoethanol. In addition the samples were not boiled prior to
electrophoresis. A constant current of 20mA was applied through the
stacking gel and 30mA through the resolving gel in native-PAGE running
buffer (see Appendix I) for 3-4 hours.
2.5.8 Transfer of Proteins to Nitrocellulose Membranes
Proteins separated under both denaturing and native conditions were
attached to a solid phase prior to immunological assay. A Bio-Rad
Transblot™ wet transfer tank (Bio-Rad, UK) was used for both transfer
methods in accordance with manufacturers guidelines. The apparatus used
is shown in figure 2.5.8a. There were two differences between transfer of
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denatured and native proteins. For transfer of denatured proteins wet-blot
buffer (25mM Tris, 192mM glyeine and 20% methanol) was used whereas
native proteins were transferred in 0.7% acctie aeid. The differences in
these buffers imparted different behaviour on the proteins. Denatured
proteins continued to exhibit anionic migration due to the continued
binding of SDS and the presence of Tris and glycine in the transfer buffer.
Native proteins in the continued absence of SDS and the removal of the
electrophoresis buffer migrated towards the cathode. In both cases the












Figure 2.5.8a: Apparatus used for transfer of denatured and
native proteins to nitrocellulose membranes.
Wet-blot buffer used for transfer of denatured proteins contained
25mM Tris, 192mM glycine and 20% methanol. Transfer was
undertaken for approximately 16 hours at 25V. The buffer was
cooled throughout operation by a pipe passing cold water through
the apparatus.
2.5.9 Slot-blotting
Initial optimisation of primary antisera concentrations required for
analysis of proteins attached to nitrocellulose membranes (Millipore, UK)
was carried out by slot-blotting. Purified antigen was applied to the
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membrane with a vacuum using a Bio-Dot SF apparatus and filter papers
(Bio-Rad, UK). Proteins attached to the membrane were then detected by
either ECL or ECF detection methods (Amersham, UK) described below.
2.5.10 Immunodetection of Immobilised Proteins
Two similar methods were employed to detect proteins transferred to
nitrocellulose membranes. The ECL kit (Amersham, UK) required exposure
to light-sensitive film whereas visualisation of fluorescence produced
using the ECF kit (Amersham, UK) was undertaken using the STORMT M
Phosphorlmager on the blue fluorescence mode. Quantification of protein
abundance within samples was more easily achieved using the ECF kit. Use
of the ECL and ECF kits and the STORM™ Phosphorlmager was in
accordance with manufacturers guidelines.
2.6 Fluorescence
2.6.1 Indirect Immunofluorescence in Mammalian Cells
Transiently transfected cell lines cultured in glass chamber slides under
normal conditions as described in 2.4.5 were washed with phosphate-
buffered saline (PBS) before being fixed in Bouins fixative (Appendix I)
for 5 minutes at room temperature. With the plastic chamber still attached
to the glass slide the Bouins fixative was removed and replaced with PBS.
Washing in PBS for 5 minutes with gentle agitation at room temperature
was repeated three times to remove the fixative. The cells were
permeabilised by adding PBS containing 1% bovine serum albumin (BSA),
10% normal goat serum and 0.2% Non Idet P-40 for 20 minutes with gentle
agitation at room temperature. Washing in PBS for 5 minutes with gentle
agitation at room temperature was repeated three times to remove the
detergent. The cells were incubated in blocking solution (PBS containing
1% BSA and 10% normal goat serum) for two hours at room temperature
with gentle agitation to reduce non-specific antibody binding. Primary
antisera was subsequently added and incubated for at least 16 hours at 4°C.
Excess primary antisera was removed by washing in PBS for 5 minutes
with gentle agitation at room temperature; this was repeated three times.
Fluorescent conjugates of appropriate secondary antisera were diluted 1:30
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in blocking solution and incubated for two hours in the dark at room
temperature with gentle agitation. Prolonged PBS washes of 10 minutes at
room temperature with gentle agitation were repeated at least three times.
After removal of the plastic chambers, coverslips were mounted using
Citifluor (UKC, UK) and sealed using clear nail varnish. Slides were then
viewed by confocal microscopy or stored in the dark at 4°C.
2.6.2 Direct fluorescence in Mammalian Cells
Cells transiently transfected with constructs encoding the enhanced
green fluorescent protein (EGFP; Clontech, UK) were viewed after fixing
or live as described below.
a) Fixed Cells: Removal of the culture media was followed by washing in
PBS for 5 minutes at room temperature with gentle agitation. Subsequently
the cells were fixed by incubation for 5 minutes in Bouins (Appendix I) at
room temperature. Three washes of 5 minutes in PBS at room temperature
preceded removal of the plastic chamber slide and mounting as previously
described.
b) Live Cells: In the absence of a specialised perfusion chamber
allowing observation of living cells cultured on circular glass coverslips
at 37°C an alternative method was employed. Chamber slides containing
EGFP-expressing cells were maintained at 37°C using an OmniSlide
thermocycler (Hybaid, UK). Removal of the chamber was followed by
mounting in DPBS using rubber adhesive and glass coverslips. The use of
rubber adhesive followed Clontech's guidelines which suggest that nail
varnish may adversely affect EGFP fluorescence. Viewing of the live
sample was limited to approximately 5 minutes to avoid the adverse effects
of temperature reductions.
2.6.3 Confocal Microscopy
Analysis of indirect immunofluorescence on cells and tissues was
undertaken using a Zeiss Axiovert 100M microscope and LSM510 scanning
module with oil immersion x40, x63 and xlOO objectives (Zeiss, UK). Scans
were performed at either 1024x1024 or 2048x2048 pixels resolution. Data
analysis was undertaken using a Dell Optiplex Gxi computer (Zeiss, UK).
Confocal microscopy allows analysis of specimens whist reducing
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background fluorescence from out of focus objects. A schematic







Figure 2.6.3a: A schematic representation of confocal microscopy.
Fluorescence is excited by an appropriate wavelength of light provided
by the laser source. The laser beam is focussed onto the sample using
one or more specific dichroic mirrors and an objective. Fluorescence
emitted from the sample is focused through the confocal aperture so
that emissions from voxels outside the plane of focus (shown in yellow)
are omitted from the image collected by the photomultiplier tube
(PMT). Data collected by the PMT can be transferred to computer for
immediate analysis. Multiple lasers and fluorophores may be used at
one time through the specific nature of the dichroic mirrors and by
using filters.
Immunocytochemistry (ICC) using secondary antisera conjugated with
fluorophores such as fluorescein isothiocyanate (FITC) or Tetramethyl
rhodamine isothiocyanate (TRITC) allows simultaneous visualisation of
antigen binding. The excitation and emission spectra for FITC and TRITC
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are distinct (figure 2.6.3b) which allows colocalisation studies to be carried
out. The excitation of FITC and EGFP was undertaken with a 488nm argon
laser set at between 8 and 15% of maximum power. Detection of light
emitted from FITC was carried out with a 505-535nm bandpass filter. TRITC
excitation was achieved using a 543nm HeNe laser set at 40 to 100% of
maximum power which was detected using a longpass 585nm filter.
Visualisation of EGFP was undertaken as described for FITC-conjugated
antisera as their excitation and emission spectra are similar.
ex em ex em
Wavelength (nm)
Figure 2.6.3b: Excitation and emission spectra for fluorescein
isothiocyanate (FITC) and tetramethyl rhodamine isothiocyanate
(TRITC).
The maximal excitation wavelengths for FITC and TRITC are
distinct which allowed use of specific lasers for each fluorophore
conjugate. FITC excitation was undertaken using an argon laser at
488nm (vertical green line) whereas TRITC excitation was
achieved using a HeNe laser at 543nm (vertical red line). FITC
emissions were detected using a bandpass filter between 505 and
535nm (green box) with those of TRITC detected using a 585nm
longpass filter (red arrow). Although the longer emission spectra
overlap, the relative intensity is low thus interference between
the two dyes was not significant. Excitation spectra (ex), emission
spectra (em).
When using FITC conjugates in the absence of TRITC conjugated secondary
antisera the nuclear stain propidium iodide (Sigma-Aldrich, UK) was
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sometimes used by addition to Citifluor at a final concentration of lOpg/ml.
The emission spectra for this dye coincided with those of TRITC and hence
they were never used together. Phase contrast images collected at the same
time as fluorescence were overlaid allowing three sets of data to be viewed
in a single two-dimensional image. Furthermore due to the focused nature
of the excitatory laser beam (figure 2.6.3b), confocal microscopy permits
visualisation of tissue as a series of optical slices. This feature reduces the
need for serial sectioning and allows representation of data as a three-
dimensional image useful in observing stereological relationships.
2.7.1 Data Analysis
Raw data was manipulated in Microsoft Excel 4.0 (MacWarehouse, UK),
standard errors were calculated using GB-Stat 6 (Dynamic Microsystems,
USA) and statistical analyses carried out using StatView 4.02
(MacWarehouse, UK). One-way analysis of variance (ANOVA) was




This chapter will focus on the building of mammalian expression
constructs used throughout the in vitro studies in this thesis.
Whereas the expression of the gene of interest in a comparatively
physiological context is the end point of most studies, the genetic material
often requires manipulation prior to this. In order to generate sufficient
DNA for subsequent studies, bacterial cultures are used to propagate DNA as
part of a plasmid. Mammalian expression vectors such as pcDNA3
(Invitrogen, NL) have sequences that allow their propagation in both
prokaryotes and eukaryotes and for this reason they are often referred to
as shuttle vectors. The shuttle vector pcDNA3 contains origins of
replication from the Escherichia coli plasmid ColEl and the filamentous
bacteriophage fl which enable propagation at a high copy number in
transformed bacteria for propagation. In mammalian cells a different
origin is recognised which derives from the simian virus SV40. The
enhanced green fluorescent protein (EGFP) C-terminal fusion vectors are
also capable of propagation in bacteria using the origin of replication from
fl and the pBR322 backbone. Like pcDNA3, the EGFP C-terminal (EGFP-C)
fusion vectors rely on the SV40 origin to maintain their propagation in
mammalian cells.
Selection of pcDNA3 and pBluescript KS+ (Stratagene, USA) in E.coli is
undertaken by resistance to the P-lactam antibiotic ampicillin. Resistance is
encoded by a (3-lactamase gene the product of which cleaves the P-lactam
ring preventing its entry into the bacterium. Ampicillin like other
penicillin-derived antibiotics inhibits growth of gram-negative bacteria
such as E.coli by inhibiting synthesis of the cell wall component
peptidoglycan. Ampicillin inhibits peptidoglycan crosslinking in two ways;
by acting as an analogue of D-alani ne-D-alanine and by binding to and
inhibiting the transglycosylase/transpeptidase activity of the essential
penicillin binding proteins (PBPs) 1A, 2 and 3. The reduced crosslinking of
this net-like structure within the periplasmic space reduces its strength
eventually leading to lysis.
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Two key characteristics of pcDNA3 made it a suitable candidate for these
studies. pcDNA3 contains a neomycin resistance gene (neoR) which encodes
an aminoglycoside 3'-phosphotransferase. Neomycin and its analogue G418
are aminoglycoside antibiotics which are effective against mammalian
cells as well as bacteria. Protein synthesis is inhibited by G418 binding to
the ribosome at multiple sites which may also lead to misreading of mRNA.
The presence of neoR allows selection of stably transfected cells by
application of G418 over a period of 4 to 6 weeks.
The pEGFP-C vectors encode a neoR protein which also confers resistance to
the related antibiotic kanamycin in E.coli. By employing a single antibiotic
resistance gene these fusion vectors maintain a relatively small size which
increases their structural durability.
High expression of the inserted gene in mammalian cells is a desirable
characteristic for most studies. This is mainly conferred by upstream
promoter and enhancer sequences in the vector which recruit RNA
polymerase II producing large numbers of transcripts from which an
amino acid sequence may be translated. In pcDNA3 the human
cytomegalovirus (CMV) promoter from the immediate early genes is used.
The CMV promoter is a strong constitutive promoter and like the SV40
immediate early promoter present in the cDNA cloning vector pcD produces
large quantities of RNA transcripts from the insert. Both pcDNA3 and pcD
contain poly-A addition site sequences 3' of the inserted gene. This feature
provides the mRNA molecule produced with a degree of protection from
RNase degradation as this is another factor which can limit final levels of
protein expressed.
Essentially the vectors used for mammalian expression constructs contain
the necessary sequences for propagation and selection in both E.coli and a
variety of mammalian cells. Furthermore the presence of a strong
constitutive promoter may provide high expression in a comparatively
physiological context.
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3.2 Methods
This section will cover the strategies used in the engineering of constructs
for expression of various genes and cDNA sequences within mammalian
cells. Many of the basic molecular biology protocols such as restriction
endonuclease digestion, agarose gel electrophoresis and ligation are
described in detail within chapter 2.
These constructs include those encoding the key gonadotrophin subunits
and granins as well as genes such as chloramphenicol acetyltransferase
(CAT) used to assay transfection efficiency. The pcDNA3 shuttle vector
(Invitrogen, NL) was used for all constructs described in this chapter with
the exception of the enhanced green fluorescent protein (EGFP) fusion
constructs derived from the pEGFP-C vectors (Clontech, UK).
3.2.1 The Ovine aGSU Expression Construct
The ovine gonadotrophin alpha subunit (aGSU) cDNA in pSP72 was a kind
gift from T.E.Adams (Aus). Subcloning of the aGSU was relatively
straightforward and a simplified schematic representation of the cloning
strategy used is shown in figure 3.2.1a.
The original plasmid containing the aGSU cDNA was digested with EcoRI to
excise the 716bp full-length cDNA. After verifying that the DNA sample was
completely digested, the remaining reaction volume was electrophoresed
overnight in a 0.8% agarose gel and extracted as described in sections 2.3.2
& 3 . pcDNA3 was similarly digested with EcoRI and due to the presence of
compatible cohesive termini (both EcoRI) on the linearised vector,
phosphatase treatment was undertaken to reduce the likelihood of the
plasmid self-ligating. Calf intestinal phosphatase (CIP; Boehringer
Mannheim, UK) was used at lOx the recommended concentration to ensure
complete removal of the 5' phosphate groups as described in section 2.3.6 .
Ligation of the oaGSU cDNA and pcDNA3 was undertaken using Ready-to-
Go™ ligase tubes as described in section 2.3.7. Subcloning efficiency
competent E.coli DH5a cells (Gibco BRL, UK) were transformed with the
ligation products in accordance with manufacturer's guidelines using 2pl
of the ligation reactions. Plasmid preparations were assessed by restriction
digests with two objectives; to ascertain the presence of the aGSU cDNA and
to determine its orientation. Analysis of the predicted construct sequence
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determined that Pst I digestion would produce different size fragments








representation of the subcloning
of ovine aGSU cDNA into pcDNA3.
1) pcDNA3 was linearised by
treatment with the restriction
enzyme FcoRI. 2) The 5' termini
were dephosphorylated using CIP
preventing self-ligation of the
vector. 3) The Ec o RI - d i g e s t ed
ovine aGSU cDNA was ligated
with the dephosphorylated
pcDNA3. This reaction was not
directional and therefore
required screening to ascertain
the orientation of the insert.
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Pst I Pst I
(2333)
Pst I Pst I
(573) (948)
Figure 3.2.1b: Schematic
representation of the screening
strategy employed to determine
orientation of the ovine aGSU
cDNA after subcloning into
pcDNA3.
a) Pst 1 digestion of the pcDNA3
vector containing the ovine
aGSU in the reverse orientation
in regard to the CMV promoter
should yield fragments of 4196,
1385 and 581 bp. b) Pst I
digestion of the pcDNA3 vector
containing the ovine aGSU in
the same orientation as the CMV
promoter should yield
fragments of 4625, 1385 and 153
bp.
Figures shown in red refer to
the ovine aGSU sequence.
Pst I
(2333)
Positive recombinants were also digested with EcaRI to ascertain whether
treatment with excess concentrations of C1P had degraded the 3' overhangs
produced by linearisation of the vector. Large-scale preparation of this
plasmid construct was undertaken as described in section 2.3.10 The
predicted size of this construct was 6162bp.
3.2.2 The Ovine FSHji cDNA Expression Construct
Both the cDNA and genomic oFSH[3 constructs were engineered so that the
native FSH[3 3' UT region was absent. This was carried out to obtain levels of
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expression unaffected by the low mRNA stability caused by the long 3' UT of
oFSH(3 in vitro (Mountford et al., 1992).
The full-length cDNA for oFSHJi in pSP72 was a kind gift from T.E.Adams
(Aus). A simplified schematic representation of the cloning strategy used to





representation of the subcloning
of the ovine FSHp cDNA into pcDNA3.
1) pcDNA3 was linearised by
treatment with the blunt-cutting
restriction enzyme EcoRV.
2) The 5' termini were
dephosphorylated using CIP to
prevent self-ligation of the vector.
3) The Pvnll-digested ovine FSHjf
cDNA was ligated with the
dephosphorylated pcDNA3. This
reaction was not directional and
therefore required screening so as
to ascertain the orientation of the
insert. Combination of the EcoR V
and PvmII termini abolished the
recognition sites for each of these
enzymes.
<a
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The oFSH(i cDNA was excised from pSP72 by PvuII digestion cutting at +10
and +454bp which included the entire coding region. The mRNA
polyadenylation signal was provided by the bovine growth hormone
sequence located at 1018-1249bp 3' to the pcDNA3 polylinker. The digest was
verified prior to overnight agarose gel electrophoresis and gel extraction
of the fragment. EcoRV is the only blunt-cutting restriction enzyme site
within the pcDNA3 polylinker. Following linearisation of the vector,
dephosphorylation was carried out using Shrimp alkaline phosphatase
(SAP; Boehringer Mannheim, UK) as described in section 2.3.6 . The 444bp
oFSHJi insert and dephosphorylated vector were ligated using Ready-to-GoT M
ligase tubes (Pharmacia, UK) in accordance with the manufacturer's





























representation of the screening
strategy employed to determine
orientation of the ovine FSHfi
cDNA after subcloning into
pcDNA3.
a) Apa I digestion of the pcDNA3
vector containing the ovine
FSHp in the reverse orientation
in regard to the CMV promoter
should yield fragments of 5449
and 441 bp. b) Apa\ digestion of
the pcDNA3 vector containing
the ovine FSH|3 in the same
orientation as the CMV promoter
should yield fragments of 5803
and 87bp.
Figures shown in red refer to
the ovine FSH(i sequence.
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Screening of miniprep DNA required digestion with Apa I to determine the
presence and orientation of the oFSHp cDNA insert (figure 3.2.2b). Large-
scale preparation of a positive clone was undertaken as described in section
2.3.10.
3.2.3 oFSHp Genomic DNA Expression Construct
The oFSHp genomic clone in pBluescript KS+ (Stratagene, USA) was a kind
gift from P.Brown (MRC, CRB). However this clone did not contain the
transcriptional initiation site as it was spliced downstream of the oLHp
promoter for use in a transgenic model (oLHp/oFSHp, see chapter 7). This
construct also had the poly-A addition site from Herpes simplex virus (HSV),
and had the original 3' UT removed. This feature was engineered in order to
provide oFSHp expression levels that were unaffected by this mRNA species
inherent instability.
A schematic representation of the manipulations undertaken during the
reconstruction of the full-length oFSHp genomic clone is shown in figure
3.2.3a. The pGEM4 clone containing the 5' region of the oFSHp gene was
digested with Hin dill and PstI producing a 866bp fragment containing
exons 1 and 2. The transcriptional initiation site was located 106bp from the
5' end of this fragment. The 866bp fragment was extracted after overnight
agarose gel electrophoresis. Subcloning of this H inA\\\-Pst\ fragment
directly into the 5' truncated clone was not possible due to the presence of
similar restriction sites. The presence of a unique Xho I site 95bp
downstream from the transcriptional initiation site prompted the use of
this enzyme for the splicing process. An upstream Xho I site is not present
in either the pGEM4 vector or the oFSHp gene. However pBluescript KS +
(Stratagene, USA) does contain the site within its polylinker upstream of
the Hin dill site. Ligation of the insert and the ///ndlll/Pxrl-linearised
pBluescript KS+ was carried out using Ready-to-GoT M ligase tubes
(Pharmacia, UK). Miniprep plasmid DNA was isolated from cultures
transformed with the ligation. The presence of the insert was determined
by retarded migration during agarose gel electrophoresis. Recombinant
plasmids were digested with Xhol after which the 226bp fragment was
extracted from an agarose gel run overnight. This fragment was then
ligated with the X/;rH-digested pBluescript KS+ containing the 5' truncated
oFSHp gene after dephosphorylation with SAP (Boehringer Mannheim, UK).
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strategy used to reconstruct
the oFSHfi genomic clone.
1) Directional ligation of the
866bp fragment containing
the transcriptional start site
for oFSHff into pBluescript
KS+.
2) Xlio I digestion of the




3) Ligation of the Xho I
fragment with a plasmid
containing the downstream
oFSHp sequences (exons 1-3)
and a poly-A addition site
from Herpes simplex virus




4) The reconstructed oFSH|3
gene was excised from
pBluescript KS+ and
directionally ligatcd into the
mammalian expression
vector pcDNA3 yielding a
plasmid 8.35kb in length.
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Subcloning efficiency E.coli DH5a cells were transformed with this ligation
and plasmid DNA isolated. Determining the orientation of the ligated Xho I

















strategy used to screen
recombinants for the
orientation of the Xhol
fragment containing the
transcriptional start site for
the genomic clone of oFSHp.
a) Hindlll digestion of the
pBluescript KS+/oFSHp 205-
2878 & HSV-IE 3' UT
construct containing the
266 bp Xho I transcriptional
start site fragment in the
reverse orientation in
regard to the CMV promoter
should yield fragments of
4076 and 1855bp.
b) Similar digestion of the
construct containing the
fragment in the correct
orientation should yield
fragments of 3894 and
2037bp. Figures shown in
red refer to the oFSHp
sequence.
A positive plasmid was digested with Xho I to verify that the sites were
intact. Extraction of the reconstructed oFSHff gene from pBluescript KS+ was
undertaken in two stages due to conflicts in restriction enzyme buffering
requirements. Kpnl digestion linearised the construct. Dual digestion with
Not and Seal excised the oFSHJi gene and cleaved the vector ('suicide-
cutting') to allow their resolution by agarose gel electrophoresis and
prevent vector contamination of the extracted fragment. The 3049bp oFSH|i
Kpnl-Notl fragment was ligated with a similar digestion of pcDNA3 and
transformed into subcloning efficiency E.coli DH5a cells. Preparations of
plasmid DNA were screened for insertion of the 3049bp oFSHfi Kpnl-Notl
fragment by digestion with //j'ndlll. The predicted fragments produced by
this screening strategy should include the 2037bp band as detailed in figure
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3.2.3b and a larger pcDNA3-derived fragment of 6458bp. Large-seale
preparation of this eonslruct was undertaken as described in section 2.3.10 .
3.2.4 The Human Chromogranin A Expression Construct
A 181 lbp full-length human chromogranin A (hCgA) cDNA in pGEM3-3
(Helman et al., 1988) was obtained from the American-type culture
collection (ATCC). Hindill and EcoRI restriction sites within the pGEM3-3
plasmid polylinker permitted excision of the complete hCgA cDNA. Direct
subcloning of this fragment into pcDNA3 was carried out as depicted
schematically in figure 2.3.4a.
Figure 3.2.4a: Schematic
representation of the subcloning
of human CgA cDNA into pcDNA3.
1) pcDNA3 was linearised by
treatment with Hin d 111 and
EcoRI. 2) The Hi n d 11\IEc o R I -
digested hCgA cDNA was ligated
with the similarly digested
pcDNA3. 3) The orientation of the
insert was directed by the
incompatible cohesive termini.
human CgA (1890bp)
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Hindill and FcoRI digestion of the hCgA plasmid and pcDNA3 was followed
by ligation and transformation of subcloning efficiency E.coli DH5a.
Preparations of plasmid DNA were screened for insertion of the hCgA cDNA
by simultaneous digestion with Hin dill and Bam HI. A schematic
representation of the predicted fragments produced is shown in figure














construct should produce 3
fragments of 5446, -1615 and
236bp upon digestion with
HinAlW and BamHl.
3.2.5 The EGFPC-oLHP fusion Construct
The oLH(3 subunit cDNA in pGEM3 was a kind gift from B.Miller (USA).
Fusion of the protein expressed by this cDNA and the enhanced GFP (EGFP)
required that the two sequences be ligated in frame.
The oLHp cDNA was excised with PstI. The EGFP carboxy-terminal fusion
vectors are supplied with the polylinker in three different reading frames;
pEGFP-Cl, -C2 and -C3 (Clontech, UK). Using GeneJockeyll (P.Taylor, MRC
UK), the vector producing an open reading frame (ORF) from the upstream
EGFP gene through the oFHp cDNA was determined to be pEGFP-C3. The
preservation of the ORF through the polylinker is shown in figure 3.2.5a.
The strategy used to construct the EGFP-oFHp fusion plasmid is depicted
schematically in figure 3.2.5b.
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EGFP
Tyr Lys Tyr Ser Asp Leu Glu Leu Lys Leu Arg lie Leu
TAC ARG TAG TCA GAT CTC GAG CTC AAG CTT CGA ATT CTG CA ~ G TCG




TAC AAG TAC TCA GAT CTC GAG CTC AAG CTT CGA ATT CTG CA G ATG
ATG TTC ATG AGT CTA GAG CTC GAG TTC GAA GCT TAA G AC GTC TAC
EGFP
Tyr Lys Tyr Ser Asp Leu Glu Leu Lys Leu Arg lie Leu
EGFP oLHp
Tyr Lys Tyr Ser Asp Leu Glu Leu Lys Leu Arg lie Leu Gin Met Glu
TAC AAG TAC TCA GAT CTC GAG CTC AAG CTT CGA ATT CTG CAG ATG GAG
ATG TTC ATG AGT CTA GAG CTC GAG TTC GAA GCT TAA GAC CTC TAC CTC
Figure 3.2.5a: Formation of the open reading frame between the
enhanced green fluorescent protein (EGFP) gene and the 5' terminus
of the ovine LH[3 cDNA in the polylinker of pEGFP-C3.
CO
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representation of the strategy
used to produce an EGFPC-oLHfi
fusion expression construct.
1) pEGFP-C3 was linearised by
treatment with the restriction
enzyme PstI. 2) The recessed 5'
termini were dephos-
phorylated using SAP to
prevent self-ligation of the
vector. 3) The PAil-digested
ovine LHP cDNA was ligated
with the dephosphorylated
pEGFP-C3. This reaction was not
directional and therefore
required screening so as to
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pEGFP-C3 and pGEM3/oLH[3 cDNA were digested with PstI. The vector was
subsequently dephosphorylated using SAP (Boehringer Mannheim, UK).
Ligation reactions were carried out using Ready-to-Go™ ligase tubes in
accordance with the manufacturers guidelines. The ligation was used to
transform E.coli SURE2 competent cells (Stratagene, USA). Plasmids were
screened by restriction with Apal at the recommended temperature of 30°C
(figure 3.2.5c). Large-scale preparation of this construct was undertaken as






















to determine orientation of
the ovine LH[5 cDNA after
ligation with pEGFP-C3.
a) Apal digestion of the
pEGFP-C3 vector containing
the ovine LHP cDNA in the
reverse orientation in regard
to the CMV promoter should
yield fragments of 4884 and
362bp. b) Similar digestion
of a construct containing the
ovine LH(5 cDNA in the same
orientation as the CMV
promoter should yield
fragments of 5226 and 197bp.
Figures shown in red refer to
the oLH[i cDNA sequence.
3.2.6 The EGFPC-«FSH(3 fusion Construct
The oFSHp subunit cDNA in pSP72 was a kind gift from T.E.Adams (Aus).
Excision of the oFSHp cDNA required digestion with Pvu II. Using
GeneJockeyll (P.Taylor, MRC CRB) pEGFPC-3 was determined to be the vector
which would produce an ORF between EGFP and the oFSH|i cDNA after
ligation of the PvuII and Eel\36II termini as depicted below (figure 3.2.6a).
The strategy used to construct the EGFP-oFSHji fusion plasmid is depicted
schematically in figure 3.2.6b.
















































































Lys Ser Gin His





atg ttc agg cct gag tct aga GAC AGA TGC CTT TTC AGA GTC GTA GGT GTC
Figure 3.2.6a: Formation
enhanced green fluorescent
of the ovine FSHp cDNA in
of the open reading frame between the
protein (EGFP) gene and the 5' terminus
the polylinker of pEGFP-Cl.
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representation of the strategy
used to produce an EGFPC-oFSHf)
fusion expression construct.
1) pEGFP-Cl was linearised by
treatment with the blunt-
cutting restriction enzyme
Ec/13611. 2) The 5' termini were
dephosphorylated using SAP to
prevent self-ligation of the
vector. 3) The PvnII-digcsted
ovine FSHfl cDNA was ligatcd
with the dephosphorylated





screening so as to
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pSP72/oFSH|3 cDNA was digested with Pvull and the insert extraeted after
agarose gel electrophoresis. The pEGFP-Cl vector was similarly digested
with Eel 136II prior to dephosphorylation with SAP. The ligation reactions
using Rcady-to-Go™ ligase tubes were carried out in accordance with the
manufacturers guidelines with the exception that incubation at the
recommended temperature of 16°C was extended to approximately 16 hours.
2pl of each ligation was used to transform MAXefficiency E.coli DH5a
competent cells (GibcoBRL, UK). Determination of the insert orientation in
isolated clones was undertaken by restriction digest using Pstl (see figure
3.2.6c). Large-scale preparation of plasmid DNA from a positive clone was
































to determine orientation of
the ovine FSHji cDNA after
ligation with pEGFP-Cl.
a) Pstl digestion of the
pEGFP-Cl vector containing
the ovine FSH[3 cDNA in the
reverse orientation in regard
to the CMV promoter should
yield fragments of 5047 and
130bp. b) Similar digestion
of a construct containing the
ovine FSH|) cDNA in the same
orientation as the CMV
promoter should yield
fragments of 4821 and 356bp.
Figures shown in red refer to
the oFSHp cDNA sequence.
3.2.7 The CAT Reporter Construct
Chloramphenicol acetyltransferase (CAT) activity can be measured
accurately by the method described in section 2.5.3. Use of a reporter
construct which expresses an easily measured exogenous protein allows
standardisation of protein assay results between individual samples with
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regard to transfection efficiency. Using the same mammalian expression
vector pcDNA3, a CAT cDNA in pB9 (P.Brown, MRC CRB) was subcloned using
the strategy represented schematically in figure 3.2.7a.
i?£"o .0 ^i
Figure 3.2.7a: Schematic
representation of the subcloning
of the CAT cDNA and HSV
polyadenylation signal into
pcDNA3.
1) pcDNA3 was opened by
treatment with the restriction
enzymes Bam HI and Xba I. 2) The
cohesive termini produced are not
compatible 3) The CAT cDNA is





Excision of the 800bp CAT cDNA and polyadenylation signal (polyA) was
undertaken using Bam HI and Xba I. pcDNA3 was similarly subjected to
BamWl and Xba I digestion. Gel extraction of the ~800bp CAT/polyA and
5370bp pcDNA3 fragments was undertaken as described in section 2.3.3. The
CAT cDNA and vector were ligatcd by methods described previously (2.3.7)
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and transformed into subcloning efficiency E.coli DH5a cells. Screening of
plasmid DNA was carried out by digestion with Bam HI and Xbal. Further
verification of the plasmid structure was achieved by PstI digestion as
shown in figure 3.2.7b. Large-scale preparation of the positive clone was









restriction digest of pcDNA3
containing the CAT cDNA and
HSV polyadenylation signal.
Pstl digestion of pcDNA3
containing the CAT cDNA and
HSV polyadenylation signal
should produce 2 fragments of
4721 and 1449bp.
3.3 Results
3.3.1 The Ovine aGSU Expression Construct
CIP-treatment of the EcoRI-linearised pcDNA3 produced a fragment with
migration by agarose gel electrophoresis equivalent to approximately 5.4kb
(figure 3.3.lai). The corresponding EcoRI digestion of pGEM3 successfully
excised the ovine aGSU cDNA which was visualised by agarose gel
electrophoresis (figure 3.3.1 aii). Miniprep DNA was initially screened by an
increase in size versus the empty pcDNA3 vector. Pstl screening of these
constructs distinguished plasmids containing the insert in the correct
orientation by the absence of a 581bp fragment (figure 3.3.lbi). Positive
clones were further analysed by digestion with Eco RI to excise the insert
(3.3.1 bii). This gel confirmed that CIP treatment had not damaged the EcoRI
termini.
After large-scale preparation of the pcDNA3 vector containing the ovine
aGSU cDNA, an aliquot of the plasmid was linearised by digestion with
Hin d 111 cutting within the polylinker. The resulting fragment was
visualised by agarose gel electrophoresis and corresponded to the predicted
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size of the construct of 6162bp (figure 3.3.1biii). This construct was
designated poocGSU.
3.3.2 The Ovine FSH(3 cDNA Expression Construct
PvwII digestion of pSP72/oFSHp cDNA successfully excised the insert
apparent by the 444bp fragment visualised by agarose gel electrophoresis
(figure 3.3.2ai). Gel extraction of this fragment yielded only 37.5ng as
estimated by agarose gel electrophoresis which was sufficient for a single
ligation reaction (figure 3.3.2aii). Preparation of pcDNA3 by digestion with
EcoKV linearised the vector (figure 3.3.2aiii) prior to treatment with SAP.
Ligation controls containing no insert produced no transformants
indicating the high efficiency of SAP treatment in preventing self-ligation
of the vector. Screening of eight clones by ApaI digestion demonstrated an
absence of the 441bp fragment in one sample (figure 3.3.2bi). Although the
87bp fragment was not visible the subsequent PsrI digestion clearly showed
the 4061, 1726 and 105bp fragments indicating the structural integrity of
the plasmid (figure 3.3.2bii). This construct was designated poFSHfl.
3.3.3 oFSHp Genomic DNA Expression Construct
The 900bp Hindlll-Pstl fragment containing 5' UT sequences of the oFSFip
genomic sequence was successfully excised from pGEM3 (figure 3.3.3ai).
The pBluescript KS+ was similarly digested and is also shown in figure
3.3.3ai . Both fragments were successfully extracted from the agarose gel
(figure 3.3.3aii). pBluescript KS+ DNA containing the 900bp fragment was
isolated from transformants and digested with Xhol excising the 226bp
sequence containing the transcriptional start. This fragment was
subsequently extracted from the agarose gel (figure 3.3.3bi).
The pBluescript KS+ vector containing the remaining oFSHp sequences but
with the HSV-IE 3' UT in place of the oFSHp 3' UT was digested with Xhol and
extracted from the agarose gel. Following CIP treatment, the 5931bp
dephosphorylated plasmid (figure 3.3.3bii) was ligated with the 226bp Xhol
fragment. Miniprep DNA was screened by Hindlll digestion with the
production of three band patterns (figure 3.3.3ci). The single band
produced by linearisation of empty vector is apparent in samples 1, 2 and 5.
Ligation of the 226bp fragment in the reverse orientation produced 4076
and 1855bp fragments as predicted by the screening strategy. Positive
samples produced a 3894bp fragment with similar migration to the 4076bp
fragment present in reverse samples. The difference between the 1885bp
fragment in the negative samples and the larger 2037bp fragment
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Figure 3.3.la: Preparation of pcDNA3 and the ovine aGSU cDNA for ligation.
i) pcDNA3 was linearised by digestion and treated with CIP The band in both
lanes corresponds to approximately 5 47kb. 'X' denotes l|ig of the XHinAIII size marker.
ii) The pGEM3 clone containing the ovine aGSU cDNA was digested with FctR\
The photograph shows the position of the fragment excised from the gel prior to
extraction. The position of this fragment corresponds to the 716bp cDNA. 'X*'
denotes l|ig of the XHfa&lll/EctRl size marker . Both gels contained 0.8% agarose
and were run in TAE buffer











Figure 3 3.1b: Screening pcDNA3 for insertion of the ovine aGSU cDNA.
i) Apal digestion of pcDNA3 constructs containing the ovine aGSU cDNA The absence of a
581bp fragment (arrow) indicated insertion in the correct orientation for samples 12, 13
and 15 ii) Fcii?I digestion of samples 12 and 13 produced the 716bp ovine aGSU cDNA. u'
denotes uncut plasmids iii) The TZTodlll-linearised construct exhibits the correct size of
approximately 6162bp. All gels contained 0.8% agarose and were run in TAE buffer. 'X'
denotes l|ig of the k/foxlIII size marker.
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X oFSHp X PCDNA3
Figure 33-2a: Preparation of pcDNA3 and the ovine FSHp cDNA for ligation.
i) The gel shows the extracted 444bp cDNA from PvcAl digestion of pGEM3/oFSHp cDNA
(arrow) ii) The .frziRV-linearised and SAP-treated pcDNA3 exhibits the correct size of
approximately 5 47kb (arrow). Both gels contained 0 8% agarose and were run in TAE
buffer X' denotes lpg of the size marker
Figure 3 3 2b: Screening pcDNA3 for insertion of the ovine FSHp cDNA.
i) ApaI digestion of miniprep DNA demonstrated the absence of the 441bp fragment (arrow)
in sample 2 indicating the presence of the oFSHp cDNA in the correct orientation. The 87bp
fragment was not resolved in this positive sample, ii) Psi. digestion of sample 2 after large-
scale DNA preparation. Both dilutions of the restriction digest contain the predicted 4061
and 1726bp fragments although the 105bp fragment was not resolved, u' denotes uncut
construct Both gels contained 0.8% agarose and were run in TAE buffer X denotes lpg
XAfazdlll marker
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X 1 2 X 1 2
Figure 3.3.3a: Preparation of pBluescript KS+ and the 900bp fragment containing the
ovine FSHp transcriptional start site for ligation.
i) Both plasmids were digested with HinAlW and PsA. The 900bp fragment is present in lane
1 (arrow) The approximate 3kb band in lane 2 represents the linearised pBluescript KS+
vector (arrowhead), ii) The extracted fragments appear free of contamination and
correspond to the original digestion. Both gels contained 0.8% agarose and were run in TAE
buffer. X' denotes l^g of XyXr/xlIII marker.
X 1 X 1
5641
Figure 3.3.3b: Preparation of the 226bp XhA fragment containing the ovine FSHp
transcriptional start and the pBluescript KS+ construct containing the 5 '-truncated ovine
FSHp gene and HSV-IE polyA for ligation
i) pBluescript KS+ containing the 900bp Hin&lll/PsA fragment of the ovine FSHp gene was
digested with XhiA producing a 226bp fragment (arrow). The gel (lane 1) shows this
fragment after extraction from the larger vector sequences, ii) The extracted XhA
digestion of pBluescript KS+ construct containing the 5'-truncated ovine FSHp gene and
HSV-IE polyA is shown in lane 1 after CIP treatment. The construct appears at
approximately 5 9kb as expected. Both gels contained 0.8% agarose and were run in TAE
buffer. X' denotes lug of XvXr/zdlll marker
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Figure 3.3.3c: Screening the pBluescript KS+ construct containing the 5'-truncated ovine
FSHp gene and HSV-IE polyA for insertion of the 226bp Xhd fragment containing the ovine
FSHp transcriptional start.
i) hhhdlll digestion of miniprep DNA produced three bands patterns. A single band
demonstrated the absence of the insert (lanes 1, 2 & 5). Two bands corresponding to 4076 and
1855bp indicate that the construct contains the insert in the incorrect orientation (lanes 3
& 6). Lane 4 shows the 2037bp fragment (arrow) which indicates the correct orientation of
the 226bp Xhd insert containing the ovine FSHp transcriptional start This gel contained
0.8% agarose and was run in TAE buffer, ii) Digestion of the positive sample (4) with Xhd.
excised the 226bp fragment (arrow) demonstrating the integrity of the restriction sites at
which it was ligated. This gel contained 2% agarose and was run in TBE buffer. 'X' denotes
lug ofXJhhdlU marker.
Figure 3.3.3d: Excision of the ovine FSHp gene and HSV-IE polyA from pBluescript KS+.
i) Kpn\ digestion linearised the plasmid construct (arrow) with its size corresponding to
approximately 5 8kb as expected, ii) Double digestion with JVoA and Scd. excised the modified
oFSHp gene and cut the vector respectively. The 3049bp KpiA-NoA fragment (arrow)
represents the oFSHp gene with the smaller bands being derived from the vector, iii) The
extracted 3049bp Xpnl-XoA fragment (arrow) is shown at the correct size and free of
contaminating pBluescript KS+ vector fragments. These gels contained 0.8% agarose and
were run in TAE buffer. X' denotes lpg of XffihdlW marker.
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X 1 2 3 4 X 3
Figure 3 3-3e: Screening of the pcDNA3 for insertion of the
ovine FSHp gene and HSV-IE polyA.
i) /B'/xilll digestion produced the 2037bp fragment (arrow) in minipreps 1-3 indicating
correct insertion of the oFSHp gene and HSV-IE polyA ii) Linearisation with SeaI produced
the expected 8429bp band (arrow). These gels contained 0.8% agarose and were run in TAE
buffer. X' denotes l^g of XJZi'ndlll marker.
X 1 2
Figure 3-3-4a: Subcloning the human CgA cDNA into pcDNA3
i) The pcDNA3 (lane 1) and hCgA cDNA (lane 2) fragments were extracted after JZ/'/idlll and
Ec/Rl digestion. The pcDNA fragment corresponds to approximately 5 47kb (arrowhead) and
the hCgA cDNA corresponds to approximately 1890bp (arrow), ii) Screening of recombinant
plasmids by BamHI and E/'sidlll digestion produced the 236bp fragment (arrow) and
indicated correct ligation of the cDNA. Both gels contained 0.8% agarose and were run in
TAE buffer. 'X' denotes ljxg ofX/Kr/zdlll marker
Chapter Three Mammalian Expression Constructs
122
produced by digestion of positive samples such as sample 5 is clearly
resolved on this gel. Digestion of a positive sample with XhoI excised the
226bp fragment verifying its presence in the intact construct (figure
3.3.3cii). After successful linearisation of the construct with Kpnl (figure
3.3.3di) digestion with Not I and Seal was undertaken. The activity of Not I
excised the 3049bp fragment containing the oFSH(3-HSV sequence and Seal
digested the vector producing two smaller fragments of 1767bp (Kpnl-Scal)
and 1103bp (Scal-Notl) (figure 3.3.3dii). The gel extracted 3049bp fragment
(figure 3.3.3diii) was ligated with pcDNA3 Kpnl-Notl. Plasmids isolated from
several recombinant colonies produced the 2037bp fragment after digestion
with Hindlll (figure 3.3.3ei). Furthermore the Scal-linearised construct
appeared equivalent to 8429bp by agarose gel electrophoresis (figure
3.3.3eii). This construct was designated poFSH(3g.
3.3.4 The Human Chromogranin A Expression Construct
Both pGEM3 containing the hCgA cDNA and pcDNA3 were successfully
digested with Hindlll and EcoRI prior to extraction from the agarose gel
(figure 3.3.4ai & aii). The directional cloning of the hCgA cDNA into pcDNA3
was assessed by BamMl and Hindlll. This dual digestion of plasmid DNA
isolated from minicultures produced the 236bp fragment corresponding to
the 5' region of the hCgA cDNA (figure 3.3.4b). This construct was
designated phCgA.
3.3.5 The EGFPC-oLHp fusion Construct
Pstl digestion of pGEM3 containing the ovine LHP cDNA excised the 519bp
fragment (figure 3.3.5ai). The pEGFP-C3 vector linearised by Pstl was
dephosphorylated using SAP (figure 3.3.5ai).
A single clone exhibited the 197bp fragment after Apal digestion (figure
3.3.5aii). This construct was designated pEGFPC-oLHp.
3.3.6 The EGFPC-oFSHp fusion Construct
The oFSHp cDNA was excised with Pvull and gel-extracted as described for
the poFSHp construct (section 3.3.2). pEGFP-Cl was linearised successfully
with Ec/13611 (figure 3.3.6a). Of the six colonies screened three contained
the oFSHp cDNA in the correct orientation as determined by the presence of
a 356bp fragment after Pstl digestion (figure 3.3.6b). According to the
suppliers of pEGFP-Cl (Clontech, UK) the 500bp fragment is non-clonable
ssDNA which is produced under some culture conditions by E.coli strains
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Figure 3.3.5a: Subcloning the ovine LHp cDNA into pEGFP-C3-
i) The ovine LIlp cDNA (lanes 1&2) and pEGFP-C3 (lanes 3&4) fragments were extracted after
PsA digestion The oLHp cDNA fragment (arrow) migrates at a position larger than the 564bp
marker due to a high GC contentwhich retards its migration The actual size of the fragment is
519bp. The SAP-treated pEGFP-C3 corresponds to approximately 4.7kb (arrowhead) The gel
contained 0.8% agarose and was run in TAE buffer. denotes l^g of the \P//2dllI marker.
ii) Screening of recombinant plasmids by Apal digestion produced the 137bp (also retarded
due to high GC content) shown by the arrow which indicated correct ligation of the insert. This






Figure 3-3-6a: Subcloning the ovine FSHp cDNA into pEGFP-Cl
i) The pEGFP-Cl (lane 1) fragment was extracted after £c~A361I digestion. The SAP-treated
vector corresponds to approximately 4 7kb (arrow). The gel contained 0.8% agarose and was
run in TAE buffer ii) Screening of recombinant plasmids by PsA digestion produced the
356bp fragment (arrow) in samples 3 and 4 indicating correct ligation of the cDNA. A larger
band (400-500 approx.) was also present in lanes 2 and 3 According to the manufacturer of
the vector (Clontech) this fragment is single-stranded DNA produced under some culture
conditions and is not clonable. This gel contained 2% agarose and was run in TBE buffer.
100' denotes the lOObp ladder used for size comparison, iii) After large-scale preparation of
a positive clone PsA digestion was repeated and again produced the 356bp fragment, u'
denotes uncut construct. V denotes l^g of LTTZodlll marker. The gel contained 1% agarose
and was run in TBE buffer.
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X cl 2345678 X Pstl
Figure 3.3.7a: Screening pcDNA3 for insertion of the CAT cDNA
i) Miniprep DNA from samples 1-8 produced the 800bp CAT insert (arrow) after BaniM/Jbal
digestion. The empty' pcDNA3 vector produced no insert (lane c). ii) The PsA digestion was
not complete as indicated by the presence of additional bands. However the diagnostic
1449hp fragment is present (arrow) indicating the structural integrity of the construct.
These gels contained 0.8% agarose and were run in TAE buffer. 'X' denotes lpg of XjKtodlll
marker.
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harbouring this plasmid. Agarose gel electrophoresis of the construct
demonstrated its supercoiled state when intact and production of a 356bp
fragment after PstI digestion (figure 3.3.6c). This construct was designated
pEGFPCl-oFSHp.
3.3.7 The CAT Reporter Construct
Excision of the CAT gene and polyA fragment from pB9 produced a
fragment of approximately 800bp. Similar digestion of pcDNA3 produced a
5428bp fragment. Recombinant plasmids were screened by Bam HI and Xbal
digestion with all eight clones producing the 800bp fragment indicating
the presence of the CAT-polyA sequence (figure 3.3.7a). Digestion of the
final plasmid construct with Pst I produced the diagnostic 1449bp fragment
(figure 3.3.7b). This reporter construct was designated pCAT.
3.4 Discussion
The majority of inserts used to engineer the constructs described in this
chapter were cDNAs. However both oFSH(3 and oLHp were also engineered as
genomic constructs (poFSHPg and poLHpg - P.Brown). This was undertaken
for two main reasons. Firstly work carried out by Irving Boime's group
established that genomic constructs for the gonadotrophin p-subunits were
expressed efficiently in cell culture (Keene et al., 1989). Introns have been
postulated to enhance expression levels in vitro. In addition, the presence
of introns would facilitate further cloning procedures such as 'exon
shuffling' and generation of oLHp/oFSHp hybrid molecules. Exclusive use of
cDNAs could rule out certain manipulations due to a paucity of suitable
restriction sites. The similar 3 exon arrangement of the P-subunit genes
may allow relatively straightforward shuffling experiments to be carried
out in cell culture initially and then in transgenics and allow elucidation of
putative sorting motifs located within the specific p-subunit exons.
The approaches used for subcloning the cDNA and genomic sequences into
pcDNA3 or pEGFP-Cl/3 relied mainly on traditional enzymatic cleavage and
ligation techniques. The structural integrity of the constructs described
during this chapter has been analysed by carefully designed restriction
mapping. However this by itself does not guarantee expression of the gene
inserted into the polylinker of the expression vector. Sequence data could
reveal structural anomalies in the event of expression problems.
Sequencing was not undertaken as expression of all constructs including
those provided from other sources (i.e. poEHpg, pbChrB73, pbSgII61) was
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confirmed by RT-PCR, RIA and indirect immunofluorescence in transiently
transfected mammalian cells (see chapters 4, 5 and 6).
The pcDNA3 vector has recently been superseded by the development of
pcDNA6 (Invitrogen, NL). This vector is based on the design of pcDNA3 but
contains a selective marker which confers resistance to the potent
antibiotic Blasticidin and contains a poly-histidine sequence downstream of
the polylinker (Invitrogen, NL). Future expression studies based on
selection of stable clones would benefit from the reduced selection time
required when using this vector. In addition the histidine tag may allow
immunocytochemical detection of antigens for which antisera are limited
or inefficient.
Further modifications or possible enhancements to in vitro expression
could be facilitated by using EGFP fusion vectors that allow fusion to the
amino-terminus of the fluorescent protein gene (Invitrogen, NL). The
expression of a fused protein from a construct of this type requires removal
of the stop codon from the 3' region of the inserted gene. However
engineering these constructs for oLH|3 would be further complicated by the
necessary removal of the sequence encoding the 7aa hydrophilic tail
which is cleaved during secretion (Bousfield et al, 1994), thus EGFP
carboxy-terminal fusion vectors were used during these studies. Without
removal of this sequence the fusion protein would be cleaved. Other
fluorescent proteins in which the EGFP gene has been mutated specifically
to alter its excitation and emission spectra are currently being developed.
Blue- and yellow-shifted variants are only available as part of fusion
vectors within limited reading frames and require specialised confocal
microscopy equipment such as an ultraviolet laser source and specific
filters but may be used in the future.
Other approaches for expression construct production include PCR
amplification of the insert. This allows engineering of specific restriction
sites onto the termini of the insert facilitating directional cloning into the
vector of choice. This approach may be necessary for subcloning of
pbChrB73 and pbSgII61 into shuttle vectors as these constructs do not
contain suitable restriction sites for excision of the inserts. Due to the
contamination-prone nature of PCR, the insert would require verification
by sequencing.
The following three chapters will describe the application of the constructs
produced during this chapter.
Chapter Four
Gonadotrophin Secretion from a
Human Choriocarcinoma Cell line
4.1 Introduction
The JEG3 choriocarcinoma cell line is of human origin. This cell line
expresses the a and (3 subunits of human chorionic gonadotrophin (hCG)
which combine to produce the active hormone that is then secreted via the
constitutive pathway (Kohler & Bridson, 1971). Alpha subunit gene
expression is positively regulated by cyclic AMP (cAMP) leading to a ten¬
fold increase in expression. The cAMP response element (CRE) found
upstream of the alpha subunit gene consists of two 18-bp repeats
containing the palindrome TGACGTCA. This CRE resembles those found in
other mammalian systems such as the rat somatostatin and human
proenkephalin gene (Delegeane & Mellon, 1987).
Until recently no cell line existed which secreted pituitary
gonadotrophins through a regulated pathway. At this time the JEG3 cell
line provided the only model for studying gonadotrophin secretion. CG is
similar in structure to LH and FSH showing 85% and 36% amino acid
sequence homology, respectively (Lapthorn et al., 1994). The hCGp subunit
is the largest of the gonadotrophin (3 subunits at 145 amino acids due to the
presence of a 31 amino acid hydrophilic carboxy-terminal peptide which
increases the rate of gonadotrophin secretion (Muyan et al., 1996).
The apparent lack of a regulated pathway in the JEG3 cell line allows
positive measures to be taken towards inducing formation of such a
pathway. As granins have been widely implicated in the regulated
pathway of neuroendocrine cells (see 1.6.5) their role may be determined
by expression in a non-regulated secretory cell line. Formation of a
regulated pathway leading to storage and ligand-stimulated release of hCG
would implicate granin expression as a key factor in the differential
sorting of pituitary gonadotrophins.
There are two approaches with which to study the expression of exogenous
genes within mammalian cells; transient and stable transfections.
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4.1.1 Transient transfections
Methods to induce uptake of DNA by mammalian cell lines include those
mediated by calcium phosphate (Chen & Okayama, 1987), cationic lipids,
DEAE dextran, microinjection or electroporation (for a review see
(Gorman, 1986)). Calcium phosphate and lipid-mediated methods used
within this study rely on forming complexes with the plasmid DNA that
interact more efficiently with the plasma membranes of mammalian cells.
The transient nature of this type of transfection relates to the duration of
exogenous gene expression which persists for up to 80 hours. Transfected
DNA constructs may penetrate the nuclear envelope or remain cytosolic.
Transcription of transfected genes is often driven by the cytomegalovirus
(CMV) or SV40 promoters and requires the host's transcription machinery.
Transfection of cell lines is carried out during their exponential growth
phase. Cells within this highly mitotic population will obviously exhibit
significant membrane breakdown and reconstitution. Although the role of
mitotic cell division may be crucial to the initial uptake of DNA, the
concomitant nuclear membrane breakdown may permit further entry of
the exogenous plasmid DNA. It is possible to conceive that leakage of RNA
polymerase II and transcription factors during mitosis may permit some
expression of cytosolic plasmids. However it may be more likely that
plasmids which gain entry into the nucleus provide the majority of
exogenous gene expression due to the higher concentration of the
necessary transcription proteins and cofactors.
Due to the high number of plasmid molecules used during transfection it is
likely that mixtures of two or more different plasmids may result in
expression relative to the proportion of the plasmid in the original
mixture. This hypothesis allows cotransfection of multiple constructs at
various ratios to each other in an attempt to alter their relative expression
rates assuming that the toxicity of the plasmids and the promoters are
similar in all constructs cotransfected.
4.1.2 Stable transfections
Stable transfections are initially undertaken in a similar way to the
transient variety however for stable transfections all plasmids must
contain a selectable marker gene. In pcDNA3 resistance to the neomycin
analogue G418 is conferred by the neoR gene which encodes an
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aminoglycoside phosphotransferase (for more detail refer to the previous
chapter). Stable transfection requires a selectable marker to exert a
metabolic pressure upon the transfected cell which over time may lead to
integration of the plasmid containing the marker as well as the inserted
gene into the genome. Although the rate at which DNA integrates may be
significantly lower than the rate of DNA uptake, stably transfected cell
populations have the advantage of long-term exogenous gene expression
therefore obviating the need for repeated transient transfection.
Furthermore the clonal selection of colonies surviving exposure to the
antibiotic in theory produces populations of genetically identical
mammalian cells that express the transfected gene or genes at identical
levels. This second factor underlies the main disadvantage of transients in
that exogenous gene expression varies considerably between individuals.
Induction of high level gene expression by treatment of stably transfected
Vero cells with sodium butyrate has been reported (Wacker et al., 1997)
although the exact mechanism of action for this agent remains to be
determined. Although previously unsuccessful when applied to JEG3 cells
(A.Howe - personal communication) sodium butyrate and butyric acid have
been used in various cell lines to increase transfection efficiency
(Sambrook et al., 1989).
4.2 Materials and Methods
4.2.1 Calcium Phosphate-based transfection
Optimisation of this technique originally described by Graham & Van der
Eb (Graham & Van der Eb, 1973) for use with the JEG3 cell line was carried
out previously (Howe, 1995). Cells at approximately 60% confluency were
washed twice in DPBS before being replaced with cDMEM and incubated
for 2 hours under normal conditions. The transfection mix containing the
DNA and CaP04" complex was prepared as follows. For duplicate
transfections in 6cm diameter dishes 20pg DNA was added to the bottom of a
6ml polypropylene centrifuge tube containing sterile water so that the
diluted DNA solution was 450pl in total. 50pl 2.5M CaCl2 was gently added to
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the bottom of the tube after which 500|il A-[2-hydroxyethyl] piperazine-
A'-[2-ethane sulfonic acid] (HEPES)-buffered saline pH7 (HBS - see
Appendix I) was added in a similar manner. A 500pl volume of air was then
slowly released at the bottom of the tube so as to mix the constituent parts
of the transfection solution. This mixture was then incubated at room
temperature for 30 minutes. 500pl of the transfection mix was overlaid on
each of the dishes and incubated under normal culture conditions for 16
hours. Two DPBS washes were carried out prior to replacement of the
media. Culture of the transfected cells was then carried out under normal
conditions for 24 to 72 hours after which analysis of the cells and media
was carried out by methods described elsewhere in this chapter (Howe,
1995).
4.2.2 Optimisation of Lipid-based transfection
All transfection procedures are toxic towards mammalian cells. Toxicity
may be caused by small amounts of bacterial endotoxins within
preparations of DNA or adverse effects of the transfection agent used.
These toxic effects may be reduced if exposure is limited however this
requires an efficient transfection agent.
The |3-galactosidase-expressing plasmid pcDNA3.1/His/lacZ was transfected
into JEG3 cells by the various methods under assessment. Colorimetric
staining of fixed cells allowed expression of (3-galactosidase to be detected
in transfected individuals (see section 2.4.9).
Existing calcium phosphate-based transfection of JEG3 cells required
overnight incubation of the transfection mix and cells. Furthermore
despite thorough optimisation of this technique, transfection efficiency
was relatively low (Howe, 1995). In order to achieve transfection of JEG3
cells with higher efficiency, shorter incubation time and less labour
intensity, alternative lipid-based methods were evaluated.
Approximately 4xl04 cells were plated 16-20 hours prior to the
transfection. For the optimisation process 12-well cell culture plates were
routinely used. The three remaining parameters which were varied
included the amount of DNA added per well, the ratio of lipid:DNA and
duration of transfection. Clonfectin™ (Clontech, USA) and N-[l-(2,3-
Dioleoyloxy)propyl]-A, N, AMrimethylammonium methyl sulphate (DOTAP;
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Boehringer Mannheim, UK) were used in accordance with manufacturers
guidelines. The PerFect™ lipid system (Invitrogen, NL) which contains
eight different lipid mixes for evaluation was also used in accordance with
manufacturers guidelines. DMEM (containing no antibiotics or FCS) was
used for preparation of the transfection mixture and the subsequent
incubation. cDMEM was used for the post-transfection incubation.
Expression was assessed for each transfection procedure 48 hours
posttransfection by (3-galactosidase staining (section 2.4.9).
4.2.3 Optimised JEG3 Transfection
JEG3 cells were seeded in an appropriate culture vessel at approximately 4
x 105 cells/cm2 16-20 hours prior to transfection. A ratio of 6:1 for
PerFect™ lipid 4 (Pfx4) to DNA was used. The actual amount of DNA
transfected was proportional to the size of culture vessel used. For example
2.5pg of DNA was applied to each chamber of a 12-well plate which
therefore required 15pg of Pfx4. The lipid and DNA mixes were prepared
according to the manufacturers guidelines and mixed gently prior to
addition to the DPBS-washed cells. Incubation of the transfection mix at
3 7°C and 5% C02 for 3-4 hours was followed by a single DPBS wash and
replacement of cDMEM. All liquid manipulations were undertaken with
extreme care not to detach the cells. This was achieved by tilting the
culture vessel and applying the liquid to the vessel wall as opposed to
addition directly to the cell monolayer. Further incubation of the cells at
3 7°C and 5% C02 was undertaken for 24-72 hours to allow expression of
transfected genes.
4.2.4 Upregulation of hCG Expression
aGSU and hCG(3 expression were upregulated by exposure to ImM dibutyryl
3',5'-cyclic adenosine monophosphate (cAMP; Sigma-Aldrich, UK)
(Jameson et al., 1987; Howe, 1995). A working dilution of lOOmM dibutyryl
cAMP was prepared on the day of use. Incubation of JEG3 cells under
normal culture conditions was carried out for 24 hours in the presence of
ImM dibutyryl cAMP.
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4.2.5 Immunoradiometric Assay (IRMA) of hCG
This assay supplied by Serono (France) was performed by following the
manufacturers guidelines for the quantitative method with the following
modifications. The volumes of standard and sample used were 25pl and the
volume of 125I-anti-hCG reagent was also reduced by half to 250pl.
4.2.6 Granins and hCG Secretion
Plasmid constructs containing the full-length cDNAs for bovine CgB
(pbChrB73) and bovine Sgll (pbSgII61) were kind gifts from R. Fischer-
Colbrie (University of Innsbruck, Austria). These vectors contain the SV40
promoter whereas the hCgA expression construct (phCgA) contains the
CMV promoter.
In order to verify that the SV40 promoter could drive expression of the
bCgB cDNA in transfected JEG3 cells Northern analysis was carried out.
lOpg of total RNA extracted from the cell lysate was separated on a 1%
agarose gel by electrophoresis under denaturing conditions. The RNA
transferred to the nylon membrane was crosslinked by application of UV
light and subsequently probed with 30ng of the gel extracted and 32P -
labelled bCgB cDNA sequence. Visualisation and analysis of the blot was
carried out using a STORM™ Phosphorlmager (Molecular Dynamics, UK).
All three constructs were transfected into JEG3 cells using the CaP04"
method. An initial study was carried out in which each of the constructs
was transfected into 3 separate 35mm diameter dishes seeded with
approximately 3.5x10s JEG3 cells 24 hours previously. In addition some
cells were transfected with all three constructs in equal proportions. All
DNA mixes contained 10% pCAT vector with which comparative
transfection efficiencies could be determined. Mock-transfected JEG3 were
exposed to the transfection mixture containing no DNA. 24 hours post-
transfection all the cells were washed with DPBS twice and the cDMEM
replaced. All dishes except 3 of the 6 containing mock-transfected cells
received ImM dibutyryl cAMP. Exposure to dibutyryl cAMP lasted 24 hours
after which the media and lysates were harvested for hCG assay. Lysis of
the cells was carried out as described in section 2.5.1 using 200gl lOOmM
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sodium carbonate per dish. Bradford assay of the lysate was undertaken to
determine the total protein content of each sample. A volume of lysate
determined to contain lpg of total protein was subjected to CAT assay and
quantified using the STORM™ Phosphorlmager. 25pl of the lysate and
media was assayed for hCG content using the MAIAclone kit (Serono,
France).
4.2.7 Detection of oLH(3 and oFSH(3 mRNA by RT-PCR
Sheep luteal pituitary RNA and mouse kidney RNA were kind gifts from
P.Brown (MRC, CRB). Several primers were designed in order to detect
expression of oLHfi and oFSHp following the guidelines described in 2.3.15 .
The sequence details, predicted optimal annealing temperatures and
product sizes for each of these primers are listed in table 4.2.7a. Primers
designed to amplify human glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA are also detailed in table 4.2.7a and were obtained from
Clontech (UK).
All RT-PCR was carried out using the Titan™ kit (Boehringer Mannheim,
UK) in accordance with manufacturers guidelines. The oFSH(3 reactions
were assessed at annealing temperature of 56, 60 and 64°C. Annealing
temperatures of 62, 66 and 70°C were assessed for the oLH|3 RT-PCR. Each of
the oLH(3 primer combinations were also assessed for their ability to
amplify products from mouse kidney RNA.
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microscope and LSM510 scanning module (Zeiss, UK) as described in
section 2.6.3.
4.2.9 Stable transfection of JEG3 cells
Stable integration of transfected genes requires selection with an
antibiotic to which resistance is encoded on the transfected construct. In
these studies resistance to G418 was conferred by the neoR gene within
pcDNA3. For the selection process to be effective untransfected cells must
be efficiently killed.
In order to determine the G418 concentration required to carry out this
selection process G418 was titrated and applied to confluent JEG3 cultures
in duplicate wells of a 12-well plate. G418 obtained from Sigma was batch-
tested to avoid interbatch variation. cDMEM containing either 0, 31.25, 62.5,
125, 200 or 250pg/ml G418 was added to the wells and changed every 3 days.
After one week the cells were trypsinised and counted using a
haemocytometer. Three samples were counted for each duplicate well.
JEG3 cells were transfected with either genomic gonadotrophin (3-subunit
expressing construct only or in combination with poaGSU. 24 hours after
transfection using Pfx4 the cells were seeded in large culture vessels with
162cm2 growth surface. Approximately Ixl03-lxl04 cells were added to
each flask so as to achieve sufficient dispersal of individual cells from
which discrete colonies may be isolated. 200pg/ml G418 was applied to the
transfected cell population upon addition to the large flask. Selection was
maintained by regular replenishment of fresh cDMEM containing
200pg/ml G418. After 4-6 weeks of selection discrete colonies were isolated
as follows. The location of colonies was determined using an inverted
microscope and marked on the underside of the flask using a marker pen.
The media was removed and washed twice with DPBS. While still covered in
DPBS the upper surface of the flask was removed using a hot soldering
iron. 8mm diameter cloning rings supplied with sealant on one end were
placed over the marked colonies using sterile forceps after removal of the
DPBS. Approximately 25pl trypsin was added to each cloning ring using a
sterile fine-tipped plastic Pasteur pipette. Due to the breached structure of
the flask incubation at 37°C was not possible. Incubation at room
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temperature required optimisation and was varied between 30, 60, 180 and
240 seconds. Approximately 150pl cDMEM was added to each cloning ring to
halt the trypsinisation. Complete removal of the limited number of cells
was attempted by repeated pipetting of the media within the cloning ring.
This was also varied between a single removal of the media up to 20
removals and re-additions to the cloning ring. The media from the cloning
ring was transferred to a 96-well tissue culture plate and cultured under
normal conditions in the presence of a maintenance dose of 125pg/ml
G418. Isolated colonies were maintained in well sizes appropriate to the
number of cells. Clones were stored in liquid nitrogen by the method
described in section 2.4.7.
4.2.10 Genomic Analysis of Stable Transfections
Analysis of genomic DNA isolated from resuscitated clones was undertaken
so as to determine the copy number of inserted genes.
Approximately 5 xlO6 cells were scraped from the flask surface into 1ml
DPBS and centrifuged for 5 minutes at 13000rpm and 4°C in an Heraeus
Sepatech Biofuge 22R with HFA 22.2 rotor. The pellet containing the intact
cells was lysed in 500pl solution containing 1% SDS, 500pg/ml Proteinase K,
lOmM TrisHCl pH7.9, 0.15M NaCl and lOmM EDTA pH8. Incubation of the
samples for 4 hours at 37°C with occasional gentle agitation ensured
digestion of the cellular proteins. The sample was then phenol extracted
before precipitation by 1.5 volumes of 100% ethanol. The precipitated DNA
was then isolated from the solution using a siliconised glass Pasteur pipette
(prepared as described in Appendix I). The DNA was then allowed to air-
dry before being resuspended by incubation at 4°C in 1ml of sterile water.
Restriction endonucleases were chosen which would excise the oLH(3 or
oFSH(3 genomic sequences. In addition Bsml which cut within the pcDNA3
vector sequence was used to allow reprobing of the membrane to assess
integration of the neoR gene. Bsml and XhoI were incubated with lOOpl of
genomic material from wild-type and poLHpg stably-transfected JEG3 cells.
Similarly Bsml and Xbal were used to digest wild-type and poFSHpg stably-
transfected JEG3 cells. In order to estimate the number of integrated copies
copy number controls were prepared from the CsCl-purified stocks of the
poLHP and poFSH(3 constructs. 10pg of poLH|3 was digested with Xho I
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whereas poFSH(3 was digested with Xbal. Digestions of the plasmid and
genomic DNA was undertaken according to manufacturers guidelines for 2
hours. Midway through the genomic digest 40 additional units of XhoI and
Xbal were added to the oLHfl- and oFSH(3-containing reactions respectively.
Following digestion of the genomic material the DNA content was
measured by spectrophotometrical analysis at 260nm. 5pl of a fresh aliquot
of DNA loading dye (see Appendix I) was added to 15pg of each genomic
digest. This mixture was heated at 65°C for 5 minutes to remove secondary
structures prior to loading on a 0.8% agarose gel. Meanwhile copy number
controls were prepared by calculating the proportion that each
gonadotrophin p-subunit encoding fragment comprised of the human
genome.
2 pi of each plasmid restriction digest was separated by agarose gel
electrophoresis and the concentration of the fragment containing the
insert sequences estimated. The proportion that each fragment size
comprised of the human genome was then calculated. This figure was then
used to determine the amount of the fragment required to represent a















1 copy of oFSHp 6pg of the 2.4kb poFSHPg Xbal fragment
Copy number controls were loaded on each 20cm 0.8% agarose gel which
was electrophoresed at 40V overnight.
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Prior to transfer of the DNA a photograph of the gels next to a fluorescent
ruler was taken so as to orientate hybridised bands with the Lambda
Hindlll marker also run on the gel. DNA transfer, labelling of probes and
hybridisation were carried out as described in sections 2.3.17-19. The
respective full-length cDNAs provided by B.Miller (USA) and T.E.Adams
(Aus) were used as probes.
4.2.11 Analysis of Gene Expression
in Stable Transfections
The presence of specific mRNA expression from integrated oLHp genes was
assessed by RT-PCR. RNA was extracted from confluent cultures of JEG3
cells stably transfected with the either the oLH(3 gene or both the aGSU
cDNA and oLEip gene using Tri-reagent (Sigma-Aldrich, UK) as described
previously for transiently transfected cells. Two different oLHp RT-PCR
reactions were carried out using the Titan™ kit (Boehringer Mannheim,
UK) at the annealing temperature of 70°C. Primer lh33 targets the 3' UT of
the oLHp gene and was used in both RT-PCR reactions. Two different 5'
primers were used; lh53 and lh52. The former anneals to exon 2 whereas
lh52 anneals to the junction region between exons 1 and 2 of the oLHp
gene. Application of lh52 primer allowed detection of aberrant oLHp
splicing.
Detection of oLH in JEG3 cells stably transfected with the oLHp gene was
undertaken by RIA using hCG-stripped R29 antisera. Media and lysates
from confluent cultures were harvested as described in section 2.5.1.
4.2.12 Induction of Gene Expression using Butyric Acid
JEG3 cultures stably transfected with the aGSU cDNA and either the oLHp or
the oFSHp genes were assessed to determine the effect of butyric acid
treatment on expression of exogenous genes. Cultures were seeded in 12-
well plates at approximately 3.5 x 105 cells per well. Cells were maintained
in the presence of 125pg/ml G418 to prevent loss of the integrated genes.
Media from the first 48 hours of growth was removed and stored at -20°C.
Similar cDMEM containing either 0,1, 2, 4, 8, 16mM butyric acid pH8 was
added to the wells in duplicate and incubated for 22 hours. After this period
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the media was again removed and stored at -20°C. Normal cDMEM was added
to the wells and incubated for a further 48 hours. After removal and
storage of this media sample the lysates were harvested in lOOmM sodium
carbonate. RIAs were carried out to measure both intracellular and
secreted oLH and oFSH.
Duplicate wells in 6-well plates were seeded with JEG3 cells and once
confluent were treated with 16mM butyric acid for 24 hours. RNA was
harvested from these cells and RT-PCR carried out using lh52 and lh33 as
described previously.
4.3 Results
4.3.1 Lipid-based Transfection of JEG3 cells
Transfection of JEG3 cells using the lipid agent Clonfectin™ produced only
1-2 blue cells per confluent 35mm diameter well when (3-galactosidase
staining was carried out. Further trials with this lipid were abandoned due
to the obvious lack of efficiency for JEG3 cell transfection.
P-Galactosidase staining of DOTAP-mediated transfections demonstrated an
optimum incubation time of approximately 6 hours (figure 4.3.1a). Both 3
hour and 24 hour incubations exhibited less than 50% the number of
transfected cells achieved with a 6 hour incubation. The ratio of lipid to
DNA also appeared to affect transfection efficiency with a ratio of 10:1
producing the greatest number of transfected JEG3 cells. Attempts to
increase the transfection efficiency by using more lipid were
unsuccessful as shown by the drastically reduced number of blue cells
after incubation at a ratio of 30:1. A ratio of 30:1 using only 0.5pg DNA
(15:0.5 in figure 4.3.1a) was also assessed with no improvement over
previous transfection conditions.
Initial screening of the eight PerFect™ lipids provided clear evidence that
lipids Pfx4, Pfx5 and Pfx8 were most suited to transfection of JEG3 cells
(figure 4.3.1b). Further optimisation of the conditions as recommended by
the manufacturer did not provide an increase in the observed transfection
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efficiency. Notably, prolonged exposure to Pfx4 was extremely toxic
towards JEG3 cells and resulted in almost all the cells detaching from the
culture surface. Increases in lipid concentration were assessed as
previously for DOTAP transfections and similarly a reduction in



















Length of Exposure to Transfection Mix and lipid: DNA
Figure 4.3.1a: JEG3 transfection efficiencies using DOTAP.
Bar chart showing the number of transfected cells produced by
different ratios of DOTAP to DNA and lengths of incubation.
Transfections were performed in 12 well dishes on JEG3 cells at
60-80% confluency and left for 48 hours post-transfection prior
to (5-galactosidase staining of confluent wells. Total blue cells per
well were used to compare transfection efficiencies.
TS.E.M
■ Mean
The 10:1 ratio of DOTAP to DNA incubated for 6 hours provided the highest
transfection efficiency using this lipid but transfection mediated by Pfx4
under optimal conditions increased the number of transfected cells 3-fold.
Although the optimal transfection conditions produced a relatively high
number of transfected cells, the overall transfection efficiency remained
low. For comparison with other cell lines transfection efficiency is often
expressed as the percentage of transfected cells in the total population of
cells. Since approximately lxlO6 cells were present within each well of a
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12-well plate the optimal transfection efficiency obtained with Pfx4
represents only 1.4%. A representative photograph of JEG3 cells


































Length of Exposure, [lipid:DNA] and Perfect Lipid
Figure 4.3.1b: JEG3 transfection efficiencies using different
PerFpct lipids
Bar chart showing the number of transfected cells produced by
different PerFect lipids, ratios of lipid to DNA and lengths of
incubation. Transfections were performed in 12 well dishes on
JEG3 cells at 60-80% confluency and left for 48 hours post-
transfection prior to [3 -galactosidase staining of confluent wells.
Total blue cells per well were used to compare transfection
efficiencies.
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Figure 4.3.1 c: JEG3 cells transiently transfected with pcDNA3 1/His/lacZ
JEG3 cells were transiently transfected with pcDNA3 1/His/lacZ using PerFect lipids 48 hours
posttransfection the cells were fixed and stained for p-galactosidase activity
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4.3.2 Transient granin expression and hCG secretion
Northern analysis of bCgB expression from transiently transfected JEG3
cells provided evidence for production of mRNA transcripts comparable to
those expressed in ovine pituitary tissue (figure 4.3.2a). Three bands are
present within the transiently transfected JEG3 RNA samples. The smallest
band appears slightly larger than the corresponding band produced by
hybridisation with ovine pituitary RNA. This analysis confirmed that
specific mRNA for bCgB was expressed by JEG3 cells transfected with the
pbChrB73 construct. The two larger bands appear less abundant than the
smallest band and may represent non-specific hybridisation.
Bradford assay of cell lysates provided the protein concentration of each
sample which ranged between 20 and 105ng/pl. Total protein
concentration represented variations in cell number which appeared
reduced in transfected samples reflecting the toxicity of the procedure.
IRMA of hCG in the lysate and media from the transfected and control
samples provided concentrations in IU/ml. This figure was adjusted to
account for variations in cell number using the Bradford assay results. A
comparison of the total hCG expressed by control and transiently
transfected JEG3 cells is shown in figure 4.3.2b. Unstimulated cells
produced undetectable levels of hCG. Total hCG expression appeared
unchanged in cells transfected with the bCgB construct alone whereas
transfection of either hCgA or bSgll constructs caused a significant rise in
total expression levels. Cells transfected with equal amounts of all three
expression constructs exhibited hCG expression levels similar to that of
cells transfected with the bCgB construct alone and the untransfected but
stimulated cells.
Volumes of lysate containing lpg of protein were subjected to CAT assay
and the activity visualised by exposure of the TLC plate within a
Phosphorlmager cassette. A representative image obtained after a 48 hour
exposure is shown in figure 4.3.2c. All pCAT-transfected samples exhibit
CAT activity whereas samples from mock-transfected cells exhibited only
background levels. Standardisation of the CAT assay results provided a
range of figures between 0 and 1 which were applied to the Bradford-
OP J J J
Figure 4.3 2a: Northern analysis of CgB in the
ovine pituitary and transiently transfected JEG3
cells.
RNA was extracted from transiently transfected
JEG3 cells 48 hours posttransfection using
^ -i- Tri-reagent Either 10pg of total JEG3 RNA (J) or
5pg of total sheep pituitary (oP) RNA was loaded
per lane The membrane was hybridised with the
full-length bCgB cDNA Transcripts from
transfected JEG3 cells (arrow) appeared larger
than those detected in the ovine sample In
addition, two much larger transcripts were
"**
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Figure 4.3 2c: Thin layer chromatography of CAT assay reactions
Lysates were prepared from untransfected cells (-) or from cells 48 hours
posttransfection ( + ). Reactions containing acetyl coenzyme A and H4lC-
chloramphenicol were incubated at 37°C with lmg of lysate. The
percentage of total chloramphenicol which was mono-acetylated
(arrowhead) and di-acetylated (arrow) was determined using a STORM
Phosphorlmager. Reactions containing lysates from untransfected cells
displayed background levels of acetylation
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corrected hCG IRMA results giving figures which take into account
variations in transfcction efficiency between samples. In order to relate
any differences observed in hCG storage between transfected and control
JEG3 cells the mean intracellular hCG concentration was expressed as a
percentage of the total hCG expressed as shown in figure 4.3.2d.
-cAMP + 1mM cAMP
70000
60000
Treatment and Expression Constructs Transfected
Figure 4.3.2b: Total hCG expression from JEG3 cells transfected
with granin expression vectors.
Bar chart showing the relative amounts of hCG in IU expressed
by unstimulated JEG3 cells and cells exposed to ImM cAMP for 24
hours. hCgA and bSgll both cause significantly more expression
of hCG in comparison to cells transfected with the bCgB
expression plasmid. bSgll expression also causes a significant
rise in hCG expression in comparison to untransfected cells. All
cells liansfected with the bCgB expression construct either alone
or in conjunction with the hCgA and bSgll constructs exhibit
similar total hCG expression to untransfected cells. hCG





















This representation allows comparison of hCG storage profiles and
accounts for both variation in cell number and transfection efficiency.
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The bar chart indicates that transfected and control JEG3 cells treated with
ImM dibutyryl cAMP exhibit similar proportions of intracellular hCG.
Furthermore cells transfected with a single granin-expression construct
or a mixture containing all three constructs failed to exhibit significantly




























■cAMP +1 mM cAMP
Treatment and Expression Constructs Transfected
Figure 4.3.2d: Comparison of hCG storage in cAMP-stimulated
JEG3 cells transiently transfected with granin expression
vectors.
Variations in transfection efficiency were corrected for by
application of figures from CAT assays performed on cell
lysates. The percentage of CAT-adjusted hCG expressed which
remains intracellular after 48 hours of expression does not
differ significantly between untransfected cells and cells
expressing granins.
4.3.3 Transient Pituitary Gonadotrophin Expression
Transient expression of transfected pituitary gonadotrophin expression
construct was initially assessed by RT-PCR.
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The integrity of RNA extracted from JEG3 cells and ovine pituitary was
confirmed by RT-PCR using GAPDH primers (figure 4.3.3a). Amplification
of a fragment corresponding to approximately 450bp is in accordance with
the predicted product size for this reaction.
Optimisation of the oFSHfl RT-PCR demonstrated that all combinations of
primers produced an amplified DNA product of the predicted size as
detailed in figure 4.3.3b. The highest annealing temperature of 64°C
reduced the efficiency of the reaction carried out using fsh51 and fsh32
whereas other reactions containing fsh51 appeared unaffected by this
annealing temperature. Efficient amplification of the 450bp fragment
using fsh51 and fsh33 did not occur at the lowest annealing temperature of
54°C.
Temperature optimisation of the oLH(3 RT-PCR showed that at all annealing
temperatures the predicted product sizes were exhibited as shown in
figure 4.3.3 cii. No products were detected in the control reactions
containing no RNA. Verification that these reactions were specific for
amplification of oLHp sequences was demonstrated by the lack of products
in reactions containing mouse kidney RNA (figure 4.3.3ciii).
oFSHp expression from poFSHPg was confirmed by the appearance of an
amplified DNA fragment which migrated between 400 and 500bp during
agarose gel electrophoresis (figure 4.3.3d). The amplification of this
fragment coincides with that observed in the reaction containing ovine
pituitary RNA and is in accordance with the predicted product size of
approximately 490bp for fsh51 and fsh33. The specificity of the RT-PCR
was confirmed by the complete absence of amplification in samples
containing RNA from untransfected JEG3 cells.
RT-PCR in common with all polymerase-dependent nucleic acid
amplifications requires specific annealing of primer sequences. hCGp and
oLHp sequences show significant homology and non-specific amplification
of hCGp sequences using lh52, lh53 or lh33 could occur due to limited
primer mismatches. However despite the sequence similarity of oLHp and
hCGp it is apparent from the lack of amplicons in reactions containing
normal JEG3 RNA that the high annealing temperature of 70°C prevented
nonspecific priming. RT-PCR using primers lh52 and lh33 directed towards
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lOObp b oP oP JEG3 lOObp Figure 4.3.3a: GAPDH RT-PCR.
GAPDH mRNA was detected (450bp product)
using human primers in RNA from sheep
pituitaries (oP) and JEG3 cells (arrow). No
products were produced by the reaction
containing no RNA (b). The annealing
temperature for these reactions was 54°C.
The gel contained 2% agarose and was run
TBE buffer. lOObp ladders were used as
size markers.
fsh51/31 fsh51/32 fsh51/33 fsh51/34
lOObp b 56 60 64 b 56 60 64 b 56 60 64 b 56 60 64
soo
400
Figure 4.3-3b: Temperature optimisation for the oFSHp RT-PCR with four
sets of primers.
No products were produced from the control reactions containing no
RNA (b). All primer combinations produced the predicted product size
in the presence of sheep pituitary RNA (fsh51/31=412bp, fsh51/32=412bp,
fsh51/33=449bp, fsh51/34=490bp). The primer combination of fsh51
and 33 was used at the annealing temperature of 64°C for subsequent
reactions as this produced a relatively high amount of product with no
background. The gel contained 2% agarose and was run in TBE buffer. A
lOObp ladder was used for size comparison.
!h5 2/3 2 lh52/33 lh53/32 lh53/33
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Figure 4.3.3c: Temperature optimisation and specificity of oLHp RT-PCR
primers.
i) Control reactions containing no RNA produced no bands, ii) All bands were
in accordance with the predicted product
sizes for each primer pair. Annealing temperatures of 62, 66 and 70°C were
assessed. Some non-specific products were produced at the lowest annealing
temperature but were abolished as the temperature was raised. Where
l=lh52&32 (385bp), 2=lh52&33 (480bp), 3=lh53&32 (31 lbp), 4=lh53&33 (406bp).
iii) The specificity of each primer pair was also verified by RT-PCR of mouse
kidney RNA (mK) in comparison to sheep pituitary RNA (oP). These reactions
were carried out at the annealing temperature of 70°C. All gels contained 2%
agarose and were run in TBE buffer lOObp ladders were used as markers.
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10Obp b oP JEG3 T
Figure 4.3 3d: Expression of oFSHp in transiently transfected
JEG3 cells as determined by RT-PCR.
No amplified products are visible in the control reaction containing no RNA (b) or
the reaction containing untransfected JEG3 RNA (JEG3) Similar size products are
present in reactions containing sheep pituitary RNA (oP) and RNA from JEG3 cells
transiently transfected with poaGSU and poFSHpg (T). RNA was harvested using
Tri-reagent 48 hours posttransfection Primers fsh51 and fsh33 were used at
an annealing temperature of 66°C.
lOObp b JEG3 oP T J23.1 J23.2 J23.3 J23.4
Figure 4.3 3e: Expression of oLHp in transfected
JEG3 cells as determined by RT-PCR.
No amplified products are visible in the control reaction containing no RNA (b) or
the reaction containing untransfected JEG3 RNA (JEG3) Similar size products
(500bp) are present in reactions containing sheep pituitary RNA (oP) and RNA
from JEG3 cells transiently (T) or stably (J23.1-4 clones) transfected with poaGSU
and poLHpg. A larger and more abundant product (possibly two products) of
approximately 800bp is present in the reaction containing RNA from transiently
transfected JEG3 cells. This product is absent from all other reactions. RNA was
harvested using Tri-reagent 48 hours posttransfection for RNA from transients
or from confluent cultures of the stable clones. Primers fsh51 and fsh33 were
used at an annealing temperature of 66°C. The gel contained 2% agarose and was
run in TBE buffer. A lOObp ladder was used for size comparison.
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Figure 4.3 3f: Subcellular distribution of oFSH in transiently transfected JEG3 cells
i) Phase-contrast image ii) Overlay of fluorescence and phase contrast images
iii) FITC fluorescence FSH-immunoreactivity appears mesh-like' within the cytoplasm
of the transfected JEG3 cells JEG3 cells were transfected with poaGSU and poFSHpg and
fixed 48 hours later FSH primary antisera (M91) was diluted 1 500 and FITC-conjugated
goat anti-rabbit secondary antisera diluted 1 40
153
Figure 4.33g: Subcellular distribution of oLH in transiently transfected JEG3 cells.
i) Phase-contrast image ii) Overlay of fluorescence and phase contrast images,
iii) TRITC fluorescence. LH-immunoreactivity appears mesh-like' within the cytoplasm
of the transfected JEG3 cells JEG3 cells were transfected with poaGSU and poLHpg and
fixed 48 hours later. LH primary antisera (51SB7) was diluted to 2(ig/ml and TRITC-
conjugated goat anti-rabbit secondary antisera diluted 1 40
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Figure 4.3 3h: Subcellular distribution of hCG in JEG3 cells treated with ImM dibutyryl
cAMP for 24 hours.
i) Phase-contrast image ii) Overlay of fluorescence and phase contrast images
iii) TRITC fluorescence The hCG-immunoreactivity appears dispersed throughout the
cytoplasm in a mesh-like' pattern JEG3 cells were treated with ImM dibutyryl cAMP for
24 hours prior to fixing hCG antisera (PC-2) was diluted 1:250 and goat anti-mouse TRITC
conjugate diluted 1:40.
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the exon 1-2 junction and 3'UT respectively confirmed oFHp expression
from the poFHpg construct (figure 4.3.3e). RT-PCR of RNA from transiently
transfected JEG3 cells produced an amplified DNA product of approximately
480bp which coincides with that produced by the reaction containing
ovine pituitary RNA. This fragment is in accordance with the predicted
size of the amplicon for this RT-PCR. The transfected JEG3 sample also
contains two larger fragments of approximately 750-800bp with the
largest of these appearing most abundant.
Protein expression and subcellular localisation of oFSH and oLH was
observed by confocal microscopy. JEG3 cells transiently transfected with
either the poFSHpg or poLHfJg in combination with the poaGSU construct
produced cytoplasmic immunoreactivity for FSH and LH respectively
(figure 4.3.3f & g). The mesh-like pattern of immunoreactivity coincided
with an absence of aggregates or large vesicles. Furthermore this pattern
of pituitary gonadotrophin expression was similar to that observed for hCG
in untransfected dibutyryl cAMP-stimulated JEG3 cells (figure 4.3.3h).
These results confirm expression of the oFHp and oFSHp genes in
transiently transfected JEG3 cells. Furthermore the subcellular
localisation of the pituitary gonadotrophins appears similar to that of hCG.
4.3.4 Stable Pituitary Gonadotrophin Expression
Cell counts performed on JEG3 cultures after one week of G418 exposure
indicated the toxic effect of the aminoglycoside antibiotic with all doses of
G418 inducing JEG3 cell death (figure 4.3.4.a) Although all additions of
G418 caused cell death, some concentrations caused a disproportionate
amount. For example addition of 31.25, 62.5 and 125pg/ml G418 caused
additional increases in cell death of 39%, 44% and 19%. This represents a
small amount of additional selection pressure caused by the increase of
G418 from 62.5 to 125pg/ml. Addition of G418 quantities greater than
125pg/ml reduced the cell number at a much more efficient rate. 200pg/ml
G418 reduced the cell number by a further 69% and 250pg/ml by a further
54%. These data demonstrate a threshold effect of G418 action against JEG3
cell survival. Disproportionate increases in cell death occur with
incremental additions of G418 above the threshold level of 125pg/ml.
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Figure 4.3.4a: Survival of JEG3 cells at different
concentrations of G418.
Bar chart showing the number of surviving cells after one week
incubation in the presence of G418 at different final
concentrations. Cells plated in 12 well dishes were grown to 15%
confluency before addition of G418. Media was changed every 2
days and dead cells washed off during this process. After one
week the number of attached cells was estimated by counting
suspensions in a haemocytometer.
After optimisation of the transfection and isolation methodology several
JEG3 colonies containing 1 of 4 construct combinations were isolated. The
J21 Pfx4 transfection mixture contained only the poFSHfig construct
whereas J22 transfections contained both the poFSHfig and poaG S U
constructs. Sixteen J21 clones and ten J22 clones were isolated. J23
transfections were carried out using only the poLHjig construct whereas
the J24 transfection mixture contained both the poLH(3g and poaG S U
constructs. Fourteen colonies were isolated from the J23 transfection and
twenty-one from the J24 transfection. Surprisingly the rates of
proliferation for stably transfected JEG3 cells appeared unchanged in
comparison to untransfected cells.
Representative J22 and J23 clones were resuscitated for screening by
Southern hybridisation. Ten J22 clones (J22.1-9 & J22.12) were screened
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for integration of the oFSHp gene however only weak hybridisation at a
position corresponding to that of a larger fragment was observed with no
detectable oFSHjf sequences (figure 4.3.4b). Seven J23 clones (J23.1-7) were
screened for integration of the oLHJl gene. Hybridised bands equivalent in
size to the copy number controls were present in samples J23.1-5 (figure
4.3.4c). Samples J23.6 and 7 were not digested fully due to insufficient BsmI
enzyme. Other bands present in the sample appear larger than the
expected size but show far weaker hybridisation. The copy number
controls prepared for the hybridisation were used to quantify the signal
produced by the hybridisation in the J23 samples. The copy number
controls were added at 50% greater volume than desired so that they
correspond to 1.5, 7.5 and 15 copies instead of 1, 5 and 10 copies. However
this error did not prevent accurate quantitation of the signal detected in
the J23 samples using the standard curve shown below.
Copy Number
Figure 4.3/ld: Standard Curve for determining the number of
integrated copies of the oLHp gene in stably transfected JEG3
cells.
Copy number controls corresponding to 1.5, 7.5 and 15 copies
were probed by Southern hybridisation and quantified using a
STORM™ Phosphorlmager.
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Figure 4.3.4b: Southern analysis of JEG3 cells stably transfected with the oFSHp gene
Genomic DNA was extracted from JEG3 clones (J22 1-9, 12 = 1-9, 12) and untransfected
JEG3 cells (J) with 15pg DNA loaded per lane. Copy number controls prepared from the
poFSHpg construct used in the transfections corresponded to 10 (10c), 5 (5c) and 1 (1 c)
integrated copies of the oFSHp gene (arrow). No corresponding bands were detected in
the samples containing DNA from J22 clones or untransfected JEG3 cells Fragments
sizes from the XHirnJ111 marker are shown on the right of the gel








Figure 4.3.4c: Southern analysis of JEG3 cells stably transfected with the oLHp gene
Genomic DNA was extracted from JEG3 clones (J23.1-7 = 1-7) and untransfected JEG3 cells
(J) with 15pg DNA loaded per lane. Copy number controls prepared from the poLHpg
construct used in the transfections corresponded to 15 (15c), 7.5 (7.5c) and 15 (15c)
integrated copies of the oLHp gene (arrow) Corresponding bands were detected in the
samples containing DNA from J23 clones but not untransfected JEG3 cells The
abundance of integrated copies of the oLHp gene appeared similar to the signal from the
1 5 copy number control Additional larger bands were present in both untransfected
and stably transfected JEG3 samples These bands appeared larger in lanes containing
DNA from clones J23.6 and J23.7 as these were not subjected to digestion with BsnA
Fragments sizes from the X///ndlll marker are shown on the right of the gel.
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The hybridisation detected in JEG3 clones J23.1-7 corresponded to the size
of the copy number controls indicating that the integrated genes were
intact. However the level of signal detected required quantification
against the copy number controls in order to establish the amount of
integration achieved. As depicted in figure 4.3.4e, 4 out of the 7 clones
(J23.2-4 and J23.7) exhibited signal equivalent to integration of 1-2 copies
of the oLH|3 gene. Background detected in untransfected JEG3 cells
appeared low and corresponded to the level of signal detected in DNA from
J23.5 and J23.6 . The level of integration observed for J23.1 appears to
















JEG3 J23.1 J23.2 J23.3 J23.4 J23.5 J23.6 J23.7
Clone
Figure 4.3.4e: Representation of oLH[3 signal detected in J23
clones by Southern hybridisation.
Southern hybridisation of the Xho I and Bsm I digested genomic
samples was undertaken using the oLH(i cDNA. The horizontal line
on the figure corresponds to the signal equivalent to 1 copy of the
oLH[5 gene. No clones exhibited levels of hybridisation which
exactly corresponded to this standard however J23.2, J23.3 and J23.4
appear most similar. Signal equivalent to that observed for the
untransfected JEG3 DNA was detected in samples from clones J23.5
and J23.6. Intermediate levels of signal were detected for J23.1 and
J23.7.
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The media and lysates from cultures of J23.1-7 were analysed by oLH RIA
using the hCG-strippcd R29 antiscra to assess the level of protein
expression obtained after integration of 1-2 copies of the oLH|3 gene. The
data represented in figure 4.3.3f indicates that oLH formed from the
integrated (3-subunit and the endogenously expressed hCGa subunit gene
was not significantly greater in the lysates of J23 clones compared to
untransfected JEG3 cells. However media from the control cells did not
produce detectable oLH whereas all J23 exhibited detectable oLH secretion.
Although J23.3 and J23.5 media contained considerably more oLH than the
other clones, the actual level of secretion was nevertheless low at below





Figure 4.3.4f: Formation of the LH heterodimer from stably
integrated oLH[i and endogenous hCGa in JEG3 clones.
JEG3 J23.1 J23.2 J23.3 J23.4 J23.5 J23.6 J23.7
oLH was measured in confluent cultures by RIA using the hCG-
stripped R29 antisera. In comparison to the oLH detected in lysates
from untransfected JEG3 cells, no significant change is apparent in
the J23 clones. Media from the control JEG3 cells contained
undetectable oLH whereas all J23 clones contained detectable oLH.
J23.3 and J23.5 exhibited the highest oLH secretion which exceeded
1.5 n g /m 1.
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RT-PCR analysis of oLH expression by stable transfections J23.1-4 was
compared to that of transiently transfecled JEG3 cells. Reactions were
carried out using primers 1 h 5 2 and lh33 directed towards the exon 1-2
junction and 3'UT respectively. The reactions containing RNA from J23.1-4
exhibits an amplified DNA fragment of similar size to that produced by RT-
PCR of ovine pituitary RNA and transiently transfected JEG3 cells (figure
4.3.3e). Larger products from reactions containing RNA from transiently
transfected JEG3 cells were not present in similar reactions containing
RNA from J23.1-4. Although the RT-PCR carried out was not performed
with any means for quantification it is apparent that the amount of 480bp
product in transient and stable transfections is similar. These data indicate
that correctly spliced oLH[3 mRNA is produced in low abundance by both
transient and stable transfections.
Butyric acid treatment was assessed by RIA for its effect upon J22.1-2 and
J24.1-2 JEG3 stable transfections. These cells were stably transfected with
both ovine a and (3 gonadotrophin expression constructs and therefore do
not require hCGa expression in order to form heterodimers. J22 media and
lysates were assayed for oFSH content whereas J24 media was assayed for
oLH content. The oFSH RIA results depicted in figure 4.3.4g indicate that all
media and lysate fractions contained levels of oFSH equivalent to those
expressed by untransfected JEG3 cells. The exception to this is the media
fraction collected during butyric acid treatment. All normal JEG3 cells
treated with butyric acid show undetectable levels of oFSH with the
untreated cells showing 0.09ng/ml. Samples from untreated J22.1 and J22.2
cells contained 0.97 and 1.6ng/ml oFSH respectively with treated cells
exhibiting no significant increases irrespective of the butyric acid
concentration applied. These levels of oFSH are obtained from the non¬
linear portion of the RIA standard curve and therefore may not accurately
reflect differences in oFSH abundance.
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Figure 4.3.4g: Secretion of oFSH from untransfected JEG3 cells
and stably transfected clones treated with Butyric acid.
Secreted oFSH was measured by RIA. During butyric acid
treatment no oFSH was detected in untransfected cells whereas
approximately 2ng/ml was secreted by the J22 clones. However
subsequent to butyric acid treatment, secretion and storage of
oFSH by the J23 clones did not appear significantly greater than
that of untransfected cells. No oFSH was detected in the media
during the 48 hours prior to butyric acid treatment (data not
shown).
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Figure 4.3.4h: Secretion of oLH from untransfected JEG3 cells
and stably transfected clones treated with Butyric acid.
Secreted oLH was measured by RIA using the hCG-stripped R29
antisera. In comparison to the oLH detected in lysates from
untransfected JEG3 cells, no significant rise was apparent in the
J24 clones during or subsequent to butyric acid treatment.
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Figure 4.3.4i: oLHp RT-PCR of RNA from JEG3 cells transfected with poLHpg.
Primers lh.53 and lh33 anneal to exon 2 and 3' untranslated sequences respectively. The
predicted product size for this reaction is 406bp which is present in the sheep pituitary
(oP). This amplified product was not detected in the reactions which contained RNA
from JEG3 cells transiently transfected (T) with poLHpg Stably transfected cells (clone
J24.1) either untreated (-) or treated with 16mM butyric acid for 24 hours ( + ) also did
not exhibit this product. Larger products of approximately 700 and 500bp were present
in the transiently transfected samples with the former being most abundant. The
smaller of these bands was also detected in both the untreated and butyric acid-treated
stable J24.1 clones. No products were detected in the reactions containing no RNA (b) or
RNA from untransfected JEG3 cells (J). The gel contained 2% agarose and was run in TBE
buffer. A lOObp ladder (100) was used for size comparison.
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oLH RIA of J24 samples using the hCG-stripped R29 antisera gave results
with higher background than that observed for the oFSH assay. However
media samples from normal JEG3 cells and stable transfections exhibited
oLH over a wide range of concentrations. Despite large differences in oLH
measured between treatment groups no clear relationship between
butyric acid treatment and oLH secretion was exhibited (figure 4.3.4h).
In light of the high background present in the oLH RIA using the hCG
stripped R29 antisera RT-PCR was carried out on RNA from untreated and
16mM butyric acid-treated J24.1 clones. oLHp mRNA was detected using
lh53 and lh33 which anneal to exon 2 and 3'UT sequences respectively
(figure 4.3.4i). The predicted amplicon size of 406bp was produced by the
reaction containing ovine pituitary RNA. The larger fragment amplified
in the transient transfection of JEG3 cells appears approximately 800bp in
length which is comparable with that produced by RT-PCR using primers
lh52 and lh33. In addition a very faint smaller band is visible at
approximately 500bp. RT-PCR of normal and butyric acid-treated J24.1 RNA
also produced a fragment of approximately 500bp. The abundance of each
band from control and butyric acid-treated J24.1 samples appears similar.
The 500bp fragment is present in all reactions containing RNA from
p o L H p g-transfected JEG3 cells but completely absent from reactions
containing normal JEG3 RNA.
4.4 Discussion
Transfection of JEG3 cells using calcium-based techniques provided
similar results to those achieved using lipids. However the advantages of
using lipids included a reduced incubation time and less labour intensity
during the preparation of the transfection mixtures. These two factors
were crucial to the studies described in this chapter as they allowed
multiple DNA construct combinations to be transfected easily and rapidly.
Optimisation of the transfection conditions by adjustment of the lipid:DNA
ratio and incubation time did not result in significantly improved
transfection efficiencies. This suggests that the guidelines regarding the
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ratio of lipid:DNA given by the manufacturer may be applied to
transfection of the JEG3 cell line. It also appears that transfection is
highly dependent on the lipid used. This was the main feature of the
PerFect™ transfection kit which provided a spectrum of different lipids
and lipid combinations allowing direct comparison of transfection
efficiencies. The advantage of this kit is that it allowed 8 different lipids to
be tested using the same methodology and thus did not require repeated
adjustments for each lipid.
The exact chemical composition of PerFect™ lipids is not disclosed by the
manufacturer, however certain characteristics are described. Pfx4 and
Pfx5 both contain 1:1 mixes of cationic lipids whereas Pfx8 and DOTAP each
contain only one cationic lipid. The amount of positive charge displayed
by the lipids depends largely on the size of the molecules. Interestingly
Pfx5 and 8 have the greatest mean molecular weight of the lipids that most
effectively transfected JEG3 cells. Although DOTAP and Pfx4 both contain
molecules with similar mass, Pfx4 contains a mixture of two types of lipid
suggesting that this factor may be more important than the amount of
charge alone. The only other lipid mix within the PerFect™ kit with
similar molecular weight to Pfx4 is Pfx3. This transfection agent also
contains L-dioleoyl phosphatidylethanolamine (DOPE) which suggests that
this reduces uptake of DNA by JEG3 cells. Essentially lipid mixtures used in
mammalian cell transfections are diverse reflecting the general lack of
understanding at this time of the exact mechanisms underlying lipid
specificities for different cell lines. The general level of transfection
efficiency varies between cell lines and appears to be largely dependent
on the rate of proliferation exhibited. Many slow growing neuroendocrine
cell lines such as AtT-20 and LPT2 prove very difficult to transfect with
efficiencies often below 0.5%. Other cell lines such as Chinese hamster
ovary (CHO) cells exhibit far higher transfection efficiencies in excess of
30%. The relatively slow growth rate of JEG3 cells and their
neuroendocrine origin may predispose them to poor uptake of DNA,
although the exact mechanisms which prevent efficient DNA uptake
remain unclear.
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The model of hCG secretion from JEG3 cells was an attractive one as it was
known to be constitutive in nature (Suemizu et al., 1988) and devoid of
granins (Howe, 1995). Furthermore at the time this cell line was the only
one to secrete dimeric gonadotrophin. Transient transfection of granin
expression constructs and subsequent stimulation of hCG expression with
ImM dibutyryl cAMP did not provide any significant differences in hCG
storage profiles when compared to untransfected JEG3 cells. Although
normal JEG3 cells only secrete hCG and other proteins through a
constitutive pathway it was hypothesised that granin-induced aggregation
of hCG within the ER and TGN may have led to formation of a regulated
pathway detected by a reduction in the proportion of total hCG secreted.
The high background of hCG secreted normally from untransfected cells
masked any putative effects on secretion induced by expression of
granins. This hypothesis is represented schematically below.
XI XXXXXX
Figure 4.4a: Schematic representation
illustrating high background hCG
expression masking putative effects of
transient granin expression.
hCG expression by transfected (blue)
and untransfected cells is stimulated by
addition of ImM dibutyryl cAMP.
BBniBHRBfl putative changes in hCG secretion
111111111 Prof'les caused by transient gene
expression are undetectable by RIA due to
the abundance of hCG from untransfected
cells (shown in red).XXiiXXXXI
This hypothesis may explain why subtle changes in the proportion of total
hCG which is stored were not resolved between untransfected cells and
cells expressing granins. This hypothesis did not prevent detection of
changes in total hCG expression observed in transfected cells expressing
CgA or Sgll. Significantly the increase in hCG expression apparently
induced by hCgA also occurred in Chinese hamster ovary (CHO) cells
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cotransfected with oLH and hCgA expression constructs (see chapter 5). In
contrast however bSgll expression had no such effect on oLH expression
in transfected CHO cells. An extended 5' untranslated region of hCG(3 is not
present in LH(3 (Bousfield et al, 1994) and may allow interaction with Sgll
facilitating enhancement of translation. Future studies involving removal
of this 5' untranslated region or engineering of chimeric hCGp/LH(3 genes
may elucidate the role of Sgll in (3-subunit gene expression. Due to the lack
of data reporting uptake of CgA or Sgll-derived peptides by placental
trophoblasts it is likely that increased hCG expression is occurring in
transfected cells within the population. However it remains a possibility
that granin-derived peptides exert effects upon hCG expression in
untransfected JEG3 cells. This is a major drawback of transient
transfection studies measuring hCG secretion in the JEG3 cell line.
Although a plethora of granin-derived peptides has been reported to
exhibit a wide range of biological effects (see section 1.6.6), enhancement
of hCG subunit gene transcription has not been observed. However it is
perhaps significant to note that an inhibitory effect of the CgA-derived
peptide pancreastatin on PTH and CgA transcription and mRNA stability
has been reported (Zhang et al., 1994). Although production of this peptide
may lead to an autocrine self-regulation of CgA expression an effect on
hCG expression might nevertheless occur. The proteolytic capacity of JEG3
cells has not been reported but novel cleavage of CgA and Sgll may lead to
production of as yet uncharacterised peptides that enhance expression of
hCG genes transcriptionally or at the level of mRNA stability. This may
explain the observed stimulatory effect on constitutive secretion of hCG.
Cotransfection of all three granin expression constructs abolished the
enhancement of hCG expression observed in populations transfected with
either phCgA or pbSgII61 alone suggesting an inhibitory role for CgB on
the actions of CgA and Sgll. Storage of hCG has been reported to occur at a
significantly reduced rate in comparison to that of LH in vitro due to rapid
dimerisation and the presence of the hydrophilic CTP on the hCG(3 subunit
(Bielinska et al., 1994; Muyan et al., 1996). Therefore it is likely that hCG
may never be secreted exclusively via the regulated pathway despite the
presence of aggregating factors such as the granins. However it is also
likely that the high level of background hCG expressed by untransfected
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JEG3 cells may prevent detection of granin-induced hCG storage. This
hypothesis was the main reason for attempting stable transfection of the
JEG3 cell line.
The study of interactions between multiple gene products using stable
transfections requires isolation of separate clones containing each
combination of the genes of interest. Although this process would
undoubtedly be very time consuming it was undertaken with the goal of
clonal expression in mind. Results from initial generation of JEG3 cells
containing only the (3 or a and p expression constructs were disappointing.
Southern analysis of JEG3 genomic material for integration of the oFSH(3
gene suggested that no copies had stably integrated. Analysis of gene
expression by RIA substantiated this initial finding. However Southern
hybridisation of other JEG3 transfections clearly indicated the presence of
1-2 copies of oLHp genes equivalent in size to the control fragments. Clones
that appeared to contain integration of half copies are likely to have
arisen due to incomplete isolation of clonal populations. For example a
population containing cells with 1 copy and others with 2 copies may lead
to a signal representing 1.5 integrated copies of the oLHp gene. The
equivalent size of the control and sample bands suggested that the
integrated oLHp sequence had remained intact and therefore was likely to
be functional. However the frequency of integration observed was lower
than anticipated. Although the selection pressure applied using 200pg/ml
G418 was undoubtedly significant, killing 90% of untransfected cells in 7
days, it is possible that a higher concentration is required for multiple
copy integration. Alternatively the maintenance dose of 125pg/ml G418
may have been insufficient leading to partial reversal of the integration
event. Removal of sufficient selection pressure could over time have led to
homologous recombination of concatemerised sequences. This crossover
event would return the construct sequences to their original circular
form and the transfection would once again become transient.
Preferential integration of the neoR gene is unlikely due to the presence
of both the marker and insert on the same molecule. However this may
have occurred if secondary structures present within the oLH(3 gene
prevented recombination with the human genome. Recombination of LH(3
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sequences within the human genome is known to have occurred during
evolution as sequence comparisons of hLIIp and hCGp suggest that the
multiple copies of hCGp arose from hLHp gene duplications (Talmadge et al.,
19 84). Despite the difference in species, this event suggests that LHp
sequences are capable of recombining with human genomic sequences.
In light of the expression exhibited by transiently transfected JEG3 cells it
may be concluded that the lack of detectable ovine gonadotrophin
expression from stably transfected JEG3 cells is in part due to insufficient
integrated copies of the requisite genes. In addition it is possible that the
site of integration within the human genome is not conducive to high-
level gene expression. Of the possible reasons explaining the low
frequency of integrated genes, the most likely in my opinion is that
insufficient selective pressure was applied during the isolation process.
oLH RIA of J23 cultures using the hCG-stripped R29 antisera failed to
demonstrate expression levels significantly in excess of background
produced by normal JEG3 cells. The lack of detectable dimeric hormone
may have arisen due to a shortage of aGSU in the unstimulated cells or due
to poor dimerisation between the ovine and human subunits. RIA of stable
transfections containing both a and P subunits for either oFSH or oLH
obviated the requirement for cAMP-stimulated aGSU expression.
Nevertheless treatment with butyric acid failed to induce expression of
either oFSH or oLH. Due to the poor understanding of the mechanisms
through which butyric acid exerts its effect it is difficult to provide
possible reasons for the lack of efficacy displayed by this agent. It is
possible that the reported effect of butyric acid is specific to Vero cells
(Wacker et al., 1997) or that the site of gene integration prevents high-
level expression in response to this inducing agent.
The appearance of oLHp-derived amplicons from transfected but not
control JEG3 RNA which exceeded the length observed in reactions
containing ovine pituitary-derived RNA suggests aberrant splicing of the
oLHP sequence. The use of lh52 which anneals to exon 1 and 2 sequences
indicates correct splicing of this intron. However it is apparent that
fragments containing this correctly spliced junction exist in low
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abundance for both transient and stable transfections. Fragments in
excess of the 519 bases encoded by the correctly spliced oLHp mRNA must
contain intronic sequences. RT-PCR using the lh53 primer which anneals
to sequences mid-exon 2 appeared to preferentially amplify incorrectly
spliced species of oLH(3 mRNA. This may have arisen due to secondary
structures formed within the correctly spliced oLFip mRNA reducing the
priming ability of lh53. Although the correctly spliced mRNA was detected
using lh52 and lh33 in transfected JEG3 cells, using lh53 this mRNA was
only detected in the ovine pituitary sample. Application of the same
lh5 3/3 3 primer pair revealed that transiently transfected JEG3 cells
exhibited 2 species of larger transcripts of which the smaller was also
expressed by stable transfections. These results suggest that aberrant
splicing of oLHp mRNA occurs in all oLH(3-transfected JEG3 cells. It is likely
that in transients a greater abundance of total oLHp mRNA including
correctly spliced oLHp mRNA accounts for the detectable protein
expression. Transient expression of oLEl was confirmed in JEG3 cells by
indirect immunofluorescence (discussed later). The same method was not
applied for detection of protein expression from stable transfections due to
their perceived role in providing a means for biochemical assessment of
gonadotrophin secretion.
RT-PCR using primers directed towards the 5' and 3' UT regions of oFSH
mRNA detected amplicons of only the correct size in samples containing
RNA from transiently transfected JEG3 cells. The amplification of the
complete coding region with the correct size product suggests that all
three exons were correctly spliced. This suggests that expression of an
integrated and intact copy of the oFSH(3 gene in JEG3 cells would also lead to
correct splicing of oFSHp mRNA. Furthermore the detection of oFSFl in the
cytoplasm of transiently transfected JEG3 cells indicates that the oFSHp
mRNA is efficiently translated into the correct protein product.
For future biochemical analysis of pituitary gonadotrophin secretion from
JEG3 cells stably transfected clones would be required. Two alternatives to
this approach include the use of cotransfected reporters allowing
purification of the transfected population from the untransfected
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background. The pHOOK™ system (Invitrogen, NL) allows isolation of
transfected individuals via expression of surface antigens to which
immunoreactive magnetic beads may attach. The more conventional
fluorescence-activated cell sorting (FACS) may also be used with
fluorophores such as enhanced green fluorescent protein (EGFP) to obtain
a population containing only transfected cells. The main disadvantages of
these approaches is the scale of transfection required to obtain sufficient
cell numbers for analysis. Secondly, the variation of transient expression
levels between individual cells which is intrinsic to transient
transfections may lead to misleading results.
With regard to generation of stably transfected cells this chapter has
highlighted two factors that must be improved for future use of JEG3 cells;
transfection efficiency and selection pressure. Several DNA transfer
methods that were not assessed during these studies include
microinjection, electroporation and viral infection. Although effective at
transferring DNA into the nucleus, microinjection still relies on chance
recombination events for integration. Alternatively electroporation could
be used and is often applied in transfection studies as an alternative to
chemically-mediated methods. Although effective for certain cell lines
electroporation can cause severe loss of viability for others. DNA transfer
mediated by viral particles such as attenuated adenovirus is an effective
method of gene transfer especially suited for use with cell lines exhibiting
a low rate of proliferation.
Although these methods may increase the chance of DNA integration
indirectly through increased transfection efficiency, they may not cause
the necessary increase in copy number required for high-level gene
expression. Assessment of selection pressure during stable transfections
requires the processes of selection and isolation to be completed prior to
undertaking an appropriate assay. Using G418 selection, selection required
4-6 weeks and a further 3-4 weeks to obtain sufficient numbers for
analysis. Assessment of multiple selection conditions in parallel may
provide accurate data regarding the relationship between selection
pressure and integration of genes. Although this approach may
demonstrate an optimum G418 concentration for use with JEG3 cells, it
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would require selection and maintenance of several clones for each
antibiotic concentration for up to 10 weeks before data from assays would
be available. A novel potent antibiotic Blasticidin (Invitrogen, NL) used
for selection of pcDNA6-harbouring cells allows isolation of transfected
colonies within two weeks. Use of this selection marker may allow
assessment of multiple antibiotic concentrations in significantly less time.
Verification of the expression of oFSH and oLH in transiently transfected
JEG3 cells by indirect immunofluorescence provided more encouraging
results. The appearance of immunoreactive patterns which correlated
with those exhibited for hCG in cAMP-stimulated JEG3 cells emphasised the
constitutive nature of the pathway by which these cells secrete proteins.
The similar intracellular appearance of oFSH and oLH suggests that these
hormones are both secreted via the constitutive pathway when expressed
at similar levels and in the absence of granins. It may be argued that JEG3
cells are incapable of hormone secretion via a regulated pathway.
Recently however the Chinese hamster ovary (CHO) cell line which was
previously believed to secrete exclusively via the constitutive pathway has
been shown to contain a cryptic regulated pathway capable of
secretagogue-stimulated release (Chavez et al., 1996). Transiently
transfected CHO cells (see chapter 5) exhibited similar intracellular
patterns of oLH and oFSH immunoreactivity to that observed in JEG3 cells.
These results suggest that overexpression of pituitary gonadotrophins in
cells devoid of granins does not lead to the formation of subcellular
aggregates or large secretory vesicles. Transient cotransfection studies
using JEG3 cells may allow visualisation of large secretory vesicles induced
by granin expression using indirect immunofluorescence or EGFP fusion
protein expression. This approach may allow investigation of the effects of
granins on gonadotrophin trafficking in individual cells and therefore
eliminate background caused by untransfected cells. However the low
transfection efficiency of this cell line may slow progress favouring use
of an alternative cell line.
The preliminary findings of these studies indicate that oLH and oFSH are
secreted via a constitutive pathway in JEG3 cells similar to that through
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which hCG is secreted. This suggests that overexpression of the pituitary
gonadotrophins like that of hCG is not sufficient to form large secretory
granules characteristic of the regulated secretory pathway. The effect of
granins and other proteins implicated in exocytosis has yet to be
investigated in this model.
These studies have also demonstrated that detection of changes in protein
secretion at the individual cell level and at that of the cell population
require different approaches. Biochemical observation of the effect of
exogenous gene expression on the secretion of endogenously expressed
proteins by a population of cells requires that the majority of individuals
express the exogenous genes. Clonal populations expressing identical
amounts of transfected genes may allow study of secretion using
conventional protein assays providing sufficient gene expression is
obtained. Analysing secretion of endogenously expressed proteins in
transiently transfected populations must be undertaken at the level of the
individual cell. Methods such as reverse-haemolytic plaque assay, patch-
clamp analysis or indirect immunofluorescence may be used. All future
studies using this model would benefit from enhanced transfection
efficiency.
If storage of LH and FSH are to be investigated in an in vitro system an
alternative cell line which is easily manipulated may provide more easily
interpretable results. The following chapter details transient transfection
studies using the CHO cell line.
Chapter Five
Gonadotrophin Secretion from
Chinese Hamster Ovary Cells
5.1 Introduction
The Chinese hamster ovary (CHO) and CHO-K1 cell lines were isolated in
1958 (Puck et al., 1958). CHO cells are fibroblastic in appearance and
exhibit relatively rapid proliferation. Secretion of endogenously expressed
genes was until recently believed to occur exclusively via a constitutive
pathway in these cells. However labelling of glycosaminoglycan chains
with [35]S has revealed the presence of post-Golgi vesicles which colocalise
with the regulated secretory granule marker Rab3D. Furthermore the
release of these vesicles is stimulated by intracellular rises in Ca++ or by
application of a secretagogue (Chavez et al., 1996). Although details
regarding the protein content of these regulated vesicles remain to be
revealed, the presence of storage vesicles within CHO cells makes the cell
line attractive for use in secretion studies. Unlike the JEG3 cell line, CHO
cells do not endogenously express gonadotrophins and no data regarding
endogenous expression of granins has been reported. This characteristic
provides a 'clean' system in which changes in expression levels of
transfected gonadotrophins and granins may be detected with no
significant background. CHO cells are widely used for mammalian
expression studies and are relatively easy to transfect. Furthermore
recombinant human FSH has been expressed on an industrial scale using
dihydrofolate reductase (DHFR)-deficient CHO cells as hosts. The quality of
hFSH expressed in this system is high and exists predominantly in acidic
isoforms which have longer half lives and greater bioactivity (Chappel e t
al., 1998).
The aims of this study will include formation of a regulated secretory
pathway in vitro, and demonstration of the factors required for its
formation and for differential sorting of LH and FSH. Particular attention
will be directed towards the role of the granins in formation of
intracellular aggregates facilitating sorting of LH away from other
constitutively secreted proteins possibly including FSH.
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5.2 Methods
5.2.1 Optimisation of Lipid-based Transfection
Lipids supplied by Invitrogen (PerFect™) and Promega (TfxlO) were
assessed for their ability to mediate transfection of CHO cells. Both lipids
were used in accordance with the manufacturers guidelines. PerFect1 M
lipid transfections were carried out for 3.5 hours whereas TfxlO
transfections were assessed after 4, 6 and 8 hour incubations. In addition
the effect of using Opti-MEM (GibcoBRL, UK) during the transfection
process in place of DMEM with no FCS added was also assessed.
CHO-K1 transfection was carried out similarly to that of CHO cells using
Opti-MEM and PerFect™ lipids.
Transfection efficiency was assessed 48 hours post-transfection by |3-
galactosidase staining as described in section 2.4.9.
5.2.2 Detection of Gonadotrophin
and Granin mRNA by RT-PCR
RNA was extracted from control and transiently transfected CHO cells with
Tri-reagent (Sigma-Aldrich, UK) used in accordance with manufacturers
guidelines and stored at -70°C.
RT-PCR was carried out to verify expression of inserted genes from
transiently transfected constructs. The Titan™ RT-PCR kit (Boehringer
Mannheim, UK) was used as described in section 2.3.15. Detection of oFSHp
and oLHp transcripts was carried out using the primers and conditions
described in section 4.2.7. Detection of hCgA, bCgB and bSgll transcripts
required the design of novel primers undertaken using GeneJockeyll and
GCG software as described in section 2.3.16. Sequence and annealing details
of primers assessed for their ability to detect specific transcripts by RT-
PCR are contained in table 5.2.2a.
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Where, Tan is the predicted optimal annealing temperature for the primer
pair.
5.2.3 Comparative Expression of oFSH|3 Constructs
Total oFSH expression levels in CHO and CHO-KI cells were measured by RIA
48 or 72 hours after transient cotransfection of the oaGSU expression
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construct poaGSU with one of three different oFSH(3 expression constructs.
Expression levels were compared for poFSHp containing the full-length
cDNA, poFSHpg containing the genomic clone and the EGFP carboxy-
terminal fusion to the full-length oFSHj) cDNA (for vector details refer to
chapter 3). Addition of 10% pcDNA3.1/His/lacZ plasmid (Invitrogen, NL) to
the transfection mixtures allowed variations in transfection efficiency to
be estimated by P-galactosidase staining of replicate wells as described in
section 2.4.9.
Lysates and media were assayed for oFSH content by RIA as described in
section 2.5.5.
5.2.4 Expression of Gonadotrophins and Granins
In order to assess the effect of granins on transient expression of oLH,
cotransfections were performed on CHO cells in 12-well plates. All
transfection mixtures contained 10% pCAT vector to allow standardisation
of results with regard to variations in transfection efficiency by CAT
assay (see section 2.5.3). The remaining 90% of DNA in the mixture was
divided in two parts so that half would comprise constructs encoding oLH
subunits. The remaining 45% of the DNA for transfection would comprise
varying quantities of a granin construct. Total DNA in each transfection
was maintained at the appropriate level by addition of high purity
pBluescript KS+ vector. This DNA ensures that variations in transfection
efficiency caused by different ratios of lipid to DNA are reduced. The
absence of an efficient eukaryotic promoter within the pBluescript KS +
prevented transcription of bacterial sequences which may cause toxic
effects within the transfected mammalian cell.
5.2.5 Visualisation of Intracellular Gonadotrophin Traffic
Combinations of gonadotrophin and granin expression constructs were
transiently transfected into CHO and CHO-K1 cells using the respective
optimised protocol described previously.
48 to 72 hours after transient transfection cells in chamber slides were
fixed and incubated with the appropriate primary antisera overnight at
4°C. Subsequent washing and application of secondary antisera prior to
mounting were performed as described in section 2.6.1. Cells transfected
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with EGFP constructs were viewed live as described in section 2.6.2.
Confocal microscopy was carried out on all samples using a Zeiss Axiovert
100M microscope and LSM510 scanning module (Zeiss, UK) as described in
2.6.3.
5.3 Results
5.3.1 Optimisation of Lipid-based Transfection
CHO cells were effectively transfected with TfxlO at ratios of lipid to DNA of
3:1 and 5:1 (figure 5.3.1a). Opti-MEM media did not provide consistently
increased transfection efficiencies using this lipid. A maximal
transfection efficiency of 11.95±2.35% was achieved with the higher ratio
of lipid to DNA after a 6 hour incubation. A further increase in
















Tfx-10:DNA and Length of Incubation
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Figure 5.3.1a: Comparison ofCHO transfection efficiencies obtained
using TfxlO lipids with either scrum-free DMEM or Opti-MEM.
Cells plated in a 12-well dish were transfected with the
pcDNA3.1/His/lacZ plasmid and stained for [1-galactosidase activity 48
hours posttransfection. 250 cells were counted in four fields of view
for each well.
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PerFect™ lipids 5 and 8 gave greater transaction efficiencies than the
maximum obtained using TfxlO (figure 5.3.1b). Furthermore Pfx5 exhibited
a transfection efficiency of 34.2±0.2% which is almost 3-fold greater than
that obtained with TfxlO and was achieved in only 3.5 hours in comparison
to the 6 hour incubation required for TfxlO. A representative
photomicrograph of optimally transfected CHO cells after [1-galactosidase
staining is shown in figure 5.3.1c. Use of Opti-MEM provided increases in
transfection efficiency for the majority of PerFect™ lipids tested. The
transfection efficiency obtained using Pl"x5 was significantly improved















Pfx1 Pfx2 Pfx3 Pfx4 Pfx5 Pfx6 Pfx7 Pfx8
Perfect Lipid Mix
X S.E.M | | serum-free DMEM
n=2 i
*=p<0.01 Opti-MEM
Figure 5.3.1b: Comparison of CHO transfection efficiencies obtained
using PerFect lipids with either serum-free DMEM or Opti-MEM.
Cells plated in a 12-well dish were transfected with the
pcDNA3.1/His/lacZ plasmid and stained for (1-galactosidase activity 48
hours posttransfection. 250 cells were counted in four fields of view
for each well.
Transfection of the CHO-K1 cell line was achieved using PerFect™ lipids
and Opti-MEM. Surprisingly the most efficient lipid was different to that
observed for CHO cells. Pfxl exhibited a transfection efficiency of
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Figure 5 3 1c: CHO cells transiently transfected with pcDNA3 1/His/lacZ
CHO cells were transiently transfected with pcDNA3 1/His/lacZ using Pfx5 48 hours
posttransfection the cells were fixed and stained for p galactosidase activity.
Figure 5.3 le: CH0-K1 cells transiently transfected with pcDNA3 1/His/lacZ
CH0-F.1 cells were transiently transfected with pcDNA3 1/His/lacZ using Pfxl 48 hours
posttransfection the cells were fixed and stained for p-galactosidase activity
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28.7±0.4% (figure 5.3. Id), similar to that obtained from optimal
transfection of CHO cells using Pfx5. A representative photomicrograph of
(3-galactosidase stained CHO-K1 cells illustrates their appearance after
optimal transfection (figure 5.3. le). Unlike CHO cell transfection in which
several lipids demonstrated efficiencies close to or in excess of 10%, only
Pfxl and 7 provided such transfection efficiencies.
Pfx1 Pfx2 Pfx3 Pfx4 Pfx5 Pfx6 Pfx7 Pfx8
Perfect Lipid Mix
Figure 5.3.1 d: CHO-K1 transfection efficiencies obtained using
PerFect lipids and Opti-MEM.
Cells plated in a 12-well dish were transfected with the
pcDNA3.1/His/lacZ plasmid and stained for [)-galactosidase activity 48
hours posttransl'ection. 250 cells were counted in four fields of view
for each well.
5.3.2 Detection of Gonadotrophin
and Granin mRNA by RT-PCR
Optimisation of RT-PCR conditions for detection of bCgB, bSgll and oaGSU
was undertaken successfully using RNA derived from the ovine pituitary
gland (figure 5.3.2a). Optimisation of the hCgA reaction required human
pituitary RNA which was unavailable. Expression of specific mRNA in CHO
cells was detected for all transiently transfected constructs including
phCgA, pbChrB73, pbSgllbl. poaGSU, poFSHfJg and poLH(ig (figures 5.3.2b &
c). All products were specific to transfected samples and correlated well
with samples containing ovine pituitary-derived RNA with the exception
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Figure 5 -3-2a: Temperature optimisation of RT-PCRs for
ovine aGSU, bovine CgB and bovine Sgll
The ovine aGSU-specific primer combinations were assessed at 54 and 56°C Both primer
combinations produced the predicted product sizes at each annealing temperature
(a51/32=368bp, a52/32-361bp) The bovine CgB-specific primers combinations were assessed
at 56. 58 and 6f)°C The predicted products were exhibited for the cgb51 /31 (730bp ) and
cgb54/31 (504bp I reactions. No products were detected for the cgb51/32 or cgb54/32 reactions
The bovine Sgll-specific primer combinations were assessed at 58 and 60°C Both sgii52/33
and sgii53/33 reactions exhibited the predicted products of 416 and 389bp respectively. No
products were detected in any of the control reactions containing no RNA lOObp ladders were
used for size comparison The gel contained 2% agarose and was run in TBE buffer
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Figure "5.3.2b: Transient expression of granins and
ovine aGSU in CHO cells detected by RT-PCR
i) Primers cga5"? and cga34 specific for human CgA exhibited the predicted product size of
266bp in samples containing RNA from sheep pituitary (oP) or CHO cells transiently
transfected with the phCgA construct (T). No products were detected in the no RNA control (b)
or in samples containing RNA from untransfected CHO cells (C). The reactions were carried
out at the annealing temperature of 67°C ii) Expression of specific mRNA for bSgll, bCgB and
ovine aGSU was detected using primers sgii53 and 33, cgb54 and 31 and a51 and 32
respectively The annealing temperatures used were 58°C for the granin reactions and 56°C
for the aGSfi reaction The predicted product sizes were produced for the bCgB reactions
(504bp) and octGSTJ reactions (368bp) which contained either sheep pituitary RNA (oP) or RNA
from CHO cells transiently transfected with either the pbChrB73 (Tb) or poaGSU (Ta)
constructs The bSgll reaction exhibited the predicted product size of 389bp in the sheep
pituitary sample but a smaller product (280bp approx ) in samples containing RNA from CHO
cells transiently transfected with the pbSgllSl construct (Ts) No products were detected in
the no RNA control (b) or in samples containing RNA from untransfected CHO cells (C).
RNA was extracted from transiently transfected cells 48 hours posttransfection using Tri-
reagent Both gels contained 2% agarose and were run in TBE buffer lOObp ladders (100) were
used for size comparison.
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Figure 5.3.2c: Transient expression of ovine gonadotrophin p-subunits
detected by RT-PCR.
i) The oFSHfi reactions were carried out using primers fshSland fsh33
at the annealing temperature of 64°C. The predicted product is 450bp
which is approximately the size of that exhibited in reactions containing
either sheep pituitary RNA (oP) or RNA from CHO cells transiently
transfected with the poaGSU and poFSHpg constructs (CHO.oFSH). No
products were present in the no RNA control (b) or untransfected CHO
RNA (CHO) samples.
ii) The oLHp reactions were carried out using primers lh52 and 1h33
at the annealing temperature of 70°C. I'he predicted product is 480bp
which is present in samples containing either sheep pituitary RNA (oP)
or RNA from CHO cells transiently transfected with with the poaGSU and
poLfipg constructs (CHO.oLH). Two additional but less abundant
products were detected at approximately 700 and 800bp in the reaction
containing RNA from transfected CHO cells. No products were present in
the no RNA control (b) or untransfected CHO RNA (CHO) samples.
RNA was extracted from CHO cells 48 hours posttransfection using
Tri-reageru. Both gels contained 2% agarose and were run in TBL buffer.
lOObp ladders were used for size comparison.
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of bSgll which produced a smaller product (280bp) in comparison to that
from ovine samples (389bp). The oLH(3 RT-PCR also produced 2 less
abundant larger products of approximately 700 and 800bp in size. These
products were equivalent in size to those produced by RT-PCR of JEG3 cells
transiently transfected with the same constructs.
5.3.3 Comparative Expression of oFSH(3 Constructs
Prior to RIA of lysates and media fractions (3-galactosidase staining of
replicate wells was undertaken demonstrating that no significant
variations in transfection efficiency occurred (data not shown).
CHO-K1 transiently transfected with the oaGSU construct and either the
oFSH|3 cDNA, genomic sequence or EGFP fusion produced low expression of
oFSH as detected by RIA (figure 5.3.3a).
5
4
none poFSHp + puFSHPy pEGFPC-oFSHp
poaGSU + poaGSU + pouGSU
Plasmids Transiently Transfected
~|~ S.E.M [ | after 48 hrs expression
n=2 m after 72 hrs expression
Figure 5.3.3a: Total oFSH expressed by CHO-K1 cells transiently
transfected with different oFSH(3 expression constructs.
CHO-K1 cells were transfected using Pfxl. Media and lysates were
harvested 48 and 72 hours posttransfection. oFSH levels were
determined by RIA. poaGSU contains the ovine aGSU cDNA, poFSH|i
contains the ovine FSH|3 cDNA, poFSH(3g contains the ovine FSHji
genomic sequence, pEGFPC-oFSHf) contains the ovine FSH(3 cDNA





Figure 5 3 3b: Subcellular distribution of oFSHp in transiently
transfectcd CH0-K1 cells 48 hours posttransfection
CHO-K1 cells were transiently transfected with poaGSU and poFSHpg Cells were fixed in
Bouins 48 hours posttransfection Large fluorescence bodies are clearly visible within the
perinuclear region of these cells (arrows) The diameter of these intracellular bodies ranges
from approximately l-3nm FSH antisera (M91) was diluted 1:500 and FITC-conjugated goat
anti-rabbit secondary antisera diluted 1 40 Fluorescence was observed using a 4S8nm argon
laser and 505-535nm bandpass filter
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Indirect immunofluorescence of oFSH(i showed bright perinuclear signal
coinciding with the subcellular localisation of the endoplasmic reticulum
(ER) and trans-Golgi network (TGN) (figure 5.3.3b).
Similar transient transfection of CHO cells led to relatively high
expression levels from the oFSHfi construct containing the genomic
sequence with significantly less expression from the cDNA-containing
construct (figure 5.3.3c). The increased expression from the genomic
clone was unexpected. Figure 5.3.3c also demonstrates an absence of RIA-
detectable oFSH from cells transfected with the EGFPC-oFSH[3 fusion
construct.
none poFSHfi + poFSHpg pEGFPC-oFSH(5
pouGSU + porxGSU + pouGSU
Plasmids Transiently Transfected T S.E.M
□ after 48 hrs expression
***=p<o.ooi naasa I± ,
was after 72 hrs expression
Figure 5.3.3c: Total oFSH expressed by CHO cells transiently
transfected with different oFSH(3 expression constructs.
CHO cells were transfected using Pfx5. Media and lysates were
harvested 48 and 72 hours posttransfection. oFSH levels were
determined by R1A. poaGSU contains the ovine aGSU cDNA, poFSH|i
contains the ovine FSH|) cDNA, poFSHfig contains the ovine FSH[i
genomic sequence, pEGFPC-oFSH|i contains the ovine FSH[) cDNA
downstream in an ORF with EGFP.
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Comparison of the distribution of oFSH expressed by CHO cells transiently
transfected with either the cDNA or genomic clone demonstrated a
significant difference (figure 5.3.3d). The cells expressing the genomic
clone of oFSHf) exhibited a significantly lower proportion of intracellular
oFSH after 48-72 hours expression despite expressing a greater abundance





Figure 5.3.3d: Comparison of oFSH storage by CHO cells
transiently transfected with different oFSHfi expression constructs.
CHO cells were transfected using Pfx5. Media and lysates were
harvested 48 and 72 hours posttransfection. oFSH levels were
determined by RIA. The results shown represent the mean of
figures determined after 48 and 72 hours of expression. poaGSU
contains the ovine aGSU cDNA, poFSHJ) contains the ovine FSHf)
cDNA, poFSH[3g contains the ovine FSH[) genomic sequence.
5.3.4 Expression of oLH and Granins
All oLH measured in lysates and media fractions were standardised against
total protein determined by Bradford assays and for variations in
transfection efficiency by CAT assay (see sections 2.5.2-3 & figure 4.3.2c).
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In comparison to cells expressing only oLH constructs, a significant
increase in the total amount of oLH expressed was observed in cells
cotransfected with the hCgA expression construct at ratios equal to or in
excess of 75% of the oLH expression constructs (figure 5.3.4a).
none [4:0] [4:1] [4:2] [4:3] [4:4]
Ratio of oLH constructs to hCgA constructs
Figure 5.3.4a: Total oLH expression in CHO cells transiently
cotransfected with different amounts of the hCgA expression
construct.
All transfected cells received an equal amount of poaGSU and poLHJjg
constituting 45% of the total DNA added to each well. The remaining
45%> of the DNA in the transfection mix contained varied amounts of
phCgA or pBluescript KS + . Addition of pBluescript KS+ to the
transfection mix ensured that the total DNA concentration was
maintained in each transfection. The proportion of hCgA expression
constructs in the transfection mix was increased from none ([4:0]) to
a 1:1 ratio ([4:4]). All transfection mixes contained 10% pCAT as an
internal control. oLH in the media and lysatc fractions was measured
by RIA and standardised against total protein content and CAT
activity.
Although total oLH expression was increased by cotransfection of the
hCgA expression construct at the ratios shown in figure 5.3.4a, no
significant alteration in the proportion of total oLH which remained
intraccllularly was observed (figure 5.3.4b).
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none [4:0] [4:1] [4:2] [4:3] [4:4]
Ratio of oLH constructs to hCgA constructs
Figure 5.3.4b: Storage of oLH in CHO cells transiently cotransfected
with different amounts of the hCgA expression construct.
All transfected cells received an equal amount of poaGSU and poLH|3g
constituting 45% of the total DNA added to each well. The remaining
45% of the DNA in the transfection mix contained varied amounts of
phCgA or pBluescript KS + . Addition of pBlucscript KS+ to the
transfection mix ensured that the total DNA concentration was
maintained in each transfection. The proportion of hCgA expression
constructs in the transfection mix was increased from none ([4:0]) to a
1:1 ratio ([4:4]). All transfection mixes contained 10% pCAT as an
internal control. oLH in the media and lysate fractions was measured
by RIA and standardised against total protein content and CAT activity
before determining the proportion of total oLH present in the lysate.
Similar cotransfection of oLH expression constructs with increasing
amounts of the bSgll expression construct (pbSgl 161) exhibited no
significant change in the total amount of oLH transiently expressed by
CHO cells in comparison to cells containing only the oLH expression
constructs (figure 5.3.4c). However a significant difference was observed
between cells transfectcd with pbSgII61 equalling 50% and 75% of the
concentration of oLH expression constructs.
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none [4:0] [4:1] [4:2] [4:3] [4:4]
Ratio of oLH constructs to bSgll constructs
Figure 5.3.4c: Total oLH expression in CHO cells transiently
cotransfected with different amounts of the bSgll expression
construct.
All transfected cells received an equal amount of poaGSU and poLH[ig
constituting 45% of the total DNA added to each well. The remaining
45% of the DNA in the transfection mix contained varied amounts of
pbSgII61 or pBluescript KS+. Addition of pBluescript KS+ to the
transfection mix ensured that the total DNA concentration was
maintained in each transfection. The proportion of bSgll expression
constructs in the transfection mix was increased from none ([4:0]) to a
1:1 ratio ([4:4]). All transfection mixes contained 10% pCAT as an
internal control. oLH in the media and lysale fractions was measured
by RIA and standardised against total protein content and CAT activity.
Although no significant difference in total oLH expression was observed
during coexpression of the bSgll gene, significant decreases in the
proportion of oLH remaining in the lysate fraction were observed
particularly for the cells which received the lower concentrations of the
pbSgII61 construct (figure 5.4.3d). However no significant differences
were observed between cells which received different proportions of the
bSgll expression construct.
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Ratio of oLH constructs to bSgll constructs
Figure 5.3.4d: Storage of oLH in CHO cells transiently cotransfected
with different amounts of the bSgll expression construct.
All transfeeted cells received an equal amount of poaGSU and poLH[3
constituting 45% of the total DNA added to each well. The remaining
45% of the DNA in the transfection mix contained varied amounts of
pbSgllb 1 or pBlueseript KS+. Addition of pBluescript KS+ to the
transfection mix ensured that the total DNA concentration was
maintained in each transfection. The proportion of bSgll expression
constructs in the transfection mix was increased from none ([4:0]) to a
1:1 ratio ([4:4]). All transfection mixes contained 10% pCAT as an
internal control. oLH in the media and lysate fractions was measured
by R1A and standardised against total protein content and CAT activity
before determining the proportion of total oLH present in the lysate.
Comparison of the amount of oLH and oFSH stored between separate
transfection experiments using the ovine ocGSU expression construct in
conjunction with either genomic clone for oLHji or oFSH(3 demonstrated a
significant difference (figure 5.3.4e).
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Figure 5.3.4e: Comparison of oLH and oFSH storage by transiently
transfected CHO cells.
CHO cells were transf'ected using Pfx5. Media and lysates were
harvested 48 and 72 hours posttransfection. oLH and oFSH levels
were determined by RIA. All transfections contained poaGSU at a
1:1 ratio with either genomic clone for oLH[i or oFSH[3.
5.3.5 Visualisation of Intracellular Traffic
No CHO cells exhibited any staining in the absence of the appropriate
transfection or primary antisera. Propidium iodide (Sigma-Aldrich, UK)
fluorescence appeared restricted to the nucleus and mitochondria.
Indirect immunofluorescence was initially carried out on a-tubulin to
verify that the subcellular structures within the fixed cells were intact.
Figure 5.3.5a shows tubulin staining in a Bouins fixed untransfected CHO
cell and indicates that these relatively fragile cytoskeletal elements are
preserved. Staining of the endoplasmic reticulum (ER) and Golgi apparatus
using Bodipy 630/650 (Molecular Probes, NL) demonstrated the subcellular
localisation of these compartments within CHO cells (figure 5.3.5b). It
should be noted that untransfected CHO cells stained with this dye also






Figure 5 3 5a: Subcellular distribution of a-Tubulin in CHO cells
CHO cells were fixed in Bouins and stained with the a-Tubulin FITC conjugate Nucleic acids
were detected using 10pg/ml propidium iodide (i) Excitation of the fluorophores was
undertaken using the 48Snm argon and 543nm HeNe lasers and detected using 505-535nm




Figure 5.3.5b: CHO cells stained with the endoplasmic reticulum and
Golgi apparatus-specific probe Bodipy 630/650
i) Phase-contrast image, n ) Bodipy 630/650 fluorescence and phase-contrast overlay,
iii) Bodipy 630/650 fluorescence. The pattern of fluorescence appears punctate throughout
the cytoplasm and particularly concentrated at perinuclear regions Untransfected CHO cells
were fixed in Bouins and mounted in Citifluor containing lOpg/ml Bodipy 630/650
Fluorescence was detected using the HeNe 633nm laser and 64Unm longpass filter
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The subcellular localisation of oFSH in transiently transfected CHO cells did
not resemble the staining achieved with the ER/Golgi dye Bodipy 630/650.
Instead the pattern of staining resembled that of a fine mesh within the
cytoplasm (figure 5.3.5c). A small amount of punctate expression was
exhibited at 'intersections' within the 'mesh-like' staining. This pattern of
staining was almost identical to that of oLH in transiently transfected CHO
cells (figure 5.3.5d). No discernible increase in the amount of aggregation
was observed in cells transfected with the oFSH expression constructs
compared to those transfected with the oLH expression constructs.
CHO cells transfected with expression constructs for individual granins
exhibited strikingly different patterns of staining compared to those of
the pituitary gonadotrophins alone. However no staining was achieved
using antisera against Sgll or using the monoclonal CgA antisera. CHO
cells transfected with phCgA exhibited staining (using the polyclonal
antisera) which resembled the cisternae of the ER and Golgi apparatus
throughout the cytoplasm. Furthermore several vesicle-like bodies
ranging in diameter between 100-600nm were present towards the
periphery of the cell (figure 5.3.5e). Detection of bCgB in transiently
transfected CHO cells exhibited relatively large areas of concentrated
cytoplasmic staining some of which was located proximal to the plasma
membrane (figure 5.3.5 f). The transfected cells also exhibited widespread
punctate expression with the vesicle-like bodies ranging in diameter
between 0.1-2.0pm. The bCgB-immunoreactivity appears similar to the
fluorescence produced by the ER and Golgi-specific probe Bodipy 630/650
(figure 5.3.5b).
Colocalisation of oLH with hCgA and bCgB was also exhibited in
cotransfected CHO cells. Cells cotransfected with oLH and hCgA expression
constructs (figure 5.3.5g) exhibited significant colocalisation throughout
the ER and Golgi apparatus. In addition oLH-immunoreactivity appears to
predominate at the periphery of the cell. Colocalisation within distinct
fluorescent bodies ranging in diameter from 310-640nm appeared
transient. Three types of immunoreacti vity within these bodies was
observed; hCgA only, oLH only and both hCgA and oLH. Vesicles
containing hCgA only or both hCgA and oLH appeared throughout the
cytoplasm whereas those containing only oLH appeared proximal to the
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Figure 5 3-5c: Subcellular distribution of oFSH in a transiently transfected CHO cell
i) FSH-immunoreactivity (green) appears dispersed throughout the cytoplasm in a mesh-
like ' pattern, ii) Overlay of FSH-immunoreactivity, nuclear staining (blue) and phase-
contrast Cells were fixed in Bouins 48 hours posttransfection with poaGSU and poFSHpg
Primary FSH polyclonal antisera (M91) was diluted 1:500 Goat anti rabbit FITC conjugate was
diluted 1 40 Nuclear staining was undertaken using lOpg/ml propidium iodide
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Figure 5 3 5d: Subcellular distribution of oLH in a transiently transfected CHO cell
i) LH-immunoreactivity appears dispersed throughout the cytoplasm in a dense mesh-like'
pattern ii) Overlay of LH-immunoreactivity, nuclear staining (blue) and phase-contrast
Cells were fixed in Bouins 48 hours posttransfection with poaGSU and poLHpg Primary bLH
monoclonal antisera (518B7) was used at 2pg/ml Goat anti-mouse TRITC conjugate was diluted
1 40. Nuclear staining was undertaken using 10|ag/ml propidium iodide.
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Figure 5 3 5e: Subcellular distribution of hCgA in a transiently transfected CHO cell
i) hCgA-immunoreactivity appears dispersed throughout the cytoplasm in a network of
tubular structures which are presumably the endoplasmic reticulum and Golgi apparatus In
addition several areas of punctate fluorescence are present in regions proximal to the plasma
membrane These fluorescent bodies range from approximately 100-600nm in diameter, ii)
Overlay of hCgA immunorcactivity, nuclear staining (blue) and phase-contrast Cells were
fixed in Bouins 48 hours posttransfection with phCgA. Primary CgA polyclonal antisera was
diluted 1 1500 Goat anti-mouse FITC conjugate was diluted 1:40. Nuclear staining was
undertaken using lOpg/ml propidium iodide Cytoplasmic staining of nuclear material may
represent mitochondria
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Figure 5 3 5f: Subcellular distribution of bCgB in a transiently transfected CHO cell
i) Punctate bCgB-immunoreactivity appears dispersed throughout the cytoplasm These
fluorescent bodies range from approximately lOOnm to nearly 2nm in diameter. CgB-
immunoreactivity is particularly concentrated at the perinuclear region (arrow). Several of
the smaller fluorescent bodies appear juxtaposed to the plasma membrane (arrowheads)
ii) Overlay of hCgB-immunoreactivity. nuclear staining (blue) and phase-contrast. Cells were
fixed in Bouins 48 hours posttransfection with pbChrB73 Primary CgB polyclonal antisera
was diluted 1 1500 Goat anti-mouse FITC conjugate was diluted 1 40. Nuclear staining was
undertaken using lOpg/ml propidium iodide Cytoplasmic staining of nuclear material may
represent mitochondria.
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plasma membrane. Colocalisation of oLH with bCgB within cotransfected
cells (figure 5.3.5h) exhibited different colocalisation to that of oLH and
hCgA. bCgB appeared to colocalise with oLH in the ER and Golgi apparatus
with no detectable colocalisation within the bCgB-immunoreacti ve
cytoplasmic vesicles. Comparison of figures 5.3.5e & g and 5.3.5f & h
indicate that the subcellular distribution of hCgA and bCgB appears
different in oLH cotransfected cells to those expressing only the granins.
Cells transfected with phCgA and poLH(3g appear to contain more hCgA-
immunoreacti vity within small cytoplasmic vesicles than cells transfected
with phCgA alone. In contrast cells transfected with pbChrB73 and poLHfig
do not contain the abundant punctate cytoplasmic fluorescence observed
in cells expressing bCgB alone. In addition these pbChrB73/poLH(3g
cotransfected cells did not exhibit the large (l-2pm) bCgB-immunoreacti ve
vesicles present in 'bCgB only' cells.
Comparison of the staining patterns in oLH/granin cotransfected cells
with those obtained from cells transfected with only oLH expression
constructs (figures 5.3.5d, g & h) revealed striking differences. oLH
immunoreactivity appeared relatively dispersed throughout the cytoplasm
in CHO cells expressing only oLH expression constructs. Coexpression of
hCgA with oLH led to abundance colocalisation within the ER and Golgi
apparatus. Notably oLH-immunoreactivity appeared colocalised with hCgA
in 310-640nm cytoplasmic vesicles yet alone in peripheral areas of the
cell. This punctate expression was absent from cells transfected with oLH
expression constructs alone. Colocalisation of oLH and bCgB appeared to be
restricted to the ER and Golgi apparatus with no punctate expression of
oLH.
Colocalisation of oFSH and granins was not investigated due to a lack of
appropriate antisera. Fluorescence from TRITC and FITC conjugates
appeared to be inhibited by the ER and Golgi-specific dye Bodipy 630/650
and therefore prevented colocalisation of these signals.
5.3.6 Subcellular Localisation of
EGFP-Gonadotrophin (3-subunit fusion proteins
CHO cells transiently transfected with equal amounts of poaGSU and
pEGFPC-oLHp were observed directly in DPBS (figure 5.3.6a). Cells
Figure 5 3 5g: Subcellular distribution of oI.H and hCgA in a transiently transfected CHO cell
i) oLH-immunoreactivity appears throughout the cytoplasm and several punctate fluorescent
bodies are present in peripheral areas of the cell, ii) hCgA-immunoreactivity appears similarly
distributed to oLH with several areas of punctate expression lii) An overlay of oLH- (red) and
hCgA-immunoreactivity (green) with phase-contrast indicates that the punctate areas of oLH
fluorescence are located closer to the plasma membrane than that of hCgA iv) Overlay of oLH-
and hCgA-immunoreactivity only The punctate fluorescent bodies range from 310-640nm and
exhibit three types of fluorescence Some of these putative vesicles contain hCgA only (black
arrows) and others contain only oLH (white arrows) Others contain both oLH and hCgA
appearing yellow (arrowheads). The inset of panel (iv) demonstrates the degree of
colocalisation between oLH and hCgA Antigens exhibiting no colocalisation show no pixels in
the centre of the pixel distribution graph Identical images exhibit a 45° line from the bottom
left corner oLH and hCgA appear to show significant colocalisation within transiently
transfected CHO cells. Cells were transfected with poaGSU, poLHpg and phCgA then fixed in
Bouins 48 hours later. LH primary antisera (518B7) was used at 2[ig/ml and CgA antisera diluted
1 1000 Goat anti-mouse TR1TC and goat anti-rabbit FITC secondary antisera conjugates were
diluted 1:40. Fluorescence was detected using HeNe 543nm and argon 488nm lasers with 585nm
longpass and 505 535nm bandpass filters for TRITC and FITC respectively.
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Figure 5 3 5h: Subcellular distribution of oI.H and hCgR in a transiently transfected CHO cell
i) bCgB-immunoreactivity is also concentrated in the ER and TON In addition several punctate
bodies are present in the periphery of the cell ii) oLH-immunoreactivity appears throughout
the cytoplasm and particularly concentrated in the perinuclear region corresponding to the ER
and TGN iii) An overlay of oLH- (red) and bCgB-immunoreactivity (green ) with phase-contrast
indicates that the punctate areas of bCgB fluorescence are located in close proximity with the
plasma membrane, iv) Overlay of oLH- and bCgB-immunoreactivity only The punctate
fluorescent bodies range from 190-380nm and only contain bCgB (arrows). oLH and bCgB appear
colocalised within the ER and TGN (arrowhead) The inset of panel (iv) demonstrates the degree
of colocalisation between oLH and bCgB Antigens exhibiting no colocalisation show no pixels in
the centre of the pixel distribution graph Identical images exhibit a 45° line from the bottom
left corner oLH and bCgB appear to show moderate colocalisation within transiently transfected
CHO cells. Cells were transfected with poccGSU, poLHpg and pbChrB73 then fixed in Bouins 48
hours later LH primary antisera (518B7) was used at 2pg/ml and bCgB antisera diluted I 1000.
Goat anti-mouse TR1TC and goat anti rabbit FITC secondary antisera conjugates were diluted 1:40
Fluorescence was detected using HeNe 543nm and argon 488nm lasers with 585nm longpass and
505~535nm bandpass filters for TRITC and FITC respectively
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transfected with the 'empty' pEGFPC-3 construct alone exhibited
fluorescence throughout the cell including the nucleus. Cells transfected
with the pEGFPC-3, pEGFPC-oLH(3 and poaGSU exhibited punctate expression
over a background of EGFP fluorescence throughout the cell. Cells
transfected with pEGFPC-oLHP and poaGSU exhibited similar punctate
cytoplasmic bodies in the absence of EGFP background. These fluorescent
bodies ranged in size from l-2pm. Time-lapse scanning of these cells failed
to demonstrate their movement.
Cells transfected with poaGSU and pEGFPC-oFSH(3 were viewed live 24
(figure 5.3.6b & c) and 48 hours (figure 5.3.6e & f) posttransfection. After
24 hours some cells exhibited fluorescence throughout the cytoplasm and
nucleus. Other cells exhibited punctate fluorescence which appeared to
move within the cytoplasm in apparently random directions (movie
5.3.6d). These vesicles ranged in diameter between 400-630nm whereas
others which did not exhibit movement were much larger (1.69pm). The
majority of transfected cells 48 hours posttransfection exhibited punctate
cytoplasmic fluorescence. These cytoplasmic bodies ranged in diameter
between 110-350nm (figure 5.3.6e). Time-lapse scanning of these cells
revealed that many of these vesicles exhibited rapid movement within the
cytoplasm (figure 5.3.6f & movie 5.3.6g). An example of an exocytotic event
where a single vesicle appeared to fuse with the plasma membrane was
also observed. Surprisingly some vesicles localised proximal to the plasma
membrane did not exhibit this type of movement and instead appeared to
'wobble' (movie 5 3 6g)
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Figure 5.3.6a: EGFP and EGFPOoLHp fluorescence in transiently transfected CHO cells.
EGFP and EGFPC oLHp fluorescence was observed in living CHO cells 48 hours posttransfection
Panel (i) shows a CHO cell transfected with the empty' pEGFP-C3 vector alone and displays
fluorescence throughout the cell The fluorescence is particularly concentrated in the
perinuclear region corresponding to the ER and Golgi apparatus Panel (ii) shows a CHO cell
transfected with poaGSU, pEGFP-C3 and pEGFPC-oLHp. The fluorescence in this cell is also
dispersed throughout the cytoplasm and nucleus In addition several relatively large
fluorescent cytoplasmic bodies (arrows) are present with diameters of approximately l-2|xm.
Panel (iii) shows a CHO cell transiently transfected with poaGSU and pEGFPC-oLHp.
Fluorescence in this cell is punctate and restricted to the cytoplasm No diffuse fluorescence
is present in this cell The cytoplasmic bodies (arrows) appear similar to those displayed in
panel (ii). EGFP fluorescence was observed using a 48Snm argon laser and 505-535nm
bandpass filter.
207
Figure 5 3.6b: EGFPC-oFSHp fluorescence in transiently
transfected CHO cells 24 hours posttransfeclion
Several cells are present within the field of view The cell in the centre of the field of view
exhibits punctate fluorescence (arrows) These fluorescent bodies range in diameter between
400-630nm and moved sporadically within the cytoplasm Other larger fluorescent bodies
(1.69pm; arrowhead) remained in a fixed position Other cells within the field of view exhibit
fluorescence throughout their nuclei and cytoplasms. Cells were observed live using a 488nm
argon laser and 505 535nm bandpass filter This image was the first in a series taken at 32.07
second intervals.
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Figure 5 3-6e: EGFPC-oFSHp fluorescence in a transiently transfected CHO cell 48 hours
posttransfection.
CHO cells were transiently transfected with poaGSU and pEGFPC-oFSHfi. Living cells were
viewed 48 hours posttransfection Punctate fluorescence is clearly visible within the
cytoplasm of this cell (arrows). The diameter of these intracellular bodies ranges from 110-
350nm. Many of these putative vesicles exhibited sporadic movement while others located
proximal to the plasma membrane either remained in a fixed position or wobbled'
(arrowheads). This image is the first in a series taken at 32.07 second intervals. EGFP
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5.4 Discussion
Transfection of both CHO and CHO-K1 cell lines was achieved after a
relatively short optimisation process. Both cell lines were easily
transfected using PerFect™ lipids although optimal transfection was not
achieved using the same lipid mix for each. This was unexpected due to the
assumed similarity of the cell lines. Although the molecular mechanisms
involved in the specific nature of each transfection remain to be
determined, it is possible that these differences may be derived from
differential expression of cell surface proteins.
Transient expression from all constructs used in these studies was
confirmed by RT-PCR. Only RT-PCRs carried out on cells transfected with
oLH(3 expression constructs exhibited larger amplified products in addition
to the predicted products. However this larger product was less abundant
than the correct size product which is in contrast to the relationship
observed in reactions containing RNA from similarly transfected JEG3
samples. Further analysis of the situation leading to the amplification of
this product in transfected JEG3 cells suggested that it arose due to
aberrant splicing. It is therefore likely that this is also the case in CHO
cells although it appears that aberrant splicing of oLHp mRNA occurs less
frequently than in JEG3 cells .
Expression of oFSH in CHO-K1 cells was unexpectedly low. However
visualisation of transfected cells by indirect immunofluorescence
demonstrated a high concentration of oFSH immunoreactivity in the
perinuclear region, presumably proximal to the endoplasmic reticulum
(ER) and Golgi apparatus. The lack of further cytoplasmic staining in
conjunction with the low yield of oFSH from the lysate and media suggests
breakdown of oFSH in lysosomal compartments budding from the Golgi
apparatus. The reasons for this are unclear but it is perhaps likely that
misfolding or aberrant glycosylation events may have prevented
dimerisation of the oFSH molecule. It has been demonstrated in vivo that
free gonadotrophin P-subunits are digested within post-Golgi lysosomal
compartments (Bassetti et al., 1995).
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Expression studies in CHO cells revealed that, unexpectedly, higher levels
of oFSH were expressed from the combination of constructs containing the
oFSHp genomic clone as opposed to the cDNA. The reasons for this apparent
'preference' for the genomic clone may be due to the presence of cryptic
enhancer sequences within the introns. This result contrasts with that
observed for LPT2 cells (see chapter 6) where higher expression was
derived from transient transfection of the cDNA-containing construct and
suggests the involvement of regulatory mechanisms specific to the
different cell types. Comparison of the proportion of total oFSH present
within the lysate fraction in cells transfected with either the cDNA or
genomic clone demonstrated a higher level of storage from the cDNA
construct. Taken in the context of the lower overall expression level
obtained using this construct combination, these results do not suggest
concentration dependent retention of oFSH in CHO cells. The significantly
greater amount of storage achieved from the oFSHp cDNA construct
compared to the genomic clone despite lower overall expression may be
caused by differences in glycosylation although this will require further
investigation to substantiate. In contrast, LPT2 cells (see chapter 6)
exhibited a higher proportion of storage as a result of higher overall
expression derived from the oFSHp cDNA construct. This difference may be
facilitated by the lack of granin expression in normal CHO cells in
comparison to LPT2 cells which is further substantiated by the observation
that a higher proportion of oFSH is stored in the gonadotroph cell line
compared to CHO cells (compare figures 5.3.3d and 6.3.4d). Future studies
may investigate the effect of granin expression on oFSH storage in CHO
cells and allow comparison with the level of storage in LPT2 cells.
oLH secretion in the presence of individual granins was investigated in
transiently transfected CHO cells. However a startling difference in the
proportion of oLH stored in comparison to oFSH was apparent in the
absence of granin expression. The approximately 5-fold greater level of
storage of oLH in comparison to oFSH demonstrates that CHO cells are able
to differentially secrete LH and FSH. This difference may represent the
sorting of oLH into the cryptic regulated pathway of CHO cells (Chavez et
al., 1996) due to the presence of a 7aa hydrophobic region at the carboxy-
terminus of LHp. Removal of this region which is not present on the LH
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dimer in the pituitary gland (Talmadge et al., 1984) increases the rate of LH
secretion in vitro by increasing the efficiency of dimer formation
(Matzuk et al., 1989). However to substantiate these preliminary findings
in CHO cells further studies must be undertaken to verify the regulated
nature of this secretion by application of secretagogues such as forskolin
and KC1. It is unlikely that this difference is caused solely by the reported
differences in the rates of dimer assembly for LH and FSH (Matzuk et al.,
1989; Muyan et al., 1996) due to the 48-72 hour length of expression before
assay. However it was surprising that no obvious difference in the
subcellular localisation of oLH and oFSH was observed by indirect
immunofluorescence. It may therefore be possible that the 5-fold
difference in the proportion of oLH and oFSH in the lysate represents
variations within the constitutive pathway.
Unexpectedly no significant change in the amount of oLH which remained
intracellularly at the time of assay was observed in cells cotransfected
with the hCgA expression construct. However the presence of hCgA at 75-
100% of the level of oLH did cause more than a 2-fold increase in the
relative amount of oLH expressed by CHO cells. This result is very similar to
the approximately 2-fold greater increase in cAMP-stimulated hCG
expression in JEG3 cells transfected with the hCgA expression construct
compared to untransfected cells (see chapter 4). It may be likely that CgA-
derived peptides promote oLH expression via mRNA stabilisation. Some
evidence exists for interactions between CgA-derived peptides and specific
mRNA. For example pancreastatin has been demonstrated to exert an
inhibitory effect on parathyroid hormone as well as CgA expression in the
parathyroid through mRNA interactions (Zhang et al., 1994). It may be
interesting to investigate the longevity of LH(3 mRNA in the absence of
CgA and its peptides. Previous determination of the rLH(3 mRNA half-life
(44±0.5 hours) was undertaken in male rat gonadotrophs in vitro
(Bouamoud et al., 1992). Male gonadotrophs have been demonstrated to
contain higher levels of CgA as a consequence of positive regulation by
testosterone (Watanabe et al., 1998b) which suggests that the
determination of rLH(3 mRNA stability may have been subject to the
putative regulatory effects of CgA and CgA-derived peptides. Further
evidence for a role of CgA in the enhanced expression of LH(J is suggested
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by the coincidental decrease in CgA and LHp levels during repeated
passage of the murine gonadotroph LPT2 ceU line (see chapter 6).
Indirect immunofluorescence carried out on CHO cells expressing oLH and
hCgA demonstrated a distinct alteration in the subcellular localisation of
oLH in comparison to cells lacking hCgA expression. However in light of
the biochemical evidence for increased oLH expression with no
significant change in the amount of oLH storage during coexpression of
hCgA, it suggests that hCgA increases the efficiency of oLH secretion
during higher levels of expression. Observation of fixed cells did not
permit analysis of the speed of vesicle traffic. The colocalisation of oLH
and hCgA immunoreactivity within the ER and TGN together with the
appearance of dual staining cytoplasmic vesicles suggests that hCgA
aggregates with oLH in the ER and TGN and enhances the rate of
gonadotrophin release via formation of larger cytoplasmic vesicles. The
apparent divergence of hCgA and oLH within what appears to be the late
regulated secretory pathway at regions proximal to the plasma membrane
is similar to that observed in vivo (see chapter 7) (Watanabe et al., 1991;
Thomas et al., 1998). The appearance of these subplasmalemmal 'LH only'
vesicles in CHO cells cotransfected with phCgA suggests that CgA may
initiate entry of LH into the cryptic regulated secretory pathway in CHO
cells (Chavez et al., 1996). It is important to note that the apparent
maturation of the LH-containing granule occurs in the absence of Sgll
recently demonstrated to co-migrate with LH in <200nm granules during E2
treatment. This suggests the presence of conserved molecular mechanisms
in cells of non-neuroendocrine origin which permit granule maturation.
Future studies of SNARE proteins in this model may elucidate their role in
this process. It is possible that the low abundance of these 'LH only'
vesicles within the cotransfected cell represents their rapid and sporadic
movement from the TGN to the plasma membrane. Evidence for this type of
movement has been provided by analysis of living cells by time-lapse
confocal microscopy discussed later. Definitive biochemical evidence for
an increase in oLH turnover during coexpression of hCgA may be obtained
by pulse-chase analysis of stably transfected cells.
Similar investigations of LH secretion in the GH3 cell line which possess a
visually recognisable regulated pathway have indicated that a threshold of
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expression must be reached prior to LH storage (Bielinska et al., 1994). It is
therefore possible that in CHO cells the high level of oLH expression which
is further enhanced by the presence of hCgA exceeds this threshold.
However the oLH dimers are not stored effectively in characteristic
granules due to the absence of the necessary molecular machinery
expressed by gonadotrophs in vivo. The key molecules required remain to
be defined but it is likely that these involve other granins and novel
proteins such as Rab3B (Tasaka et al., 1998). No evidence for the expression
of Rab3B in CHO cells has been reported and future studies may investigate
its presence. A recent antisense study in cultured female rat gonadotrophs
has indicated that Rab3B is crucial for both constitutive and regulated
release of gonadotrophins (Tasaka et al., 1998). However in light of the
observed secretion of LH and FSH it is likely that CHO cells do posses Rab3B
or a protein with similar functional characteristics which facilitate
vesicle release. If this is the case then it may be possible to 'knock-out' this
protein using antisense technology 'forcing' the CHO cell to either store or
breakdown the excess gonadotrophins. Alternatively the role of F-actin
may be the critical factor in vesicle retention. Further analysis of this
cytoskeletal protein by indirect immunofluorescence may reveal an
absence of the necessary barrier required to partition granules away from
sites of exocytosis.
The effect of bSgll on the total level of oLH expressed did not differ
significantly from expression of oLH alone in CHO cells. This was the
expected outcome of bSgll expression on that of oLH. However this effect
of bSgll differed from that observed for hCG in JEG3 cells perhaps
reflecting differences in cell type or regulation of the respective (3-
subunits (see chapter 4). Differences in cell type may lead to alternate
processing of Sgll with production of different peptides. Alternatively the
observed difference between hCG and oLH may have arisen due to the
extended 5' UT of hCG(3 (Bousfield et al, 1994) through which Sgll or Sgll-
derived peptides may interact and exert their effect. However in contrast
to the studies carried out in JEG3 cells, bSgll expression significantly
reduced the proportion of oLH which remained in the lysate. In vivo
observations of the subcellular localisation of Sgll have demonstrated its
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colocalisation with LH in small (<200nm) regulated secretory granules
(Watanabe et al., 1991) which co-migrate during E2 treatment (Thomas et
al, 1998) and are preferentially released during the LH surge (Currie &
McNeilly, 1995). These results suggest a role for Sgll in the final stages of
LH secretion and perhaps in the promotion of exocytosis in vitro. The exact
mechanisms involved in this putative role of Sgll are as yet
uncharacterised. Sgll-derived peptides such as secretoneurin and
secretogranin LT have been demonstrated as secretagogues for dopamine
and related molecules (You et al., 1996). Future in vivo studies may
investigate the interaction of Sgll-derived peptides with the gonadotroph
as an autocrine or paracrine (lactotrophs also express Sgll) mechanism
for gonadotrophin granule release. It is possible that a mechanism such as
this may allow amplification of LH release during surge-type events.
Future in vitro studies may include cotransfection of oLH expression
constructs with both phCgA and pbSgII61 to investigate the combined
effect of these granins on LH expression and secretion. Unfortunately a
lack of suitable antisera prevented visualisation of bSgll within
transfected cells and its putative colocalisation with oLH. This experiment
may pinpoint subcellular colocalisation of oLH and bSgll to sites of
exocytosis within transfected CHO cells.
Expression of EGFP carboxy-terminal p-subunit fusions in CHO cells allowed
for the first time visualisation of gonadotrophin secretion in living cells.
Certain differences were observed between the oLHp and oFSHp fusions.
The oLHp fusion appeared to remain within the TGN as suggested by the
absence of cytoplasmic vesicles. It is likely that the relatively inefficient
dimerisation of LH (Matzuk et al., 1989) was abolished by the presence of
the EGFP structure on the P-subunit. The EGFP molecule at approximately
27kDa is considerably larger than the LHp subunit at approximately 15kDa
and may severely impede the dimerisation of LH. It is possible that future
studies may benefit from oLHp fusions to the amino terminus of EGFP.
However this fusion may require prior removal of the sequences encoding
the 7aa hydrophobic carboxy-terminus of the p-subunit as the putative
cleavage of this region may disintegrate the fusion protein.
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Similar studies using the EGFPC-oFSHp fusion protein yielded novel data
regarding the intracellular trafficking of oFSFl in living cells. The size of
these fluorescent vesicles is in accordance with reported diameters of
regulated secretory granules in gonadotrophs (Watanabe et al., 1998b) and
their type of movement correlates with that reported for similar CgB
fusions expressed in Vero cells (Wacker et al., 1997). It is likely that these
represent trafficking of the dimerised FSH hormone as free p-subunits are
retained in the ER and eventually digested (Bassetti et al., 1995) which
appears to occur with EGFPC-oLHp as previously discussed. The rapid yet
sporadic movement of regulated secretory granules might be unexpected
due to their relatively large size. However evidence presented in the
following chapter demonstrates the rapid movement of similar granules in
transfected LPT2 cells suggesting that this observation is not limited to
cells of non-neuroendocrine origin. Evidence for the secretory nature of
these vesicles is provided by the observation of a vesicle which appears to
fuse with the plasma membrane and release its contents. Although this
does not occur at the periphery of the cell one must bear in mind the
three-dimensional structure of cells which may permit vesicles to fuse
with the uppermost surface of the cell. Regular fusion events were not
observed which may reflect the relatively short periods of observation
undertaken. Future studies will undoubtedly benefit from the use of a
heated perfusion chamber allowing prolonged observation of living cells
at controlled temperatures. A further advantage of such a system includes
the ability to infuse secretagogues into the media and observe the effects
on vesicle traffic in real time. An unexpected observation was the
apparent polarisation of EGFPC-oFSHP vesicles to the periphery of some
transfected CHO cells. Gonadotrophs in vivo display this characteristic
exclusively for LH immunoreactive granules during E2 treatment (Thomas
& Clarke, 1997). Although this phenomenon occurred in only a very
limited number of transfected cells it nevertheless suggests that basic
mechanisms within diverse cell types exist that permit this type of vesicle
trafficking. However large (>100nm) cytoplasmic granules such as those
observed in cells expressing the EGFP-oFSHf) fusion protein were not
apparent in cells transfected with the normal oFSH expression constructs
suggesting EGFP-induced aggregation of the oFSH dimer. This may hinder
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'live cell' investigations into the granin-induced aggregation of
gonadotrophins although it is possible that further aggregation may be
observed during granin cotransfection studies. Conventional biochemical
means for detecting the expression of the EGFP fusion protein appeared to
be prevented possibly due to epitope-masking by the relatively large EGFP
structure. Should future studies require immunological assessment of EGFP
fusion protein secretion it may be necessary to undertake western
analysis using EGFP antisera. However this technique does not easily allow
measurement of specific protein content in high numbers of samples
unlike RIA.
The use of the CHO cell line as a 'proof of concept' model has provided some
interesting preliminary data regarding gonadotrophin secretion and the
role of granins. Notably the increased proportion of total oLH which
remains intracellularly in comparison to that of oFSH suggests the
involvement of basic molecular mechanisms expressed in cells derived
from neuroendocrine as well as non-neuroendocrine tissues. The positive
regulatory effect of hCgA on oLH expression has been demonstrated
without an increase in the proportion of oLH stored suggesting a role for
CgA in increasing the efficiency of oLH secretion. In contrast the effect of
bSgll expression demonstrated no effect on the level of oLH expression but
did show a clear reduction in the proportion of oLH which remained
intracellularly. In the context of previously reported subcellular
localisation and secretion studies this may suggest a role for Sgll in
promoting exocytosis of LH-containing vesicles. Indirect
immunofluorescence demonstrated colocalisation of both hCgA and bCgB
with oLH in the ER and TGN of cotransfected cells suggesting specific co-
aggregation. Furthermore the appearance of secretory granules
containing oLH and hCgA but not bCgB correlates with in vivo data
(Watanabe et al., 1991). This suggests that coexpression of these regulated
secretory proteins within a cell of non-neuroendocrine origin may permit
molecular interactions similar to those which occur in vivo. The use of
novel EGFP fusion constructs has provided preliminary data correlating
with previous reports of the lower efficiency of LH dimerisation compared
to that of FSH. The intracellular trafficking of EGFP-tagged oFSH within a
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cell of non-neuroendocrine origin has demonstrated that relatively large
secretory granules, possibly within the regulated pathway, exhibit rapid
movement, membrane fusion and targeting towards the plasma membrane.
Future studies will include further investigation of the effect of granins
and combinations of granins on not only LH expression and secretion but
also that of FSH. In order to achieve this, generation of stably transfected
CHO cells may be advised. With a clonal population of cells expressing
combinations of gonadotrophin subunits and granins pulse-chase analysis
may be carried out. This may allow more accurate determination of the
effects of granins and combinations of granins on basal rates of secretion




the L(3T2 Gonadotroph Cell line
6.1 Introduction
In vitro studies on gene regulation and secretion of pituitary
gonadotrophins have been hindered in the past by the absence of a
suitable cell line. Up until 1996 the JEG3 human choriocarcinoma (Kohler
& Bridson, 1971) (see chapter 4) and the aT3-l mouse gonadotroph (Windle
et al., 1990) were the only cell lines to endogenously express the aGSU.
Although the aT3-l had the advantage over JEG3 cells of being pituitary-
derived and expressing functional GnRH-R, it did not express either of the
gonadotrophin P-subunit genes whereas JEG3 cells expressed hCG(3.
Furthermore neither the JEG3 nor aT3-l cells appeared to secrete
endogenously expressed proteins via a regulated pathway. Although non-
gonadotroph derived cell lines such as the rat somatomammotroph GH3
(Tashjian et al., 1968) and mouse adrenocorticotroph AtT-20 (Gumbiner &
Kelly, 1982) cell lines did exhibit regulated secretory pathways, they did
not provide direct relevance to secretion by the gonadotroph. In 1996 a
novel mouse gonadotroph-derived cell line was described by the same
group that had previously isolated the aT3-l cell line. The LPT2 cell line
was obtained using similar methodology to that used previously for the
aT3-l cell line. Oncogenesis directed specifically to the gonadotroph was
previously carried out using the SV40 T-antigen under control of the aGSU
promoter whereas in the case of the LPT2 cell line LHp promoter sequences
were used (Thomas et al., 1996). The characteristics of LPT2 ceHs include LH
secretion under control of the GnRH-R. Indeed the secretory
characteristics of the LPT2 cell line appear almost identical to those of in
vivo gonadotrophs with the exception that this cell line does not express
the FSHp gene (Thomas et al., 1996). As yet no investigations into the role
of granins or the effect of FSHp expression within this cell line have been
reported. Due to the presence of a regulated pathway specifically suited to
secrete LH in a pulsatile manner, the LPT2 cell line provided the best model
for investigation of the molecular mechanisms involved with particular
reference to the role of granins and their assumed co-ordinate expression.
220
Chapter Six Gonaclotrophin Secretion from
the Lf5T2 Gonadotroph Cell line
22 1
Furthermore by transfection of FSHp expression constructs it may be
possible to investigate the mode of high level FSH secretion.
Two main objectives were set for these studies using LPT2 cells. Firstly to
assess the hormonal regulation of granin gene expression during a
controlled GnRH regime previously demonstrated to prime LH secretion
(Turgeon et al., 1996). Secondly to investigate the mode of secretion
employed by LPT2 cells during expression of high levels of ovine FSHp
from 3' truncated (stabilised) mRNA.
6.2 Methods
6.2.1 Radioimmunoasay of rat LH
The rLH radioimmunoassay (RIA) was carried out as using the general
methodology described in section 2.5.5 . Primary antisera against rLH
(rLH-S-11) was used at a dilution of 1:150000. rLH-RP-3 tracer material
(NIDDK, USA) for the rLH RIA was iodinated as described in section 2.5.4.
Normal rabbit serum (NRS; SAPU, UK) and Donkey anti-rabbit serum
(DARS; SAPU, UK) were used at dilutions of 1:400 and 1:16 respectively.
6.2.2 Basal LH Expression
Unstimulated LH secretion was determined by rLH RIA of media from
confluent cultures of LPT2 cells at different passage numbers ranging
from 6 to 103 passages. In addition lysates from confluent cultures of LPT2
cells at passage 38 and 103 were obtained by incubation at room
temperature for 1 hour with occasional vortexing in extraction solution
containing 62.5mM Tris.HCl pH6.8, 2% sodium dodecyl sulphate (SDS), 10%
glycerol and Complete™ protease inhibitor (Boehringer Mannheim, UK).
The protein concentration of the lysates was determined by Bradford assay
(Bio-Rad, UK).
SDS-PAGE was undertaken as described in chapter 2. 5% and 10%
acrylamide were used for the stacking and resolving gels respectively.
Samples containing 45pg of total protein were prepared in either reducing
or non-reducing buffers prior to loading. After electrophoresis the
proteins were transferred to nitrocellulose membranes after which LH
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and CgA were detected using the ECF kit (Amersham, UK). The monoclonal
primary antisera bLH518B7 was diluted to lpg/ml whereas bCgA antisera
was used at a dilution of 1:2500.
6.2.3 Basal GnRH-R Expression
Radioligand receptor binding assays were carried out by Elena Faccenda in
order to verify expression of the GnRH-R.
6.2.4 Inositol 1,4,5-trisphosphate
Production by the GnRH-R
Elena Faccenda assessed GnRH-R activity by measuring production of the
intracellular second messenger molecule inositol 1,4,5-trisphosphate (IP3).
Basal and 10~6M GnRH-stimulated activity were compared.
6.2.5 GnRH Regimes
In order to assess the effect of GnRH on gene expression and protein
secretion LPT2 cells were periodically exposed to the hypothalamic
decapeptide over a 3-4 day period. Cells were plated in 6 or 12 well dishes at
lxlO6 or 5x10s cells per well 24-48 hours prior to commencing the GnRH
regime. Cells were plated onto the normal culture surface or onto
Thermanox coverslips (GibcoBRL, UK) coated with a 1:4 dilution of Matrigel
(Becton-Dickinson, UK). All culture media contained 100 units/ml
penicillin and 0.1 mg/ml streptomycin. Either cDMEM or phenol red-free
DMEM supplemented with 10% charcoal-stripped FCS (efDMEM) was used.
Cells were cultured in efDMEM or efDMEM containing 0.2nM E2 and 20nM
dexamethasone (Sigma-Aldrich, UK). Exposure to GnRH lasted 15 minutes
with a 75 minute interpulse period. Either 3 pulses for three days or 4
pulses for four days was carried out. GnRH (Sigma-Aldrich, UK) was added
to the cultures at a final concentration of either lOnM or lpM .
6.2.6 RNase Protection Assays
Pamela Brown and Joanne McVerry undertook the RNase protection assays
(RPAs) for the LHp and aGSU respectively. RPAs were carried out in order
to quantify changes in mRNA for LH(3 and aGSU. Antisense RNA directed at
GAPDH was used to quantify protected fragments in each RPA. The control
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reactions were carried out separately and loaded in separate wells to avoid
loss of LH(i or aGSU signal caused by background from the GAPDH reaction.
6.2.7 Detection of Mouse Granin
and GnRH-R mRNA by RT-PCR
RT-PCR primers were designed following the guidelines detailed in section
2.3.16 to detect expression of the murine CgA, CgB, Sgll and GnRH-R genes.
Details regarding the primers used are contained in the table below.
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mcgb51 316 to 338 GCTCCAGTAGAAGACTCTCAAGG
r23i
58 230
mcgb31 525 to 546 TTCACCAGCATCTTCCCTGTGC
[221
58 230
msgii5 1 593 to 613 CTACCCTGGAGTCTGTGTTCC
T211
58 350
msgii3 1 921 to 943 AGGTGATAACTTTGGAGGCATCC
[231
58 350
gnrhR5 1 103 to 123 ggaaagatccgagtgaccgtg
[21]
63 369
gnrhR3 1 451 to 473 GACTGTTCAAGCTTGCTGTTGC
[221
63 369
Where, Tan is the predicted optimal annealing temperature for the primer
pair.
Detection of the specific mRNA species was undertaken using the Titan7 M
kit (Boehringer Mannheim, UK) on LPT2 lysates harvested using Tri-
reagent (Sigma-Aldrich, UK). RNA concentration was determined by
spectrophotometrical analysis and 500ng of total RNA was added to each
reaction. Amplified products were visualised by 2% agarose gel
electrophoresis in TBE buffer (see Appendix I).
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6.2.8 Optimisation of Lipid-based Transfection
Optimisation of transfections using the PerFect™ lipid system (Invitrogen,
NL) was carried out using 24-well dishes seeded with approximately 2xl05
cells per well. Transfections were undertaken on cultures exhibiting 60-
80% confluency for 6-7 hours with a ratio of lipid to DNA of 6:1.
Transfection efficiency was assessed by (3-galactosidase staining as
described in section 2.4.9 .
6.2.9 Transient FSH Expression
Cells were transfected using Pfx3 for 6 hours with the aGSU expression
construct poaGSU and either poFSH(3, poFSFiPg or pEGFPC-FSFfp. Media and
lysates were harvested after 48 or 72 hours as described in section 2.5.1.
Additionally similar transfections carried out on cells plated in glass
chamber slides were fixed in Bouins fixative (Appendix I) and subjected to
either indirect immunofluorescence or direct visualisation of EGFP as
described in sections 2.6.2-3 . Analysis of EGFP fluorescence in transiently
transfected LpT2 cells was also carried out as described in section 2.6.3.
6.3 Results
6.3.1 Basal Gene Expression
rLFI RIAs undertaken with media from unstimulated confluent cultures of
LPT2 cells revealed that even after 103 passages basal LF1 secretion was
exhibited (figure 6.3.1a). This data demonstrates the variability of
expression during progressive passaging of LPT2 cells. The lack of
adequate samples for each passage prevents statistical comparisons but
does demonstrate that detectable LH is secreted from cultures even after
prolonged passaging.
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Figure 6.3.1a: Secretion of rLH from LPT2 cells after increasing
numbers of passage in culture.
Media from confluent LPT2 cultures incubated for 24 hours was
measured for LH content by rLH RIA.
SDS-PAGE using lysates from two representative passage numbers (p38 and
p 103) revealed that both expressed detectable levels of rLHp and CgA.
However the amount of rLHp signal detected at the predicted size of
approximately 15kDa in the p38 sample far exceeded that of the pl03
sample (figure 6.3.1b). This result correlates with the suggested decline in
secreted LH detected by rLH RIA (figure 6.3.1a). It should be noted
however, that the observed difference in intracellular LHp abundance
between these two samples appears far greater than that observed for
secreted LH. Interestingly neither sample produced an immunoreactive
band at the predicted size when treated with the reducing loading buffer
containing p-mercaptoethanol. The samples probed for CgA content
presented a strong band between the 64 and 98kDa markers in the p38
samples treated with non-reducing or reducing loading buffers which is
in agreement with the reported migration of CgA during SDS-PAGE (figure













Figure 6.3 lb: Comparison of LHp
abundance in I.pT2 cell lysates
after different lengths of passage
Lysates from cells after 38 and 103
passages were prepared in non-
reducing (NR) and reducing (R)
loading buffers A band
corresponding to the reported size
of the LHp subunit (15kDa approx.)
was detected (arrow) in samples
prepared in non-reducing buffer
but not in reducing buffer The
abundance of LHp in pl03 was
much less than that observed for
lysates after 38 passages 45pg of
total protein was loaded per lane
LII primary antisera (517B8) was
used at lpg/ml Protein detection






Figure 6.3.1c: Comparison of CgA
abundance in LPT2 cell lysates
after different lengths of passage.
Lysates from cells after 38 and 103
passages were prepared in non-
reducing (NR) and reducing (R )
loading buffers. A band
corresponding to the reported size
of monomeric CgA (70-85kDa) was
detected (arrow) in p38 samples
prepared in non-reducing buffer
and reducing buffer This band
was not visible in lysates taken
after 103 passages. 45pg of total
protein was loaded per lane
CgA primary antisera was diluted
1 2500. Protein detection was
undertaken using the ECL kit
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show immunorcactivity at this position even after extended incubation
(data not shown).
Assessment of basal G11RH-R expression by radioligand binding
demonstrated significant displacement of 125I-labelled GnRH by 10~6M of
the D-Trp6 GnRH ethylamide peptide as shown in figure 6.3. Id. The figure
also indicates that the amount of non-specific binding of the radiolabeled





Figure 6.3. Id: Displacement of 125I-GnRH binding from LPT2
membranes using 10-6M D-Trp6 GnRH ethylamide.
Membranes isolated from a single culture of LPT2 cells after 62
passages were assessed for their ability to specifically bind GnRH.
The difference between total binding and non-specific binding is
equivalent to the specific GnRH binding ability of LPT2 cells.
6.3.2 Effects of GnRH Treatment
Application of 10~bM GnRH to LPT2 after 62 passages produced an
approximate 40-fold increase in IP3 production in comparison to untreated
cells (figure 6.3.2a).
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Figure 6.3.2a: Effect of 1()-6M GnRH treatment on IP3 production
from LPT2 cells.
LPT2 cells after 62 passages were labelled with tritiated inositol
for 24 hours. Subsequently each culture was either mock-treated
or given a single dose of 1()-6M GnRH. Lysates were then
harvested and assayed for radioactive IP3 content.
Despite efficient detection of 0.5pg of the 128-base sense strand of mouse
LHP (mLHP), no mLHp was detected in the LPT2 lysates after pulsatile
treatment with 10"8M GnRH. The predicted 197bp protected fragment was
not detected in lysates from untreated LPT2 cells or those which received
either 2 or 3 days of GnRH pulses (figure 6.3.2b).
The RPA carried out to detect the murine aGSU mRNA in 10~8M GnRH-
treated cells did detect the protected fragment at the predicted size of 230bp
(figure 6.3.2c). However larger fragments presumably a result of
inefficient RNase digestion of the 300-base probe were also present. The
aGSU mRNA signal was quantified with regard to the parallel detection of
GAPDH mRNA which produced the predicted fragment at 316bp and is also
shown in figure 6.3.2c. The GAPDH-corrected aGSU mRNA levels are
represented in figure 6.3.2d.
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Figure 6.3.2b: mLHp RNase pruiection assay of Lpl'2 cells
after treatment with ltlnM GnRII
Cells were grown on Matrigel-coated coverslips in the presence of 0.2mM oestradiol and
20nM dexamethasone. GnRH-treated cells received three lOnM pulses per day 115 minute
pulse and 75 minute interval) All samples including untreated (-), 2 days of GnRII (2)
and 3 days of GnRH (3) did not exhibit the protected fragment of 197bp (filled arrow)
Undigested probe is visible in the samples which corresponds to the 24Sbp band in
lane containing only the mLHp probe (EMBL no.Y10415) shown in lane P and the
arrowhead. Positive controls demonstrated efficient protection of the 12Sbp fragment
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Figure 6.3.2c: maGSU RNase protection assay of LpTo cells
after treatment with lOnM GnRH.
All cells were grown in the presence of 0 2mM oestradiol and 20nM
dexamethasone except for lanes marked (-). GnRH-treated cells received
three lOnM pulses per day (15 minute pulse and 75 minute interval)
All samples including untreated without oestradiol and dexamethasone (-),
untreated with oestradiol and dexamethasone ( + ), 1 day of GnRH (1).
2 days of GnRH (2) and 3 days of GnRH (3) exhibited the protected
fragment of approximately 230bp (arrow) Undigested probe is visible in
the samples and in the lane containing only the maGSU probe (P)
Internal controls measuring GAPDH mRNA abundance were carried out
separately and are shown in the panel below the main gel. Increased
abundance of the maGSU mRNA was apparent in samples which had received
2 days of GnRH treatment (i.e. 6 pulses) in comparison to controls and cells
treated for 1 and 3 days M denotes the lane containing a lOObp marker
All cells were grown on Matrigel-coated coverslips.
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show immunoreactivity at this position even after extended incubation
(data not shown).
Assessment of basal GnRH-R expression by radioligand binding
demonstrated significant displacement of 12<iI-labelled GnRH by 10~6M of
the dTrp6 GnRH peptide as shown in figure 6.3.Id. The figure also indicates
that the amount of non-specific binding of the radiolabeled ligand is very


















Figure 6.3.Id: Displacement of 125I-GnRH binding from LPT2
membranes using l() hM d'l'rp6 GnRH.
Membranes isolated from a single culture of LpT2 cells after 62
passages were assessed for their ability to specifically bind GnRH.
The difference between total binding and non-specific binding is
equivalent to the specific GnRH binding ability of LPT2 cells.
6.3.2 Effects of GnRII Treatment
Application of 10"6M GnRH to LPT2 after 62 passages produced an
approximate 40-fold increase in IP3 production in comparison to untreated
cells (figure 6.3.2a).
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Figure 6.3.2a: Effect of 10~6M G11RH treatment on IP3 production
from LpTo cells.
LPT2 cells after 62 passages were labelled with tritiated inositol
for 24 hours. Subsequently each culture was either mock-treated
or given a single dose of 106M GnRH. Lysates were then
harvested and assayed for radioactive IP3 content.
Despite efficient detection of 0.5pg of the 128-base sense strand of mLHp,
no mLHp was detected in the LPT2 lysates after pulsatile treatment with 10"
8M GnRH. The predicted 197bp protected fragment was not detected in
lysates from untreated LPT2 cells or those which received either 2 or 3 days
of GnRH pulses (figure 6.3.2b).
The RPA carried out to detect the murine aGSU mRNA in 10 8M GnRH-
treated cells did detect the protected fragment at the predicted size of 230bp
(figure 6.3.2c). However larger fragments presumably a result of
inefficient RNase digestion of the 300-base probe were also present. The
aGSU mRNA signal was quantified with regard to the parallel detection of
GAPDH mRNA which produced the predicted fragment at 316bp and is also
shown in figure 6.3.2c. The GAPDH-corrected aGSU mRNA levels are
represented in figure 6.3.2d.
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Figure 6.3 2b: mLH(3 RNase protection assay of LPT2 cells
after treatment with lOnM GnRH
Cells were grown on Matrigel-coated coverslips in the presence of 0 2mM oestradiol and
20nM dexamethasone GnRH-treated cells received 3 lOnM pulses per day (15 minute
pulse and 75 minute interval) All samples including untreated (-), 2 days of GnRH (2)
and 3 days of GnRH (3) did not exhibit the protected fragment of 197bp (filled arrow)
Undigested probe is visible in the samples which corresponds to the 2d8bp band in
lane containing only the mLHp probe (EMBL no Y1041S) shown in lane P' and the
arrowhead Positive controls demonstrated efficient protection of the 128bp fragment
down to 0 5pg of the sense strand (empty arrow). M' denotes the lane containing a
lOObp marker.
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Figure 6.3 2c: maGSU RNase protection assay of LPT2 cells
after treatment with lOnM GnRH
Cells were grown on Matrigel-coated coverslips in the presence of 0.2mM
oestradiol and 20nM dexamethasone except for lanes marked (-). GnRH-
treated cells received three lOnM pulses per day (15 minute pulse and 75
minute interval) All samples including untreated without oestradiol and
dexamethasone (-), untreated with oestradiol and dexamethasone (+),
1 day of GnRH (1), 2 days of GnRH (2) and 3 days of GnRH (3) exhibited
the protected fragment of approximately 230bp (arrow) Undigested probe
is visible in the samples and in the lane containing only the maGSU probe (P)
Internal controls measuring GAPDH mRNA abundance were carried out
separately and are shown in the panel below the main gel Increased
abundance of the maGSU mRNA was apparent in samples which had received
2 days of GnRH treatment (i.e 6 pulses) in comparison to controls and cells
treated for 1 and 3 days. M' denotes the lane containing a lOObp marker.
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Figure 6.3.2d: Quantification by RPA of murine aGSU
in L(iT2 cells treated with pulsatile KHM GnRH.
RNase protection assays (RPAs) were carried out on lysates of
control and GnRH-treated L|5T2 cells. 3 GnRH pulses were given
daily to cells cultured in the presence of Matrigel, 0.2nM oestradiol
and 20nM dexamethasone. The untreated control samples were
taken at the begining of the experiment whereas theE2/DEX and
Matrigel treated control samples were harvested at the end of day

















The control sample which did not receive GnRH, E2 or DEX and was plated
on standard culture surface exhibited the lowest abundance for aGSU
mRNA. No significant rise in aGSU mRNA abundance was apparent in
lysates harvested from cultures after three days in media containing
0.2nM E2 and 20nM DEX whilst plated on Matrigel. Maximal stimulation of
aGSU mRNA abundance was evident after 2 days and a total of 6 pulses.
Lysates harvested after 3 or 9 GnRH pulses (days 1 and 3) exhibited
significantly lower levels of aGSU mRNA abundance.
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In correlation with the lack of mLH(3 mRNA detection by RPA, rLH detected
in the media of GnRH-treated and untreated LPT2 cells was equivalent to
background levels (data not shown). This level of LH expression is lower
than that observed for basal LH secretion (figure 6.3.1a) and showed no
significant response to GnRH treatment despite the presence of Matrigel,
E2 and DEX. This experiment was undertaken with L[5T 2 cells after
approximately 75 passages.
A GnRH regime consisting of four lpM pulses per day for four days did not
reduce the basal LH secretion in LPT2 cells after 44 passages. LH levels
secreted by GnRH-treated and untreated cells on the final day of the
regime are shown in figure 6.3.2e.
18
Pulse 1 Inter- Pulse 2 Inter- Pulse 3 Inter- Pulse 4
pulse 1 pulse 2 pulse 3
Day Four Media Fractions
T S.E .M | | untreated
n=2 Hi 10-6M GnRFI treated
Figure 6.3.2e: Secretion of LH by control and 10~6M GnRH-trcated
LPT2 cells on day four of a 4 pulses per day regime.
LH was assayed by rLH RIA. Media fractions represent LH secretion
during the 15 minute GnRH pulse period or the 75 minute inter-
pulse period.
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Although no difference in the amount of LH secreted from control and
GnRH-treated cells was observed, a marked difference in the amount of LH





T S.E.M □ untreated
n=2 SUB 10"6M GnRH treated
Figure 6.3.7.f: Storage, of LH by control and 10"6M GnRH-treated
LPT2 cchs at the end of day four during a 4 pulses per day regime.
LH present in lysates was assayed by rLH R1A. Lysates were
harvested after a total of 16 10 6M GnRH pulses in treated cells.
Where *=p<0.05.
Furthermore increased LH release was apparent during the overnight
incubations. Whereas untreated cells secreted 19±1.5ng LH per 107 cells in
17 hours over the 3 nights, cells treated with lpM GnRH secreted on
average 27.5±0.7ng during the same 17 hour periods which is significantly
greater (p=<0.001) as shown below in figure 6.3.2g.
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mGnRH-R mCgA mSgll mCgB
Figure 6.3 2h: Effect of GnRH on expression of GnRH-R and granins in LPT2 cells detected by RT-PCR
i) GnRH-R expression was detected by the appearance of the amplified product corresponding to the
predicted size of 370bp The band is present in both untreated (C) and LPT2 cells which received lOnM
GnRH pulses 4 times daily over four days (gl). No products were detected in the control
reaction which contained no RNA (b). (ii) Sc (iii) CgA, Sgll and CgB expression was detected by the
appearance of amplified products corresponding to the predicted sizes of 295, 350 and 230bp Similar
size products were detected in reactions containing RNA from LpTo cells after no treatment (C), after
4 days of four lOnM GnRH pulses (gl) and after 4 days of four lpM GnRH pulses (g2) These products
were also present in reactions which contained mouse pituitary RNA (mP). No products were detected
in the control reactions which contained no RNA (b)
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Figure 6.3.2g: Effect of 10 6M GnRH treatment on LH secretion by
LpT2 cells during 17 hour overnight incubations.
Media from untreated L|iT2 cells and L[3T2 cells treated with 1 (>6M
GnRH four times per day were isolated 17 hours after the last pulse
each day. The data represents the mean LH determined after days 1,
2 and 3 of the four day regime by rLH RIA.
RT-PCR detected CgA, CgB, Sgll and GnRH-R mRNA before and after
treatment with either 10~6 or 10~8M GnRH (see figure 6.3.3h). Although
these reactions were not carried out using primers amplifying an internal
control such as GAPDH, these results indicate that specific target RNA was
present in all samples.
6.3.3 Optimisation of Lipid-based Transfection
Initial attempts to transfect the LpT2 cell line did not provide significant
transfection efficiencies as illustrated by the photomicrograph of P-
galactosidase stained cells in figure 6.3.3ai. However repeated passaging of
the cell line using the diluted trypsin-EDTA solution resulted in
morphological changes which appeared to aid adherence to the culture
surface. Transfection of cultures after approximately 50 passages were
Figure 6.3.3a: LpT2 cells transiently transfected with pcDNA3 1/His/lacZ
and stained for p-galactosidase activity 48 hours later
i) Low passage LPT2 cells grow in clumps and transfect relatively poorly.
ii) LPT2 cells after approximately 55 passages exhibit greater adherence
to the culture surface and a higher transfection efficiency Magnification = x200.
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significantly more successful as shown by the photomicrograph in figure
6.3.3 ai i. This figure represents the optimal transfection efficiency
obtained after screening with the eight lipids in the PerFectT M
transfection kit (Invitrogen, NL) which provided the transfection
efficiencies shown below.
10
Pfx1 Pfx2 Pfx3 Pfx4 Pfx5 Pfx6 Pfx7 Pfx8
PerFect Lipid
Figure 6.3.3b: Transfection of LPT2 cells using PerFect lipids.
Cells were transfected in 12 well dishes for 3.5 hours using each lipid
mix at a 6:1 ratio to DNA. The proportion of cells expressing the
transfected lacZ gene (pcDNA3.1/His/lacZ) was determined 48 hours
posttransfection by (i-galactosidase staining. 1000 cells were counted
per well and the proportion stained blue represented the transfection
efficiency.
Transfection using Pfx3 provided the most efficient transfection of
approximately 9%. Lipids Pfx2, 6 and 8 also provided relatively high
transfection efficiencies in comparison to the remaining lipids and the
almost undetectable transfection of lower passage LPT2 cells (figure
6.3.3ai).
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6.3.4 Transient FSH Expression
As expected control LPT2 cells transfected with only the poaGSU construct
did not express FSH. Cells transfected with the poFSHPg construct alone
which therefore relied on endogenous aGSU expression to form the
heterodimeric FSHaji hormone, produced significant amounts of FSH as did
cells transfected with both poaGSU and poFSHfig constructs (figure 6.3.4a).
72hrs 48hrs 72hrs 48hrs 72hrs 48hrs 72hrs
none poaGSU poFSH|3g poFSHpg + poaGSU
Plasmids Transfected and Duration of Incubation
Figure 6.3.4a: Total oFSH expressed by L|3T2 cells transiently
transfected with either the oFSHj) subunit expression construct
alone or in conjunction with the ovine aGSU expression construct.
Cells were mock-transfected or transfected with the poaGSU alone.
FSH heterodimer formation was assessed in cells transfected with
only the oFSHfi subunit expression construct which therefore relied
upon endogenous murine aGSU. This was compared with cells
transfected with both the ovine aGSU and FSHp expression constructs
after 48 and 72 hours of expression.
Comparisons of the percentage of total oFSH which remained
intracellularly after 48-72 hours in cells transfected with either poFSHfig
alone or both poFSHflg and poaGSU revealed a significant difference
(figure 6.3.4b). Cells transfected with both ovine expression constructs
(intra-species hetcrodimcr) exhibited storage of only 26.7±2.9% compared
to 37.0±0.6% in cells expressing the inter-species FSH heterodimer.
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Figure 6.3.4b: Comparison of the proportion of FSH stored in LPT2
eells transfected with the oFSHp subunit alone or in conjunction with
the aGSU expression construct.
oFSH was assayed by RIA in the lysates and media of transiently
transfected cells after 48 or 72 hours. Cells transfected with the oFSFip
subunil expression construct alone required endogenous murine
aGSU to form the FSH heterodimer detectable by RIA. The data
represented in the bar chart represents the mean figures for the
proportion of the total oFSH which remained intracellularly after 48
and 72 hours in cells transfected with the p-subunit construct alone







The total amounts of oFSH expressed by LPT2 cells were compared between
transfections containing poaGSU in conjunction with poFSHp or poFSHPg
or pEGFPC3-oFSHp. The differences in oFSH detected are shown in figure
6.3.4c. Mock-transfected cells expressed little detectable oFSH as expected.
However cells transfected with the EGFP-oFSHp construct expressed similar
background levels of oFSH as detected by RIA. LPT2 cells transfected with
the ovine aGSU and oFSHp cDNA constructs exhibited significantly higher
expression than cells transfected with the ovine aGSU and genomic oFSHp
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constructs. This difference was apparent between samples taken after 48
and 72 hours.
48hrs 72hrs 48hrs 72hrs 48hrs 72hrs 48hrs 72hrs
none poFSHp poFSHpg pEGFPC-oFSHp
+ poaGSU + poaGSU + poaGSU
Plasmids Transfected and Duration of Incubation
Figure 6.3.4c: Total oFSH expressed by L[iT2 cells transiently
transfected with the aGSU expression construct and different oFSHfi
constructs.
oFSH was determined 48 or 72 hours posttransfection by RIA of lysates
and media. FSH detected in mock-transfected L(iT2 cells indicates the
level of background. The ovine FSHp cDNA construct exhibited
significantly higher expression than that of the genomic oFSHp
clone after 48 and 72 hours. No significant oFSH was detected in cells
transfected with the EGFPC-FSHp fusion construct.
Comparison between the percentage of total oFSH stored in cell transfected
with the poaGSU and either poFSHp or poFSHPg also revealed significant
differences. LPT2 cells transfected with the genomic clone for oFSHp
exhibited reduced storage in comparison to cells transfected with the cDNA
construct (figure 6.3.4d).
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Figure 6.3.4d: Storage of oFSH in transiently transfected LPT2 cells.
LPT2 cells were transiently transfected with either the cDNA or
genomic clone for oFSHp in conjunction with the oaGSU expression
construct. oFSH in media and lysates was measured by RIA after 48 or
72 hours. The percentage of total oFSH which was present
intracellularly was compared between cells transfected with either
oFSHp construct.
However the proportion of oFSH storage observed in cells transfected with
the aGSU and genomic oFSHp constructs also appears to have declined
between the experiments shown in figure 6.3.4b and d. This reduction
from 26.7±2.9 to 18.5±0.8 is statistically significant (n=4, p<0.05). It is
important to note that these investigations were carried out using the
same batch of LPT2 cells but after different numbers of passages. The
previous experiment investigating the secretion of hybrid FSH molecules
used cells after 44 passages whereas in the latter experiment the cells had
undergone 65 passages.
6.3.5 Intracellular Trafficking of FSH fusion proteins
LPT2 cells transiently transfected with the poaGSU and pEGFPC-oFSHp
constructs were viewed after fixing in Bouins. Although the cells appear
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Figure 6.3 .5a: Series of Z-scan images from LpT2 cells
transiently transfected with poaGSU and pEGFPC-oFSHp
Optical sections were taken through the Z-plane at 0.6|im intervals. The main picture shows
a clump of several LpT2 cells in which some are expressing the transfected constructs
Fluorescent bodies are presentwithin the cytoplasm towards the periphery of the cell These
putative vesicles range from 500nm (arrow) to 1 l^m (arrowhead) in diameter EGFP
fluorescence was observed in fixed cells 4S hours posttransfection using a 4SSnm argon laser
and 505-535nm bandpass filter
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Figure 6 3.5b: Gallery of time-lapse images of EGFPC-oFSHp fluorescence from
a transiently transfected LpTo cell
This rounded LPT2 cell exhibits punctate fluorescence ranging from 280-990nm in diameter
These fluorescent bodies exhibit apparently random movement within the Lp'i'2 cell. Images
were taken 48 hours posttransfection with poaGSU and pEGFPC-oFSHp. Scans were performed
at 15 second intervals. EGFP fluorescence was observed in fixed cells 48 hours posttransfection
using a 488nm argon laser and 505-535nm bandpass filter The fluorescence begins to fade
over time due to photobleaching
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poorly attached to the glass surface of the chamber slide, a serial Z-scan
revealed the presence of several areas of punctate fluorescence located
towards the cell periphery (figure 6.3.5a). These structures ranged from
approximately 500 to llOOnm in diameter.
Similar analysis of a living L|3T2 cells transfected with the same
combination of constructs demonstrated the rapid movement of these
fluorescent bodies (figure 6.3.5b and movie 6.3.5c). The individual images
within the series were taken at 15 second intervals demonstrating the
relatively rapid movement of the fluorescent bodies. It can be seen that
the direction of their movement appears to be largely random and to occur
sporadically.
6.4 Discussion
Studies on the control of endogenous LH expression from LPT2 cells were
hampered by the apparent transient nature of the LHP subunit gene
expression. LPT2 cells were derived from the mouse pituitary by targeted
expression of the SV40 T-antigen to LHp-expressing gonadotrophs (Thomas
et al., 1996). This popular method for deriving cell lines inhibits tumour
suppressing proteins responsible for maintenance of DNA integrity. The
SV40 T-antigen interacts with several of these proteins leading to
mutations which in time may cause uncontrolled proliferation. For
example binding of the T antigen to the hypophosphorylated form of pi 05-
RB which normally prevents cell proliferation by inhibiting expression
of the proto-oncogene c-myc, leads to unregulated cell proliferation
(Marshall, 1991). In isolated cell lines the SV40 T-antigen continues to be
expressed interfering with maintenance of the genomic structure. During
repeated passaging in culture the effects of the mutations arising due to T-
antigen expression may become apparent. In these studies several effects
were observed including most notably a drastic decrease in LHp mRNA
expression. Although this effect was without doubt the most detrimental to
these studies other effects were also apparent. CgA expression appeared
unchanged when analysed by RT-PCR but western analysis clearly showed
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reduced expression of the unprocessed protein suggesting increased
susceptibility to the processing enzyme prohormone convertase PCI. CgA
has been demonstrated as a substrate for PCI in the mouse
adrenocorticotroph AtT-20 cell line (Eskeland et al., 1996). It is also
possible that due to an accumulation of mutations in the CgA gene, the
mature protein exhibits structural anomalies which predispose it to a
lysosomal destination thus accounting for unchanged mRNA expression
and reduced immunoreactivity for CgA.
Significantly reduced storage of transiently expressed oFSH was also
apparent between passages 44 and 65. Although endogenous LH expression
appeared drastically reduced in passage 103 compared to that of passage 38,
the proportion of intracellular LH in the lower passage cells appeared
much higher which also suggests reduced storage with increasing
passage. Despite the putative effects of lower LH abundance within high
passage cells,
it is likely that reduced storage of LH and FSH was a direct effect of the
reduction in CgA abundance intracellularly. Certainly the role of CgA as a
mediator of LH sorting to the regulated pathway suggested by its
aggregative nature (Yoo & Albanesi, 1990a), interaction with membrane
proteins (Yoo, 1994) and colocalisation with LH in immature or condensing
vesicles (Watanabe et al., 1991) strongly implicates CgA as a key protein in
the regulated pathway. Exclusive in vitro aggregation of LH induced by
lysates containing CgA further implicates the granin in the gonadotroph
regulated pathway (Colomer et al., 1995). Evidence for a role of CgA in LH
and FSH aggregation in gonadotrophs is also suggested by their
colocalisation in large granules (Watanabe et al., 1991) demonstrating that
CgA may interact with both pituitary gonadotrophins. The reduced storage
of LH and FSH coinciding with an apparent reduction in expression of
intact CgA in L(3T2 cells implicates this granin in intracellular
accumulation of the pituitary gonadotrophins. To further substantiate
these preliminary findings future studies may involve targeted disruption
of CgA expression using antisense oligonucleotides in lower passage LPT2
cells. Alternatively treatment of LPT2 cells with dexamethasone which
upregulates CgA expression (Fischer-Colbrie et al., 1989) may reveal this
granin's effect on LH storage in vitro. Comparisons of granule
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morphology in rat gonadotrophs has demonstrated decreased diameter of
CgA-immunoreactive granules in castrated males compared to controls
(Watanabe et al., 1998b). Whether this directly effects LH storage may be
revealed by future studies using the LPT2 cell l'ne-
Morphological differences were also observed during these studies with an
overall change from round 'clumpy' cells to those with increased
adherence and neuron-like processes. Coupled with these morphological
changes was an increase in the rate of proliferation by approximately
two-fold which may have accounted for the significant rise in
transfection efficiency. Clearly this increase in transfection efficiency
aided studies of oFSHp expression but the relevance of any findings made
under these circumstances could be disputed in light of changes in LHP
and CgA expression. The initial attraction of the LPT2 cell 4ne was due to its
apparent regulated expression of LH secretion (Turgeon et al., 1996).
Nevertheless comparison of gene expression in low and high passage LPT2
cells may allow assignment of key proteins involved in formation of the
regulated secretory pathway. Use of differential display in which multiple
semi-specific RT-PCRs are carried out on cell lysates allows comparison of
gene expression by changes in mRNA profiles. Application of this
technique may not only reveal proteins involved in regulated secretion
but also gonadotroph-specific transcription factors.
Despite the aberrant expression of LHP and CgA in the LPT2 cell line after
repeated passage some significant findings regarding gonadotrophin
expression during GnRH stimulation were observed. The cells used during
the lOnM GnRH treatment were not in excess of 103 passages yet did not
exhibit LHP expression. However LPT2 cells analysed by western analysis
were derived from fully confluent cultures and hence were not
undergoing rapid growth which may explain their detectable LH
expression. During GnRH regimes cells were not plated at the same high
density as LPT2 cells tended to clump and detach from the culture surface
easily and this may have been exaggerated by the repetitive liquid
manipulations during this type of experiment. It is therefore likely that
the reduced LHP expression occurring as a result of high passage was
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compounded by a cell density effect such that cells undergoing growth
exhibited further reduction in LH(3 expression. It may also be noted that
expression of the LH(3 subunit may be derived from only a few mRNA
molecules due to the relatively long half-life of LH(3 mRNA demonstrated to
be approximately 44 hours (Bouamoud et al., 1992). aGSU mRNA was
detected in these cells and expression was clearly affected by application
of lOnM GnRH displaying a biphasic response. Over the three day
experiment a total of nine GnRH pulse were administered with maximal
stimulation of aGSU mRNA levels occurring after the second day or six
GnRH pulses. This result is in accord with observations made on aGSU
mRNA abundance in aT3-l cells treated with lOOnM GnRH continuously for
1 to 120 hours. This study also demonstrated maximal stimulation after 24
and 48 hour exposure after which aGSU mRNA levels were reduced (Windle
et al., 1990). Reduction of the aGSU mRNA abundance to levels equivalent
to those after day one suggests delayed negative regulation perhaps
mediated by a specific regulatory protein. Assignment of this protein may
be undertaken using differential display. It is important to recognise that
the changes in aGSU mRNA levels were not investigated with regard to
changes in free aGSU abundance. The aims of these studies were to
investigate the secretion of LH so that changes in aGSU expression should
be taken in this context. In the absence of detectable LH levels further
investigation of aGSU expression was deemed inappropriate to the aims of
the study. Future studies in which secreted LH may be detected will allow
any effects of changes in aGSU expression to investigated.
The use of LPT2 cells after reduced passage allowed the effect of application
of a higher dose of GnRH to be investigated. The relatively high dose of
lpM GnRH on LH secretion provided evidence for delayed stimulation of
the constitutive pathway. During administration of the lpM GnRH pulses
LH secretion appeared unchanged in comparison with untreated cells
suggesting that this level of basal secretion was obtained by a constitutive
pathway. The presence of a regulated pathway in these cells would have
been observed by an increased release of LH in GnRH-stimulated cells in
comparison to untreated cells (Turgeon et al., 1996). The high level of
GnRH repeatedly applied to the cells prevented accumulation of LH
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intracellularly as evidenced by the lack of increased secretagogue-
stimulated LH secretion. Furthermore intracellular LH was also reduced in
cells treated with lpM GnRH suggesting that untreated LPT2 cells contain
some LH within a releasable pool. This persistent basal level of LH
secretion and reduction in intracellular abundance correlates with an in
vivo study investigating the effects of continuous high-level application
of GnRH to ewes and suggests a level of basal LH secretion independent of
control by GnRH presumably occurring through a constitutive pathway
(McNeilly et al., 1991b). However a delayed effect of GnRH on this
constitutive LH secretion was observed during the relatively long
overnight incubations between the daily GnRH pulses. GnRH-treated cells
displayed a significantly greater amount of LH release during the 17 hour
periods in comparison to untreated cells. This low level LH secretion
immediately following a series of high-level GnRH stimulation may
represent an attempt to replenish the intracellular stores for future
regulated secretory episodes. However due to the repeatedly high dose of
GnRH applied, significant intracellular accumulation of LH may not occur.
A transcriptional mechanism for regulation of constitutive LH secretion
may exist. GnRH-R activation stimulates delayed PKC activity promoting
the MAP-kinase pathway leading to formation of the AP-1 complex for
which a binding site exists in the rLHp promoter (Shupnik, 1996b; Naor et
al., 1998). The apparent 'leakage' of LH from GnRH-stimulated cells
overnight must represent constitutive secretion in the absence of GnRH-
induced Ca++ fluxes. However the delayed nature of PKC activation may
account for the transcriptional effect of GnRH-R activation after a
prolonged interval. The reasons why this LH is not immediately diverted
from the constitutive to the regulated pathway so that stores may be
replenished are uncertain. It is likely that a threshold level of constitutive
LH secretion must be achieved in order to obtain sufficient LH to form
storage granules. Indeed constitutive secretion has been shown to precede
storage of LH in GH3 cells (Bielinska et al., 1994). As the initial
characterisation of the LPT2 ceL line demonstrated efficient augmentation
of LH stores during pulsatile administration of lOnM GnRH-R agonist
(Turgeon et al., 1996), it is likely that the 100-fold higher dose of GnRH
stimulates a predominantly secretory response with a reduced but not
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intracellularly evident by the lack of increased secretagogue-stimulated
LH secretion. Furthermore intracellular LH was also reduced in cells
treated with lpM GnRH suggesting that untreated LPT2 cells contain some
LH within a releasable pool. This persistent basal level of LH secretion and
reduction in intracellular abundance correlates with an in vivo study
investigating the effects of continuous high-level application of GnRH to
ewes and suggests a level of basal LH secretion independent of control by
GnRH presumably occurring through a constitutive pathway (McNeilly et
al., 1991b). However a delayed effect of GnRH on this constitutive LH
secretion was observed during the relatively long overnight incubations
between the daily GnRH pulses. GnRH-treated cells displayed a
significantly greater amount of LH release during the 17 hour periods in
comparison to untreated cells. This low level LH secretion immediately
following a series of high-level GnRH stimulation may represent an
attempt to replenish the intracellular stores for future regulated secretory
episodes. However due to the repeatedly high dose of GnRH applied,
significant intracellular accumulation of LH may not occur.
A transcriptional mechanism for regulation of constitutive LH secretion
may exist. GnRH-R activation stimulates delayed PKC activity promoting
the MAP-kinase pathway leading to formation of the AP-1 complex for
which a binding site exists in the rLHp promoter (Shupnik, 1996b; Naor et
al., 1998). The apparent 'leakage' of LH from GnRH-stimulated cells
overnight must represent constitutive secretion in the absence of GnRH-
induced Ca++ fluxes. However the delayed nature of PKC activation may
account for the transcriptional effect of GnRH-R activation after a
prolonged interval. The reasons why this LH is not immediately diverted
from the constitutive to the regulated pathway so that stores may be
replenished are uncertain. It is likely that a threshold level of constitutive
LH secretion must be achieved in order to obtain sufficient LH to form
storage granules. Indeed constitutive secretion has been shown to precede
storage of LH in GH3 cells (Bielinska et al., 1994). As the initial
characterisation of the LPT2 cell line demonstrated efficient augmentation
of LH stores during pulsatile administration of lOnM GnRH-R agonist
(Turgeon et al., 1996), it is likely that the 100-fold higher dose of GnRH
stimulates a predominantly secretory response with a reduced but not
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abolished effect upon LH(3 transcription thus preventing sufficient
intracellular accumulation of LH to form a regulated pathway. Recent use
of antisense molecules directed at Rab3B have demonstrated its importance
in both regulated and constitutive secretion form gonadotrophs (Tasaka et
al., 1998). Similar application of this technique to LPT2 cells chronically
treated with GnRH may prevent release of low levels of LH leading to
intracellular accumulation. Ultrastructural examination of these cells may
determine the threshold of LH required to form the dense-core secretory
granules representative of the regulated pathway.
Transfection of LPT2 cells was only achieved using passage numbers in
excess of 55 reflecting an increase in adhesion and rate of proliferation.
Without this beneficial side of passage-induced change no data on oFSH
expression would have been obtained. FSHp dimerisation with endogenous
aGSU or that derived from expression of poaGSU resulted in secretion of
FSH. However significant differences in storage profiles between cells
expressing the ovine and inter-species molecule suggests preferential
retention of the inter-species FSH heterodimer. This data is particularly
interesting in light of studies carried out on oLHp/oFSHp transgenic mice
that overexpress the oFSHp gene (P.Brown - in press) and therefore also
form an inter-species FSH heterodimer (see chapter 7). Overexpression of
the oFSHp gene increased intracellular levels of FSH to four times the level
of mFSH. This inter-species FSH heterodimer did not appear significantly
different in size when compared to the endogenous mFSH molecule
suggesting that differential glycosylation did not play a role in this
phenomenon. Analysis of the colocalisation of LH and FSH in this
transgenic model suggests that overexpression of oFSHp leads to increased
colocalisation of the gonadotrophins within peripheral areas of the
gonadotroph normally exclusive to LH (see chapter 7). These data suggest
that storage of the inter-species FSH molecule occurs both in vitro and in
vivo and that this may occur more efficiently than storage of oFSHa(3 in
vitro. The mechanisms by which this occurs remain to be determined but
they may involve slower intracellular transit time of the inter-species
heterodimer due to less efficient dimerisation which predisposes FSH to
sorting into the regulated pathway. A reduced rate of dimerisation
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between subunits of LH in comparison to those of CG has been
demonstrated and may represent a possible mechanism for the more
efficient storage of LH in transfected GH3 cells (Muyan et al., 1996).
Dimerisation of FSH has been reported to occur at a rapid rate similar to
that of CG in vitro (Matzuk et al., 1989). However the studies detailed in this
thesis have been carried out using the oFSH(3 gene without its native 3' UT
region which allows higher FSH expression (Mountford et al., 1992). It is
likely that cells with basal levels of aGSU expression form the FSHa(3 less
efficiently than cells which have been cotransfected with the poaGSU
expression construct and therefore express aGSU levels equivalent to those
of oFSHfL Furthermore although cells transfected with only the poFSHPg
construct may express significantly lower amounts of FSH dimer,
individual cells may express much higher amounts of the oFSHp subunit
due to its exclusivity within the transfection mixture. In these cells the
oFSHp subunit may have been more likely to exceed the abundance of
endogenous dimerisation rate-limiting aGSU thus decreasing the amount
of FSH dimer formed. However this 'loitering' of the oFSHp subunit within
the ER and trans-Golgi network (TGN) may potentiate sorting of the FSHa p
dimer to the regulated pathway.
Further analysis of transient oFSH expression in LPT2 cells revealed that
the construct containing the oFSHp cDNA resulted in significantly greater
expression levels than those obtained with the genomic clone. This
difference may have arisen due to the presence of intronic regulatory
sequences although these have yet to be characterised. In light of the
differences in level of expression the greater proportion of oFSH stored in
cells transfected with the cDNA construct in comparison to the genomic
construct suggests that aggregation may be caused by high level
expression and lead to increased storage. These results are not definitive as
further investigation must be carried out to assess whether an
intracellular pool does exist and whether it is releasable under
secretagogue stimulation. These results contrast with similar experiments
carried out on Chinese Hamster ovary (CHO) cells (see chapter 5) which
demonstrated reduced oFSH storage in cells transfected with the aGSU and
oFSHp genomic clone despite higher expression than that obtained with
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the cDNA construct. CHO cells unlike LPT2 cells do not endogenously
express granins and therefore may not benefit from their aggregative
properties which may promote sorting of abundant gonadotrophins to a
regulated pathway.
Expression of the EGFPC-oFSHp fusion protein was not detectable by oFSH
RIA in the lysates or media of transfected cells presumably due to masking
of the epitope. This was also the case for transiently transfected CLIO cells
(see chapter 5) suggesting that this effect was not cell-specific. Confocal
analysis of transiently transfected LPT2 cells demonstrated that the fusion
protein had been packaged into discrete intracellular bodies of
comparable size to regulated secretory granules. It is not clear from these
analyses whether the intracellular bodies indeed represent FSH within the
regulated pathway in vitro. Observation of EGFPC-oFSHp fluorescence in
living cells demonstrated rapid movement of the putative vesicles.
Furthermore these vesicles exhibited the apparently random movement
previously associated with microtubule-dependent transport of
fluorescently-tagged CgA in Vero cells (Wacker et al., 1997). This suggests
that the EGFPC-oFSHp subunit had dimerised with aGSU as no reports of
free p-subunit packaging exist. In the gonadotrophs of castrated rats
where P-subunits abundance is greater than that of the aGSU, the former
are retained in the endoplasmic reticulum (ER) and eventually degraded
(Bassetti et al., 1995). It is therefore likely that free EGFPC-oFSHp would also
be retained in the ER if dimerisation did not occur and that this would
eventually be followed by lysosomal breakdown.
Real-time observation of secretagogue-stimulated release of these vesicles
will require a perfusion chamber accessory for the confocal microscope.
This may allow verification that these fluorescent bodies do indeed
represent granules of the regulated pathway. Observation of two
fluorescent protein fusions in the same cell may be possible using the
enhanced yellow fluorescent protein (EYFP) which has different
excitation and emission spectra to EGFP. Expression of both gonadotrophin
P-subunits each labelled with a different fluorophore may allow real-time
observation of the differential sorting of LH and FSH.
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Similar experiments undertaken using CHO cells (see chapter 5) have also
demonstrated vesicle formation with similar characteristics. This is
surprising due to the assumed lack of molecular machinery required for
regulated pathway formation. There are at least two scenarios that may
explain these findings. The first is that the fluorescent vesicles present in
both transiently transfected CHO and LPT2 cells represent the constitutive
secretory pathway. This may be verified by stimulation of transfected cells
with a suitable secretagogue during real-time observation. The second is
that the presence of EGFP stabilises the gonadotrophin dimer which allows
preferential self-aggregation independently of more conventional granin
mediated means. Future experiments may benefit from novel destabilised
EGFP variants (Clontech, USA) which may contribute less structural
stability to the P-subunit structure and therefore reduce the opportunity
for self-aggregation.
These studies have demonstrated the complexity of the LPT2 ceH line.
Although initially shown to express LH in a regulated manner (Turgeon et
al., 1996), these studies have been hampered by the apparent transient
nature of LHp expression. This basal level of LHP expression appeared to
decrease after repeated passage in culture. Furthermore the coincidental
decrease in intact CgA abundance intracellularly appeared to reduce the
storage ability of the cells.
Two important responses to pulsatile GnRH administration have been
demonstrated. Firstly, that in accordance with observed effects in the aT3-
1 cell line (Windle et al., 1990), aGSU mRNA abundance peaks after 48
hours of stimulation with lOnM GnRH and falls thereafter. Perhaps more
relevant to this thesis is the observation of a persistent level of basal LH
secretion similar to that observed in ewes (McNeilly et al., 1991b) which
may be transcriptionally upregulated in a delayed fashion after pulsatile
administration of a higher lpM GnRH dose. This effect appeared after one
day (4 pulses) of GnRH treatment and was maintained over a three day
period. This increased expression of LH was not sufficient to enter the
regulated pathway suggesting that a threshold for regulated secretion may
occur. This is particularly important as it suggests a mechanism whereby
low level expression of gonadotrophins such as FSH may result in
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constitutive secretion despite similar protein structure to LH which is
secreted primarily but not exclusively via the regulated pathway.
Transient transfection studies also revealed data regarding expression of
oFSH in the LPT2 ceH Lne. High expression of the oFSH subunits leads to a
significantly greater proportion of oFSH remaining intracellularly after
48-72 hours suggesting that in granin-expressing LPT2 cells a
concentration-dependent sorting mechanism may exist. Furthermore the
observed decrease in intact CgA abundance intracellularly may account
for the reduction in oFSH storage observed during experiments carried out
on cells after different lengths of passage.
Overall the findings of these studies have strengthened the hypothesis
that differential sorting of gonadotrophins occurs due to differences in
their intracellular abundance thus influencing their aggregation which





Studies covered previously within this thesis have been undertaken
completely in vitro. As a means of comparison, investigation of
gonadotrophin expression in mouse pituitaries will be carried out.
Although predominantly ovine and bovine genes were used during i n
vitro investigations, murine tissue will be used for two reasons. Firstly,
murine tissue is readily available and easily obtained. Secondly and more
importantly, a transgenic mouse model relevant to these studies has been
engineered (P.Brown et al - paper submitted).
The transgenic mouse developed by Brown et al contains the oFSH(3 gene
under control of the oLHfi promoter. Furthermore to counteract the
negative posttranscriptional regulation of the oFSHp mRNA the 3' UT of the
molecule was replaced with the HSV-IE polyadenylation signal. The
objective of this oLH(3/oFSHp construct was to drive high level expression
of oFSHp comparable to that of oLHP exclusively in gonadotrophs. This
construct is similar to the oFSHp expression construct poFSHPg used in the
previous chapters (see section 3.2.3) except that the plasmid construct
directs oFSHp via the CMV promoter instead of the oLHP sequence.
Comparison of expression by these essentially similar constructs in vitro
and in vivo may yield important data regarding the intracellular
trafficking of FSH in these systems.
Use of in vivo models to study complex interaction of intracellular
molecules has the advantage of presenting a functional system complete
with all the necessary molecular machinery. Previously described use of
cell lines (chapters 4, 5, and 6) has required additional gene expression in
order to create a model equivalent to the in vivo gonadotroph. Although
such an approach may be useful in assigning roles to individual proteins,
it may not allow the study of interactions between many proteins in the
presence of as yet uncharacterised factors. For this reason analysis of in
vivo murine gonadotrophs will be undertaken.
The use of confocal microscopy has already been demonstrated in this
thesis as a powerful tool for dissection of intracellular interactions.
Stereological aspects of pituitary gland anatomy with respect to spatial
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orientation of gonadotrophs and their close relationship with lactotrophs
requires extensive serial sectioning of pituitary tissue. Confocal
microscopy obviates the need for preparation of 5pm sections due to the
ability to 'filter out' fluorescence from tissue above and below the optical
plane (figure 2.6.3a). This characteristic allows observation of relatively
thick sections and compilation of a series of images by optical sectioning.
The studies described in this chapter will include confocal analyses of
gonadotrophin and granin expression in the murine pituitary gland.
Analysis of the oLH(3/oFSH(3 transgenic model will also be carried out with
regard to the level of FSH expression intracellularly and its subcellular
localisation.
7.2 Methods
7.2.1 Extraction of Pituitary Glands
All animal manipulations were undertaken by Judith McNeilly and Pamela
Brown. Pituitaries were removed from adult male non-transgenic and
oLHp/oFSH(3 transgenic mice immediately post-mortem after being killed
by a Home Office Schedule 1 procedure using CO2. The pituitary glands
were then either placed in Bouins fixative (see Appendix I) for confocal
analyses or stored in liquid nitrogen.
7.2.2 Observation of Pituitaries
by Indirect Immunofluorescence
Essentially indirect immunofluorescence using intact pituitaries from
adult mice was performed as described for cell lines with some
modifications. Samples were maintained in an intact form and not mounted
until after all antisera and washes had been carried out. Antisera
applications and PBS washes were undertaken in microcentrifuge tubes.
Due to the intact structure of the pituitary gland all incubations of
antisera and PBS washes were extended so as to obtain maximal penetration
of the tissue. The method used was a modification of that described by
Thomas & Clarke (Thomas & Clarke, 1997). Incubation in Bouins fixative
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was extended to 5 hours after which tissue was stored at room temperature
in 70% ethanol. Rehydration of tissue was carried out by sequential
washing in 50% and 25% ethanol followed by PBS (Sigma-Aldrich, UK)
with each stage lasting approximately 1 hour. Permeabilisation and
blocking were carried out simultaneously in PBS containing 1% BSA
(Sigma-Aldrich, UK) and 10% normal Goat serum (SAPU, UK) with 0.3%
Triton X-100 (Sigma-Aldrich, UK) for 24 hours at 4°C with gentle agitation.
Addition of primary antisera was followed by incubation in the same
conditions for a further 72 hours. LH was detected using the monoclonal
bLH 518B7 antisera (J.Rosen, USA) diluted to 5pg/ml. FSH was detected
using the polyclonal M91 antisera (A.S.McNeilly, MRC CRB) at a 1:200
dilution whereas CgA antisera (R.Fischer-Colbrie, Austria) was diluted to
1:1000. After extended PBS washes secondary antisera diluted 1:20 in
blocking/ permeabilising buffer were added and incubated for 24 hours at
4°C with gentle agitation. After washing the samples were sectioned by
hand using a razor blade and dissecting microscope. Thick sections of
between 0.5 and 1.5 mm were mounted in Citifluor (UKC, UK) using Easiseal
adhesive chambers (Hybaid, UK) and glass coverslips. Slides were then
viewed immediately by confocal microscopy or stored in the dark at 4°C
until later visualisation.
Comparison of levels of FSH expression in negative and positive transgenic
pituitaries was undertaken using LH as a reference. Signal detected for
FSH in negative mice was adjusted using the amplification settings within
the LSM510 module software (Zeiss, UK) to match that of LH. Positive
pituitaries were then analysed while maintaining these settings so that
any changes in FSH abundance could be related to that of LH.
7.2.3 Western Analysis of Pituitary Extracts
Pituitaries stored in liquid nitrogen were removed and thawed at room
temperature. The tissue was then homogenised in lOOmM sodium carbonate
containing Complete™ protease inhibitor (Boehringer Mannheim, UK)
using a mini-pestle (Kontes, USA) and microcentrifuge tube.
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Electrophoresis under non-denaturing conditions (as described in section
2.5.7) was undertaken using either 10 or 20pg total protein (determined by
Bradford assay - see section 2.5.2) per lane in a 5% stacking and either a
7.5% or 10% resolving gel. Non-denatured marker proteins (Sigma-
Aldrich, UK) also run on the gel were separately stained using 0.1% Amido
black in 20% ethanol and 7% acetic acid. Detection of the transferred
proteins from pituitary samples was undertaken using the ECF kit
(Amersham, UK) in accordance with the manufacturers guidelines.
Primary antisera was used at the following dilutions. bLH518B7 (J.Rosen,
USA) was diluted to lpg/ml, M91 (A.S.McNeilly, MRC CRB) was used at a
1:1000 dilution and hSgll antisera (C-19; Santa Cruz Biotechnologies, USA)
was diluted to 0.5pg/ml. Detection of the fluorescent signal produced by the
conjugated secondary antisera was carried out using a STORM1" M
Phosphorlmager (Molecular Dynamics, UK) on blue fluorescence mode in
accordance with the manufacturers guidelines.
7.3 Results
7.3.1 Gonadotrophins and Granins in Normal Gonadotrophs
Preparation of whole pituitary glands from male mice for indirect
immunofluorescence showed excellent penetration of the tissue by the
antisera providing detectable signal throughout the tissue. Furthermore
the appearance of pituitary cells appeared undamaged in comparison to
semi-thick sections (data not shown). Complete preservation of blood
vessels and cells throughout the gland allowed their close relationship
with gonadotrophs to be observed.
Gonadotrophs identified by immunoreactivity for LH appeared either
alone or in clusters of 2-3 cells. All gonadotrophs appeared to be
bihormonal as FSH immunoreactivity showed a high degree of
colocalisation with that of LH. No monohormonal cells were observed
although the ratio of LH to FSH did not appear identical in all gonadotrophs
(figures 7.3.1a, b & c and movie 7.3.Id). Many gonadotrophs were
demonstrated to exist juxtaposed to blood vessels (figures 7.3.le and 7.3.lh).
The divergent subcellular localisation of LH and FSH is suggested by the
Figure 7.31a: Projection of LH and FSH immunoreactivity in a 12.8|rm series
of optical sections through a murine pituitary gland
LH immunoreactivity (i) is shown in red and FSH immunoreactivity (ii) in
green. The overlaid images (iii) demonstrate that peripheral areas of
gonadotrophs contain LH immunoreactivily exclusively. Colocalisation of LH
and FSH (yellow) occurs in the central cytoplasmic areas of the gonadotrophs,
'['his image was compiled from 21 optical sections of a pituitary tissue slice
approximately l-2mm thick. LH antisera (518B7) was used at 5ng/ml and
FSH antisera (M91) diluted 1:200 Secondary TRITC and FITC conjugates
were diluted 1 20 TRITC and FITC fluorescence were observed using 543nm HeNe






Figure 7.3 lb: Colocalisation of LH and FSH immunoreactivity in a 12 8pm optical
section through a murine pituitary gland
i) Overlay of LH immunoreactivity (red) and FSH immunoreactivity (green)
demonstrate that peripheral areas of gonadotrophs contain LH immunoreactivity
exclusively. Colocalisation of LH and FSH (yellow) occurs in the central
cytoplasmic areas of the gonadotrophs This image was compiled from 21 optical
sections of a pituitary tissue slice approximately l-2mm thick LH antisera (518B7)
was used at 5pg/ml and FSH antisera (M91) diluted 1 200 Secondary TRITC and FITC
conjugates were diluted 1 20 TRITC and FITC fluorescence were observed using
543nm HeNe and 48Snm argon lasers with 585nm longpass and 505 535nm
bandpass filters respectively.
ii) Colocalisation of pixels from LH-and FSH-immunoreactivity Overlay of
identical images would produce a red 45° line from the bottom left hand corner of
the graph. The thickness of the 45° line containing predominantly blue pixels
indicates that LH and FSH show moderate colocalisation
iii) Intense (red) LH-immunoreactivity appears distributed over a larger area of
the gonadotrophs than FSH-iiiimuiioieactivity (iv) depsite similar levels of
maximal fluorescence (artificially adjusted) This demonstrates that the absence of
FSH-immunoreactivity at the periphery of the gonadotroph is not due to a lower
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Figure 7.3-lc: Rotation of a Z-scan projection of LH and FSH
immunoreactivity in murine gonadotrophs.
Colocalisation of LH (red) and FSH (green) immunoreactivity is depicted by yellow All
gonadotrophs contain peripheral LH immunoreactivity with FSH colocalised within
more central regions of the cells. The 12 8pm thick projected image was derived from
21 serial optical sections This image was obtained from a pituitary tissue slice
approximately l-2mm thick LH antisera (518B7) was used at 5pg/ml and FSH antisera
(M91) diluted 1 200 Secondary TRITC and FITC conjugates were diluted 1 20. TRITC and
FITC fluorescence were observed using 543nm HeNe and 488nm argon lasers with
585nm longpass and 505 535nm bandpass filters respectively Bar = 10pm
2S1
Figure 7.3.le: LH and FSH immunoreactivity in a gonadotroph juxtaposed to a capillary
Panels (i)-(iii) contain the phase contrast TR1TC ( LH ) and FITC (FSH) images respectively
When overlaid these images produce the composite image depicted in panel (iv). The close
association of the gonadotroph with the blood vessel (marked * in panel (i)) is clearly
depicted The inset of panel (iv) shows the degree of colocalisation exhibited by LH and FSH
The thickness of the 45° line containing predominantly blue pixels indicates that LH and
FSH show moderate colocalisation. Overlay of identical images would produce a red 45° line
from the bottom left hand corner of the graph This image was obtained from a pituitary
tissue slice approximately 1 2mm thick. LH antisera (518B7) was used at 5pg/ml and FSH
antisera (M91) diluted 1 200 Secondary TRITC and FITC conjugates were diluted 1 20. TRITC
and FITC fluorescence were observed using 543nm HeNe and 488nm argon lasers with
585nm longpass and 505~535nm bandpass filters respectively
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Figure 7.3.If: Z-scan of a murine gonadotroph showing a semi-divergent
subcellular distribution of LH and FSH.
Images (i)-(iii) show dual indirect immunofluorescence of LH (red) and FSH (green) in
optical sections of an intact gonadotroph taken at 2pm intervals Image (ii) is split to show
the individual levels of FSH (iia) and LH (iib) These images are also represented graphically
in panels A ' and B\ LH immunoreactivity is clearly at the periphery of the gonadotroph
whereas FSH immunoreactivity appears predominantly in the central cytoplasmic areas
Some LH immunoreactivity is also present in the peri-nuclear area The semi-divergent
nature of LH and FSH immunoreactivity is depicted in the pixel distribution graph (C) which
shows no clear 45° line from the bottom left corner which would indicate colocalisation
However the two antigens are not completely segregated as this would be represented by an
absence of pixels in the centre of the graph This image was obtained from a pituitary tissue
slice approximately l-2mm thick LH antisera (51SB7) was used at 5ug/ml and TSH antisera
(M91) diluted 1 200 Secondary TRITC and FITC conjugates were diluted 1 20 TRITC and FITC
fluorescence were observed using 543nm HeNe and 4S8nm argon lasers with 585nm
longpass and 505-535nm bandpass filters respectively
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Figure 7.3 lg: LH and CgA immunoreactivity in a gonadotroph juxtaposed to a capillary
Panels (i)-(iii) contain the TRITC (LH) and FITC (CgA) and phase contrast images
respectively. When overlaid these images produce the composite image depicted in panel
(iv). Panels A' and B' show the intensity of TRITC and FITC fluorescence Panel C' shows
the colocalisation of pixels for LH and CgA L11 immunoreactivity appears throughout the
cytoplasm of the gonadotroph but particularly concentrated towards the plasma membrane
CgA shows distribution within the gonadotroph similar to that of LH but with less intense
fluorescence in the central cytoplasmic regions CgA-immunoreactivity is absent from the
plasma membrane region proximal to the blood vessel whereas LH-immunoreactivity
remains (arrow) LH and CgA exhibit colocalisation as depicted by the intensity of pixel
distribution within panel C'. In addition an outer area of lower colocalisation is apparent by
the blue pixels in the graph (overlay of identical images would produce a red 45° line from
the bottom left hand corner of the graph) Weak CgA-immunoreactivity is also present
within the cell opposite the gonadotrophs (arrowhead). This image was obtained from a
pituitary tissue slice approximately l-2mm thick LH antisera (318B7) was used at 3pg/ml and
CgA antisera was diluted 1 1000. Secondary TRITC and FITC con jugates were diluted 1 20
TRITC and FITC fluorescence were observed using 543nm HeNe and 488nm argon lasers with
585nm longpass and 505-535nm bandpass filters respectively
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red halo appearance of LH immunoreactivity when superimposed with FSH
immunoreacti vity and by the difference in distribution of
immunoreactivity despite similar fluorescent intensity (figure 7.3.1b). The
pixel distribution diagram shown in the inset of figure 7.3.1b indicates
that FSH and LH show moderate colocalisation. In a series of higher
magnification optical sections taken at 2pm intervals LH immunoreactivity
can clearly be seen to exist at the periphery whereas FSH is confined to
more central areas of the gonadotroph cytoplasm (figure 7.3.If).
Colocalisation of LH and FSH is demonstrated by the pixel distribution
diagram which indicates a semi-divergent relationship within this
gonadotroph.
CgA immunoreactivity also appeared to occur in gonadotrophs although
some faint staining was also observed in neighbouring cells, presumably
lactotrophs (figure 7.3.lh). Examination of the subcellular localisation of
LH and CgA revealed that although CgA immunoreactivity appeared
throughout the cytoplasm, it was particularly concentrated at the
periphery of the gonadotroph with LH. This relationship appeared
conserved around the gonadotroph plasma membrane except at the
interface between the cell and blood vessel (figure 7.3. lh). In this region
of the gonadotroph LH immunoreactivity predominates with a complete
absence of CgA. The pixel distribution diagram in figure 7.3. lh indicates
that the majority of LH and CgA immunoreactivity is colocalised (yellow
and green pixels). However the halo of blue pixels indicates a lesser degree
of divergence between these two proteins.
7.3.2 Gonadotrophins and Granins in
Gonadotrophs of Transgenic Mice
Pituitaries from positive male oLHp/oFSH(3 transgenic mice were analysed
by indirect immunofluorescence with regard to their expression of oFSH|i
(figure 7.3.2a). Initial observation of FSH immunoreactivity demonstrated
that it was localised exclusively to gonadotrophs as in negative mice. FSH
levels in gonadotrophs from negative mice were compared to those of
positive mice using the same pinhole, laser power and amplification
settings. Whereas LH and FSH levels were adjusted to appear equivalent in
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Figure 7.3.2a: Dual indirect immunofluorescence lor LH and FSH in non-transgenic and
oLHp/oFSHp transgenic mouse pituitary glands
Panels (i) and (ii) depict LH immunoreactivity in non-transgenic and oLHp/oFSHp transgenic
gonadotrophs respectively The levels of LH appear similar in both samples. FSH immunoreactivity
is depicted for non-transgenic and transgenic pituitary glands in panels (iii) and (iv) respectively
FSH abundance appears greater in the oLHp/oFSHp transgenic model compared to the
gonadotrophs of non-trangenic mice The overlaid LH and FSH images for the non-trangenic and
oLHp/oFSHp transgenic mice are shown in panels (v) and (vi) respectively The red halo of LH
immunoreactivity predominant in non-transgenic gonadotrophs is absent from all oLHp/oFSHp
transgenic gonadotrophs. The effect of increased FSH expression in the transgenic model is also
depicted by the pixel distribution graphs for non-transgenic (A) and oLHp/oFSHp transgenic (B)
gonadotrophs I.H and FSH exhibit moderate colocalisation in non-transgenic gonadotrophs
indicated by the relatively thick 45° line in A' The level of colocalisation in the transgenic model
appears increased as evident by the comparatively narrow and more intense pixel distribution The
angle of this line is also increased in the transgenic model reflecting the greater abundance of FSH
immunoreactivity in comparison to that of LH
This image was obtained from a pituitary tissue slice approximately l-2mm thick LH antisera
(51SB7) was used at 5pg/ml and FSH antisera (M91) diluted 1 20U Secondary TRITC and FITC
conjugates were diluted 1 20 TRITC and FITC fluorescence were observed using 543nm HeNe and
488nm argon lasers with 585nm longpass and 505 535nm bandpass filters respectively
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Figure 7.3.2b: Comparison of LH, FSH and Sgll expression in the pituitary glands of non-
transgenic and oLHp/oFSHp transgenic mice by PAGE under non-denaturing conditions.
i) LH was detected using monoclonal primary antisera (51SB7) at lpg/ml The LH dimer is
present at approximately 29kDa in accordance with its predicted molecular mass No
significant difference in size or abundance of LH was apparent between the non-transgenic
(NTg) and transgenic (Tg) samples. FSH was detected using the polyclonal M91 primary
antisera diluted 1:1000. The FSH dimer is present at approximately 33kDa in both NTg and Tg
pituitary samples.
FSH appears 4-fold more abundant in the Tg sample Both 10% acrylamide gels were loaded
with 20|*g total protein per lane ii) Sgll was detected using monoclonal hSgll antisera (C-19)
at 0 5pg/ml A single band was present in both NTg and Tg samples which corresponded to
approximately 75kDa. The Tg sample contained approximately 2-fold greater Sgll than the Nig
sample. lOpg total protein was loaded per lane. The resolving gel contained 7.5% acrylamide.
Fluorescent conjugates of secondary antisera (components of the ECF kit) were detected and
quantified using a STORM Phocphorlmager
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negative mice, FSH exhibited greater abundance over LH in transgenic
gonadotrophs and therefore over levels of FSH in normal gonadotrophs.
This is indicated by the differences between the pixel distribution
diagrams from non-transgenic and oLHp/oFSHp transgenic mice. In tissue
from non-transgenic mice where the fluorescent intensities from LH and
FSH immunoreactivity were adjusted to similar levels, the pixel
distribution forms a 45° line. In transgenic tissue the pixel distribution
forms a much steeper line reflecting an approximate 2-fold excess of
signal from the FSH (FITC) channel over the LH (TRITC) channel. In
addition the colocalisation of LH and FSH in the oLtip/oFSIip gonadotrophs
also appears altered. This is indicated by the comparatively narrow
distribution of pixels in the image from the transgenic pituitary compared
to that of the non-transgenic pituitary (figure 7.3.2a).
Pituitary content of LH, FSH and Sgll were also compared in normal and
transgenic mice by Western analysis after PAGE under non-denaturing
conditions (figure 7.3.2b). Quantification of the fluorescent signal from
each LH band (figure 7.3.2c) shows that LH levels appear essentially
unchanged between normal and transgenic male pituitaries.
100
Wild-type Transgenic
Source of Pituitary Gland
Figure 7.3.2c: Abundance
of LH in normal and
transgenic mouse pituitary
glands.
Protein was extracted frorr
pituitaries of adult male mice anc
20pg separated by PAGE undei
non-denaturing conditions. LF
abundance was determined using
the ECF kit (Amersham, UK) and
STORMtm Phosphorlmager.
However the abundance of total FSH in pituitary tissue derived from
oLHp/oFSHp transgenic mice appears approximately 3.8-fold greater than
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in negative mice (figure 7.3.2d). This level of increase is twice as large as
that observed by confocal microscopy. It is also important to note that
formation of the inter-species FSH molecule containing oFSH|) and maGSU
results in a heterodimer of equivalent size to that of the endogenous mFSH
(figure 7.3.2d).
Figure 7.3.2d: Abundance of
FSH in normal and transgenic
mouse pituitary glands.
Protein was extracted from
pituitaries of adult male mice and
20pg separated by PAGE under
non-denaturing conditions. FSH
abundance was determined using
the ECF kit (Amersham, UK) and a
STORMtm Phosphorlmager.
Wild-type Transgenic























The lack of significant change in LH levels was expected as was the
increased levels of FSH. However unexpectedly quantification of the
abundance of Sgll revealed an approximate 1.7-fold increase in abundance
of this granin in transgenic pituitaries compared to normal pituitaries
(figure 7.3.2e).
Figure 7.3.2e: Abundance
of Secretogranin II in normal
and transgenic mouse
pituitary glands.
Protein was extracted from
pituitaries of adult male mice and
lOpg separated by PAGE under
non-denaturing conditions. Sgll
abundance was determined using
the ECF kit (Amersham, UK) and a
STORM™ Phosphorlmager.
Wild-type Transgenic
Source of Pituitary Gland




The presence of entirely bihormonal gonadotrophs in both wild-type male
mice and oLH(3/oFSH(3 transgenic male mice suggests that overexpression
of oFSH(3 under control of the oLHp promoter exhibited complete
gonadotroph specificity. The tissue specificity of the oLH(3 promoter has
previously been demonstrated using a CAT reporter in transgenic mice
(Brown et al., 1993). The close association of gonadotrophs with capillaries
was demonstrated for the majority of gonadotrophs despite limitation of
phase contrast image collection to the cut surface. This association has
obvious biological consequences including exposure to systemic
regulatory factors such as GnRH and E2 and a direct path for release of
gonadotrophins into the bloodstream. The deliberate nature of the
interaction is suggested by the observation of the gonadotroph in figure
7.3.1b which appears at least partly, to wrap itself around the capillary
thus increasing the surface area via which systemic interactions may
occur. It is also interesting to note that in many of the gonadotrophs the
nucleus was located towards the blood vessel which may aid reception of
systemic factors which act via transcriptional responses.
The subcellular colocalisation of LH and CgA correlates with previous data
regarding their presence in large FSH-containing granules (Watanabe et
al., 1991). However the novel observation of their colocalisation at the
periphery of the gonadotroph suggests a role for CgA during shunting of
LH granules to the site of release. Most significantly CgA
immunoreactivity was absent at this site next to the capillary suggesting a
change in granule morphology perhaps to that of the smaller LH and Sgll
only subclass demonstrated to be preferentially released during the LH
surge (Watanabe et al., 1991; Currie & McNeilly, 1995; Thomas et al., 1998).
It is not clear what happens to CgA at this stage but it is likely that the
granin may be proteolytically cleaved by enzymes such as prohormone
convertase 2 (PC2) which has been demonstrated to interact with CgA
(Seidah et al., 1987). Subsequent conformational changes in the structure
of CgA may prevent immunodetection and facilitate the final stages of
granulogenesis prior to exocytosis. Future studies will undoubtedly benefit
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from antisera to granin-derived peptides with which this final stage of LH
secretion may be investigated.
The divergent subcellular localisation of LH and FSH is similar to that
reported in ewes treated with E2 (Thomas & Clarke, 1997). It is possible that
in males this effect is derived from metabolism of testosterone which may
be studied using castrate mice. However this may have negative effects on
CgA expression as reported in rats which leads to abnormal granule
morphology (Watanabe et al., 1998). Furthermore the biological
significance of what appears to be gonadotroph priming in male mice
remains uncertain promoting the direction of future studies towards that
of divergent subcellular gonadotrophin localisation in female mice during
the oestrus cycle. The intracellular behaviour of high levels of oFSHP
during the oestrus cycle of transgenic mice may reveal the secretory
mechanisms which result in the biological effects of increased litter size
compared to non-transgenic mice (P.Brown - personal communication). As
demonstrated by these studies using males, the divergent subcellular
localisation of LH and FSH in transgenic gonadotrophs where FSH is
overexpressed is abolished. This suggests that the colocalisation of LH and
FSH which does exist in normal gonadotrophs is promoted in this
transgenic line due to high level expression. This increased colocalisation
within gonadotrophs suggests that FSH is packaged into what are
exclusively LH-containing granules in normal gonadotrophs. To verify
this hypothesis secretagogue stimulated release of FSH at levels
comparable to LH may be undertaken. Further physiological
investigations of this transgenic line are currently underway (P.Brown -
personal communication). Fine detail from electron microscopy (EM)
regarding the granule morphology and colocalisation of LH and FSH as
well as granins in these transgenic gonadotrophs may yield compelling
evidence for significant entry of FSH into the regulated secretoiy
pathway.
Although these results suggest that FSH may enter the regulated pathway
as a result of increased expression, it is not clear what effect this has on
expression of granins in gonadotrophs. The localisation of CgA with LH at
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discrete subcellular locations suggests a specific role for CgA in LH
granule biogenesis. More specifically the absence of CgA colocalisation
with LH at the putative site for exocytosis next to the capillary suggests
that CgA does not participate directly in the final stages of LH secretion.
Previous reports have demonstrated LH colocalisation with CgA and Sgll in
larger granules but exclusively with Sgll in smaller granules (Watanabe
et al., 1991; Thomas et al., 1998). It may be likely that maturation of
granules occurs and that CgA is present during mobilisation of LH
granules but is either excluded immediately prior to the exocytosis or is
subject to proteolytic processing preventing immunodetection at the
release site. Although limitations regarding availability of primary
antisera prevented colocalisation studies of FSH and CgA it may be assumed
by the localisation of CgA to central cytoplasmic areas that some degree of
colocalisation with FSH occurs. It is likely that this perinuclear area
represents the location of the Golgi network and suggests that CgA has a
role in the early differential sorting of LH and FSH. The limited
availability of transgenic pituitaries prevented investigation of CgA
colocalisation with LH in this system. However the other key granin
implicated in LH secretion, Sgll, may have undergone changes in
expression as a result of increased intracellular FSH abundance. Although
the small sample size prevented statistical analysis of the comparative
abundancies, it is clear that Sgll abundance is increased in the transgenic
pituitary. However the Sgll antiserum was ineffective for indirect
immunofluorescence on whole pituitaries and thus prevented clarification
regarding the cell type in which Sgll appears to be upregulated. Sgll has
previously been reported to colocalise exclusively with LH in small
(200nm) granules and with LH, CgA and FSH in larger (500nm) granules. It
may be likely that as a result of increased FSH(3 expression promoting
colocalisation of FSH with LH, more small electron-dense granules are
formed. Although the mechanism of regulation has not been determined it
may be likely that Sgll expression is upregulated to meet the increased
requirement for small vesicles. A mechanism of positive feedback within
gonadotrophs may occur via changes in cytoskeletal elements caused by
the assumed increase in the abundance of granules.
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In conclusion these studies have demonstrated that confocal microscopy
on preparations of whole pituitaries allows visualisation of indirect
immunofluorescence in conjunction with collection of phase-contrast
images. It is this combination of semi-intact tissue preparation and the
multi-channel capabilities of confocal microscopy which have permitted
visualisation of the close relationship between gonadotrophs and blood
vessels. Dual labelling with antisera directed towards LH and FSH as well as
LH and CgA has demonstrated their subcellular localisations with regard to
each other. As previously demonstrated in ewes treated with oestradiol
(Thomas & Clarke, 1997), LH and FSH in the gonadotrophs of male mice
exhibit differential subcellular localisation with LH predominantly located
at the cell's periphery. Due to the preserved structure of the pituitary
gland blood vessels this relationship between LH and FSH was put in
context of the cellular end point of gonadotroph function that being
secretion into the juxtaposed capillary. LH appeared to concentrate in the
subplasmalemmal areas of the gonadotroph furthest from the blood vessel
suggesting a process of preparation prior to shunting around the cell
periphery to the site of release. Further detail regarding the role of CgA in
this process was suggested by its colocalisation with LH during the stages
leading to exocytosis. Notably however CgA appeared absent at the putative
site of release suggesting perhaps a regulatory role facilitated by its
proteolytic cleavage or perhaps recycling to aid sorting of newly
synthesised LH molecules. In the novel transgenic mouse model where a
stabilised form of the oFSHP mRNA is expressed under control of the LHp
promoter, levels of hybrid FSH 2 to 4-fold greater than in normal mice
were detected. This FSH appeared to migrate at a similar rate to that of
mFSH suggesting similar glycosylation of the respective subunits. Most
importantly this hybrid FSH appears to colocalise with mLH in the
subplasmalemmal area of gonadotrophs suggesting that high-level
expression of FSH is sufficient for its entry into the regulated pathway.
Future analysis of similar female transgenics may allow this altered
intracellular trafficking to be put in context of the oestrus cycle with
particular relevance to the impact on reproductive physiology.
Chapter 8
General Discussion
The approaches used during this thesis have involved both in vitro and in
vivo systems. This combination has proved successful as it has allowed
comparison of observations for each protein investigated in a variety of
systems. The initial choice of cell line was difficult, mainly due to the lack
of a suitable cell line. However, limited success was achieved using the
constitutively secreting JEG3 choriocarcinoma cell line. Other cell lines
with regulated secretory pathways such as the murine adrenocorticotroph
AtT-20, murine gonadotroph aT3-l and rat somatomammotroph GH3 cell
lines proved inappropriate for lipid-based transfection studies due to slow
growth rates and poor transfection efficiencies (data not reported). The
easily transfected CHO cell line enabled investigation of gonadotrophin
secretion in the presence of individual granins. Although these
transfections were transient, some interesting preliminary data regarding
an apparent upregulation of oLH expression by CgA and a reduction in oLH
storage by Sgll were obtained. In addition the use of confocal microscopy
enabled visualisation of LH colocalised with CgA and CgB at different stages
of secretion. Encouragingly the semi-divergent colocalisation of LH and
CgA in CHO cells also appeared to occur in murine gonadotrophs in vivo.
Finally a suitable gonadotroph cell line, LPT2 (Thomas et al, 1996) was
engineered during the course of these studies. Although use of this novel
cell line was hampered by transient LHP expression and poor adherence to
culture surfaces, three key observations were made. Firstly, upregulation
of aGSU expression by pulsatile GnRH administration peaked on the second
day of treatment before falling again in accordance with previous data
from the aT3-l cell line (Windle et al., 1990). Secondly, a relatively high
dose GnRH regime caused increased constitutive secretion of LH,
presumably via a transcriptional mechanism. This data correlates with
previous findings in ewes chronically treated with GnRH (McNeilly et al.,
1991). Thirdly, high passage LPT2 cells demonstrated an absence of CgA in
conjunction with a reduction in the proportion of LH remaining
intracellularly. This is further evidence which supports a role of this
granin during regulated secretion.
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The novel use of EGFP fusion proteins to study gonadotrophin secretion in
vitro provided exciting visualisation of FSH vesicle traffic in CHO and LPT2
cells. Although the carboxy-terminal EGFP structure appeared to enhance
aggregation of the FSH heterodimers in the absence of granins, this
technique enabled observation of movement and fusion of FSH granules
within a living cell for the first time. This important development in the
study of gonadotrophin secretion may in the future, allow real-time
observation of LH and FSH secretion in a single cell. This will require
engineering of an EGFP/oLHp construct which is capable of heterodimer
formation and may involve use of an amino-terminus fusion vector. In
addition some specialised equipment for confocal microscopy including
bandpass filters for distinction of EGFP and EYFP signals will be required
as their emission spectra differ by only 10-15nm.
Indirect immunofluorescence carried out on semi-intact murine pituitary
glands has for the first time enabled visualisation of LH and FSH or CgA in
gonadotrophs which were clearly juxtaposed to blood vessels. This
technique has confirmed the semi-divergent colocalisation of LH with FSH
(Thomas & Clarke, 1997) and LH with CgA (Watanabe et al., 1991) and
related them to the position of the nearby sinusoid. Although carried out
on untreated males this technique will be essential for observation of
colocalisation events during the oestrus cycle. Perhaps most significantly
of all this technique has allowed the visualisation of enhanced
colocalisation of LH and FSH in the oLHp/oFSHp transgenic model. This
suggests that 4-fold overexpression of FSH levels in gonadotrophs can lead
to FSH entering the small (>200nm) LH/Sgll/CSP-only granules (Thomas et
al., 1998) which occur at the periphery of the gonadotroph. Further EM-
based investigation carried out on females may reveal whether FSH is
colocalised with LH or is alone in similar FSH-only granules responding to
GnRH-induced [Ca++]j fluxes and E2 treatment in a similar manner to LH.
These results in conjunction with previously reported data have enabled
construction of the model for gonadotrophin secretion shown in figure 8a.
This model raises specific questions regarding differential gonadotrophin
secretion and the role of granins. In the remainder of this chapter these
questions and the strategies that might be used to address them will be
discussed.
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Figure 8a: A model for constitutive and
regulated gonadotrophin secretion.
Ql: Does the high rate of dimerisation prevent FSH sorting to the regulated
pathway?
Q2: If FSHp is expressed at high levels (i.e: equivalent to LHp), can it be
sorted to the regulated pathway?
Q3: Can LH be packaged directly into >300nm and <200nm secretory vesicles?
Q4: Do large granules mature into smaller LH-only granules and if so what
happens to the FSH?
Q5: Do large bihormonal granules contain IP3-Rs, SNAREs etc. and are they
capable of fusion with the plasma membrane?
Q6: What happens to CgA prior to LH release?
Ql: Do CgA/CgA-derived peptides enhance translation of LHP ?
Q8: Does SgH have a role during the fusion event?
Q9: Are Sgll-derived peptides produced by gonadotrophs and do they have an
autocrine effect on LH release?
Q10: What is the maximum capacity for constitutive release of LH/FSH and
are they the same and are they altered by granins?
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Several key points of gonadotrophin secretion are contained within boxes
in the model. Notably the rates of dimerisation for LH and FSH are
different and it has been proposed that this may represent a mechanism
whereby LH and FSH are differentially sorted (Muyan et al., 1994). The rate
at which inter-species FSH forms a heterodimer has not been investigated
in transiently transfected LPT2 cells or the oLHp/oFSHp transgenic model
despite increased storage in comparison to the intra-species FSH
heterodimers. This difference in the rate of dimerisation may still
represent the reason FSH is normally secreted via the constitutive
pathway. To resolve this question it may be necessary to engineer a
transgenic model in which high levels of an intra-species FSH
heterodimer are expressed. This model may also confirm the preliminary
findings from the oLHp/oFSHp transgenic model which suggest that FSH
enters the regulated secretory pathway when overexpressed. However it
still remains to be determined whether the increased colocalisation of LH
and FSH in this transgenic model truly represents FSH sorting to the final
stages of the regulated pathway. To answer this question ongoing studies
of the oLHp/oFSHp transgenic model may involve EM analysis during E2
treatment to observe whether FSH exhibits priming as reported for LH
granules in sheep (Thomas et al 1998). In addition it may be necessary to
sample hypophyseal blood during administration of pulsatile GnRH to
establish whether FSH exhibits the reported time-lag observed between
GnRH and LH release (Padmanabhan et al., 1997). This may indicate that
FSH is present within either similar or the same secretory vesicles as LH.
LH is present in at least two types of granule; the larger FSH-containing
and the smaller LH-only varieties (Watanabe et al., 1991). Do these
morphologically distinct granules represent two separate regulated
secretory pathways? If they do then this would imply that the larger
bihormonal granules are capable of fusion with the plasma membrane.
However if these granules represent the same secretory pathway this
would suggest that the larger granules condense and form the smaller LH-
only granules. In this scenario what happens to the FSH at the periphery
of the granule? In order to answer these questions two approaches may be
taken. Firstly an in vitro study of L(3T2 cells stably transfected with EGFP
and EYFP fusions of FSH and LH respectively. This system would enable
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real-time visualisation of FSH and LH transit through the regulated
pathway. Colocalisation in post-Golgi vesicles may be followed by
divergence closer to the plasma membrane. Real-time analysis of
transgenic animals expressing fluorophore fusion hormones has yet to be
reported. The presence of the fluorescent proteins on LH and FSH may
prevent their biological function and this could be verified by bioassay of
proteins secreted by cell lines. Targeting gene expression to gonadotrophs
in adults using adenoviral vectors or GnRH-polylysine transporters may
avoid disruption to reproductive development caused by the fluorescent
proteins. Primary culture of these genetically modified gonadotrophs may
enable real-time visualisation of LH and FSH secretion in a more
physiological context. The recent report by Tasaka et al demonstrated the
efficacy of inhibiting both constitutive and regulated secretion by
gonadotrophs in vitro through application of Rab3B antisense
oligonucleotides (Tasaka et al., 1998). Using this approach together with a
pulsatile GnRH regime it may be possible to observe an increase in the
proportion of smaller (more mature) LH granules. This observation would
suggest that in response to GnRH, gonadotrophin granules migrate
towards the plasma membrane and mature as they do so. If granules do
indeed mature in response to GnRH-R activation this would raise the
question of how this message is conveyed to the granule and the signal
converted into a cellular response? Since CgA has been observed on the
periphery of bihormonal granules (Currie & McNeilly - personal
communication) and has been demonstrated to bind the IP3-R (Yoo, 1994),
this granin is a leading candidate for effecting changes in granule
morphology. A possible mechanism for this may involve conformational
changes in CgA structure or the degree of aggregation in response to a
reduction in calcium concentration within the granule lumen. This
change may be facilitated through activation of the IP3-R calcium
channel by its agonist produced during GnRH-R activation. CgA unlike CgB
requires high calcium concentrations for aggregation and may therefore
be well-suited to a role where relatively small reductions in calcium
concentration are a signal.
Indirect immunofluorescence carried out on transfected CHO cells and
murine gonadotrophs demonstrated colocalisation of CgA with LH except at
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putative exocytosis sites. In CHO cells CgA-only granules were apparent
although not at peripheral areas of the cell. In murine gonadotrophs CgA-
immunoreactivity appeared absent from the subplasmalemmal areas
juxtaposed to the blood vessel. What happens to CgA prior to LH exocytosis
in vivo? At least two possibilities could account for the lack of CgA-
immunoreactivity immediately prior to LH exocytosis. Firstly, CgA may be
proteolytically digested within the granule thus altering its conformation
and requiring use of antisera directed at specific peptides. Secondly,
recycling of CgA and CgA-derived peptides may also occur. To establish
whether either of these hypotheses are correct antisera directed at CgA-
derived peptides may be used in immunohistochemical applications and
RIAs to determine the location of processed CgA in vivo.
The observed enhancement of oLH expression from CHO cells cotransfected
with the CgA expression construct and similar enhancement of hCG
expression suggests a possible interaction of CgA or CgA-derived peptides
during translation of these (3-subunit genes. By creating a transgenic
knockout of the CgA gene in mice it may be possible to observe the effects
of CgA removal on levels of LH expression as well as the formation of the
regulated secretory pathway. Recent work by Watanabe et al has
demonstrated a reduction in the diameters of CgA-positive granules
following castration (Watanabe et al., 1998). It is possible that a complete
absence of CgA in the gonadotroph may completely abolish granule
formation and therefore the regulated secretory pathway. Alternatively
stable transfection of the LPT2 cell line with antisense directed towards
CgA may be carried out as this may yield similar results more rapidly.
The colocalisation of Sgll and CSP with LH in granules which are
preferentially released during the LH surge (Thomas et al., 1998; Currie &
McNeilly, 1995) has led to speculation that Sgll has a role during fusion of
the granule with the plasma membrane. This hypothesis is strengthened
by a report which has observed that rat gonadotrophs lack the calcium
sensor synaptotagmin which is involved in fusion pore formation
(Jacobsson & Meister, 1996). To test this hypothesis a similar approach may
be taken to that described for the previous question. The generation of a
Sgll knockout and application of antisense technology to LPT2 cells may
determine a role for this granin in LH secretion.
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In addition the hypothesis that Sgll-derived peptides act on the
gonadotroph as a means of autocrine regulation which is perhaps
heightened during the LH surge may be tested by application of these
peptides to gonadotrophs either in vivo or in vitro. As a prerequisite for
this experiment it would be necessary to verify by RIA that Sgll-derived
peptides are released during the preovulatory LH surge. Investigation of
serum levels of Sgll in the oLH(J/oFSH(3 transgenic model may strengthen
the hypothesis that Sgll levels are raised in the gonadotroph during
increased regulated secretion.
The final question raised by this model relates to the constitutive secretory
pathway. As observed in LPT2 cells and ewes (McNeilly et al., 1991)
chronically treated with GnRH, LH like FSH can be released via the
constitutive pathway. Expression of LH and FSH at high levels enables
their entry into the regulated pathway in the presence of granins. Is
there a threshold of gonadotrophin expression that must be exceeded
before entry into the regulated pathway and it is the same for LH and FSH?
Also, is this threshold lowered by the presence of one or more granins?
Stable transfection of LPT2 cells with an inducible FSH expression system
may allow determination of this threshold. Determination of this putative
level for LH may require similar transfection of primary cultures of
gonadotrophs from the NGF1-A knockout mouse which does not express
endogenous LH (Lee et al., 1996).
In conclusion this thesis has demonstrated further evidence for the role of
granins during regulated secretion of gonadotrophins in vitro and i n
vivo. Transient transfection studies carried out on CHO cells have
suggested that CgB colocalises with LH in the Golgi apparatus only whereas
CgA also colocalises with LH in granules located in non-peripheral areas
of the cytoplasm. Additionally, CgA appears to exert significant
enhancement of oLH expression in cotransfected CHO cells suggesting an
interaction at the post-transcriptional level. Surprisingly cotransfection
studies involving oLH and Sgll suggested that this granin reduced the
amount of oLH storage in CHO cells. Use of the novel LPT2 ceH line has
demonstrated an increase in constitutive secretion of LH during chronic
GnRH treatment and reduction in the proportion of LH stored in the
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absence of intracellular CgA. Indirect immunofluorescence carried out on
male murine gonadotrophs in vivo has demonstrated a semi-divergent
relationship between CgA and LH where the granin appears to exit the
granule prior to exocytosis. Similar confocal analysis of the oLH(J/oFSH(3
transgenic model which expresses FSH at four times the wild-type level
has suggested that FSH entry into the regulated secretory pathway of
gonadotrophs may be enhanced by its overexpression.
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Siliconised Pasteur Pipettes (Sambrook et al 1989)
In a fume hood:
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